133
VYHLÁŠKA
Ministerstva zdravotnictví
ze dne 1. června 1998,
kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů
Ministerstvo zdravotnictví stanoví podle § 15 odst. 5 zákona č. 48/1997 Sb., o veřejném zdravotním pojištění a o změně a doplnění některých souvisejících zákonů:
Čl. I
Vyhláška č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění vyhlášek č. 109/1997 Sb., č. 131/1997 Sb., č. 220/1997 Sb., č. 317/1997 Sb. a č. 72/1998 Sb., se mění takto:
Oddíl B přílohy č. 2, v němž jsou uvedeny léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek, zní:
„Léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek
ODDÍL B
| 1 | A01AA | léčiva k profylaxi zubního kazu (fluorid sodný) | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.1 | MG | 0,90 | |||
| 00211 | NATRIUM FLUORATUM SLOVAKOFARMA | tbl 250x0.55mg | SLO | SK | |||||
| 2 | A01AB | protiinfekční léčiva pro lokální aplikaci | lok. | H | |||||
| 2.1 | A01AB08 | neomycin | lok. | 5 | GM | 623,90 | H | ||
| 78243 | BYKOMYCIN ORAL | plv por 10x1.3 mu | BGL | D | |||||
| 2.2 | A01AB10 | natamycin | lok. | 20 | MG | 8,10 | |||
| 88317 | PIMAFUCIN | gtt 1x20 ml 2,5% | YEL | NL | |||||
| 3 | A01AC | kortikosteriody pro lokální aplikaci | lok. | L/DER,STO, ORL | |||||
| 3.1 | A01AC01 | triamcinolon | lok. | 1 | GM | 14,00 | L/DER,STO, ORL | ||
| 03613 | KENALOG IN ORABASE | pst 5gm 0.1% | BMS | GB | |||||
| 3.2 | A01AC02 | dexametason | lok. | 1 | GM | 11,95 | L/DER,STO, ORL | ||
| 4 | A02A | adsorbční antacida | p.o. | ||||||
| 4.1 | A02AD | kombinace hliníku, vápníku a hořčíku (pevné lékové formy) | p.o. | 10 | DF | 7,75 | |||
| 00156 | GASTROGEL SLOVAKOFARMA | tbl 50x500mg | SLO | SK | |||||
| 4.2 | A02AD | kombinace hliníku, vápníku a hořčíku (tekuté lékové formy) | p.o. | 50 | ML | 7,75 | |||
| 5 | A02BA | antiulceróza ze skupiny H2-antagonistů | p.o. | ||||||
| 5.1 | A02BA01 | cimetidin | p.o. | 0.80 | GM | 4,30 | |||
| 87755 | CIMETIDINE CADILA | tbl obd 100x200 mg | CAD | IND | |||||
| 5.2 | A02BA02 | ranitidin do 150 miligramů včetně v jedné tabletě | p.o. | 0.30 | GM | 4,30 | |||
| 68857 | APO-RANITIDINE | tbl obd 60x150mg | APT | CND | |||||
| 96056 | RANISAN | tbl obd 30x150mg | PMP | CZ | |||
| 80541 | RANITIN 150 | tbl obd 100x150mg | TRT | IND | |||
| 96283 | ULCOSAN | tbl obd 30 | GNO | CZ | |||
| 91280 | RANITAL 150 MG | tbl obd 30x150 | LEK | SLO | |||
| 68857 | APO-RANITIDINE | tbl obd 60x150mg | APT | CND | |||
| 68843 | APO-RANITIDINE | tbl obd 500x150 | APT | CND | |||
| 5.3 | A02BA03 | famotidin do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 4,30 | |
| 75832 | APO-FAMOTIDINE 20 MG (LEKOVKA) | tbl obd 100x20 mg | APT | CND | |||
| 96193 | FAMOSAN | tbl obd 20x20 | PMP | CZ | |||
| 80537 | QUAMATEL 20 | tbl obd 28x20 mg | GED | H | |||
| 94207 | ULFAMID | tbl 20x20mg | KRK | SLO | |||
| 5.4 | A02BA04 | nizatidin | p.o. | 0.30 | GM | 4,30 | |
| 5.5 | A02BA06 | roxatidin | p.o. | 0.15 | GM | 4,30 | |
| 5.6 | A02BA07 | ranitidin bismut citrat | p.o. | 0.8 | GM | 30,70 | |
| 5.7 | A02BA02 | ranitidin nad 150 miligramů v jedné tabletě | p.o. | 0.30 | GM | 4,10 | |
| 80542 | RANITIN | 300 | tbl obd 100x300mg | TRT | IND | ||
| 5.8 | A02BA03 | famotidin nad 20 mg v 1 tabletě | p.o. | 40 | MG | 4,10 | |
| 67539 | ULCERAN 40 | tb. obd 500x40 mg | MOE | CY | |||
| 67537 | ULCERAN 40 | tb. obd 30x40 mg | MOE | CY | |||
| 67536 | ULCERAN 40 | tb. obd 10x40 mg | MOE | CY | |||
| 6 | A02BA | antiulceróza ze skupiny H2-antagonistů | parent. | H | |||
|---|---|---|---|---|---|---|---|
| 6.1 | A02BA01 | cimetidin | parent. | 0.80 | GM | 32,80 | H |
| 91782 | LOCK - 2E | inj. 5x2 ml | CAD | IND | |||
| 6.2 | A02BA02 | ranitidin | parent. | 0.30 | GM | 70,00 | H |
| 6.3 | A02BA03 | famotidin | parent. | 40 | MG | 70,00 | H |
| 7 | A02BB | antiulceróza ze skupiny prostaglandinů | p.o. | Z | |||
| 7.1 | A02BB01 | misoprostol | p.o. | 0.80 | MG | 55,00 | Z |
| 97404 | CYTOTEC | tbl 50x200rg | SEA | GB | |||
| 8 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | p.o. | L/GIT,INT | |||
| 8.1 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 28,00 | L/GIT,INT |
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 25,00 | L/GIT,INT |
| 56500 | HELICID | cps 14x20mg | LEX | CZ | |||
| 60160 | ULTOP | cps 14x20mg | KRK | SLO | |||
| 12507 | GASEC-20 | cps 14x20mg | MHA | CH | |||
| 53346 | GASEC-20 | cps 28x20mg | MHA | CH | |||
| 53345 | GASEC-20 | cps 7x20mg | MHA | CH | |||
| 8.3 | A02BC02 | pantoprazol | p.o. | 40 | MG | 25,00 | L/GIT,INT |
| 8.4 | A02BC03 | lansoprazol | p.o. | 30 | MG | 25,00 | L/GIT,INT |
| 9 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | parent. | H | |||
|---|---|---|---|---|---|---|---|
| 9.1 | A02BC01 | omeprazol | parent. | 20 | MG | 211,75 | H |
| 76644 | LOSEC 40 MG PRO INFUS. | inj sic 5x40 mg | AST | S | |||
| 10 | A02BX | ostatní léčiva peptického vředu | p.o. | ||||
| 10.1 | A02BX | ostatní léčiva peptického vředu (bismut subsalicylat) | p.o. | 3 | DF | 22,80 | |
| 10.2 | A02BX02 | sukralfát | p.o. | 4 | GM | 11,40 | |
| 91217 | VENTER | tbl 50x1 gm | KRK | SLO | |||
| 93131 | VENTER | gra 50x2gm | KRK | SLO | |||
| 10.3 | A02BX03 | pirenzepin | p.o. | 0.1 | GM | 8,75 | |
| 93547 | GASTROZEM | tbl 20x25mg | ALK | MAC | |||
| 10.4 | A02BX12 | bizmut subcitrát | p.o. | 0.48 | GM | 23,60 | |
| 11 | A02BX | ostatní léčiva peptického vředu | parent. | H | |||
| 11.1 | A02BX03 | pirenzepin | parent. | 20 | MG | 108,00 | H |
| 04395 | GASTROZEPIN | inj. 5x2 ml/10mg | BOE | D | |||
| 12 | A02DA | antiflatulencia a spasmolytika ATC skupiny A03A | p.o. | ||||
| 12.1 | A02DA01 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 11,50 | |
| 91846 | CEOLAT | tbl 20x80mg | KCH | D | |||
| 12.2 | A02DA01 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 22,10 | |
| 55950 | SAB SIMPLEX | sus 50x15ml(sacky) | PDA | D | |||
| 93500 | SAB SIMPLEX | sus 1x30ml | PDA | D | |||
| 93501 | SAB SIMPLEX | sus 4x30ml | PDA | D | |||
| 12.3 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 5,10 | |
| 12.4 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 5,10 | |
| 12.5 | A03AX58 | alverin | p.o. | 0.18 | GM | 5,10 | |
| 13 | A03AB | anticholinergika s kvarterní oniovou skupinou | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 13.1 | A03AB03 | oxyfenon | p.o. | 25 | MG | 2,35 | |||
| 13.2 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 12,70 | |||
| 13.3 | A03AB11 | poldin | p.o. | 12 | MG | 2,35 | |||
| 13.4 | A03AB20 trospium chlorid | p.o. | 40 | MG | 12,70 | ||||
| 12528 | SPASMEX 15 | tbl 50x15mg | PFL | D | |||||
| 14 | A03AD | muskulotropní spasmolytika | p.o. | ||||||
| 14.1 | A03AD01 | papaverin | p.o. | 0.1 | GM | 0,70 | |||
| 14.2 | A03AD02 | drotaverin | p.o. | 0.1 | GM | 5,05 | |||
| 02551 | NO-SPA | tbl 20x40mg | CHN | H | |||||
| 15 | A03AD | muskulotropní spasmolytika | parent. | ||||||
| 15.1 | A03AD01 | papaverin | parent. | 0.1 | GM | 18,35 | |||
| 03576 | PAPAVERIN SPOFA | inj. 10x2 ml/60 mg | SPX | CZ | |||||
| 15.2 | A03AD02 | drotaverin | parent. | 0.1 | GM | 25,90 | |||
| 02552 | NO-SPA | inj 5x2ml/40mg | CHN | H | |||||
| 16 | A03BA | alkaloidy beladony s terciální aminovou skupinou | p.o. | ||||||
| 16.1 | A03BA01 | atropin | p.o. | 1.5 | MG | 0,50 | |||
| 000444 | ATROPIN SPOFA | tbl 20x0.5mg | LEX | CZ | |||||
| 17 | A03BA | alkaloidy beladony s terciální aminovou skupinou | parent. | ||||||
| 17.1 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.5 | MG | 8,55 | |||
| 00394 | ATROPIN BIOTIKA 1MG | inj 10x1ml/1mg | HBS | SK | |||||
| 17.2 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.5 | MG | 16,60 | |||
| 00392 | ATROPIN BIOTIKA 0.5MG | inj 10x1ml/0.5mg | HBS | SK | |||||
| 18 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.o. | ||||||
| 18.1 | A03BB01 butylskopolamin | p.o. | 60 | MG | 10,00 | ||||
| 10154 | BUSCOLYSIN | drg 20x10mg | PMM | BG | |||||
| 19 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.rect. | |||||
|---|---|---|---|---|---|---|---|---|
| 19.1 | A03BB01 | butylskopolamin | p.rect. | 60 | MG | 15,00 | ||
| 20 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | parent. | |||||
| 20.1 | A03BB01 | butylskopolamin | parent. | 60 | MG | 37,65 | ||
| 03712 | BUSCOLYSIN | inj 10x1ml 20mg | PMM | BG | ||||
| 08668 | BUSCOLYSIN | inj 50x20mg | PMM | BG | ||||
| 08867 | BUSCOLYSIN | inj 100x20mg | PMM | BG | ||||
| 21 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.o. | |||||
| 21.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2 | DF | 3,75 | ||
| 21.2 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2 | DF | 3,75 | ||
| 88708 | ALGIFEN | tbl 20 | LEX | CZ | ||||
| 21.3 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2 | ML | 4,90 | ||
| 91981 | ALGIFEN | gtt 1x10ml 500mg/ml | GNO | CZ | ||||
| 22 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.rect. | |||||
| 22.1 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2 | DF | 10,15 | ||
| 91517 | ALGIFEN | sup 5 | LEX | CZ | ||||
| 23 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | parent. | |||||
| 23.1 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2 | DF | 52,60 | ||
| 88709 | ALGIFEN | inj 5x5ml | HBS | SK | ||||
| 24 | A03EA | spasmolytika, psycholeptika, analgetika v kombinaci | p.rect. | |||||
| 24.1 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2 | DF | 9,60 | ||
| 91261 | SPASMOPAN | sup 5 | LEX | CZ | ||||
| 25 | A03FA | prokinetika (cisaprid) | p.o. | L/GIT,INT,PDD,PSY | ||||
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, do 5 mg v 1 tabletě včetně) | p.o. | 30 | MG | 42,00 | L/GIT,INT,PDD,PSY | |
| 94898 | PREPULSID | tbl 30x5mg | JAN | B | ||||
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, od 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30 | MG | 39,95 | L/GIT,INT,PDD,PSY | |
| 94899 | PREPULSID FORTE | tbl 50x10 mg | JAN | B | ||||
| 25.3 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30 | MG | 35,95 | L/GIT,INT,PDD,PSY |
| 25.4 | A03FA02 | cisaprid (tekuté lékové formy) | p.o. | 30 | MG | 46,20 | L/GIT,INT,PDD,PSY |
| 93392 | PREPULSID | sus 1x200ml | JAN | B | |||
| 93393 | PREPULSID | sus 1x100ml | JAN | B | |||
| 26 | A03FA | prokinetika (ostatní) | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 26.1 | A03FA01 | metoclopramid | p.o. | 30 | MG | 4,25 | |
| 03376 | CERUCAL | tbl 50x10mg | VAD | D | |||
| 93104 | DEGAN | tbl 40x10mg | LEK | SLO | |||
| 26.2 | A03FA03 | domperidon | p.o. | 30 | MG | 4,25 | |
| 26.3 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 4,25 | |
| 27 | A03FA | prokinetika | p.rect. | ||||
| 27.1 | A03FA01 | metoclopramid | p.rect. | 30 | MG | 42,45 | |
| 09519 | PASPERTIN PRO INFANTIBUS | sup 5x10mg | KCH | D | |||
| 27.2 | A03FA02 | cisaprid | p.rect. | 30 | MG | 51,90 | |
| 93391 | PREPULSID | sup 6x30 mg | JAN | B | |||
| 27.3 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 42,45 | |
| 28 | A03FA | prokinetika | parent. | O | |||
| 28.1 | A03FA01 | metoclopramid | parent. | 30 | MG | 20,50 | O |
| 93105 | DEGAN | inj 50x2ml/10mg | LEK | SLO | |||
| 28.2 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,85 | O |
| 29 | A04AA | antiemetika ze skupiny serotoninových antagonistů | p.o. | X | |||
| 29.1 | A04AA01 | ondansetron (do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 960,50 | X |
| 29.2 | A04AA01 | ondansetron (nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 820,00 | X |
| 98177 | ZOFRAN | tbl 10x8mg | GLA | D | |||
| 29.3 | A04AA02 | granisetron | p.o. | 2 | MG | 820,00 | X |
| 29.4 | A04AA03 | tropisetron | p.o. | 5 | MG | 740,00 | X |
| 62529 | NAVOBAN | cps 5x5mg | SAN | CH | |||
| 30 | A04AA | antiemetika ze skupiny serotoninových antagonistů | parent. | X | ||||
|---|---|---|---|---|---|---|---|---|
| 30.1 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16 | MG | 1584,00 | X | |
| 80479 | ZOFRAN | inj 5x2ml/2mg/ml | GLA | I | ||||
| 30.2 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16 | MG | 1296,00 | X | |
| 80480 | ZOFRAN | inj 5x4ml/2mg/ml | GLA | I | ||||
| 30.3 | A04AA02 | granisetron | parent. | 3 | MG | 961,75 | X | |
| 30.4 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5 | MG | 850,00 | X | |
| 66849 | NAVOBAN | inj 10x5ml | SAN | CH | ||||
| 96863 | NAVOBAN | inj 1x5ml | SAN | CH | ||||
| 30.5 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5 | MG | 1370,75 | X | |
| 31 | A04AD | různá antiemetika | p.o. | |||||
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 | MG | 2,85 | ||
| 88321 | MEDRIN | tbl 20x25mg | LEX | CZ | ||||
| 31.2 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.1 | GM | 3,40 | ||
| 00320 | THEADRYL | tbl 10x100mg | LEX | CZ | ||||
| 32 | A04AD | různá antiemetika | p.rect. | |||||
| 32.1 | A04AD | různá antiemetika (theoklát moxastinu) | p.rect. | 0.1 | GM | 9,60 | ||
| 00951 | THEADRYL | sup 10x50mg | LEX | CZ | ||||
| 33 | A05AA | hepatika ze skupiny žlučových kyselin | p.o. | L/GIT,INF | ||||
| 33.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1 | GM | 21,95 | L/GIT,INF | |
| 94865 | CHENOSAN | cps 50x250mg | PMP | CZ | ||||
| 33.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 30,60 | L/GIT,INF | |
| 97864 | URSOSAN | cps 50x250mg | PMP | CZ | ||||
| 34 | A05AX | ostatní hepatika | p.o. | |||||
| 34.1 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3 | DF | 1,60 | ||
| 34.2 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5,65 | ||
| 93157 | ISOCHOL (DRAZOVKA) | drg 30x400mg | LEX | CZ | ||||
| 97881 | ISOCHOL (BLISTR 3X10) | drg 30x400mg | LEX | CZ | ||||
| 35 | A05BA | léčiva onemocnění jater | p.o. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4 | DF | 12,50 | |||||
| 35.2 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 6,60 | |||||
| 35.3 | A05BA03 | silymarin | p.o. | 0.21 | GM | 6,60 | |||||
| 04368 | FLAVOBION | tbl obd 50x70mg | LEX | CZ | |||||||
| 36 | A05BA | léčiva onemocnění jater | parent. | H | |||||||
| 36.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1 | DF | 47,75 | H | ||||
| 92325 | ESSENTIALE N | inj 5x5 ml | NAT | D | |||||||
| 36.2 | A05BA03 | silymarin | parent. | 0.35 | GM | 2093,60 | H | ||||
| 37 | A06A | osmoticky působící nevstřebatelné cukry | p.o., p.rect. | L/GIT,INT,GER | |||||||
| 37.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4 | DF | 299,90 | L/GIT,INT,GER, CHI | ||||
| 69482 | FORTRANS | plv 1x4 (sacky) | BEF | F | |||||||
| 37.2 | A06AD11 | laktulóza | p.o. | 6.7 | GM | 5,40 | L/GIT,INT,GER, PDD | ||||
| 02816 | LACTULOSA INFUSIA | sir 1x500 ml 50% | IHO | CZ | |||||||
| 86612 | LACTULOSA INFUSIA | sir 1x250 ml 50% | IHO | CZ | |||||||
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 3,80 | L/GIT,INT,GER | ||||
| 69052 | IMPORTAL | plv 50x10gm(sacky) | ZYM | CH | |||||||
| 37.4 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2 | DF | 178,00 | |||||
| 92489 | YAL | sol 10x67.5 ml | TRM | D | |||||||
| 38 | A07AA | střevní antimykotická léčiva | p.o. | ||||||||
| 38.1 | A07AA02 | nystatin | p.o. | 1.5 | MU | 6,10 | |||||
| 38.2 | A07AA03 | natamycin | p.o. | 0.3 | GM | 44,65 | |||||
| 02046 | PIMAFUCIN | tbl obd 20x100 mg | YEU | NL | |||||||
| 39 | A07EA | kortikosteroidy pro rektální aplikaci nebo působící v tlustém střevu | p.rect., p.o. | ||||||||
| 39.1 | A07EA03 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,70 | |||||
| 84000 | RECTODELT | sup 6x5mg | TRM | D | |||||||
| 84001 | RECTODELT | sup 6x10mg | TRM | D | |||||||
| 39.2 | A07EA03 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,70 | |||||
| 84003 | RECTODELT | sup 6x100mg | TRM | D | |||||||
| 39.3 | A07EA03 | prednison (od 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,35 | |
| 84002 | RECTODELT | sup 6x30mg | TRM | D | |||
| 39.4 | A07EA06 | budesonid | p.rect. | 2 | MG | 278,20 | L/GIT,INT |
| 39.5 | A07EA06 | budesonid | p.o. | 9 | MG | 140,00 | P |
| Léčbu perorálním budesonidem ordinuje gastroenterolog nebo internista v akutní atace, popřípadě v chronické fázi Crohnovy choroby, zejména tam, kde vzniká potřeba léčby steroidy a současně nutnost minimalizovat jejich systémové účinky. | |||||||
| 40 | A07EC | aminosalicylová kyselina a její deriváty | p.o. | L/GIT,INT | |||
|---|---|---|---|---|---|---|---|
| 40.1 | A07EC01 | sulfasalazin | p.o. | 2 | GM | 18,40 | L/GIT,INT,REV |
| 72968 | SALAZOPYRIN EN | tbl 100x500 mg | KBP | S | |||
| 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 29,60 | L/GIT,INT |
| 76479 | ASACOL | tbl obd 100x400mg | TLT | CH | |||
| 96057 | SALOZINAL | tbl obd 50x250 mg | PMP | CZ | |||
| 93235 | SALOFALK | tbl ent 100x250 mg | FAK | D | |||
| 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 47,50 | L/GIT,INT |
| 41 | A07EC | aminosalicylová kyselina a její deriváty | p.rect. | L/GIT,INT | |||
| 41.1 | A07EC02 | mesalazin | enm | 1.5 | GM | 87,35 | L/GIT,INT |
| 93770 | SALOFALK KLYSMEN | enm 7x60gm | FAK | D | |||
| 41.2 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.5 | GM | 146,15 | L/GIT,INT |
| 93239 | SALOFALK 250 | sup 30x250mg | FAK | D | |||
| 93238 | SALOFALK 250 | sup 10x250mg | FAK | D | |||
| 41.3 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.5 | GM | 126,20 | L/GIT,INT |
| 83135 | PENTASA | sup 28x1gm | FEI | DK | |||
| 42 | A07FA | protiprůjmové mikroorganismy | p.o. | L/PDD,GIT,GER | |||
| 42.1 | A07FA | protiprůjmové mikroorganismy | p.o. | 2 | ML | 3,95 | L/PDD,GIT,GER |
| 09158 | HYLAK FORTE | gtt 1x30ml | MCK | D | |||
| 09159 | HYLAK FORTE | gtt 1x100ml | MCK | D | |||
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou | p.o. | 4 | DF | 3,95 | L/PDD,GIT,GER |
| 42.3 | A07FA | protiprůjmové mikroorganismy (Escherichia coli) | p.o. | 1 | DF | 45,00 | L/PDD |
| 42.4 | A07BC | diosmectin (plv. susp.) | p.o. | 1 | DF | 3,95 | L/PDD |
| 43 | A09AA | enzymové přípravky | p.o. | |||||
|---|---|---|---|---|---|---|---|---|
| Léčbu Wobenzymem indikuje onkolog, chirurg nebo lymfolog u lymfedému po radikálních operacích pro malignitu. | ||||||||
| 43.1 | A09AA | enzymové přípravky (s pankreatinem, dle lipázy) | p.o. | 5000 | FI | 1,05 | ||
| 04139 | PANZYNORM FORTE | drg 30 | KRK | SLO | ||||
| 43.2 | A09AA | multienzymy (Wobenzym) | p.o. | 6 | DF | 15,00 | P | |
| 43.3 | A09AA02 | multienzymy (dle lipázy, do 10.000 FI v1 tabletě včetně) | p.o. | 5000 | FI | 1,50 | ||
| 02420 | PANCREOLAN FORTE | tbl ent 30x220mg | LEX | CZ | ||||
| 43.4 | A09AA02 | multienzymy (dle lipázy, nad 10.000 FI v 1 tabletě) | p.o. | 5000 | FI | 1,85 | ||
| 67418 | PANCREASE HL | cps 100 | CIL | CH | ||||
| 21362 | PANGROL 400 | tbl obd 48 | BCE | D | ||||
| 44 | A09AC | pepsin a kyselinotvorné látky | p.o. | |||||
| 44.1 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2 | DF | 2,85 | ||
| 45 | A10A | insuliny (rozpustné humánní) | parent. | L/DIA | ||||
| 45.1 | A10AA | insuliny (rozpustné humánní, 100 U/ml, cartridge) | parent. | 40 | U | 28,60 | L/DIA | |
| 76316 | VELOSULIN HM 100 UT/MLI | inj 1x10 ml/1ku | NOO | DK | ||||
| 75419 | INSUMAN HOECHST RAPID OPTIPEN | inj 5x3ml/300ut | HOE | A | ||||
| 76061 | ACTRAPID HM PENFILL | 5x3 ml/300ut | NOO | DK | ||||
| 92608 | HUMULIN R CARTRIDGE | 5x3 ml/300ut | LIL | F | ||||
| 90979 | ACTRAPID HM PENFILL | 5x1,5 ml/150ut | NOO | DK | ||||
| 96713 | HUMULIN N (NPH) CARTRIDGE | 5x1,5 ml/150ut | LIL | F | ||||
| 96732 | HUMULIN R CARTRIDGE | 5x1,5 ml/150ut | LIL | F | ||||
| 45.2 | A10AA | insuliny (rozpustné humánní, 40 U/ml) | parent. | 40 | U | 20,30 | L/DIA | |
| 97520 | HUMULIN R | inj 1x10ml/400ut | LIL | F | ||||
| 44576 | HUMULIN R 100 | inj 1x10ml/1ku | LIL | F | ||||
| 40878 | INSULIN-HM MIX 30 | inj 1x10ml/1 ku | LEX | CZ | ||||
| 40875 | INSULIN HN NPH | inj 1x10ml/1 ku | LEX | CZ | ||||
| 40876 | INSULIN - HM R | inj 1x10ml/1 ku | LEX | CZ | ||||
| 88345 | INSULIN ACTRAPID HM | inj 1x10ml/400ut | NOO | DK | ||||
| 75414 | INSUMAN HOECHST RAPID 40 UT/ML | inj 1x10ml/400ut | HOE | A | ||||
| 45.3 | A10AA | insuliny (rozpustné lisylinsuliny) | parent. | 40 | U | 33,80 | L/DIA | |
| 89133 | HUMALOG 40 IU | inj 1x10ml/400ut | LIL | F | ||||
| 45.4 | A10AA | Iinsuliny (rozpustné lisylinsuliny, 100 U/ml, cartridge) | parent. | 40 | U | 36,40 | L/DIA | |
| 46 | A10A | insuliny (rozpustné monokomponentní) | parent. | |||||
|---|---|---|---|---|---|---|---|---|
| 46.1 | A10AA | insuliny (rozpustné monokomponentní) | parent. | 40 | U | 13,50 | ||
| 83725 | INSULIN-MONO N | inj 1x10ml/400ut | LEX | CZ | ||||
| 47 | A10A | insuliny (suspenzní humánní) | parent. | L/DIA | ||||
| 47.1 | A10AA | insuliny (suspenzní humánní, 100 U/ml, cartridge) | parent. | 40 | U | 28,60 | L/DIA | |
| 75420 | INSUMAN HOECHST BASAL OPTIPEN | inj 5x3 ml/300 ut | HOE | A | ||||
| 75421 | INSUMAN HOECHST KOMB T15 OPTIPEN | inj 5x3 ml/300 ut | HOE | A | ||||
| 75422 | INSUMAN HOECHST KOMB T25 OPTIPEN | inj 5x3 ml/300 ut | HOE | A | ||||
| 75423 | INSUMAN HOECHST KOMB T50 OPTIPEN | inj 5x3 ml/300 ut | HOE | A | ||||
| 92604 | HUMULIN M2 (20/80) CARTRIDGE | inj 5x3 ml/300 ut | LIL | F | ||||
| 92605 | HUMULIN M3 (30/70) CARTRIDGE | inj 5x3 ml/300 ut | LIL | F | ||||
| 92607 | HUMULIN N (NPH) CARTRIDGE | inj 5x3 ml/300 ut | LIL | F | ||||
| 99400 | INSULATARD HM PENFILL | inj. 5x1,5ml/150ut | NOO | DK | ||||
| 99401 | INSULATARD HM PENFILL | inj. 5x3ml/300ut | NOO | DK | ||||
| 61169 | MIXTARD 10 PENFILL | 5x3 ml/300ut | NOO | DK | ||||
| 61168 | MIXTARD 20 PENFILL | 5x3 ml/300ut | NOO | DK | ||||
| 99408 | MIXTARD 30 HM PENFILL | 5x3 ml/300ut | NOO | DK | ||||
| 61167 | MIXTARD 40 HM PENFILL | 5x3 ml/300ut | NOO | DK | ||||
| 61166 | MIXTARD 50 HM PENFILL | 5x3 ml/300ut | NOO | DK | ||||
| 91162 | MIXTARD 10 PENFIL | 5x1.5ml/150ut | NOO | DK | ||||
| 61163 | MIXTARD 20 PENFILL | 5x1.5/150ut | NOO | DK | ||||
| 99407 | MIXTARD 30 HM PENFILL | 5x1.5/150ut | NOO | DK | ||||
| 61164 | MIXTARD 40 PENFILL | 5x1.5/150ut | NOO | DK | ||||
| 61165 | MIXTARD 50 PENFILL | 5x1.5/150ut | NOO | DK | ||||
| 47.2 | A10AA | insuliny (suspenzní humánní, 40 U/ml) | parent. | 40 | U | 20,30 | L/DIA | |
| 42468 | HUMULIN L | inj 1x10ml 40ut/ml | LIL | F | ||||
| 78283 | HUMULIN M2(20/80) | inj 1x10ml | LIL | F | ||||
| 78284 | HUMULIN M3(30/70) | inj 1x10ml | LIL | F | ||||
| 97521 | HUMULIN N | inj 1x10ml/400ut | LIL | F | ||||
| 78281 | HUMULIN U | inj 1x10ml 40ut/ml | LIL | F | ||||
| 44570 | HUMULIN M3(30/70) | inj 1x10ml/1ku | LIL | F | ||||
| 44567 | HUMULIN N 100 M.J./ML | inj 1x10ml/1ku | LIL | F | ||||
| 48 | A10A | insuliny (suspenzní monokomponentní) | parent. | |||||
| 48.1 | A10AA | insuliny (suspenzní monokomponentní) | parent. | 40 | U | 10,70 | ||
| 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | CZ | ||||
| 83727 | INSULIN-MONO ID | inj 1x10ml/400ut | LEX | CZ | ||||
| 83728 | INSULIN-MONO SD | inj 1x10ml/400ut | LEX | CZ | ||||
| 03992 | PUR-INSULIN-NEUTRAL LECIVA | inj 1x10ml/400ut | LEX | CZ | ||||
| 04128 | PUR-INSULIN-SUPERDEP LECIVA | inj 1x10ml/400ut | LEX | CZ | ||||
| 49 | A10BA | léčiva snižující hladinu cukru ze skupiny derivátů biguanidu a inhibitorů alfa-glukosidáz | p.o. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.1 | A10BA02 | metformin | p.o. | 2 | GM | 9,50 | |||||||
| 53961 | METFORMIN 850 LECIVA | tbl obd 50x850 mg | LEX | CZ | |||||||||
| 53960 | METFORMIN 500 LECIVA | tbl obd 100x500 mg | LEX | CZ | |||||||||
| 49.2 | A10BA03 | buformin | p.o. | 0.2 | GM | 3,80 | |||||||
| 02558 | SILUBIN RETARD | drg 60x100 mg | GRU | D | |||||||||
| 08498 | ADEBIT | tbl 40x50 mg | CHN | H | |||||||||
| 49.3 | A10BF01 | akarboza | p.o. | 0.3 | GM | 10,50 | |||||||
| 50 | A10BB | léčiva snižující hladinu cukru ze skupiny derivátů sulfonylmočoviny | p.o. | ||||||||||
| 50.1 | A10BB01 | glibenklamid (do 1mg v jedné tabletě včetně) | p.o. | 10 | MG | 2,35 | |||||||
| 91881 | MANINIL 1 | tbl 120x1mg | BCE | D | |||||||||
| 50.2 | A10BB01 | glibenklamid (nad 1mg v jedné tabletě) | p.o. | 10 | MG | 0,95 | |||||||
| 91783 | BETANASE | tbl 10x10x5mg | CAD | IND | |||||||||
| 94556 | GILEMAL | tbl 120x5mg | CHN | H | |||||||||
| 91880 | MANINIL 5 | tbl 120x5mg | BCE | D | |||||||||
| 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 1,40 | |||||||
| 94523 | GLUCOBENE | tbl 120x1.75mg | MCK | D | |||||||||
| 50.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 0,95 | |||||||
| 96870 | GLI-BASAN | tbl 120x3.5mg | SGW | D | |||||||||
| 94525 | GLUCOBENE | tbl 120x3.5mg | MCK | D | |||||||||
| 50.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,80 | |||||||
| 50.6 | A10BB03 | tolbutamid | p.o. | 1.5 | GM | 2,55 | |||||||
| 00120 | DIRASTAN | tbl 5x10x500 mg | SLO | SK | |||||||||
| 50.7 | A10BB04 | glibornurid | p.o. | 38 | MG | 4,90 | |||||||
| 50.8 | A10BB05 | tolazamid | p.o. | 1 | GM | 2,55 | |||||||
| 50.9 | A10BB07 | glipizid | p.o. | 10 | MG | 4,65 | |||||||
| 87110 | ANTIDIAB | tbl obd 30x5 mg | KRK | SLO | |||||||||
| 93333 | MINIDIAB | tbl 30x5 mg | LEX | CZ | |||||||||
| 50.10 | A10BB08 | gliquidon | p.o. | 60 | MG | 5,95 | |||||||
| 50.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 8,50 | |
| 04345 | DIAPREL (DIAMICRON) | tbl 60x80 mg | SVE | F | |||
| 50.12 | A10BB12 | glymepirid | p.o. | 2 | MG | 8,50 | |
| 51 | A11CA | vitamin A a jeho deriváty | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | kU | 1,20 | |
| 00347 | VITAMIN A SLOVAKOFARMA | cps 50x30ku | SLO | SK | |||
| 52 | A11CA | vitamin A a jeho deriváty | parent. | ||||
| 52.1 | A11CA01 | retinol (vitamin A) | parent. | 50 | KU | 12,40 | |
| 00396 | AXEROPHTHOL BIOTIKA | inj 5x1ml/50ku | BTA | SK | |||
| 53 | A11CC | vitamin D a jeho deriváty (kalcitriol) | p.o. | P | |||
| Léčbu ordinuje internista, endokrinolog, urolog, pediatr a lékař na dialyzační jednotce: a) léčba renální osteodystrofie u nemocných s chronickou renální insuficiencií (především u dialyzovaných nemocných), b) léčba křivice rezistentní na vitamin D, c) léčba osteomalacie rezistentní na vitamin D, d) léčba hypoparathyreózy rezistentní na léčbu vitaminem D a vápníkem. | |||||||
| 53.1 | A11CC04 | kalcitriol | p.o. | 1 | RG | 55,20 | P |
| 91548 | ROCALTROL | cps 30x0.25rg | HLR | CH | |||
| 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | ||||
| 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 | kU | 13,35 | |
| 00679 | INFADIN RYBI TUK | sol 100ml 0.1mg/1ml | SLO | SK | |||
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 | kU | 0,80 | |
| 00716 | INFADIN | gtt 1x10ml 10mg/1ml | SLO | SK | |||
| 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | kU | 0,55 | |
| 00353 | VITAMIN D SLOVAKOFARMA | cps 1x300ku | SLO | SK | |||
| 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 19,40 | |
| 54.5 | A11CC03 | alfacalciferol | p.o. | 1 | MG | 0,70 | |
| 54.6 | A11CC05 | cholecalciferol | p.o. | 0.5 | MG | 4,00 | |
| 12023 | VIGANTOL OEL | ole 1x10 ml 500 rg/ml | MEC | D | |||
| 55 | A11CC | vitamin D a jeho deriváty (kalcitriol) | parent. | P | |||
|---|---|---|---|---|---|---|---|
| Léčbu ordinuje internista, endokrinolog, urolog, pediatr nebo lékař pracující na dialyzační jednotce: léčba těžkých forem renální osteopatie nereagující na perorální léčbu kalcitriolem. | |||||||
| 55.1 | A11CC04 | kalcitriol | parent. | 1 | RG | 170,45 | P |
| 76423 | CALCIJEX | inj 25x1ml/2rg | ABB | USA | |||
| 94426 | CALCIJEX | inj 25x1ml/1rg | ABB | USA | |||
| 56 | A11CC | vitamin D a jeho deriváty (ostatní) | parent. | ||||
| 56.1 | A11CC01 | ergokalciferol | parent. | 6 | kU | 0,85 | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1ml/7.5mg | BTA | SK | |||
| 57 | A11DA | vitamin B1 a jeho deriváty | parent. | H | |||
| 57.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75 | MG | 5,90 | H |
| 57.2 | A11DA01 | thiamin (vit. B1) | parent. | 50 | MG | 5,90 | H |
| 00616 | THIAMIN LECIVA | inj 10x2 ml/100 mg | LEX | CZ | |||
| 92502 | THIABENE | inj 6x2 ml/100 mg | MCK | D | |||
| 70478 | VITAMIN B1 RATIOPHARM | inj 6x2 ml/100 mg | MCK | D | |||
| 58 | A11GA | vitamin C | parent. | H | |||
| 58.1 | A11GA01 | kyselina askorbová (vitamín C) | parent. | 0.2 | GM | 4,00 | H |
| 92729 | ACIDUM ASCORBICUM BIOTIKA | inj 5x5 ml/500 mg | HBS | SK | |||
| 59 | A11HA | vitamin B2, B6 a E | parent. | H | |||
| 59.1 | A11HA02 | pyridoxin (vitamín B6) | parent. | 0.16 | GM | 16,20 | H |
| 00584 | PYRIDOXIN LECIVA | inj 5x1 ml/50mg | LEX | CZ | |||
| 59.2 | A11HA03 | tokoferol (vitamín E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 72,95 | H |
| 59.3 | A11HA03 | tokoferol (vitamín E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,75 | H |
| 59.4 | A11HA04 | riboflavin (vitamín B2) | parent. | 20 | MG | 6,25 | H |
| 60 | A11JA | kombinace vitamínů | parent. | H | |||
| 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 124,20 | H |
| 94847 | VITALIPID N INFANT | inf 10x10 ml | KBP | S | |||
| 94846 | VITALIPID N ADULT | inf 10x10 ml | KBP | S | |||
| 61 | A12A | soli vápníku včetně kombinací vápníku a fluoru | p.o. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.1 | A12AA | vápník (na obsah vápníku) | p.o. | 0.5 | GM | 1,70 | |||||
| 99808 | BIOMIN H | plv 60x3 gm (sacky) | BMN | SK | |||||||
| 89786 | BIOMIN H | plv 30x3 gm (sacky) | BMN | SK | |||||||
| 61.2 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 0,60 | |||||
| 00064 | CALCIUM SLOVAKOFARMA | tbl 50x500 mg | SLO | SK | |||||||
| 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 2,60 | |||||
| 88663 | TBL.CALCII CARBONICI 0.5 GLO | tbl 100 | GAO | CZ | |||||||
| 61.4 | A12AA07 | chlorid vápenatý (tekuté lékové formy, na obsah vápníku) | p.o. | 0.2 | GM | 0,65 | |||||
| 00676 | CALCIUM CHLORATUM | sol 100 ml 10% | GNO | CZ | |||||||
| 61.5 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.5 | GM | 2,60 | |||||
| 61.6 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1 | DF | 5,50 | L/INT,GYN,ORT, REV | ||||
| 61.7 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1 | DF | 4,10 | L/INT,GYN,ORT, REV | ||||
| 62 | A12AA | soli vápníku | parent. | ||||||||
| 62.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3 | GM | 61,30 | |||||
| 00407 | CALCIUM BIOTIKA | inj 10x10ml/1gm | HBS | SK | |||||||
| 62.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.2 | GM | 3,05 | |||||
| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10 ml 10% | HBS | SK | |||||||
| 63 | A12BA | soli draslíku | p.o. | ||||||||
| 63.1 | A12BA | draslík v kombinaci s hořčíkem (na obsah draslíku) | p.o. | 1 | GM | 10,00 | |||||
| 76036 | TROMCARDIN FORTE | tbl obd 100 | TRM | D | |||||||
| 63.2 | A12BA | draslík (na obsah draslíku) | p.o. | 1.5 | GM | 2,50 | |||||
| 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,50 | |||||
| 91600 | KALNORMIN | tbl 30x1gm | IDA | H | |||||||
| 64 | A12BA | soli draslíku | parent. | O | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1 | DF | 13,50 | O | ||||
| 02132 | CARDILAN | inj 10x10 ml | HBS | SK | |||||||
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 51,70 | O | ||||
| 02486 | KALIUM CHLORATUM LECIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ | |||||||
| 65 | A12CC | soli hořčíku | p.o. | L/INT,NEU,PSY | |||||||
| 65.1 | A12CC | hořčík (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY, GYM | ||||
| 99891 | MAGNESIUM 250MG PHARMAVIT | tbl eff 20 | PVI | H | |||||||
| 65.2 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY, GYM | ||||
| 65.3 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY, GYM | ||||
| 65.4 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY, GYM | ||||
| 65.5 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY, GYM | ||||
| 65.6 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY, GYM | ||||
| 65.7 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,90 | L/INT,NEU,PSY, GYM | ||||
| 66 | A12CC | soli hořčíku | parent. | O | |||||||
| 66.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1 | GM | 23,45 | O | ||||
| 00498 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 10% | HBS | SK | |||||||
| 66.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1 | GM | 10,55 | O | ||||
| 00499 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 20% | HBS | SK | |||||||
| 67 | A12CD | soli fluoru | p.o. | ||||||||
| 67.1 | A12CD01 | fluorid sodný | p.o. | 88 | MG | 4,45 | |||||
| 09495 | OSSIN RETARDDRAGEES | tbl obd 100x40mg | GRU | D | |||||||
| 68 | A14A | anabolické steroidy | parent. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 68.1 | A14AB01 | nandrolon | parent. | 2 | MG | 2,85 | ||||
| 00609 | SUPERANABOLON | inj 5x1ml/25mg | SPX | CZ | ||||||
| 69 | A16A | ostatní léčiva alimentárního traktu | parent. | O | ||||||
| 69.1 | A16AA01 | levokarnitin | parent. | 2 | GM | 365,00 | O | |||
| 69.2 | A16AX01 | tioktová kyselina | parent. | 0.2 | GM | 103,65 | O | |||
| 86092 | THIOCTACID 600 T | inj 5x24ml/600mg | ASD | D | ||||||
| 70 | B01AA | antithrombotika ze skupiny antagonistů vitaminu K | p.o. | |||||||
| 70.1 | B01AA03 | warfarin | p.o. | 7.5 | MG | 4,05 | ||||
| 94114 | WARFARIN | tbl 100x5 mg | ORN | SF | ||||||
| 94113 | WARFARIN | tbl 100x3 mg | ORN | SF | ||||||
| 70.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.6 | GM | 4,70 | ||||
| 70.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.6 | GM | 5,60 | ||||
| 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) | parent. | U | ||||||
| 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 30040,80 | U | |||
| 66533 | KYBERNIN P | inj 1x500ut+10ml aq | BEH | A | ||||||
| 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | BEH | A | ||||||
| 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 30040,80 | U | |||
| 72 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (heparin) | parent. | O | ||||||
| 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,70 | O | |||
| 74999 | HEPARIN BIOCHEMIE 25000UT | inj 100x5ml/25ku | BCA | A | ||||||
| 93746 | HEPARIN LECIVA | inj 1x10ml/50ku | LEX | CZ | ||||||
| 00477 | HEPARIN RETARD LECIVA | inj 5x1ml/25ku | LEX | CZ | ||||||
| 73 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (ostatní) | p.o.,parent. | O | ||||||
| 73.1 | B01AB04 | dalteparin do 2,5 KU včetně v jedné ampuli | parent. | 3 | KU | 105,00 | O | |||
| 94857 | FRAGMIN | inj 10x0.2ml/2.5ku | PHA | S | ||||||
| 73.2 | B01AB04 | dalteparin nad 2,5 KU do 5 KU včetně v jedné ampuli | parent. | 3 | KU | 90,00 | O | |
| 94858 | FRAGMIN | inj 10x0.2ml/5ku | PHA | S | ||||
| 73.3 | B01AB04 | dalteparin nad 5 KU v jedné ampuli | parent. | 3 | KU | 66,00 | O | |
| 94855 | FRAGMIN | inj 10x1ml/10ku | PHA | S | ||||
| 94856 | FRAGMIN | inj 10x4ml/10ku | PHA | S | ||||
| 73.4 | B01AB05 | enaxaparin do 20 mg včetně v jedné ampuli | parent. | 3 | KU | 105,00 | O | |
| 73.5 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3 | KU | 90,00 | O | |
| 73.6 | B01AB05 | enoxaparin nad 40 mg do 80 mg včetně v jedné ampuli | parent. | 3 | KU | 85,00 | O | |
| 73.7 | B01AB05 | enoxaparin nad 80 mg v jedné ampuli | parent. | 3 | KU | 66,00 | O | |
| 73.8 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3 | KU | 105,00 | O | |
| 73.9 | B01AB06 | nadroparin nad 2,85 do 3,8 KU včetně v jedné ampuli | parent. | 3 | KU | 90,00 | O | |
| 73.10 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3 | KU | 85,00 | O | |
| 73.11 | B01AB06 | nadroparin nad 7,6 KU v jedné ampuli | parent. | 3 | KU | 66,00 | O | |
| 73.12 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU | 90,00 | O | |
| 76570 | FLUXUM 3200UT AXA | inj 6x0.3ml/3200ut | ASW | I | ||||
| 73.13 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3 | KU | 90,00 | O | |
| 56535 | FLUXUM 4250UI AXA | inj 6x0.4ml/4250ut | ASW | I | ||||
| 73.14 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3 | KU | 85,00 | O | |
| 76571 | FLUXUM 6400UI AXA | inj 6x0,4ml/6400ut | ASW | I | ||||
| 73.15 | B01AB08 | reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3 | KU | 105,00 | O | |
| 73.16 | B01AB08 | reviparin nad 1,432 KU v jedné ampuli | parent. | 3 | KU | 90,00 | O | |
| 73.17 | B01AB11 | sulodexid | parent. | 600 | U | 64,90 | O | |
| 73.18 | B01AB11 | sulodexid | p.o. | 250 | U | 13,55 | L/OPH,INT,NEU, DIA,GER | |
| 74 | B01AC | antiagregancia trombocytů | p.o. |
|---|
a) alergie a prokazatelná intolerance kyseliny acetylsalicylové,
b) necitlivost na kyselinu acetylsalicylovou zjištěná agregačním vyšetřením v hemokoagulační laboratoři,
c) podání pacientům po interavaskulárních intervencích (stenty, PTCA, rotablace, atherektomie, laserové atheroplastiky a
pod.), podání obvykle v kombinaci s kyselinou acetylsalicylovou po dobu časově omezenou (obvykle jeden měsíc po výkonu).
Léčbu indobufenem ordinuje internista, kardiolog nebo neurolog:
a) alergie a prokazatelná intolerance kyseliny acetylsalicylové,
b) nutno pouze krátkodobého antiagregačního účinku (např. před chirurgickým výkonem).
| 74.1 | B01AC05 | ticlopidin | p.o. | 0.5 | GM | 50,00 | P | |||
| 74.2 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,55 | ||||
| 72813 | ANOPYRIN 30MG | tbl 20x30mg | SLO | SK | ||||||
| 72812 | ANOPYRIN 30MG | tbl 50x30mg | SLO | SK | ||||||
| 74.3 | B01AC06 | kyselina acetylsalicylová (od 0,1 do 0,15 g v jedné tabletě včetně) | p.o. | 1 | DF | 1,00 | ||||
| 74.4 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,70 | ||||
| 99295 | ANOPYRIN 100M | tbl 20x100mg | SLO | SK | ||||||
| 71960 | GANOPYRIN 100MG | tbl 50x100mg | SLO | SK | ||||||
| 74.5 | B01AC10 | indobufen | p.o. | 0.3 | GM | 18,00 | P | |||
| 75 | B01AC | antiagregancia trombocytů | parent. | H | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 75.1 | B01AC07 | dipyridamol | parent. | 0.2 | GM | 229,60 | H | |||
| 01500 | PERSANTIN | inj 5x2ml/10mg | BOE | D | ||||||
| 98377 | PERSANTIN | inj 5x2ml/10mg | THM | D | ||||||
| 98378 | PERSANTIN | inj 5x2ml/10mg | BNE | A | ||||||
| 75.2 | B01AC10 | indobufen | parent. | 0.3 | GM | 91,40 | H | |||
| 75.3 | B01AC13 | abciximab | parent. | 1 | DF | 14779,25 | H | |||
| 76 | B01AD | trombolytika | parent. | U | ||||||
a) léčba akutního infarktu myokardu, kteří byli v posledních 12 měsících léčeni streptokinázou, nebo mají v anamnéze
alergickou reakci na streptokinázu.
Na pracovištích, která mají specializovaný léčebný postup ve smlouvě se zdravotní pojišťovnou:
a) intrakoronární trombolýza,
b) trombolýza akutních a subakutních uzávěrů periferních cév.
| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3691,20 | U |
| 10937 | STREPTASE | inj sic 1x750 ku | BEH | D | |||
| 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3505,50 | U |
| 94697 | KABIKINASE | inj sic 1x1.5mu | KBP | S | |||
| 76.3 | B01AD02 | alteplaza | parent. | 0.1 | GM | 44257,70 | U/P |
| 76.4 | B01AD04 | urokináza (do 100 kU v jedné dávce včetně) | parent. | 3 | MU | 76267,30 | U/P |
| 76.5 | B01AD04 | urokináza (nad 500 kU v jedné dávce) | parent. | 3 | MU | 43542,15 | U/P |
| 76.6 | B01AD04 | urokináza (od 100 do 500 kU v jedné dávce) | parent. | 3 | MU | 46386,55 | U/P |
| 76.7 | B01AD07 | retepláza | parent. | 20 | U | 44257,70 | U/P |
| 77 | B02AA | antifibrinolytika ze skupiny aminokyselin | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 39,75 | |
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 41,65 | |
| 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 39,45 | |
| 97410 | EXACYL | tbl fc 20x500mg | SFH | F | |||
| 97410 | EXACYL | sol 5x10 ml/1gm | KBP | S | |||
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 19,80 | |
| 02123 | PAMBA | tbl 10x250mg | CWO | D | |||
| 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. | ||||
| 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 66,50 | |
| 78.2 | B02AA02 | kyselina tranexámová | parent. | 2 | GM | 65,20 | |
| 97411 | EXACYL I.V. | inj 5x5ml/500mg | SFH | F | |||
| 78.3 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 192,60 | |
| 69793 | PAMBA | inj 5x5ml/50mg | CWO | D | |||
| 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | H | |||
| 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 720,00 | H |
| 02787 | ANTILYSIN SPOFA | inj 5x10ml/100ku | SPX | CZ | |||
| 80 | B02BA | vitamin K a jeho deriváty a další lokální hemostyptika | p.o. | ||||
| 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 10,80 | |
| 00720 | KANAVIT | gtt 1x5ml 20mg/ml | SLO | SK | |||
| 80.2 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 30,00 | L/OPH,HEM |
| 81 | B02B | vitamin K a jeho deriváty a další lokální hemostyptika | parent. | ||||
|---|---|---|---|---|---|---|---|
| 81.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10 | MG | 14,60 | |
| 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 17,15 | |
| 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK | |||
| 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 89,70 | O/OPH,HEM |
| 82 | B02BB | lidský fibrinogen | parent. | U | |||
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 6154,50 | U |
| 52772 | FIBRINOGEN IMMUNO I.V. 1000MG | inj sic 1000mg+50ml | IMM | A | |||
| 83 | B02BC | lokální hemostatika | lok. | ||||
| 83.1 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1 | DF | 5,65 | |
| 88753 | SPOFAX (CIPKY HEMOSTAT.KON.) | sup 5x2.2gm | LEX | CZ | |||
| 83.2 | B02BC | lokální hemostatika (pěna) | lok. | 1 | C2 | 1,50 | |
| 94888 | HYPRO-SORB (60X100X3.5MM) | ext 1 ks | HVV | CZ | |||
| 97230 | HYPRO-SORB O (TVAR TROJUHELN.) | ext 20ks | HVV | CZ | |||
| 83.3 | B02BC01 | absorbovatelná želatinová houba | lok. | 1 | C2 | 2,90 | |
| 02198 | GELASPON | spn 1ks(8.5x4x1cm) | ANW | D | |||
| 83.4 | B02BC06 | thrombin (houba) | lok. | 1 | DF | 58,10 | |
| 83.5 | B02BC | lokální hemostatin (zásyp) | lok. | 1 | GM | 3,15 | |
| 84 | B02BD | koagulační faktory (faktor VIII a faktor IX) | parent. | B/P | |||
a) prevence a léčba krvácivých stavů u nemocných s vrozeným či získaným nedostatkem faktoru VIII,
b) u nemocných s výskytem inhibitoru proti fakotru VIII v nízkém titru (do 5 Bethesda jednotek),
c) vepřový faktor VIII je indikován u nemocných s vysokým titrem protilátek proti lidskému faktoru VIII a s nízkým titrem
protilátek proti vepřovému faktoru VIII.
Léčbu koagulačním faktorem IX ordinuje hematolog:
prevence a léčba krvácivých stavů u nemocných s prokázaným deficitem faktoru IX. eventuálně u nemocných s přítomností
inhibitoru faktoru VIII.
| 84.1 | B02BD02 | koagulační faktor VIII (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 500 | U | 5200,00 | B/P |
| 84.2 | B02BD02 | koagulační faktor VIII (středně čištěný) | parent. | 500 | U | 5200,00 | B/P |
| 88800 | PORCINE FACTOR VIII:C(HYATE:C) | inj 20ml/400-700ut | SPY | GB | |||
| 84.3 | B02BD04 | koagulační faktor IX (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 350 | U | 3360,00 | B/P |
| 84.4 | B02BD04 | koagulační faktor IX (středně čištěný) | parent. | 350 | U | 3360,00 | B/P | |||
| 84.5 | B02BD01 | kombinace koagulačních faktorů IX,II,VII a X | parent. | 350 | U | 3360,00 | B/P | |||
| 94227 | HEMOFACTOR HT | inj sic 1x500ut+sol | GFO | E | ||||||
| 84.6 | B02BD02 | koagulační faktor VIII (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 500 | U | 6250,00 | B/P | |||
| 84.7 | B02BD02 | koagulační faktor VIII (vysoce čištěný) | parent. | 500 | U | 6250,00 | B/P | |||
| 84.8 | B02BD04 | koagulační faktor IX (vysoce čištěný, z tuzemské plazmyzakázkovou frakcionací) | parent. | 350 | U | 4270,00 | B/P | |||
| 84.9 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350 | U | 4270,00 | B/P | |||
| 85 | B02BD | koagulační faktory (ostatní koagulační faktory) | parent. | X | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 85.1 | B02BD | srážecí faktory | parent. | 350 | U | 3043,25 | X | |||
| 85667 | FIBROGAMMIN P | inj 1x250ut+1x4ml | BEH | D | ||||||
| 85668 | FIBROGAMMIN P | inj 1x1.25ku+1x20ml | BEH | D | ||||||
| 85.2 | B02BD02 | koagulační faktor VIII středně čištěný s von Willebrandovým faktorem | parent. | 500 | U | 8000,00 | X | |||
| 85.3 | B02BD03 | aktivita obcházející inhibitor faktoru VIII | parent. | 10 | KU | 339500,00 | X | |||
| 85.4 | B02BD05 | koagulační faktor VII | parent. | 6 | KU | 90000,00 | X | |||
| 85.5 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.5 | kU | 1543,25 | X | |||
| 85.6 | B02BD02 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500 | U | 8750.00 | X | |||
| 86 | B03AA | soli dvojmocného železa | p.o. | |||||||
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 2,80 | ||||
| 86.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 3,05 | ||||
| 00677 | FERRONAT | sus 1x100ml/3gm | GNO | CZ | ||||||
| 86.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,45 | ||||
| 86.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,45 | ||||
| 86.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,45 | ||||
| 86.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,60 | ||||
| 85662 | FERRO 66 | gtt1x20 ml | PRA | D | ||||||
| 86.7 | B03AA07 | síran železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,15 | ||||
| 04370 | FERRONAT RETARD | tbl obd 30 | LEC | CZ | ||||||
| 86.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,45 | |||
| 87 | B03AC | soli trojmocného železa | parent. | O | |||||
|---|---|---|---|---|---|---|---|---|---|
| 87.1 | B03AC | železo trojmocné, parenterální přípravky | parent. | 0.1 | GM | 30,35 | O | ||
| 04084 | FERRUM LEK I.M. | inj 50x2ml/100mg | LEK | SLO | |||||
| 87.2 | B03AC02 | hydroxid železitý se sacharózou | parent. | 0.1 | GM | 33,25 | O | ||
| 02788 | FERRUM LEK I.V. | inj 50x5ml/100mg | LEK | SLO | |||||
| 87.3 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.1 | GM | 26,15 | O | ||
| 88 | B03AD | soli dvojmocného železa v kombinaci s kyselinou listovou | p.o. | L/GYN,HEM | |||||
| 88.1 | B03AD | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 5,30 | L/GYN,HEM | ||
| 88.2 | B03AD | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,30 | L/GYN,HEM | ||
| 97861 | LÖSFERRON FOL BRAUSENTABLETTEN | tbl eff 30 | ASD | A | |||||
| 88.3 | B03AD02 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 2,35 | L/GYN,HEM | ||
| 89141 | FERRETAB COMP. | cps 100 | LAR | A | |||||
| 89140 | FERRETAB COMP. | cps 30 | LAR | A | |||||
| 88.4 | B03AD03 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 5,30 | L/GYN,HEM | ||
| 89 | B03AE | soli dvojmocného železa v ostatních kombinacích | p.o. | ||||||
| 89.1 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.1 | GM | 5,70 | |||
| 89.2 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.1 | GM | 5,45 | |||
| 89.3 | B03AE10 | chlorid železnatý/kyselina listová | p.o. | 0.1 | GM | 5,45 | |||
| 89.4 | B03AE10 | fumarat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,45 | |||
| 89.5 | B03AE10 | glukonat železnatý/kyselina listová | p.o. | 0.1 | GM | 5,45 | |||
| 89.6 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.1 | GM | 3,05 | |||
| 89.7 | B03AE10 | síran železnatý/kyselina listová | p.o. | 0.1 | GM | 6,55 | |||
| 96043 | AKTIFERRIN COMPOSITUM | cps 100 | MCK | A | |||||
| 96042 | AKTIFERRIN COMPOSITUM | cps 30 | MCK | A | |||||
| 89.8 | B03AE10 | síran železnatý/serin (pevné lékové formy) | p.o. | 0.1 | GM | 5,70 | |||
| 94584 | AKTIFERRIN | cps 50 | MCK | D | |||||
| 89.9 | B03AE10 | síran železnatý/serin (tekuté lékové formy) | p.o. | 0.1 | GM | 7,15 | |||
| 99138 | AKTIFERRIN | gtt 1x30ml | MCK | D | |||||
| 90 | B03BA | vitamin B12 a jeho deriváty | parent. | |||||
|---|---|---|---|---|---|---|---|---|
| 90.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,50 | ||
| 00641 | VITAMIN B12 LECIVA 300RG | inj 5x1ml/300rg | LEX | CZ | ||||
| 90.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0,20 | ||
| 66997 | B12 ANKERMANN 1000RG | inj 1x5ml 1000rg/ml | WGP | D | ||||
| 66998 | B12 ANKERMANN 1000RG | inj 5x5ml 1000rg/ml | WGP | D | ||||
| 92503 | NEUROBENE | inj 6x1ml/1000rg | MCK | D | ||||
| 09979 | VITAMIN B12 | inj 10x1ml/1mg | VJP | D | ||||
| 23608 | VITAMIN B12 | inj 100x1ml/1mg | VJP | D | ||||
| 00643 | VITAMIN B12 LECIVA 1000RG | inj 5x1ml/1000rg | LEX | CZ | ||||
| 97506 | VITAMIN B12-RATIOPHARM | inj 6x1ml/1000rg | MCK | D | ||||
| 91 | B03BB | kyselina listová a její deriváty | p.o. | |||||
| 91.1 | B03BB01 | kyselina listová | p.o. | 10 | MG | 1,05 | ||
| 76064 | ACIDUM FOLICUM LECIVA | drg 30x10mg | LEX | CZ | ||||
| 92 | B03XA | ostatní protianemická léčiva | parent. | K/P | ||||
a) léčba klinicky významné anémie (s hladinou hemoglobinu nižší než 90 g/l, s vyššími hodnotami při manifestních příznacích
anémie) u nemocných zařazených do dialyzačního programu, nemocných s chronickým renálním selháním, nemocných s
nádorovým onemocněním po radikální cytostatické léčbě nebo ozáření,
b) léčba anémie u nemocných s aplastickou anémií, erythroblastoftýzou, myelodysplastickým syndromem a anémií po
transplantaci kostní dřeně,
c) léčba těžké anémie nezralých dětí.
| 92.1 | B03XA01 | erythropoetin | parent. | 2 | KU | 1060,90 | K/P |
| 85532 | EPREX | inj 6x10ku/ml+str. | CIL X | CH | |||
| 94346 | EPREX | inj 6x10ku/ml | CIL X | CH | |||
| 96354 | RECORMON | inj 10x1ku | BOM X | A | |||
| 96355 | RECORMON | inj 10x2ku | BOM X | A | |||
| 96356 | RECORMON | inj 5x5ku | BOM X | A | |||
| 56526 | RECORMON S 1000IU | inj sic 10x1ku+solv | BOM X | A | |||
| 93 | B05AA | substituenty plazmy a plazmatické proteiny (albumin) | parent. | B | |||
|---|---|---|---|---|---|---|---|
| 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2880,30 | B |
| 75089 | ALBUMIN LIDSKY SP 5% SEVAC | inf 1x250ml | USO | CZ | |||
| 93787 | ALBUMIN LIDSKY SP 20% SEVAC | inf 1x100ml(nts) | USO | CZ | |||
| 98147 | ALBUMIN LIDSKY SP 20% SEVAC | inj 5x1ml | USO | CZ | |||
| 97907 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x250ml | GFO | E | |||
| 97908 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x500ml | GFO | E | |||
| 97909 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x50ml | GFO | E | |||
| 97910 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x100ml | GFO | E | |||
| 20819 | HUMAN ALBUMIN 50 DESSAU | inf 1x250ml | PDE | D | |||
| 20818 | HUMAN ALBUMIN 50 DESSAU | inf 1x100ml | PDE | D | |||
| 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2880,30 | B | |
| 10124 | HUMAN ALBUMIN 20% | inf 1x100ml | BTP | D | ||||
| 20818 | HUMAN ALBUMIN 50 DESSAU | inf 1x100ml 5% | PDE | D | ||||
| 20819 | HUMAN ALBUMIN 50 DESSAU | inf 1x250ml 5% | PDE | D | ||||
| 93.3 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 974,00 | B | |
| 94 | B05AA | substituenty plazmy a plazmatické proteiny (ostatní) | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 94.1 | B05AA05 | dextran (koncentrace 10%) | parent. | 500 | ML | 172,80 | O | |
| 00589 | RHEODEXTRAN INFUSIA (SOL.PHYS.) | inf 1x500ml 10% | IHO | CZ | ||||
| 00590 | RHEODEXTRAN INFUSIA 10% V GLUC. | inf 1x500ml | IHO | CZ | ||||
| 94.2 | B05AA05 | dextran (koncentrace 6%) | parent. | 500 | ML | 101,20 | O | |
| 00431 | DEXTRAN INFUSIA 6% V F1/1 | inf 1x500ml(sklo) | IHO | CZ | ||||
| 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 115,20 | O | |
| 96380 | TENSITON I.V.(KREVNI EXPANDER) | inf 1x500ml(lahev) | IHO | CZ | ||||
| 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 252,80 | O | |
| 62639 HAEMACCEL 3.5% | inf 10x500ml | BEH | D | |||||
| 03622 HAEMACCEL 3.5% | inf 1x500ml | BEH | D | |||||
| 94.5 | B05AA07 | hydroxyethylškrob | parent. | 500 | ML | 401,00 | O | |
| 98352 | ELOHAST 6% | inf 1x500ml(plast) | LPD | A | ||||
| 98351 | ELOHAST 6% | inf 1x500ml(sklo) | LPD | A | ||||
| 72155 | HAES-STERIL 6% | inf 1x500ml(plast) | FRE | D | ||||
| 72154 | HAES-STERIL 6% | inf 1x500ml(sklo) | FRE | D | ||||
| 75007 | ELOHAST 6% | inf 1x500ml(vak) | LPD | A | ||||
| 95 | B05BA | roztoky k parenterální výživě (glukóza až do 40% koncentrace) | parent. | O | ||||
| 95.1 | B05BA03 | glukóza 10% (od 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 13,00 | O | |
| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1x250ml (sklo) | IMA | SK | ||||
| 66872 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x250ml (sklo) | IHO | CZ | ||||
| 92531 | 10% DEXTROSE IN WATER F. INJ. USP | inf. 1x250ml (sklo) | SFR | I | ||||
| 95.2 | B05BA03 | glukóza 10% (od 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,15 | O | |
| 78248 | 10% GLUCOSE I.V. INFUSION BAXTER | inf 20x500ml (vak) | BXT | GB | ||||
| 92534 | 10% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (pp) | SFR | D | ||||
| 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 35,00 | O | |
| 92530 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml (sklo) | SFR | I | ||||
| 69747 | ARDEANUTRISOL G 10 | inf 1x80ml | ARD | CZ | ||||
| 86524 | ARDEANUTRISOL G 10 | inf 40x80ml | ARD | CZ | ||||
| 62374 | INFUSIO GLUCOSI 10 IMUNA | inf 1x100ml (sklo) | IMA | SK | ||||
| 86346 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x100ml (sklo) | IHO | CZ | ||||
| 92536 | 10% DEXTROSE IN WATER F. INJ. USP | inf 1x100ml (vak) | SFR | D | ||||
| 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ML | 4,70 | O | |
| 92540 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml (vak) | SFR | I | ||||
| 92539 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml (vak) | SFR | I | ||||
| 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 30,40 | O | |
| 55623 | INFUSIO GLUCOSI 20 IMUNA | inf 1x100ml (sklo) | IMA | SK | ||||
| 95.6 | B05BA03 | glukóza 20% (více než 100 ml v jednom balení) | parent. | 100 | ML | 6,85 | O | |
| 75194 | GLUCOSE-LOSUNG 20 SALVIA (PLAST) | inf 1x1000ml 20% | CLS | D | ||||
| 95.7 | B05BA03 | glukóza 5% (od 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,45 | O | |
| 97729 | GLUCOSE INJECTION 5%W/V BIEFFE | inf 1x250ml (sklo) | BFF | I | ||||
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml (sklo) | IMA | SK | ||||
| 92520 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x250ml (sklo) | SFR | I | ||||
| 95.8 | B05BA03 | glukóza 5% (od 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,95 | O | |
| 83695 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x500ml | CPL | IND | ||||
| 92521 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (sklo) | SFR | I | ||||
| 92523 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (pp) | SFR | I | ||||
| 92527 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (vak) | SFR | I | ||||
| 96873 | GLUKOSE 5 BRAUN (PLASCO LAHV.) | inf 1x500ml 5% | BME | D | ||||
| 95.9 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 27,10 | O | |
| 92519 | 5% DEXTROSE IN WATER F. INJ. USP | inf. 1x100ml (sklo) | SFR | I | ||||
| 96871 | GLUCOSE 5 BRAUN (SKLO LAHV.) | inf 1x100ml 5% | BME | D | ||||
| 95.10 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100 | ML | 4,10 | O | |
| 92529 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml (vak) | SFR | I | ||||
| 83696 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x1000ml | CPL | IND | ||||
| 92528 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x1000ml (vak) | SFR | I | ||||
| 95.11 | B05BA03 | glukóza do 10% vč. (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 93,40 | O | |
| 00465 | GLUCOSUM LECIVA 10% | inj 10x10ml 10% | LEX | CZ | ||||
| 95.12 | B05BA03 | glukóza nad 10% (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 101,00 | O | |
| 95.13 | B05BA03 | glukóza nad 20% (od 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 18,60 | O | |
| 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ | ||||
| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml (sklo) | IMA | SK | ||||
| 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 32,40 | O | |
| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml (sklo) | IMA | SK | ||||
| 95.15 | B05BA03 | glukóza nad 20% (více než 250 ml v jednom balení) | parent. | 100 | ML | 8,45 | O | |
| 75199 | GLUCOSE-LOSUNG 40 SALVIA (SKLO) | inf 1x1000ml 40% | CLS | D | ||||
| 75206 | GLUCOSE-LOSUNG 40 SALVIA (PLAST) | inf 1x1000ml 40% | CLS | D | ||||
| 96 | B05BA | roztoky k parenterální výživě (ostatní) | parent. | H | ||||
|---|---|---|---|---|---|---|---|---|
| 96.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100 | ML | 39,65 | H | |
| 91112 | NUTRAMIN NEO | inf 1x500ml 4% | IHO | CZ | ||||
| 96338 | AMINO-MEL OPTIMAL 3,5% | inf. 1x1000ml | LPD | A | ||||
| 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 76,20 | H | |
| 96.3 | B05BA01 | aminokyseliny (koncentrace od 10 do 14% včetně) | parent. | 100 | ML | 79,65 | H | |
| 62343 | VALMIN 18EF | inf 12x500ml | KBP | S | ||||
| 96.4 | B05BA01 | aminokyseliny (koncentrace od 6 do 10 % včetně) | parent. | 100 | ML | 49,50 | H | |
| 91293 | NUTRAMIN NEO | inf 1x500ml 8% | IHO | CZ | ||||
| 75378 | AMINOSTERIL KE 10% ZUCKER-FREE | inf 6x1000ml | FRE | D | ||||
| 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml) | parent. | 100 | ML | 220,80 | H | |
| 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml) | parent. | 100 | ML | 200,90 | H | |
| 60105 | NUTRALIPID P 20% EMULZE | inf 1x100ml | VUA | CZ | ||||
| 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml) | parent. | 100 | ML | 54,40 | H | |
| 75442 | INTRALIPID | INF 12X500ML 10% | KPB | S | ||||
| 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml) | parent. | 100 | ML | 75,90 | H | |
| 96.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100 | ML | 14,80 | H | |
| 69765 | ARDEANUTRISOL FR 5 | inf 1x500ml | ARD | CZ | ||||
| 69764 | ARDEANUTRISOL FR 5 | inf 1x300ml | ARD | CZ | ||||
| 86464 | ARDEANUTRISOL FR 5 | inf 12x500ml | ARD | CZ | ||||
| 92222 | ARDEANUTRISOL FR 5 | inf 12x300ml | ARD | CZ | ||||
| 86463 | ARDEANUTRISOL FR 5 | inf 12x400ml | ARD | CZ | ||||
| 86459 | ARDEANUTRISOL FR 5 | inf 1x400ml | ARD | CZ | ||||
| 96.10 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100 | ML | 18,15 | H | |
| 69771 | ARDEANUTRISOL FR 20 | inf 1x500ml | ARD | CZ | ||||
| 86473 | ARDEANUTRISOL FR 20 | inf 1x400ml | ARD | CZ | ||||
| 86478 | ARDEANUTRISOL FR 20 | inf 12x500ml | ARD | CZ | ||||
| 86477 | ARDEANUTRISOL FR 20 | inf 12x400ml | ARD | CZ | ||||
| 96.11 | B05BA03 | fruktóza (koncentrace od 5 do 10% včetně) | parent. | 100 | ML | 15,90 | H | |
| 69768 | ARDEANUTRISOL FR 10 | inf 1x500ml | ARD | CZ | ||||
| 86466 | ARDEANUTRISOL FR 10 | inf 1x400ml | ARD | CZ | ||||
| 86471 | ARDEANUTRISOL FR 10 | inf 12x500ml | ARD | CZ | ||||
| 86470 | ARDEANUTRISOL FR 10 | inf 12x400ml | ARD | CZ | ||||
| 69767 | ARDEANUTRISOL FR 10 | inf 1x300ml | ARD | CZ | ||||
| 96.12 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100 | ML | 7,20 | H | |
| 55611 | INFUSIO SORBITOLI 5 IMUNA | inf 1x3000 (vak) | IMA | SK | ||||
| 96.13 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100 | ML | 11,25 | H | |
| 85590 | INFUSIO SORBITOLI 20 IMUNA | inf 1x1000 (vak) | IMA | SK | ||||
| 44331 | INFUSIO SORBITOLI 20 IMUNA | inf 1x500 (sklo) | IHO | CZ | ||||
| 68878 | INFUSIO SORBITOLI 20 IMUNA | inf 1x500 (vak) | IMA | SK | ||||
| 96.14 | B05BA03 | sorbitol (koncentrace od 5 do 10% včetně) | parent. | 100 | ML | 8,75 | H | |
| 85586 | INFUSIO SORBITOLI 10 IMUNA | inf 1x1000 (vak) | IMA | SK | ||||
| 8873 | INFUSIO SORBITOLI 10 IMUNA | inf 1x500 (sklo) | IMA | SK | ||||
| 96.15 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100 | ML | 17,00 | H | |
| 96.16 | B05BA03 | xylitol (koncentrace nad 5%) | parent. | 100 | ML | 23,35 | H | |
| 86224 | ARDEANUTRISOL XY 10 | inf 12x500ml | ARD | CZ | ||||
| 69716 | ARDEANUTRISOL XY 10 | inf 1x500ml | ARD | CZ | ||||
| 96.17 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100 | ML | 13,50 | H | |
| 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 57,60 | H | |
| 72160 | AMINO-MEL 3,5% G | inf 6x1000ml | LPD | A | ||||
| 72159 | AMINO-MEL 3,5% G | inf 10x500ml | LPD | A | ||||
| 72162 | AMINO-MEL 5% G | inf 6x1000ml | LPD | A | ||||
| 72163 | AMINO-MEL 5% G | inf 10x500ml | LPD | A | ||||
| 72164 | AMINO-MEL 5% G | inf 6x900ml | LPD | A | ||||
| 80580 | NUTRAMIN C | inf 1x250ml | IHO | CZ | ||||
| 91305 | NUTRAMIN C | inf 1x500ml | IHO | CZ | ||||
| 91663 | NUTRAMIN NEO SX | inf 1x500ml 4% | IHO | CZ | ||||
| 91665 | NUTRAMIN NEO SX | inf 1x500ml 8% | IHO | CZ | ||||
| 96204 | NUTRAMIN U | inf 1x500ml | IHO | CZ | ||||
| 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9%) | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 97.1 | B05BB01 | chlorid sodný 0.9% (od 100 do 250 ml včetně) | parent. | 100 | ML | 11,80 | O | |
| 62328 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x250ml (sklo) | IMA | SK | ||||
| 92509 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(sklo) | SFR | I | ||||
| 92515 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(vak) | SFR | I | ||||
| 97749 | SODIUM CHLORIDE 0,9% BIEFFE. | inf 1x250ml(sklo) | BFF | I | ||||
| 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 22,80 | O | |
| 92508 | 0.9% W/V SODIUM CHLORIDE I.V. | inf 1x100ml(sklo) | SFR | I | ||||
| 97.3 | B05BB01 | chlorid sodný 0.9% (více než 250 ml v balení) | parent. | 100 | ML 3,90 | O | |
| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml (vak) | IMA | SK | |||
| 83698 | SODIUM CHLORIDE I.V.B.P.CORE | inf 1x1000ml 0.9% | CPL | IND | |||
| 92518 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x2000ml(vak) | SFR | I | |||
| 92513 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(pp) | SFR | I | |||
| 98 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (ostatní) | parent. | 92518 | |||
|---|---|---|---|---|---|---|---|
| 98.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100 | ML 10,50 | H | |
| 75372 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A | |||
| 75374 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A | |||
| 75360 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A | |||
| 75362 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A | |||
| 75370 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A | |||
| 75368 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A | |||
| 75358 | ELO-MEL ISOTON | inf 6x1000ml(plast) | LPD | A | |||
| 75356 | ELO-MEL ISOTON | inf 6x1000ml(sklo) | LPD | A | |||
| 75366 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(plast) | LPD | A | |||
| 75364 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(sklo) | LPD | A | |||
| 98.2 | B05BB01 | elektrolyty | parent. | 100 | ML 8,25 | H | |
| 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ | |||
| 85112 | ARDEAELYTOSOL R 1/1 | inf 12x500ml | ARD | CZ | |||
| 83702 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x1000ml | CPL | IND | |||
| 83701 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x500ml | CPL | IND | |||
| 98238 | DARROW'S SOLUTION | inf 1x500ml | BME | D | |||
| 85896 | INFUSIO DARROWI IMUNA | inf 1x1000ml(vak) | IMA | SK | |||
| 91841 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 10x1000ml | BXT | GB | |||
| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK | |||
| 96889 | RINGERLACTAB DAB 7 BRAUN | inf 1x1000ml(pe) | BME | D | |||
| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ | |||
| 96892 | RINGER'S INJECTION BRAUN | inf 1x1000ml | BME | D | |||
| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BXT | GB | |||
| 69440 | RINGER-LOSUNG SALVIA (PLAST) | inf 1x1000ml | CLS | D | |||
| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml (vak) | IMA | SK | |||
| 84545 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x3000ml (vak) | IMA | SK | |||
| 69438 | RINGER-LACTAT SALVIA (PLAST) | inf 1x1000ml | CLS | D | |||
| 92600 | INFUSIO DARROWI IMUNA | inf 1x3000ml (vak) | IMA | SK | |||
| 97013 | INFUSIO DARROWI INSTITUTE HUMAN | inf 1x500ml | HUA | H | |||
| 69442 | RINGER-LOSUNG SALVIA (SKLO) | inf 1x1000ml | CLS | D | |||
| 69439 | RINGER-LACTAT SALVIA (SKLO) | inf 1x1000ml | CLS | D | |||
| 01695 | NATRII CHLORIDI 10% MEDVIR | inf 1x100ml | VYS | CZ | |||
| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml (vak) | IMA | SK | |||
| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml (vak) | MKS | CZ | |||
| 96891 | RINGER'S INJECTION BRAUN | inf 1x500ml | BME | D | |||
| 96888 | RINGERLACTAT DAB 7 BRAUN | inf 1x500ml (pe) | BME | D | |||
| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml (vak) | IMA | SK | |||
| 84554 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x2000ml (vak) | IMA | SK | |||
| 69235 | RINGER'S SOLUTION U. S. P. BIEFFE | inf 1x500ml (sklo) | BFF | I | |||
| 92599 | INFUSIO DARROWI IMUNA | inf 1x2000ml (vak) | IMA | SK | |||
| 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml (vak) | IMA | SK | |||
| 89861 | INFUSIO RINGERI INFUSIA R 1/1 | inf 1x500ml (sklo) | IHO | CZ | |||
| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml (sklo) | IMA | SK | |||
| 84543 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x1000ml (vak) | IMA | SK | ||||||
| 70529 | INFUSIO RINGERI MEDICAMENTA | inf 1x500ml | MVM | CZ | ||||||
| 69736 | ARDEALYTOSOL H 1/1 | inf 1x500ml | ARD | CZ | ||||||
| 69695 | ARDEALYTOSOL RL 1/1 | inf 1x500ml | ARD | CZ | ||||||
| 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml (sklo) | IMA | SK | ||||||
| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml (vak) | MKS | CZ | ||||||
| 86486 | ARDEALYTOSOL H 1/1 | inf 12x500ml | ARD | CZ | ||||||
| 92775 | INFUSIO DARROWI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ | ||||||
| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml (vak) | IMA | SK | ||||||
| 87250 | INFUSIO HARTMANNI INFUSIA H 1/1 | inf 1x500ml (sklo) | IHO | CZ | ||||||
| 70524 | INFUSIO HARTMANNI MEDICAMENTA | inf 1x500ml | MVM | CZ | ||||||
| 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ML | 9,30 | H | |||
| 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | ||||||
| 56702 | INFUSIO F 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ | ||||||
| 98.4 | B05BB03 | trometamol | parent. | 100 | ML | 23,55 | H | |||
| 99 | B05BC | roztoky k osmotické diuréze | parent. | H | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 99.1 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml) | parent. | 100 | ML | 12,45 | H | |||
| 89155 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | ||||||
| 99.2 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml včetně) | parent. | 100 | ML | 19,75 | H | |||
| 89154 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | ||||||
| 99.3 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml) | parent. | 100 | ML | 14,10 | H | |||
| 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | IHO | CZ | ||||||
| 99.4 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml včetně) | parent. | 100 | ML | 22,20 | H | |||
| 44382 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x250ml(sklo) | IHO | CZ | ||||||
| 99.5 | B05BC02 | karbamid | parent. | 90 | GM | 1159,10 | H | |||
| 00628 | UREA VUAB | inf sic 1x90gm | VUA | CZ | ||||||
| 100 | B05C | roztoky k irigaci | lok. | H | ||||||
| 100.1 | B05CB01 | chlorid sodný | lok. | 1000 | ML | 38,15 | H | |||
| 100.2 | B05CX02 | sorbitol | lok. | 1000 | ML | 38,15 | H | |||
| 100.3 | B05CX03 | glycin | lok. | 1000 | ML | 54,75 | H | |||
| 100.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1000 | ML | 20,00 | H | |||
| 101 | B05D | roztoky k peritoneální dialýze | parent. | H | ||||||
| 101.1 | B05D | přípravky pro peritoneální dialýzu | parent. | 1000 | ML | 236,50 | H | |||
| 101.2 | B05DA | isotonické roztoky | parent. | 1000 | ML | 236,50 | H | |||
| 101.3 | B05DB | hypertonické roztoky | parent. | 1000 | ML | 236,50 | H | |||
| 102 | B05X | přídavky do nitrožilně podávaných roztoků (hydrogenuhličitan sodný) | parent. | O | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 102.1 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100 | ML | 127,90 | O | |||
| 00524 | NATRIUM HYDROGENCARBONIC.LECIVA | inj 6x20ml 4.2% | LEX | CZ | ||||||
| 03569 | NATRIUM HYDROGENCARBONIC.LECIVA | inj 5x20ml 4.2% | LEX | CZ | ||||||
| 102.2 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100 | ML | 11,25 | O | |||
| 31352 | ALKALIGEN-INSTITUTE HUMAN | inf 1x400ml | HUA | H | ||||||
| 103 | B05X | přídavky do nitrožilně podávaných roztoků (ostatní) | parent. | H | ||||||
| 103.1 | B05X | přídavky do i.v. roztoků | parent. | 100 | ML | 284,25 | H | |||
| 103.2 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100 | ML | 19,60 | H | |||
| 103.3 | B05XA03 | chlorid sodný (koncentrace 5,85% včetně) | parent. | 100 | ML | 24,75 | H | |||
| 103.4 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 25,75 | H | |||
| 103.5 | B05XA04 | chlorid amonný | parent. | 100 | ML | 11,95 | H | |||
| 103.6 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100 | ML | 53,55 | H | |||
| 103.7 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10 | ML | 12,85 | H | |||
| 103.8 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 130,80 | H | |||
| 103.9 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100 | ML | 28,30 | H | |||
| 103.10 | B05XC | vitaminy | parent. | 1 | DF | 45,00 | H | |||
| 97955 | MULTIBIONTA PRO INFUSIONE | inf 15x10ml | MEC | D | ||||||
| 103.11 | B05XX | ostatní i.v. roztoky | parent. | 100 | ML | 7,80 | H | |||
| 104 | B05Z | roztoky k hemodialýze a hemofiltraci | lok. | H | ||||||
| 104.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1000 | ML | 170,00 | H | |||
| 87560 | ARDEADIALYSOL MAX I | inf 1x250ml | ARD | CZ | ||||||
| 87562 | ARDEADIALYSOL MAX I | inf 1x300ml | ARD | CZ | ||||||
| 87576 | ARDEADIALYSOL MAX I | inf 1x400ml | ARD | CZ | ||||||
| 69646 | ARDEADIALYSOL MAX I | inf 1x500ml | ARD | CZ | ||||||
| 87612 | ARDEADIALYSOL MAX II | inf 1x250ml | ARD | CZ | ||||||
| 87613 | ARDEADIALYSOL MAX II | inf 1x300ml | ARD | CZ | ||||||
| 87614 | ARDEADIALYSOL MAX II | inf 1x400ml | ARD | CZ | ||||||
| 69649 | ARDEADIALYSOL MAX II | inf 1x500ml | ARD | CZ | ||||||
| 104.2 | B05ZA | hemodialytika, koncentráty | lok. | 1000 | ML | 128,60 | H | |||
| 105 | C01AA | kardioglykosidy z náprstníku | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 105.1 | C01AA02 | acetyldigoxin | p.o. | 0.5 | MG | 1,05 | |||
| 105.2 | C01AA04 | digitoxin | p.o. | 0.1 | MG | 1,05 | |||
| 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,05 | |||
| 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | GNO | CZ | |||||
| 03542 | DIGOXIN 0.250 LECIVA | tbl 30x0.25mg | LEX | CZ | |||||
| 83318 | DIGOXIN 0.125 LECIVA | tbl 30x0.125mg | LEX | CZ | |||||
| 105.4 | C01AA08 | metildigoxin | p.o. | 0.2 | MG | 1,05 | |||
| 106 | C01AA | kardioglykosidy z náprstníku | parent. | ||||||
| 106.1 | C01AA05 | digoxin | parent. | 0.25 | MG | 6,75 | |||
| 00435 | DIGOXIN SPOFA | inj 10x2ml/0.5mg | SPX | CZ | |||||
| 106.2 | C01AA08 | metildigoxin | parent. | 0.2 | MG | 6,75 | |||
| 106.3 | C01AC01 | g-strofantin | parent. | 0.25 | MG | 24,00 | |||
| 107 | C01BA | antiarytmika, třída Ia | p.o. | ||||||
| 107.1 | C01B | ipratropium | p.o. | 30 | MG | 55,00 | |||
| 88433 | ITROP | tbl fc 20x10mg | BOE | D | |||||
| 107.2 | C01BA | detajmii bitartras | p.o. | 75 | MG | 14,75 | |||
| 23113 | TACHMALCOR | drg 50x25mg | VAD | D | |||||
| 107.3 | C01BA01 | chinidin | p.o. | 1.2 | GM | 19,80 | |||
| 70549 | TBL.CHINIDINI SULFURICI O.2 MVM | tbl 1000x0.2gm | MVM | CZ | |||||
| 107.4 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 27,90 | |||
| 107.5 | C01BA02 | prokainamid | p.o. | 3 | GM | 39,50 | |||
| 62311 | APO-PROCAINAMIDE 250MG | cps 100x250mg | APT | CND | |||||
| 107.6 | C01BA03 | disopyramid | p.o. | 0.4 | GM | 12,65 | |||
| 107.7 | C01BA08 | prajmalin | p.o. | 30 | MG | 14,40 | |||
| 90992 | NEO-GILURYTMAL | tbl obd 50x20mg | GIU | D | |||||
| 108 | C01BA | antiarytmika, třída Ia | parent. | O | |||||
| 108.1 | C01B | ipratropium | parent. | 3 | MG | 800,90 | O | ||
| 88432 | ITROP | inj 5x1ml/0.5mg | BOE | D | |||||
| 108.2 | C01BA02 | prokainamid | parent. | 3 | GM | 248,20 | O | |
| 108.3 | C01BA03 | disopyramid | parent. | 0.4 | GM | 248,20 | O | |
| 108.4 | C01BA05 | ajmalin | parent. | 0.3 | GM | 255,40 | O | |
| 99356 | GILURYTMAL 10 I.V. | inj 5x10ml/50mg | GIU | D | ||||
| 109 | C01BB | antiarytmika, třída Ib | p.o. | |||||
|---|---|---|---|---|---|---|---|---|
| 109.1 | C01BB02 | mexiletin | p.o. | 0.8 | GM | 10,45 | ||
| 91178 | KATEN | cps 100x100mg | SLO | SK | ||||
| 93311 | KATEN RETARD | tbl 50x400mg | SLO | SK | ||||
| 109.2 | C01BB03 | tocainid | p.o. | 1.2 | GM | 10,45 | ||
| 110 | C01BB | antiarytmika, třída Ib | parent. | O/INT,KAR | ||||
| 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,25 | O/INT,KAR | |
| 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 359,70 | O/INT,KAR | |
| 04100 | MEXITIL | inj 5x10ml 250mg | BOE | D | ||||
| 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 359,70 | O/INT,KAR | |
| 111 | C01BC | antiarytmika, třída Ic | p.o. | |||||
| 111.1 | C01BC03 | propafenon (100 mg a více v jedné tabletě) | p.o. | 0.3 | GM | 12,30 | ||
| 111.2 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 17,60 | ||
| 91276 | PROLEKOFEN | tbl fc 50x150mg | LEK | SLO | ||||
| 91277 | PROLEKOFEN | tbl fc 50x300mg | LEK | SLO | ||||
| 112 | C01BC | antiarytmika, třída Ic | parent. | O/INT,KAR | ||||
| 112.1 | C01BC03 | propafenon | parent. | 0.3 | GM | 169,15 | O/INT,KAR | |
| 91275 | PROLEKOFEN | inj 10x10ml/35mg | LEK | SLO | ||||
| 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 142,20 | O/INT,KAR | |
| 113 | C01BD | antiarytmika, třída III | p.o. | |||||
| 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 5,10 | ||
| 96599 | SEDACORON 200MG | tbl 50x200mg | EBW | A | ||||
| 114 | C01BD | antiarytmika, třída III a adenosin | parent. | O/INT,KAR | ||||
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 22,00 | O/INT,KAR | |
| 96600 | SEDACORON | inj 5x3ml/150mg | EBW | A | ||||
| 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 142,20 | O/INT,KAR | |
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 730,50 | O/INT,KAR | |
| 91615 | ADENOCOR | inj 6x2ml/6mg | SWI | F | ||||
| 115 | C01CA | adrenergní a dopaminergní léčiva (norepinefrin a dopamin) | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 115.1 | C01CA03 | norepinefrin | parent. | 6 | MG | 68,30 | O | |
| 00536 | NORADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | ||||
| 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 111,90 | O | |
| 04380 | TENSAMIN | inj 10x5ml | LEX | CZ | ||||
| 116 | C01CA | adrenergní a dopaminergní léčiva (ostatní) | parent. | H | ||||
| 116.1 | C01CA02 | isoprenalin | parent. | 90 | MG | 15978,40 H | ||
| 116.2 | C01CA05 | norfenefrin | parent. | 25 | MG | 24,30 | H | |
| 09450 | NOVADRAL PRO INFUSIONE | inf 5x5ml 1ml/10mg | GOD | D | ||||
| 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 467,15 | H | |
| 86762 | DOBUJECT | inf 5x5ml/250mg | LOY | SF | ||||
| 116.4 | C01CA09 | metaraminol | parent. | 50 | MG | 195,65 | H | |
| 116.5 | C01CA10 | metoxamin | parent. | 30 | MG | 41,85 | H | |
| 116.6 | C01CA11 | mepentermin | parent. | 30 | MG | 104,00 | H | |
| 116.7 | C01CA17 | midodrin | parent. | 7.5 | MG | 85,35 | H | |
| 116.8 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1 | DF | 700,00 | P | |
anamnézou anafylaktického šoku vyvolaného alergií na hmyz.
| 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | X | |||||
|---|---|---|---|---|---|---|---|---|---|
| 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4315,90 | X | ||
| 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F | |||||
| 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | ||||||
| 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,20 | |||
| 86677 | NIT-RET | tbl 50x2.5mg | SLO | SK | |||||
| 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 3,60 | |||
| 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,55 | |||||
| 99304 | NITRO MACK RETARD 5MG | cps 30x5mg | SLO | SK | |||||||
| 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 4,20 | |||||
| 78807 | WESORBIDE 20MG | tbl 100x20mg | HKP | HKJ | |||||||
| 78806 | WESORBIDE 10MG | tbl 100x10mg | HKP | HKJ | |||||||
| 118.5 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,60 | |||||
| 91591 | CARDIKET RETARD120 | cps ret 20x120mg | SWP | D | |||||||
| 118.6 | C01DA08 | isosorbid dinitrát (od 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60 | MG | 3,00 | |||||
| 97866 | MAYCOR RETARD 40MG | cps 30x40mg | CCS | CZ | |||||||
| 118.7 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 3,30 | |||||
| 76402 | SORBIMON 20MG | tbl 100x20mg | MCK | D | |||||||
| 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D | |||||||
| 76401 | SORBIMON 20MG | tbl 50x20mg | MCK | D | |||||||
| 61467 | ISMN AL 20 | tbl 100x20mg | APA | D | |||||||
| 92568 | ISMN AL 20 | tbl 60x20mg | APA | D | |||||||
| 96190 | MONOSAN 20MG | tbl 30x20mg | PMP | CZ | |||||||
| 118.8 | C01DA08 | isosorbit dinitrát (od 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60 | MG | 1,50 | |||||
| 97720 | APO-ISDN 30MG | tbl 100x30mg | APT | CND | |||||||
| 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 3,00 | |||||
| 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D | |||||||
| 76403 | SORBIMON 40MG | tbl 20x40mg | MCK | D | |||||||
| 76404 | SORBIMON 40MG | tbl 50x40mg | MCK | D | |||||||
| 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | H | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,90 | H | ||||
| 94559 | PERLINGANIT ROZTOK | inf 10x10ml/10mg | SWP | D | |||||||
| 97184 | PERLINGANIT ROZTOK | inf 1x50ml/50mg | SWP | D | |||||||
| 04348 | NITRO-MACK | inj 10x5ml/5mg | MAC | D | |||||||
| 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 126,80 | H | ||||
| 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | ||||||||
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,65 | |||||
| 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D | |||||||
| 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 9,00 | |||||
| 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | |||||
|---|---|---|---|---|---|---|---|---|
| 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 6,20 | ||
| 00231 | NITROGLYCERIN SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK | ||||
| 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,10 | ||
| 122 | C01DX | ostatní vazodilatancia | p.o. | |||||
| 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,90 | ||
| 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 5,70 | ||
| 83662 | MOLSIHEXAL 2MG | tbl 50x2mg | HEX | D | ||||
| 83663 | MOLSIHEXAL 2MG | tbl 100x2mg | HEX | D | ||||
| 122.3 | C01DX12 | molsidomin (od 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 4,05 | ||
| 83474 | MOLSIHEXAL 4MG | tbl 30x4mg | HEX | D | ||||
| 83664 | MOLSIHEXAL 4MG | tbl 50x4mg | HEX | D | ||||
| 86442 | MOLSIHEXAL 4MG | tbl 60x4mg | HEX | D | ||||
| 83665 | MOLSIHEXAL 4MG | tbl 100x4mg | HEX | D | ||||
| 76155 | CORVATON FORTE | tbl 30x4mg | HBS | SK | ||||
| 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,15 | ||
| 83666 | MOLSIHEXAL RETARD | tbl ret 50x8mg | HEX | D | ||||
| 86432 | MOLSIHEXAL RETARD | tbl ret 30x8mg | HEX | D | ||||
| 86443 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D | ||||
| 83475 | MOLSIHEXAL RETARD | tbl ret 100x8mg | HEX | D | ||||
| 122.5 | C01DX17 | trimetazidin | p.o. | 40 | MG | 8,20 | ||
| 123 | C01DX | ostatní vazodilatancia | parent. | H | ||||
| 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 14,10 | H | |
| 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 107,80 | H | |
| 76158 | CORVATON | inj 10x1ml/2mg | HBS | SK | ||||
| 124 | C01EA | prostaglandiny | parent. | X | ||||
| 124.1 | C01EA01 | alprostadil | parent. 0,5 | MG | 3442,50 | X | ||
| 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ | ||||
| 70426 | KARON | inj 0.2ml/100rg+sol | LEX | CZ | ||||
| 61219 | PROSTIN VR | inj 1x1ml/0.5mg | UPJ | B | ||||
| 124.2 C01EA01 alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 676,75 | X | |||
| 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D | ||||
| 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 7,45 | |||||
| 68571 | DOPAGEN | tbl obd 50x250mg | ANN | IRL | |||||||
| 01328 | DOPEGYT | tbl 50x250mg | EGI | H | |||||||
| 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 12,00 | |||||
| 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 12,00 | |||||
| 125.4 | C02AC05 | moxonidin | p.o. | 0.3 | MG | 12,00 | |||||
| 125.5 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,60 | |||||
| 02629 | CRYSTEPIN | drg 30 | LEX | CZ | |||||||
| 125.6 | C02LB01 | methyldopa/hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 5,05 | |||||
| 125.7 | C02LB01 | methyldopa/hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2 | DF | 3,50 | |||||
| 125.8 | C02AC06 | rilmenidin | p.o. | 1 | MG | 12,00 | |||||
| 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | H | |||||||
| 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 71,70 | H | ||||
| 92074 | CATAPRESAN | inj 5x1ml/0.15mg | BOE | D | |||||||
| 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | ||||||||
| 127.1 | C02CA | metazosin | p.o. | 20 | MG | 6,10 | |||||
| 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 7,05 | |||||
| 23338 | ADVERSUTEN-1 | tbl 50x1mg | VAD | D | |||||||
| 94315 | DEPRAZOLIN MITE | tbl 10x1mg | LEX | CZ | |||||||
| 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 2,55 | |||||
| 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ | |||||||
| 127.4 | C02CA06 | urapidil | p.o. | 50 | MG | 7,05 | |||||
| 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O | |||||||
| 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 231,05 | O | ||||
| 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D | |||||||
| 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D | |||||||
| 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 2,05 | |||
| 00110 | DIHYDRALAZIN SLOVAKOFARMA | tbl 50x25mg | SLO | SK | |||||
| 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,65 | |||
| 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,60 | L/INT,KAR | ||
| 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | H | |||||
| 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 290,50 | H | ||
| 03451 | HYPERSTAT | inj 1x20ml/300mg | SCH | USA | |||||
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 31,10 | H | ||
| 90484 | NEPRESOL | inj 5x25mg+solv. | CGC | CH | |||||
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 280,25 | H | ||
| 131 | C03AA | thiazidová diuretika | p.o. | ||||||
| 131.1 | C03AA03 | hydrochlorothiazid | p.o. | 25 | MG | 0,80 | |||
| 00168 | HYDROCHLOROTHIAZID LECIVA | tbl 20x25mg | LEX | CZ | |||||
| 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | ||||||
| 132.1 | C03BA | metipamid | p.o. | 2.5 | MG | 1,05 | |||
| 94810 | HYPOTYLIN | tbl 30x2.5mg | LEX | CZ | |||||
| 132.2 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,60 | |||
| 83551 | URANDIL | tbl 30x50mg(blistr.) | LEX | CZ | |||||
| 132.3 | C03BA10 | xipamid | p.o. | 20 | MG | 1,05 | |||
| 132.4 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,05 | |||
| 96696 | INDAP | cps 30x2.5mg | PMP | CZ | |||||
| 132.5 | C03B | cikletanin | p.o. | 50 | MG | 1,05 | |||
| 132.6 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,05 | |||
| 133 | C03CA | kličková diuretika | p.o. | ||||||
| 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,95 | |||
| 86717 | FURANTHRIL | tbl 50x40mg | PMM | BG | |||||
| 96375 | FUROMEX | tbl 100x40mg | ORN | SF | |||||
| 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40mg | SLO | SK | |||||
| 97935 | FURSEMID | tbl 100x40mg | BLU | CHO | ||||
| 96441 | FUROMEX | tbl 1000x40mg | ORN | SF | ||||
| 96737 | APO-FUROSEMIDE 20MG | tbl 1000x20mg | APT | CND | ||||
| 96809 | DRYPTAL | tbl 50x40mg | BER | GB | ||||
| 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,10 | ||
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK | ||||
| 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,95 | ||
| 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,10 | ||
| 134 | C03CA | kličková diuretika | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 16,40 | O | |
| 08984 | FURANTRAL | inj 25x2ml/20mg | PWO | PL | ||||
| 75072 | FUROSEMID-RATIOPHARM | inj 5x2ml/20mg | MCK | D | ||||
| 86904 | FURANTHRIL | inj 100x2ml/20mg | PMM | BG | ||||
| 86903 | FURANTHRIL | inj 50x2ml/20mg | PMM | BG | ||||
| 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,90 | O | |
| 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK | ||||
| 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 16,40 | O | |
| 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 7,90 | O | |
| 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 556,10 | O | |
| 135 | C03D | kalium šetřící diuretika | p.o. | |||||
| 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 5,25 | ||
| 96362 | XENALON-100 | tbl obd 20x100mg | MHA | CH | ||||
| 96361 | XENALON-50 | tbl obd 20x50mg | MHA | CH | ||||
| 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,60 | ||
| 87662 | AMICLARAN | tbl 50x5mg | SLO | SK | ||||
| 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,25 | ||
| 136 | C03EA | kombinace thiazidových a kalium šetřících diuretik | p.o. | |||||
| 136.1 | C03EA | středně silná diuretika a kalium šetřící látky | p.o. | 1 | DF | 1,25 | ||
| 88518 | AMICLOTON | tbl 30 | SLO | SK | ||||
| 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,65 | ||
| 83716 | AMILORID HCT AL | tbl 20 | APA | D | ||||
| 55924 | AMILORID HCT AL | tbl 30 | APA | D | ||||
| 83717 | AMILORID HCT AL | tbl 50 | APA | D | ||||
| 83718 | AMILORID HCT AL | tbl 100 | APA | D | ||||
| 70515 | APO-AMILZIDE 5/50MG | tbl 100x5mg/50mg | APT | CND | ||||
| 60194 | AQUARETIC | tbl 30 | AZU | D | ||||
| 60196 | AQUARETIC | tbl 100 | AZU | D | ||||
| 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 10,00 | ||
| 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 21,30 | O | |
| 01511 | REGITIN | inj 5x1ml 10mg | CGC | CH | ||||
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 80,25 | O | |
| 00440 | DIVASCOL | inj 10x1ml/10mg | SPX | CZ | ||||
| 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | |||||
| 138.1 | C04AC01 | kyselina nikotinová | p.o. | 0.2 | GM | 0,45 | ||
| 138.2 | C04AD | etophyllin | p.o. | 0.3 | GM | 1,65 | ||
| 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK | ||||
| 138.3 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 5,20 | ||
| 02673 | XANIDIL | tbl 30x150mg | LEX | CZ | ||||
| 75028 | XANIDIL RETARD | tbl ret 20x500mg | LEX | CZ | ||||
| 138.4 | C04AD03 | Pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 9,70 | ||
| 04184 | AGAPURIN | drg 60x100mg | SLO | SK | ||||
| 138.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 8,65 | ||
| 96180 | AGAPURIN 600 RETARD | tbl obd 20x600mg | SLO | SK | ||||
| 138.6 | C04AD03 | pentoxifyllin (od 100 do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 9,10 | ||
| 74961 | AZUPENTAT 400 RETARD | tbl obd 20x400mg | AZU | D | ||||
| 74962 | AZUPENTAT 400 RETARD | tbl obd 50x400mg | AZU | D | ||||
| 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | |||||
| 139.1 | C04AC | olamini nicotinas | parent. | 0.9 | GM | 20,50 | ||
| 139.2 | C04AD | etophyllin/theophyllin | parent. | 0.3 | GM | 11,30 | ||
| 00541 | OXYPHYLLIN | inj 5x2ml | HBS | SK | ||||
| 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,35 | ||
| 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 29,95 | ||||
| 31409 | TRENTAL | inj 10x15ml/300mg | HOE | D | ||||||
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK | ||||||
| 69241 | PENTILIN 100 | inj 5x5ml/100mg | KRK | SLO | ||||||
| 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,05 | ||||
| 91032 | SECATOXIN FORTE | gtt 1x25ml/62.5mg | GNO | CZ | ||||||
| 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,70 | ||||
| 140.3 | C04AE51 | hydrogenované ergotové alkaloidy, kombinace | p.o. | 2 | ML | 1,75 | ||||
| 88088 | ERSILAN | gtt 50ml | GNO | CZ | ||||||
| 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | |||||||
| 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 59,00 | ||||
| 00432 | DH-ERGOTOXIN LECIVA | inj 5x1ml/0.3mg | LEX | CZ | ||||||
| 142 | C04AX | jiná periferní vasodilatancia | p.o. | |||||||
| 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,40 | ||||
| 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,90 | ||||
| 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,40 | ||||
| 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,40 | ||||
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,40 | ||||
| 97026 | ENELBIN RETARD | tbl obd 50x100mg | LEX | CZ | ||||||
| 143 | C04AX | jiná periferní vasodilatancia | parent. | |||||||
| 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 15,20 | ||||
| 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 52,70 | ||||
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 52,70 | ||||
| 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ | ||||||
| 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | |||||||
| 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 1,00 | ||||
| 144.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1 | GM | 0,75 | ||||
| 144.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1 | DF | 1,00 | |||||
| 144.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1 | GM | 0,75 | |||||
| 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1 | DF | 1,00 | |||||
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,75 | |||||
| 00832 | AVIRIL H | ung 1x30gm | LEX | CZ | |||||||
| 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 145.1 | C05AX | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,80 | |||||
| 01966 | KETAZON H | ung 1x20gm 5% | LEX | CZ | |||||||
| 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | ||||||||
| 146.1 | C05BA | přípravky s heparinem k zevnímu použití | lok. | 1 | GM | 0,85 | |||||
| 146.2 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,85 | |||||
| 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D | |||||||
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D | |||||||
| 03575 | HEPAROID LECIVA | ung 1x30gm | LEX | CZ | |||||||
| 72931 | THROMBAREDUCT 60000 | ung 1x200gm | AZU | D | |||||||
| 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | ||||||||
| 147.1 | C05CA | bioflavonoidy (hydroxyethylrutosid) | p.o. | 0.9 | GM | 7,25 | |||||
| 147.2 | C05CA | bioflavonoidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,30 | |||||
| 04361 | ANAVENOL | drg 60x32mg | LEX | CZ | |||||||
| 147.3 | C05CA | bioflavonoidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,10 | |||||
| 02635 | ANAVENOL | gtt 1x25ml | GNO | CZ | |||||||
| 147.4 | C05CA | bioflavonoidy (tribenosid) | p.o. | 0.6 | GM | 7,25 | |||||
| 147.5 | C05CA04 | troxerutin | p.o. | 0.9 | GM | 7,25 | |||||
| 04336 | CILKANOL | cps 30x300mg | LEX | CZ | |||||||
| 147.6 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 7,25 | |||||
| 148 | C05 | jiné kapiláry stabilizující látky | p.o. | ||||||||
| 148.1 | C05BX01 | jiné kapiláry stabilizující látky (dobesilat vápenatý) | p.o. | 0.75 | GM | 6,90 | |||||
| 148.2 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 5,75 | |||||
| 94327 | YELLON | cps 30x20mg | SLO | SK | |||||||
| 149 | C05 | jiné kapiláry stabilizující látky | parent. | H | ||||
|---|---|---|---|---|---|---|---|---|
| 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 55,50 | H | |
| 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,95 | O | |
| 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D | ||||
| 08510 | AETHOXYSKLEROL 0,5% | inj 5x2ml 0.5% | KRS | D | ||||
| 149.3 | C05BB02 | polidokanol (od 0,5 do 1 % včetně) | parent. | 1 | ML | 17,20 | O | |
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml 1% | KRS | D | ||||
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml 1% | KRS | D | ||||
| 149.4 | C05BB02 | polidokanol (od 1 do 3 % včetně) | parent. | 1 | ML | 19,20 | O | |
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml 2% | KRS | D | ||||
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml 3% | KRS | D | ||||
| 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 20,90 | O | |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml 4% | KRS | D | ||||
| 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | L/KAR,INT | ||||
| 150.1 | C07AA07 Sotalol | p.o. | 0.16 | GM | 6,50 | L/KAR,INT | ||
| 83480 | SOTAHEXAL MITE | tbl 20x80mg | HEX | D | ||||
| 83668 | SOTAHEXAL MITE | tbl 50x80mg | HEX | D | ||||
| 83669 | SOTAHEXAL MITE | tbl 100x80mg | HEX | D | ||||
| 83481 | SOTAHEXAL | tbl 20x160mg | HEX | D | ||||
| 83670 | SOTAHEXAL | tbl 50x160mg | HEX | D | ||||
| 83671 | SOTAHEXAL | tbl 100x160mg | HEX | D | ||||
| 86641 | SOTALEX MITE | tbl 50x80mg | BRI | D | ||||
| 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | |||||
| 151.1 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,25 | ||
| 02484 | TRIMEPRANOL | tbl 50x40mg | SLO | SK | ||||
| 151.2 | C07AA | metipranolol (do 10 mg v 1 tabletě včetně) | p.o. | 10 | MG | 0,60 | ||
| 02483 | TRIMEPRANOL | tbl 50x10mg | SLO | SK | ||||
| 151.3 | C07AA02 | oxprenolol | p.o. | 0.1 | GM | 2,80 | ||
| 151.4 | C07AA03 | pindolol | p.o. | 15 | MG | 2,80 | ||
| 96757 | APO-PINDOL 5 | tbl 100x5mg | APT | CND | ||||
| 151.5 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,80 | ||
| 151.6 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2,80 | ||
| 151.7 | C07AA16 | tertatolol | p.o. | 5 | MG | 2,80 | ||
| 151.8 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,40 | ||||
| 96998 | SANDONORM | tbl 30x1mg | LEX | CZ | ||||||
| 151.9 | C07AA23 | penbutolol | p.o. | 40 | MG | 2,80 | ||||
| 151.10 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,80 | ||||
| 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | O | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 152.1 | C07AA | metipranolol | parent. | 10 | MG | 64,10 | O | |||
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK | ||||||
| 152.2 | C07AA | talinolol | parent. | 50 | MG | 95,80 | O | |||
| 20405 | CORDANUM | inj 10x5ml/10mg | VAD | D | ||||||
| 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 101,40 | O | |||
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 101,40 | O | |||
| 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 921,30 | O | |||
| 91614 | DAROB | inj 5x4ml/40mg | KNO | D | ||||||
| 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | |||||||
| 153.1 | C07AB02 | metoprolol | p.o. | 0.15 | GM | 2,80 | ||||
| 62493 | METOPROLOL DH 100MG DIAG HUMAN | tbl 100x100mg | GNS | GB | ||||||
| 92491 | METOPROLOL DH 50MG DIAG HUMAN | tbl 100x50mg | GNS | GB | ||||||
| 96755 | APO-METOPROLOL 100 | tbl 100x100mg | APT | CND | ||||||
| 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND | ||||||
| 153.2 | C07AB03 | atenolol | p.o. | 75 | MG | 3,60 | ||||
| 83643 | ATEHEXAL 50 | tbl obd 50x50mg | HEX | D | ||||||
| 83644 | ATEHEXAL 50 | tbl obd 100x50mg | HEX | D | ||||||
| 83646 | ATEHEXAL 100 | tbl obd 30x100mg | HEX | D | ||||||
| 83647 | ATEHEXAL 100 | tbl obd 50x100mg | HEX | D | ||||||
| 83648 | ATEHEXAL 100 | tbl obd 100x100mg | HEX | D | ||||||
| 62857 | ATENOBENE 50MG | tbl obd 50x50mg | MCK | D | ||||||
| 62860 | ATENOBENE 100MG | tbl obd 50x100mg | MCK | D | ||||||
| 89255 | ATENOLOL AL 50 | tbl obd 30x50mg | APA | D | ||||||
| 89256 | ATENOLOL AL 50 | tbl obd 50x50mg | APA | D | ||||||
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D | ||||||
| 89258 | ATENOLOL AL 100 | tbl obd 30x100mg | APA | D | ||||||
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D | ||||||
| 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D | ||||||
| 89769 | BETASYN 100 | tbl obd 30x100mg | TRM | D | ||||||
| 80438 | BETASYN 100 | tbl obd 100x100mg | TRM | D | ||||||
| 61487 | BLOCOTENOL 25 | tbl obd 50x25mg | AZU | D | ||||||
| 72987 | CATENOL 50 | tbl 100x50mg | CAD | IND | ||||||
| 72988 | CATENOL 100 | tbl 100x100mg | CAD | IND | ||||||
| 96445 | COROTENOL 100 | tbl obd 30x100mg | MHA | CH | ||||
| 65388 | TENORMIN | tbl obd 28x50mg | ZNC | GB | ||||
| 80437 | BETASYN 50 | tbl obd 100x50mg | TRM | D | ||||
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D | ||||
| 89252 | ATENOLOL AL 25 | tbl obd 30x25mg | APA | D | ||||
| 89253 | ATENOLOL AL 25 | tbl obd 50x25mg | APA | D | ||||
| 65389 | TENORMIN | tbl obd 28x100mg | ZNC | GB | ||||
| 61490 | BLOCOTENOL 50 | tbl obd 50x50mg | AZU | D | ||||
| 83642 | ATEHEXAL 50 | tbl obd 30x50mg | HEX | D | ||||
| 153.3 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 6,00 | ||
| 86324 | SECTRAL | tbl obd 20x200mg | RRO | F | ||||
| 80058 | SECTRAL 400 | tbl obd 30x400mg | RRO | F | ||||
| 75939 | ACECOR 400MG | tbl obd 30x400mg | SPA | I | ||||
| 153.4 | C07AB05 | betaxolol | p.o. | 20 | MG | 6,00 | ||
| 96475 | LOKREN 20MG | tbl fc 28x20mg | LSY | F | ||||
| 153.5 | C07AB07 | bisoprolol | p.o. | 10 | MG | 6,00 | ||
| 153.6 | C07AB08 | celiprolol | p.o. | 0.2 | GM | 6,00 | ||
| 153.7 | C07AB12 | nebivolol | p.o. | 5 | MG | 6,00 | ||
| 154 | C07AB | beta-blokátory, s beta-1 selektivitou | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1430,25 | O | |
| 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 2442,70 | O | |
| 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB | ||||
| 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1430,25 | O | |
| 155 | C07AG | alfa, beta-blokátory | p.o. | L/KAR,INT | ||||
| 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 19,40 | L/KAR,INT | |
| 98005 | LABETALOL DH 100MG DIAG HUMAN | tbl obd 100x100mg | GNS | GB | ||||
| 155.2 | C07AG02 | karvedilol (do 6,25mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 73,00 | L/KAR,INT | |
| 155.3 | C07AG02 | karvedilol (nad 6,25mg v 1 tabletě) | p.o. | 37.5 | MG | 30,00 | L/KAR,INT | |
| 156 | C07AG | alfa, beta-blokátory | parent. | H | ||||
| 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 959,40 | H | |
| 87508 | TRANDATE | inj 5x20ml/100mg | GLA | GB | ||||
| 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | |||||
| 157.1 | C07BB03 | atenolol a thiazidy | p.o. | 1 | DF | 4,50 | ||
| 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,50 | ||
| 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertens. | p.o. | 0.5 | DF | 0,75 | |
| 04367 | TRIMECRYTON | tbl 30(lekovka) | LEX | CZ | |||
| 76981 | TRIMECRYTON | tbl 30(blistr) | LEX | CZ | |||
| 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 13,50 | L/INT,KAR |
| 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 10,30 | |
| 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 10,30 | |
| 62524 | LOMIR | tbl 30x2.5mg | SAN | CH | |||
| 83370 | LOMIR SRO RETARD | cps ret 30x5mg | SAN | CH | |||
| 158.4 | C08CA05 | nifedipin | p.o. | 30 | MG | 2,00 | |
| 91199 | CORINFAR | drg 100x10mg | VAD | D | |||
| 97771 | NIFESAN | tbl obd 50x10mg | PMP | CZ | |||
| 87164 | SPONIF 10 | tbl obd 50x10mg | SLO | SK | |||
| 88754 | CORDIPIN | tbl 50x10mg | KRK | SLO | |||
| 158.5 | C08CA05 | nifedipin (retadrované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,15 | |
| 98043 | CORINFAR RETARD | drg 30x20mg | VAD | D | |||
| 98044 | CORINFAR RETARD | drg 50x20mg | VAD | D | |||
| 98045 | CORINFAR RETARD | drg 100x20mg | VAD | D | |||
| 94129 | DEPIN-E RETARD | tbl ret 100x20mg | CAD | IND | |||
| 91692 | NIFECARD RETARD | tbl ret 30x20mg | LEK | SLO | |||
| 65381 | NIFEHEXAL 20 RETARD | tbl obd 50x20mg | HEX | D | |||
| 65382 | NIFEHEXAL 20 RETARD | tbl obd 100x20mg | HEX | D | |||
| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO | |||
| 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,55 | |
| 65384 | NIFEHEXAL 40 RETARD | tbl obd 50x40mg | HEX | D | |||
| 65385 | NIFEHEXAL 40 RETARD | tbl obd 100x40mg | HEX | D | |||
| 83667 | NIFEHEXAL 40 RETARD | tbl ret 20x40mg | HEX | D | |||
| 158.7 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 163,05 | X |
| 88860 | NIMOTOP S | tbl 100x30mg | BAY | D | |||
| 97032 | NIMOTOP | tbl 126x30mg | BAY | D | |||
| 97031 | NIMOTOP | tbl 42x30mg | BAY | D | |||
| 158.8 | C08CA07 | nisoldipin | p.o. | 20 | MG | 10,30 | |
| 158.9 | C08CA08 | nitrendipin | p.o. | 20 | MG | 10,30 | |
| 158.10 | C08CA09 | lacidipin | p.o. | 4 | MG | 10,30 | |
| 158.11 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,50 | L/INT,KAR |
| 159 | C08CA | antagonisté vápníku dihydropyridinové řady | parent. | H | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 159.1 | C08CA03 | isradipin | parent. | 5 | MG | 3145,10 | H | ||||
| 96533 | LOMIR I.V. | inj 5x10ml 0.1mg/ml | SAN | CH | |||||||
| 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3145,10 | H | ||||
| 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3517,10 | X | ||||
| 88858 | NIMOTOP S | inf 1x50ml/10mg | BAY | D | |||||||
| 94535 | NIMOTOP S | inf 5x50ml/10mg | BAY | D | |||||||
| 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | ||||||||
| 160.1 | C08DA01 | verapamil | p.o. | 0.24 | GM | 5,25 | |||||
| 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D | |||||||
| 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D | |||||||
| 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D | |||||||
| 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D | |||||||
| 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D | |||||||
| 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D | |||||||
| 98019 | VERAPAMIL DH 120MG DIAG HUMAN | tbl obd 500x120mg | GNS | GB | |||||||
| 160.2 | C08DA01 | verapamil (retardované lékové formy s mg) | obsahem 240 | p.o. | 0.24 | GM | 6,30 | ||||
| 93679 | LEKOPTIN RETARD | tbl obd 20x240mg | LEK | SLO | |||||||
| 43877 | VEROGALID ER 240MG | tbl ret 30x240mg | GNO | CZ | |||||||
| 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,25 | |||||
| 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | H | |||||||
| 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 318,00 | H | ||||
| 092210 | LEKOPTIN | inj 50x2ml/5mg | LEK | SLO | |||||||
| 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | ||||||||
| 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,40 | |||||
| 93186 | BLOCALCIN | tbl 50x60mg | LCM | CZ | |||||||
| 94321 | BLOCALCIN 90 RETARD | tbl ret 30x90mg | LCM | CZ | |||||||
| 94314 | DIACORDIN 60 | tbl 50x60mg | LEX | CZ | |||||||
| 93711 | DIACORDIN 90 RETARD | tbl 30x90mg | LEX | CZ | |||||||
| 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,45 | |||||
| 76736 | DIACORDIN 120 RETARD | tbl ret 30x120mg | LEX | CZ | |||||||
| 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H | |||
|---|---|---|---|---|---|---|---|
| 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 326,50 | H |
| 99136 | DILZEM PARENTERAL | inj sic 5x100mg+sol | GOD | D | |||
| 93135 | DILZEM PARENTERAL | inj sic 5x25mg+5ml | GOD | D | |||
| 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | ||||
| 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 5,50 | |
| 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND | |||
| 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS | |||
| 31385 | TENSIOMIN 12.5MG | tbl 30x12.5mg | EGI | H | |||
| 164.2 | C09AA01 | kaptopril (od 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 5,00 | |
| 68839 | APO-CAPTO | tbl 100x25mg | APT | CND | |||
| 91021 | CAPOTEN | tbl 90x25mg | BMS | GB | |||
| 60242 | CAPOTEN | tbl 30x25mg | BMS | GB | |||
| 56195 | CAPOTEN | tbl 30x25mg | BMS | AUS | |||
| 56196 | CAPOTEN | tbl 90x25mg | BMS | AUS | |||
| 97873 | ALKADIL | tbl 40x25mg | ALK | MAC | |||
| 31215 | TENSIOMIN 25MG | tbl 30x25mg | EGI | H | |||
| 164.3 | C09AA02 | enalapril (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 6,05 | |
| 83505 | EDNYT 2.5MG | tbl 28x2.5mg | GED | H | |||
| 83507 | EDNYT 5MG | tbl 28x5mg | GED | H | |||
| 55637 | ENALAPRIL LACHEMA 5 | tbl 100x5mg | LCM | CZ | |||
| 85927 | ENALAPRIL LACHEMA 5 | tbl 20x5mg | LCM | CZ | |||
| 62596 | ENAP 5 | tbl 20x5mg | KRK | SLO | |||
| 164.4 | C09AA02 | enalapril (od 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 5,15 | |
| 55638 | ENALAPRIL LACHEMA 10 | tbl 100x10mg | LCM | CZ | |||
| 92576 | ENALAPRIL LACHEMA 10 | tbl 20x10mg | LCM | CZ | |||
| 83509 | EDNYT 10MG | tbl 28x10mg | GED | H | |||
| 94178 | ENAP 10 | tbl 20x10mg | KRK | SLO | |||
| 164.5 | C09AA02 | enalapril (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 4,05 | |
| 83511 | EDNYT 20MG | tbl 28x20mg | GED | H | |||
| 55639 | ENALAPRIL LACHEMA 20 | tbl 100x20mg | LCM | CZ | |||
| 85928 | ENALAPRIL LACHEMA 20 | tbl 20x20mg | LCM | CZ | |||
| 94179 | ENAP 20 | tbl 20x20mg | KRK | SLO | |||
| 164.6 | C09AA03 | lisinopril | p.o. | 10 | MG | 8,75 | |
| 67562 | DAPRIL 10 | tbl 30x10mg | MOE | CY | |||
| 67563 | DAPRIL 20 | tbl 20x20mg | MOE | CY | |||
| 67561 | DAPRIL 5 | tbl 30x5mg | MOE | CY | |||
| 164.7 | C09AA04 | perindopril | p.o. | 4 | MG | 10,30 | |
| 66375 | PRESTARIUM (COVERSYL) | tbl 30x4mg | SVE | F | |||
| 164.8 | C09AA05 | ramipril | p.o. | 2.5 | MG | 10,30 | |
| 62431 | TRITACE 1.25 | cps 20x1.25mg | HOE | D | |||
| 62432 | TRITACE 2.5 | cps 20x2.5mg | HOE | D | |||
| 62433 | TRITACE | cps 20x5mg | HOE | D | |||
| 562643 | TRITACE 1.2 | cps 50x1.25mg | HOE | D | |||
| 562646 | TRITACE 2.5 | cps 50x2.5mg | HOE | D | |||
| 62649 | TRITACE 5 | cps 50x5mg | HOE | D | |||
| 164.9 | C09AA06 | quinapril | p.o. | 15 | MG | 10,30 | |
| 99254 | ACCUPRO 10 | tbl obd 30x10mg | LEX | CZ | |||
| 62530 | ACCUPRO 20 | tbl obd 30x20mg | LEX | CZ | |||
| 62383 | ACCUPRO 5 | tbl obd 30x5mg | LEX | CZ | |||
| 94959 | ACCUPRO 10 | tbl obd 30x10mg | GOD | D | |||
| 94960 | ACCUPRO 20 | tbl obd 30x20mg | GOD | D | |||
| 164.10 | C09AA07 | benazepril | p.o. | 7.5 | MG | 10,30 | |
| 164.11 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 10,30 | |
| 164.12 | C09AA10 | trandolapril | p.o. | 2 | MG | 10,30 | |
| 83730 | GOPTEN 2MG | cps 28x2mg | KNO | D | |||
| 164.13 | C09AA11 | spirapril | p.o. | 6 | MG | 10,30 | |
| 164.14 | C09AA12 | delapril | p.o. | 30 | MG | 10,30 | |
| 164.15 | C09AA13 | moexipril | p.o. | 15 | MG | 10,30 | |
| 164.16 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 4,70 | |
| 91022 | CAPOTEN | tbl 90x50mg | BMS | GB | |||
| 56198 | CAPOTEN | tbl 90x50mg | BMS | AUS | |||
| 97874 | ALKADIL | tbl 40x50mg | ALK | MAC | |||
| 31216 | TENSIOMIN 50MG | tbl 20x50mg | EGI | H | |||
| 165 | C09AA | inhibitory angiotenzin konvertujícího enzymu | parent. | H | |||
|---|---|---|---|---|---|---|---|
| 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 30,35 | H |
| 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO | |||
| 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | ||||
| 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 6,10 | |
| 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 6,10 | |
| 60148 | ENAP H | tbl 20 | KRK | SLO | |||
| 166.3 | C09BA06 | quinapril a diuretika | p.o. | 1 | DF | 6,95 | |
| 76708 | ACCUZIDE | tbl obd 30 | GOD | D | |||
| 166.4 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 6,95 | |
| 166.5 | C09B | trandolapril/verapamil | p.o. | 1 | DF | 16,60 | |
| 167 | C09CA | antagonisté angiotensinu II | p.o. | Z | |||
|---|---|---|---|---|---|---|---|
| 167.1 | C09CA01 | losartan | p.o. | 50 | MG | 33,00 | Z |
| 167.2 | C09CA03 | valsartan | p.o. | 80 | MG | 33,00 | Z |
| 56239 | DIOVAN 80 | cps 28x80 | NPA | CH | |||
| 167.3 | C09CA04 | irbesartan | p.o. | 150 | MG | 33,00 | Z |
| 168 | C10AA | hypolipidemika ze skupiny statinů | p.o. | P | |||
a) léčba pacientů s familiární hypercholesterolemií,
b) léčba pacientů s manifestní atherosklerózou s izolovanou hypercholesterolemií nebo s kombinovanou hyperlipoproteinemií s pouze mírným zvýšením triacylglycerolu,
c) léčba pacientů s kumulací rizikových faktorů s izolovanou hypercholesterolemií nebo s kombinovanou hyperlipoproteinemií s pouze mírným zvýšením triacylglycerolu,
d) u ostatních pacientů pouze po předchozím schválení revizním lékařem.
| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 39,60 | P | |
| 168.2 | C10AA01 | simvastatin (od 10 do 20 mg v jedné tabletě včetně) | p.o. | 15 | MG | 33,10 | P | |
| 168.3 | C10AA01 | simvastatin (nad 20 mg v jedné tabletě ) | p.o. | 15 | MG | 23,65 | P | |
| 168.4 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 30 | MG | 39,60 | P | |
| 168.5 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě ) | p.o. | 30 | MG | 31,50 | P | |
| 168.6 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 20 | MG | 44,00 | P | |
| 168.7 | C10AA03 | pravastatin (nad 10 mg v jedné tabletě) | p.o. | 20 | MG | 35,00 | P | |
| 86040 | LIPOSTAT 20MG | tbl 30x20mg | BMS | I | ||||
| 168.8 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 40 | MG | 37,40 | P | |
| 65335 | LESCOL 20MG | cps 28x20mg | SAN | CH | ||||
| 168.9 | C10AA04 | fluvastatin (nad 20 mg v jedné tabletě) | p.o. | 40 | MG | 29,75 | P | |
| 65336 | LESCOL 40MG | cps 28x40mg | SAN | CH | ||||
| 168.10 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 10 | MG | 39,20 | P | |
| 168.11 | C10AA05 | atorvastatin (nad 10 MG v jedné tabletě) | p.o. | 10 | MG | 23,65 | P | |
| 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | |||||
|---|---|---|---|---|---|---|---|---|
| 169.1 | C10AB | etofylin klofibrát | p.o. | 0.5 | GM | 5,20 | ||
| 96992 | DUOLIP FORTE 500 | tbl 100x500mg | MCK | A | ||||
| 96357 | DUOLIP FORTE 500 | tbl 30x500mg | MCK | A | ||||
| 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 10,00 | |
| 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 10,00 | |
| 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 10,00 | |
| 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 0.3 | GM | 22,30 | |
| 92327 | LIPANTHYL 200 M | cps 30x200mg | LCM | CZ | |||
| 76502 | LIPANTHYL 200 M | cps 30x200mg | FFR | F | |||
| 169.6 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 10,00 | |
| 84430 | LIPANOR | cps 30x100mg | SWI | F | |||
| 169.7 | C10AD06 | acipimox | p.o. | 500 | MG | 12,00 | |
| 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | P | |||
|---|---|---|---|---|---|---|---|
a) léčba pacientů s hyperlipoproteinemií s vysokou hladinou cholesterolu,
b) léčba pacientů s pruritem při biliární cirhóze.
| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 34,15 | P |
| 94031 | VASOSAN P | plv 1x400gm | FOP | D | |||
| 94033 | VASOSAN S | plv 1x400gm | FOP | D | |||
| 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 60,75 | P |
| 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | ||||
|---|---|---|---|---|---|---|---|
| 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,00 | |
| 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ | |||
| 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 2,00 | |
| 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | ||||
| 172.1 | D01AC01 | klotrimazol | lok. | 1 | GM | 2,00 | |
| 86262 | CANESTEN | crm 1x20gm | LEX | CZ | |||
| 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D | |||
| 86397 | CLOTRIMAZOL AL 1% | crm 1x50gm 1% | APA | D | |||
| 172.2 | D01AC02 | mikonazol | lok. | 1 | GM | 2,00 | |
| 172.3 | D01AC03 | ekonazol | lok. | 1 | GM | 4,00 | |
| 172.4 | D01AC03 | ekonazol (lékové formy lipogelu a pasty) | lok. | 1 | GM | 4,65 | |
| 62665 | PEVARYL | pst 1x30gm 1% | CIL | CH | |||
| 172.5 | D01AC05 | isokonazol | lok. | 1 | ML | 2,00 | |
| 172.6 | D01AC08 | ketokonazol | lok. | 1 | GM | 2,00 | |||||
| 172.7 | D01AC10 | bifonazol | lok. | 1 | GM | 5,00 | |||||
| 172.8 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,55 | |||||
| 99248 | MYFUNGAR | crm 1x30gm | LEX | CZ | |||||||
| 99249 | MYFUNGAR | plv ads 1x30gm | LEX | CZ | |||||||
| 172.9 | D01AC12 | fenticonazol | lok. | 1 | GM | 2,00 | |||||
| 172.10 | D01AC20 | kombinace | lok. | 1 | GM | 2,00 | |||||
| 172.11 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 2,00 | |||||
| 172.12 | D01AC60 | bifonazol, kombinace | lok. | 1 | GM | 30,00 | P | ||||
| Léčbu ordinuje dermatolog u onychomykóz, doložených kultivačním vyšetřením a dokladovanou kontraindikací k použití systémové antimykotické terapie. | |||||||||||
| 172.13 | D01AC | sertakonazol | lok. | 1 | GM | 4,00 | |||||
| 173 | D01AE | antimykotika pro lokální podání ostatních skupin | lok. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 173.1 | D01AE | jiná antimykotika k zevnímu použití (nitroethanoldodecylsulfonat) | lok. | 1 | ML | 0,90 | |||||
| 00799 | NITROFUNGIN | liq 1x25ml | GNO | CZ | |||||||
| 173.2 | D01AE04 | kyselina undecylenová | lok. | 1 | GM | 0,85 | |||||
| 00871 | MYKOSEPTIN | ung 1x30gm | LEX | CZ | |||||||
| 173.3 | D01AE14 | ciclopirox | lok. | 1 | GM | 4,00 | |||||
| 76150 | BATRAFEN | crm 1x20gm | HBS | SK | |||||||
| 76152 | BATRAFEN | liq 1x20ml | HBS | SK | |||||||
| 06291 | BATRAFEN ROZTOK | sol 1x20ml 1% | HOE | D | |||||||
| 173.4 | D01AE15 | terbinafin | lok. | 1 | GM | 4,00 | |||||
| 173.5 | D01AE16 | amorolfin | lok. | 1 | GM | 4,00 | |||||
| 173.6 | D01AE18 | tolnaftat | lok. | 1 | GM | 2,00 | |||||
| 173.7 | D01AE19 | tolciklát | lok. | 1 | GM | 2,00 | |||||
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1 | GM | 2,00 | |||||
| 173.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1 | GM | 0,65 | |||||
| 02353 | HEXADECYL | spr 1x70ml | GNO | CZ | |||||||
| 173.10 | D01AE | naftini hydrochlorid | lok. | 1 | GM | 3,00 | |||||
| 174 | D01BA | antimykotika pro celkové podání | p.o. | P |
|---|
a) léčba onychomykóz způsobených dermatofyty (doložených kultivačním nebo mikroskopickým vyšetřením),
b) léčba těžkých forem dermatomykóz způsobených dermatofyty (doložených kultivačním nebo mikroskopickým vyšetřením).
| 174.1 | D01BA01 | griseofulvin | p.o. | 0.5 | GM | 5,90 | |||||||
| 01606 | GRICIN | tbl 100x125mg | VAD | D | |||||||||
| 174.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 71,50 | P | ||||||
| 62387 | LAMISIL | tbl 14x125mg | SAN | CH | |||||||||
| 62388 | LAMISIL | tbl 14x250mg | SAN | CH | |||||||||
| 175 | D02AB | emolliencia obsahující oxid zinečnatý | lok. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,70 | |||||||
| 88597 | TEKUTY PUDR AA 100GM GLO | sus 1x100gm | GAO | CZ | |||||||||
| 88598 | TEKUTY PUDR S MENTOLEM | sus 1x116gm | GAO | CZ | |||||||||
| 176 | D02AC | emolliencia obsahující měkký parafin a tukové produkty | lok. | L/DER,PDD | |||||||||
| 176.1 | D02AC | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) | lok. | 1 | ML | 0,80 | L/DER,PDD | ||||||
| 60078 | LINOLA-FETT OLBAD | ole 1x250ml | WOL | D | |||||||||
| 89996 | LINOLA-FETT OLBAD | ole 1x200ml | WOL | D | |||||||||
| 176.2 | D02AC | měkký parafin a tukové produkty (nad 250 ml v 1 balení) | lok. | 1 | ML | 0,60 | L/DER,PDD | ||||||
| 60079 | LINOLA-FETT OLBAD | ole 1x500ml | WOL | D | |||||||||
| 60406 | BALNEUM HERMAL | liq 2x500ml(1000ml) | HEM | D | |||||||||
| 176.3 | D02AC01 | měkký parafin a tukové produkty (do 250 gm v 1 balení včetně) | lok. | 1 | GM | 0,80 | L/DER,PDD | ||||||
| 176.4 | D02AC01 | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1 | GM | 0,60 | L/DER,PDD | ||||||
| 60406 | BALNEUM HERMAL | liq 2x500ml(1000ml) | HEM | D | |||||||||
| 176.5 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny | lok. | 1 | ML | 0,60 | L/DER,PDD | ||||||
| 177 | D02AX | jiná emolliencia a protektiva | lok. | ||||||||||
| 177.1 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1 | GM | 1,75 | |||||||
| 00891 | POLYSAN | pst 1x50gm | SLO | SK | |||||||||
| 177.2 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1 | GM | 0,65 | |||||||
| 04192 | POLYSAN | pst 1x650gm | SLO | SK | |||||||||
| 88603 | POLYSAN CUM OLEUM HELIANTI GLO | ung 1x900gm | GAO | CZ | |||||||||
| 177.3 | D03AX | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1 | ML | 0,50 | |||||||
| 177.4 | D03AX02 | dextranomer | lok. | 1 | GM | 4,00 | |
| 178 | D03BA | proteolytické enzymy | lok. | P | |||
|---|---|---|---|---|---|---|---|
a) léčba bércových vředů,
b) léčba nekrotických poúrazových nebo pooperačních ran,
c) ošetřování nekrotických ran a dekubitů.
| 178.1 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1 | GM | 81,10 | P |
| 01915 | CHYMOTRYPSIN INFUSIA | plv ads 1x1gm | IHO | CZ | |||
| 178.2 | D03BA | proteolytické enzymy (kolagenáza) | lok. | 1 | GM | 19,00 | P |
| 178.3 | D03BA | proteolytické enzymy (plasmin/deoxiribonukleáza) | lok. | 1 | GM | 15,00 | P |
| 62518 | FIBROLAN | ung 1x50gm | PDA | D | |||
| 42261 | FIBROLAN | ung 1x100gm | PDA | D | |||
| 178.4 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1 | GM | 29,50 | P |
| 179 | D05AA | antipsoriatika ze skupiny dehtů a derivátů vitaminu D | lok. | ||||
|---|---|---|---|---|---|---|---|
a) léčba torpidních lokalizovaných forem psoriázy nereagující na standardní léčbu v množství maximálně 100 g týdně.
b) v ostatních případech pouze po schválení revizním lékařem zdravotní pojišťovny.
| 179.1 | D05AA | dehty (odbarvený dehet) | lok. | 1 | GM | 1,25 | ||
| 179.2 | D05AA | dehty | lok. | 1 | GM | 0,75 | ||
| 92428 | BALSAMUM VISNEVSKI CSC | sus 1x600gm | CSP | CZ | ||||
| 92430 | BALSAMUM VISNEVSKI CSC | sus 1x3kg | CSP | CZ | ||||
| 00859 | ICHTOXYL | ung 1x30gm | LEX | CZ | ||||
| 00860 | ICHTOXYL | ung 1x1000gm | LEX | CZ | ||||
| 00889 | PITYOL | ung 1x30gm | LEX | CZ | ||||
| 00894 | SALOXYL | ung 1x30gm | LEX | CZ | ||||
| 00895 | SALOXYL | ung 1x1000gm | LEX | CZ | ||||
| 85950 | SUSPENSIO VISNEVSKI + PICE LIQUID | sus 1x1000gm | HEO | CZ | ||||
| 86399 | SUSPENSIO VISNEVSKI + PICE LIQUID | sus 1x1000gm | PSR | CZ | ||||
| 92553 | SUSPENSIO VISNEV.+PICE LIQ.TAU. | sus 1x400gm | TAU | CZ | ||||
| 92554 | SUSPENSIO VISNEV.+PICE LIQ.TAU. | sus 1x800gm | TAU | CZ | ||||
| 05595 | UNGUENTUM ICHTHAMOLI LECIVA 10% | ung 1x1000gm 10% | LEX | CZ | ||||
| 05868 | UNGUENTUM ICHTHAMOLI LECIVA 10% | ung 1x900gm 10% | LEX | CZ | ||||
| 83870 | UNGUENTUM ICHTAMOLI 10% MVM | ung 1x1kg | MVM | CZ | ||||
| 83871 | UNGUENTUM ICHTAMOLI 20% MVM | ung 1x1kg | MVM | CZ | ||||
| 85331 | UNGUENTUM ICHTHAMOLI LECIVA 10% | ung 1x20gm 10% | LEX | CZ | ||||
| 92547 | UNGUENTUM ICHTAMOLI 10% TAURUS | ung 1x400gm | TAU | CZ | ||||
| 92548 | UNGUENTUM ICHTAMOLI 10% TAURUS | ung 1x800gm | TAU | CZ | ||||
| 179.3 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1 | ML | 4,35 | ||
| 90618 | OXSORALEN | liq 1x50ml 0.15% | GER | A | ||||
| 179.4 | D05AC01 | dithranol | lok. | 1 | GM | 4,00 | |
| 179.5 | D05AX02 | kalcipotriol | lok. | 1 | GM | 12,00 | P |
| 179.6 | D05AX04 | tacalcitol | lok. | 1 | GM | 16,00 | P |
| 180 | D05BB | retinoidy pro celkové podání | p.o. | P | |||
|---|---|---|---|---|---|---|---|
a) léčba těžkých generalizovaných forem psoriázy nereagujících na jinou léčbu,
b) ostatní těžké formy poruchy keratinizace nereagující na jinou léčbu pouze po předchozím schválení revizním lékařem
c) kožní T-lymfomy
| 180.1 | D05BB01 | etretinát | p.o. | 35 | MG | 86,20 | P | ||||
| 180.2 | D05BB02 | acitretin | p.o. | 35 | MG | 86,20 | P | ||||
| 76660 | NEOTIGASON ROCHE 10MG | cps 30x10mg | HLR | CH | |||||||
| 76661 | NEOTIGASON ROCHE 25MG | cps 30x25mg | HLR | CH | |||||||
| 180.3 | D05BA02 methoxalen | p.o. | 10 | MG | 4,25 | L/DER | |||||
| 03733 | OXSORALEN | cps 50x10mg | GER | A | |||||||
| 181 | D06AX | antibiotika k zevnímu použití | lok. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 181.1 | D06AA | tetracyklin a deriváty | lok. | 1 | GM | 3,00 | |||||
| 181.2 | D06AX | neomycin/bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,90 | |||||
| 55759 | PAMYCON NA PRÍPRAVU KAPEK | plv 1x1 lahv | BTA | SK | |||||||
| 181.3 | D06AX | neomycin/bacitracin (zásyp do 2 g včetně) | lok. | 1 | GM | 14,00 | |||||
| 01062 | FRAMYKOIN | plv ads 1x2gm | IHO | CZ | |||||||
| 181.4 | D06AX | neomycin/bacitracin (zásyp nad 2 g) | lok. | 1 | GM | 2,40 | |||||
| 01063 | FRAMYKOIN | plv ads 1x20gm | IHO | CZ | |||||||
| 181.5 | D06AX | neomycin/bacitracin (mast) | lok. | 1 | GM | 2,50 | |||||
| 01066 | FRAMYKOIN | ung 1x10gm | LEX | CZ | |||||||
| 181.6 | D06AX | primycin | lok. | 1 | GM | 2,50 | |||||
| 181.7 | D06AX02 chloramfenikol | lok. | 1 | GM | 2,95 | ||||||
| 03015 | CHLORAMPHENICOL LECIVA | ung 1x10gm 1% | LEX | CZ | |||||||
| 181.8 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1 | GM | 8,50 | |||||
| 181.9 | D06AX09 | mupirocin (nad 5 g v jednom balení) | lok. | 1 | GM | 5,30 | |||||
| 182 | D06BA | sulfonamidy s obsahem stříbrných solí k lokálnímu podání | lok. | L/DER,CHI | |||||||
| 182.1 | D06BA | sulfathiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,10 | L/DER,CHI | ||||
| 182.2 | D06BA | jsulfathiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 1,00 | L/DER,CHI |
| 182.3 | D06BA01 | sulfadiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,40 | L/DER,CHI |
| 62229 | DERMAZIN | crm 1x50gm 1% | LEK | SLO | |||
| 182.4 | D06BA01 | sulfadiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 1,15 | L/DER,CHI |
| 182.5 | D06BA02 | sulfathiazol | lok. | 1 | GM | 1,05 | |
| 00899 | SULFATHIAZOL SLOVAKOFARMA | ung 1x20gm 5% | SLO | SK | |||
| 182.6 | D06BA03 | mafenid | lok. | 1 | GM | 1,00 | L/DER,CHI |
| 182.7 | D06BA51 sulfadiazin stříbrný v kombinaci | lok. | 100 | CM2 | 21,45 | L/DER,CHI | |
| 183 | D07AA | kortikosteroidy třídy I, slabě účinné | lok. | ||||
|---|---|---|---|---|---|---|---|
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 2,55 | |
| 00858 | HYDROCORTISON LECIVA | ung 1x10gm 1% | LEX | CZ | |||
| 01958 | HYDROCORTISON LECIVA | ung 1x50gm 1% | LEX | CZ | |||
| 183.2 | D07AA03 | prednisolon | lok. | 1 | GM | 3,50 | |
| 60097 | LINOLA-H-FETT N | crm 1x100gm | WOL | D | |||
| 184 | D07AB | kortikosteroidy třídy II, středně účinné | lok. | ||||
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,50 | |
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,50 | |
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,50 | |
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,50 | |
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,25 | |
| 02828 | TRIAMCINOLON LECIVA | crm 1x10gm 0.1% | LEX | CZ | |||
| 02829 | TRIAMCINOLON LECIVA | ung 1x10gm 0.1% | LEX | CZ | |||
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1 | ML | 2,90 | |
| 02826 | TRIAMCINOLON | lot 1x15gm | GNO | CZ | |||
| 184.7 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1 | GM | 0,75 | |
| 02488 | TRIAMCINOLON | spr 1x55.8gm | GNO | CZ | |||
| 184.8 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1 | ML | 1,00 | |
| 184.9 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 1,50 | |
| 02415 | DEXAMETHAZON LECIVA | crm 10gm 0.01% | LEX | CZ | |||
| 01965 | DEXAMETHAZON LECIVA | ung 1x10gm 0.025% | LEX | CZ | |||
| 185 | D07AC | kortikosteroidy třídy III, účinné (fluorované) | lok. | ||||
|---|---|---|---|---|---|---|---|
| 185.1 | D07AC01 | betamethason dipropionát | lok. | 1 | GM | 2,55 | |
| 98034 | DIPROSONE | crm 1x30gm | SCH | B | |||
| 98032 | DIPROSONE | ung 1x30gm | SCH | B | |||
| 88489 | KUTERID | crm 29gm | LEK | SLO | |||
| 88495 | KUTERID | ung 20gm | LEK | SLO | |||
| 185.2 | D07AC01 | betamethason valerát | lok. | 1 | GM | 3,35 | |
| 185.3 | D07AC02 | fluklorolon | lok. | 1 | GM | 3,50 | |
| 185.4 | D07AC04 | fluocinolon | lok. | 1 | GM | 3,00 | |
| 04156 | GELARGIN | gel 1x25gm | LEX | CZ | |||
| 97900 | SYNALAR | gel 1x30gm | ICI | GB | |||
| 97901 | SYNALAR | ung 1x30gm | ICI | GB | |||
| 97902 | SYNALAR | crm 1x30gm | ICI | GB | |||
| 185.5 | D07AC06 | diflukortolon | lok. | 1 | GM | 3,50 | |
| 185.6 | D07AC08 | fluocinonid | lok. | 1 | GM | 3,00 | |
| 185.7 | D07AC09 | budesonid | lok. | 1 | GM | 3,25 | |
| 185.8 | D07AC12 | halometason | lok. | 1 | GM | 3,35 | |
| 185.9 | D07AC17 | flutikason | lok. | 1 | GM | 3,50 | |
| 186 | D07AC | kortikosteroidy třídy III, účinné (nefluorované) | lok. | L/DER,ALG,PDD | |||
| 186.1 | D07AC13 | mometazon | lok. | 1 | GM | 6,85 | L/DER,ALG,PDD |
| 186.2 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1 | GM | 6,85 | L/DER,ALG,PDD |
| 83154 | DERMATOP | crm 1x10gm 2.5mg/gm | HBS | SK | |||
| 83156 | DERMATOP | ung 1x10gm 2.5mg/gm | HBS | SK | |||
| 186.3 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1 | GM | 6,00 | L/DER,ALG,PDD |
| 187 | D07AD | kortikosteroidy třídy IV, vysoce účinné | lok. | L/DER | |||
| 187.1 | D07AD01 | klobetasol | lok. | 1 | GM | 4,50 | L/DER |
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,75 | L/DER |
| 97019 | BETACORTON | liq 1x25ml | SEG | CH | |||
| 188 | D07BB | kortikosteroidy, středně účinné, kombinace s antiseptiky | lok. | |||||
|---|---|---|---|---|---|---|---|---|
| 188.1 | D07BA01 | prednisolon/cloroxin | lok. | 1 | GM | 3,80 | ||
| 188.2 | D07BB | flumethason pivalat/kyselina salicylová | lok. | 1 | GM | 3,00 | ||
| 188.3 | D07BB01 | flumetason a antiseptika | lok. | 1 | GM | 3,90 | ||
| 03405 | LORINDEN C | ung 15gm | POL | PL | ||||
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1 | GM | 1,45 | ||
| 02975 | TRIAMCINOLON | spm 40gm | GNO | CZ | ||||
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 | GM | 0,60 | ||
| 02825 | TRIAMCINOLON COMPOSITUM | spr 51.4gm | GNO | CZ | ||||
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,40 | ||
| 02827 | TRIAMCINOLON | tct 1x10ml | GNO | CZ | ||||
| 188.7 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,85 | ||
| 04178 | TRIAMCINOLON E LECIVA | ung 1x20gm | LEX | CZ | ||||
| 188.8 | D07BA01 | prednisolon/hexamidin diisothionát | lok. | 1 | GM | 2,00 | ||
| 189 | D07X | kortikosteroidy, jiné kombinace | lok. | |||||
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 2,00 | ||
| 189.2 | D07XA02 | prednisolon/kyselina salicylová | lok. | 1 | ML | 1,50 | ||
| 92411 | ALPICORT | sol 1x100ml | WOL | D | ||||
| 189.3 | D07XB01 | flumetason | lok. | 1 | GM | 4,50 | ||
| 09297 | LOCACORTEN TAR | ung 1x60gm | CGC | CH | ||||
| 189.4 | D07XB02 | triamcinolon | lok. | 1 | GM | 1,85 | ||
| 04160 | TRIAMCINOLON S LECIVA | ung 1x30gm | LEX | CZ | ||||
| 189.5 | D07XC | diflucortolon/isoconasol | lok. | 1 | GM | 2,80 | ||
| 189.6 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,80 | ||
| 189.7 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,80 | ||
| 189.8 | D07XD | halcinonid/kyselina salicylová | lok. | 1 | ML | 3,65 | ||
| 189.9 | D07XD | halcinonid/močovina | lok. | 1 | GM | 3,65 | ||
| 189.10 | D07XA01 | hydrocortison/natamycin/neomycin | lok. | 1 | GM | 2,00 | ||
| 189.11 | D07XA01 | hydrocortison/natamycin/neomycin | lok. | 1 | ML | 2,00 | |||||
| 190 | D08A | antiseptika a desinficiencia | lok. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190.1 | D08AC02 | chlorhexidin | lok. | 1000 | ML | 182,80 | |||||
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,65 | |||||
| 05579 | UNGUENTUM ACIDI BORICI LECIVA | ung 1x1000gm 3% | LEX | CZ | |||||||
| 84467 | UNGUENTUM ACIDI BORICI 10% CSC | ung 1x1000gm | CSP | CZ | |||||||
| 23045 | UNGUENTUM ACIDI BORICI 3% CSC | ung 1x1000gm | CSP | CZ | |||||||
| 92479 | UNGUENTUM ACIDI BORICI 10% TAU. | ung 1x400gm | TAU | CZ | |||||||
| 92480 | UNGUENTUM ACIDI BORICI 10% TAU. | ung 1x800gm | TAU | CZ | |||||||
| 190.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10 | GM | 1,35 | |||||
| 84469 | SOLUTIO JARISCH CSC | liq 1x1000gm | CSP | CZ | |||||||
| 92555 | SOLUTIO JARISCH TAURUS | sol 1x500gm | TAU | CZ | |||||||
| 92556 | SOLUTIO JARISCH TAURUS | sol 1x1000gm | TAU | CZ | |||||||
| 92780 | SOLUTIO JARISCH CSL4 PROFARMA | sol 1x500gm | PSR | CZ | |||||||
| 92781 | SOLUTIO JARISCH CSL4 PROFARMA | sol 1x1000gm | PSR | CZ | |||||||
| 190.4 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení ) | lok. | 1 | ML | 1,00 | |||||
| 62318 | BETADINE (CHIRURG.) | liq 1x120ml | EGI | H | |||||||
| 190.5 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1 | ML | 0,50 | |||||
| 190.6 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1 | GM | 2,00 | |||||
| 190.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení včetně) | lok. | 1 | GM | 1,00 | |||||
| 190.8 | D08AH | kloroxin | lok. | 1 | GM | 0,80 | |||||
| 03008 | ENDIARON | pst 1x30gm 5% | LEX | CZ | |||||||
| 190.9 | D08AJ | bromid benzododecinia (vodný roztok do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,35 | |||||
| 190.10 | D08AJ | bromid benzododecinia (tinktura do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,35 | |||||
| 00739 | AJATIN TINCTURA | tct 1x50ml 1% | SLO | SK | |||||||
| 190.11 | D08AJ | chlorid karbetopendecinia (tinktura do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,30 | |||||
| 00814 | SEPTONEX | tct 1x50ml 1% | SLO | SK | |||||||
| 191 | D08AX | jiná antiseptika a desinficiencia | lok. | H | |||||||
| 191.1 | D08AX | hexamidin/chlorhexidin | lok. | 1 | ML | 124,15 | H | ||||
| 191.2 | D08AX | noxytiolin | lok. | 2.5 | GM | 503,40 | H | ||||
| 191.3 | D08AX | noxytiolin/tetrakain | lok. | 2.5 | GM | 503,40 | H | ||||
| 191.4 | D08AX | taurolidin | lok. | 1 | GM | 96,65 | H | |||
| 93242 | TAUROLIN | gel 1x50gm/1.75gm | GSO | CH | ||||||
| 192 | D10A | lokálně podávaná léčiva k léčbě akne | lok. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 4,10 | ||||
| 03740 | RETIN A | crm 1x30gm 0.05% | CIL | CH | ||||||
| 97573 | RETIN A | crm 1x30gm 0.025% | CIL | CH | ||||||
| 192.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1 | GM | 4,50 | ||||
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,20 | ||||
| 192.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1 | ML | 4,50 | ||||
| 192.5 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,50 | ||||
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0,40 | ||||
| 91816 | INOXITAN | lot 100ml 50mg/ml | GNO | CZ | ||||||
| 192.7 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,60 | ||||
| 192.8 | D10AF01 | klindamycin | lok. | 1 | ML | 2,00 | ||||
| 192.9 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 3,00 | ||||
| 192.10 | D10AF02 | erythromycin (lékové formy roztoků) do 60 mg včetně v jednom balení | lok. | 1 | ML | 2,35 | ||||
| 98204 | ERYFLUID | sol 1x30ml | PFB | F | ||||||
| 192.11 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,00 | ||||
| 192.12 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 2,00 | ||||
| 192.13 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,90 | ||||
| 75285 | ERYFLUID | sol 1x100ml | PFB | F | ||||||
| 193 | D10B | celkově podávaná léčiva k léčbě akné | p.o. | X | ||||||
| 193.1 | D10BA01 | isotretinoin | p.o. | 30 | MG | 94,95 | X | |||
| 91843 | ROACCUTANE ROCHE | cps 30x20mg | HLR | CH | ||||||
| 11685 | ROACCUTANE ROCHE | cps 30x10mg | HLR | CH | ||||||
| 194 | D11AX | jiná dermatologika | lok. | L/DER | ||||||
| 194.1 | D11AX | celulóza (lékové formy zásypů) | lok. | 1 | GM | 10,00 | L/DER | |||
| 194.2 | D11AX | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 10,001 | L/DER |
| 194.3 | D11AX | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,45 | L/DER,ONK |
| 03739 | EFUDIX | ung 1x20gm 5% | HLR | CH | |||
| 195 | G01AA | vaginálně podávaná antimykotika a antibiotika | vag. | ||||
|---|---|---|---|---|---|---|---|
a) léčba bakteriální vaginózy v těhotenství,
b) vaginitis s průkazem citlivosti bakteriálních kmenů na clindamycin.
| 195.1 | G01AA01 | nystatin | vag. | 100 | KU | 1,00 | |
| 195.2 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25 | MG | 4,20 | |
| 02047 | PIMAFUCIN | tbl vag 20x25mg+apl | YEU | NL | |||
| 195.3 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25 | MG | 7,65 | |
| 195.4 | G01AA10 | klindamycin | vag. | 1 | GM | 13,10 | P |
| 196 | G01AF | vaginálně podávané imidazolové deriváty | vag. | ||||
|---|---|---|---|---|---|---|---|
| 196.1 | G01AF | deriváty imidazolu | vag. | 0.1 | GM | 6,50 | |
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,80 | |
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 9,10 | |
| 62862 | CANDIBENE(FUNGIZID-RATIOPHARM) | tbl vag 6x100mg | MCK | D | |||
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,80 | |
| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D | |||
| 196.5 | G01AF04 | mikonazol | vag. | 0.1 | GM | 9,10 | |
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,80 | |
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 32,00 | |
| 06095 | GYNO-PEVARYL 50 | glo vag 15x50mg | CIL | CH | |||
| 06096 | GYNO-PEVARYL 150 | glo vag 3x150mg | CIL | CH | |||
| 196.8 | G01AF11 | ketoconazol | vag. | 0.4 | GM | 13,75 | |
| 196.9 | G01AF12 | fenticonazol | vag. | 0.1 | GM | 13,75 | |
| 196.10 | G01AF17 | oxikonazol | vag. | 0.6 | GM | 82,90 | |
| 99250 | GYNO-MYFUNGAR | tbl vag 1x600mg | LEX | CZ | |||
| 196.11 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80 | MG | 13,80 | |
| 196.12 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80 | MG | 32,00 | |
| 197 | G01AX | vaginálně podávaná jiná antiinfektiva a antiseptika | vag. | ||||
|---|---|---|---|---|---|---|---|
| 197.1 | G01AX | laktobacillus | vag. | 1 | DF | 10,50 | |
| 197.2 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1 | DF | 18,00 | |
| 197.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5 | GM | 36,00 | |
| 197.4 | G01AX | nitrofurantoin | vag. | 0.2 | GM | 2,05 | |
| 03629 | FURANTOIN LECIVA | tbl vag 30x100mg | LEX | CZ | |||
| 197.5 | G01AX | polykresol | vag. | 1 | GM | 1,50 | |
| 197.6 | G01AX05 | nifuratel | p.o. | 0.6 | GM | 16,00 | L/GYN,URN |
| 197.7 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.2 | GM | 9,40 | |
| 197.8 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.2 | GM | 6,30 | |
| 94623 | BETADINE | gel vag 1x100gm+apl. | MUP | CH | |||
| 197.9 | G01AX12 | ciklopirox | vag. | 1 | GM | 6,40 | |
| 76153 | BATRAFEN | crm vag 40gm+6xapl. | HBS | SK | |||
| 197.10 | G01A | sulfathiazol | vag. | 1 | DF | 6,75 | |
| 197.11 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1 | DF | 6,55 | |
| 198 | G02AB | uterotonika ze skupiny námelových alkaloidů | p.o. | ||||
| 198.1 | G02AB02 | ergotové alkaloidy | p.o. | 0.2 | MG | 1,15 | |
| 198.2 | G02AB03 | ergometrin | p.o. | 0.2 | MG | 1,15 | |
| 199 | G02AB | uterotonika ze skupiny námelových alkaloidů | parent. | ||||
| 199.1 | G02AB01 | methylergometrin | parent. | 0.2 | MG | 16,30 | |
| 00509 | METHYLERGOMETRIN SPOFA | inj 5x1ml/0.2mg | SPX | CZ | |||
| 199.2 | G02AB03 | ergometrin | parent. | 0.2 | MG | 9,60 | |
| 200 | G02AD | uterotonika ze skupiny prostaglandinů | p.o. | H | |||
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 97,50 | H |
| 86287 | PROSTIN E2 | tbl 10x0.5mg | UPJ | GB | |||
| 201 | G02AD | uterotonika ze skupiny prostaglandinů | vag. | K/P | |||
a) preindukce porodu při ukončení těhotenství,
b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,
d) v poporodním období při závažné metrorhagii.
| 201.1 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 951,70 | K/P |
| 201.2 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 448,65 | K/P |
| 91607 | PROSTIN E2 | tbl vag 4x3mg | UPJ | B | |||
| 201.3 | G02AD02 | dinoproston (od 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1176,60 | K/P |
| 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | K/P | |||
|---|---|---|---|---|---|---|---|
a) preindukce porodu při ukončení těhotenství,
b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,
d) v poporodním období při závažné metrorhagii.
| 202.1 | G02AD01 | dinoprost | parent. | 25 | MG | 666,80 | K/P |
| 202.2 | G02AD02 | dinoproston | parent. | 0.5 | MG | 398,80 | K/P |
| 67188 | PROSTIN E2 SS 1MG/ML | inj 1x0.75ml | UPJ | B | |||
| 67189 | PROSTIN E2 SS 10MG/ML | inj 1x0.5ml | UPJ | B | |||
| 202.3 | G02AD04 | karboprost | parent. | 0.25 | MG | 691,10 | K/P |
| 202.4 | G02AD05 | sulproston | parent. | 0.5 | MG | 666,80 | K/P |
| 203 | G02CA | tokolytika ze skupiny beta-sympatomimetik | p.o. | P | |||
|---|---|---|---|---|---|---|---|
| Léčbu ordinuje gynekolog: pouze jako pokračování parenterální aplikace tokolytik. | |||||||
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 11,05 | P |
| 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A | |||
| 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 24,20 | P |
| 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 24,20 | P |
| 21391 | PARTUSISTEN | tbl 50x5mg | BOE | D | |||
| 204 | G02CA | tokolytika ze skupiny beta-sympatomimetik | parent. | U/P | |||
a) zahájení tokolytické léčby po 20. týdnu těhotenství,
b) léčba porodní dystokie,
c) intrapartální akutní tokolýza.
| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 46,40 | U/P |
| 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 46,40 | U/P |
| 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 46,40 | U/P |
| 03399 | PARTUSISTEN | inf 25x10ml/0.5mg | BOE | D | |||
| 205 | G02CB | inhibitory prolaktinu | p.o. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 205.1 | G02CB | tergurid | p.o. | 1 | MG | 4,35 | |||||
| 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ | |||||||
| 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 15,00 | |||||
| 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,55 | |||||
| 83321 | LYSENYL FORTE | tbl 30x0.2mg-blistr | LEX | CZ | |||||||
| 04372 | LYSENYL FORTE | tbl 30x0.2mg-lekov. | LEX | CZ | |||||||
| 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 27,70 Z | |||||
| 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 27,70 Z | |||||
| 206 | G03B | androgeny | p.o. | L/END,ONK,GYN,SEX | |||||||
| 206.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 30,10 | L/END,ONK,GYN, SEX | ||||
| 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,50 | L/END,ONK,GYN, SEX | ||||
| 09591 | PROVIRON 25 | tbl 20x25mg | SAG | D | |||||||
| 09592 | PROVIRON 25 | tbl 50x25mg | SAG | D | |||||||
| 207 | G03B | androgeny | parent. | L/END,ONK,GYN,SEX | |||||||
| 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 12,15 | L/END,ONK,GYN, SEX | ||||
| 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK | |||||||
| 00372 | AGOVIRIN | inj 5x1ml/25mg | SPX | CZ | |||||||
| 208 | G03CA | přirozené a semisyntetické estrogeny | p.o. | P | |||||||
a) substituční léčba žen po předčasné menopauze,
b) léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
Estriol, léčbu ordinuje gynekolog, urolog, sexuolog nebo endokrinolog: léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 208.1 | G03CA | mestranol | p.o. | 0.15 | MG | 3,85 | P | |
| 21105 | MESTRANOL | tbl 20x50rg | VJP | D | ||||
| 208.2 | G03CA57 | přírodní konj. estrogeny (do 625 RG včetně v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 7,50 | P | |
| 56299 | OESTROFEMINAL 0.3 | cps 21x0.3mg | MAC | D | ||||
| 83387 | OESTROFEMINAL 0.6 | cps 21x0.6mg | MAC | D | ||||
| 208.3 | G03CA03 | estradiol (do 2 mg v jedné tabletě včetně) | p.o. | 2 | MG | 8,00 | P | |
| 208.4 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 2 | MG | 5,55 | P | |
| 208.5 | G03CA03 | estradiol (s uvolněním do 50 RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 5,55 | P | |||||
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 100 RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 8,00 | P | |||||
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 12,00 | P | |||||
| 208.8 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 6,00 | P | |||||
| 76922 | OESTROGEL | gel 1x80gm | LBE | F | ||||||||
| 208.9 | G03CA03 | estradiol | vag. | 25 | RG | 6,00 | P | |||||
| 208.10 | G03CA04 | estriol | p.o. | 2 | MG | 8,00 | P | |||||
| 31315 | OVESTIN | tbl 30x2mg | ORG | NL | ||||||||
| 208.11 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,25 | P | |||||
| 97170 | OVESTIN | crm 15gm+aplikator | ORG | NL | ||||||||
| 208.12 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 6,00 | P | |||||
| 97590 | ORTHO-GYNEST D | sup vag 6 | CIL | CH | ||||||||
| 208.13 G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,30 | P | ||||||
| 208.14 | G03CA57 | přírodní konj. estrogeny (nad 625 RG v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 5,25 | P | |||||
| 09467 | OESTROFEMINAL 1.25 | cps 21x1.25mg | MAC | D | ||||||||
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 5,00 | ||||||
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK | ||||||||
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK | ||||||||
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,75 | ||||||
| 00529 | NEOFOLLIN | inj 5x1ml/5mg | BTA | SK | ||||||||
| 209.3 | G03CA04 | estriol | parent. | 2 | MG | 4,40 | ||||||
| 210 | G03D | progestiny | p.o. | L/GYN,URN,END,INT, SEX | ||||||||
| 210.1 | G03DA02 | medroxyprogesteron | p.o. | 5 | MG | 4,10 | L/GYN,URN,END, INT,SEX | |||||
| 91231 | PROVERA | tbl 24x5mg | UPJ | B | ||||||||
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 17,80 | L/GYN,URN,END, INT,SEX | |||||
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 4,10 | L/GYN,URN,END, INT,SEX | |||
| 210.4 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,85 | L/GYN,URN,END, INT,SEX | |||
| 210.5 | G03DC03 | lynestrenol | p.o. | 5 | MG | 3,50 | L/GYN,URN,END, INT,SEX | |||
| 210.6 | G03DC05 | tibolon | p.o. | 2.5 | MG | 33,45 | Z | |||
| 96226 | LIVIAL | tbl 1x28 | ORG | NL | ||||||
| 211 | G03D | progestiny | parent. | L/GYN,URN,SEX | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 211.1 | G03DA03 | hydroxyprogesteron | parent. | 10 | MG | 1,80 | L/GYN,URN,SEX | |||
| 00531 | NEOLUTIN FORTE | inj 5x1ml/125mg | SPX | CZ | ||||||
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 4,60 | L/GYN,URN,SEX | |||
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | SK | ||||||
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,20 | L/GYN,URN,SEX | |||
| 02094 | AGOLUTIN | inj 5x2ml/60mg | BTA | SK | ||||||
| 212 | G03E | androgeny a ženské pohlavní hormony | parent. | L/GYN,END,SEX | ||||||
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 25,70 | L/GYN,END,SEX | |||
| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK | ||||||
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 75,00 | L/GYN,END,SEX | |||
| 213 | G03F | progestiny a estrogeny | p.o. | P | ||||||
léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 213.1 | G03FA01 | norethisteron a estrogen | p.o. | 1 | DF | 9,50 | P |
| 213.2 | G03FA01 | norethisteron a estrogen | transd. | 50 | RG | 9,50 | P |
| 213.3 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,20 | P |
| 67425 | CYCLO-MENORETTE | tbl obd 3x21(=63) | WYE | D | |||
| 84582 | CYCLOOSTROGYNAL | drg 21 | ASH | D | |||
| 84583 | CYCLOOSTROGYNAL | drg 3x21(=63) | ASH | D | |||
| 213.4 | G03FB05 | norethisteron a estrogen | p.o. | 1 | DF | 7,55 | P |
| 213.5 | G03HB01 | cyproteron/estradiol | p.o. | 0.75 | DF | 7,95 | P |
| 83374 | CILMEN | drg 3x21(11+10) | SAG | D | |||
| 214 | G03GA | gonadotrofin (choriový) | parent. | L/GYN,END,PDD,SEX | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 25,90 | L/GYN,END,PDD, SEX | ||||
| 10809 | PREGNYL | inj 3x500ut+solv. | ORG | NL | |||||||
| 214.2 | G03GA01 | choriový gonadotrofin (od 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 17,55 | L/GYN,END,PDD, SEX | ||||
| 00563 | PRAEDYN | inj 5x1.5ku+5x2ml | LEX | CZ | |||||||
| 11951 | PREGNYL | inj 3x1500ut+solv. | ORG | NL | |||||||
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 11,60 | L/GYN,END,PDD, SEX | ||||
| 02966 | PRAEDYN | inj sic 5x3ku+sol | LEX | CZ | |||||||
| 96314 | PREGNYL | inj 3x5000ut+solv. | ORG | NL | |||||||
| 215 | G03GA | gonadotrofin (lidský) | parent. | Z | |||||||
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 367,40 | Z | ||||
| 83166 | PERGOGREEN 75 | inj sic 10x75ut+1ml | LSE | CH | |||||||
| 83167 | PERGOGREEN 75 | inj sic 10x75ut+1ml | SRO | I | |||||||
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 367,40 | Z | ||||
| 215.3 | G03GA05 | folitrofin beta | parent. | 75 | U | 600,00 | Z | ||||
| 215.4 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75 | U | 600,00 | Z | ||||
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | L/GYN,END,SEX | |||||||
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,35 | L/GYN,END,SEX | ||||
| 83672 | CLOMHEXAL 50 | tbl 10x50mg | HEX | D | |||||||
| 02628 | GRAVOSAN | tbl 30x50mg | LEX | CZ | |||||||
| 217 | G03HA | antiandrogeny | p.o. | L/PSY,END,URN,GYN, SEX | |||||||
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 200,00 | L/PSY,END,URN, GYN,SEX | ||||
| 77006 | ANDROCUR 10MG | tbl 15x10mg | SAG | D | |||||||
| 77007 | ANDROCUR 10MG | tbl (3x15)=45x10mg | SAG | D | |||||||
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 73,15 | L/PSY,END,URN, GYN,SEX | ||||
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D | |||||||
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D | |||||||
| 218 | G03HA | antiandrogeny | parent. | L/PSY,SEX | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 137,80 | L/PSY,SEX,URN | |||||
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D | ||||||||
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | L/GYN,END,HEM, ALG, SEX | ||||||||
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 85,60 | L/GYN,END,HEM, ALG,SEX | |||||
| 67525 | ANARGIL 100MG | cps 100x100mg | MOE | CY | ||||||||
| 67526 | ANARGIL 100MG | cps 200x100mg | MOE | CY | ||||||||
| 67527 | ANARGIL 100MG | cps 500x100mg | MOE | CY | ||||||||
| 67528 | ANARGIL 200MG | cps 100x200mg | MOE | CY | ||||||||
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY | ||||||||
| 67530 | ANARGIL 200MG | cps 500x200mg | MOE | CY | ||||||||
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 48,45 | L/GYN,END,HEM, ALG,SEX | |||||
| 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | |||||||||
| 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 7,90 | ||||||
| 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 20,00 | ||||||
| 220.3 | G04AB04 | kyselina oxolinová | p.o. | 1 | GM | 7,90 | ||||||
| 91101 | DESUROL | tbl 50x250mg | LEX | CZ | ||||||||
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | |||||||||
| 221.1 | G04AC01 | nitrofurantoin | p.o. | 0.2 | GM | 2,00 | ||||||
| 90510 | FURANTOIN LECIVA | tbl ent 20x100mg | LEX | CZ | ||||||||
| 221.2 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,00 | ||||||
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | |||||||||
| 222.1 | G04BC | rozpouštědla močových kamenů | p.o. | 10 | GM | 6,15 | ||||||
| 02150 | ALKALIT | gra 1x200gm | IHO | CZ | ||||||||
| 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX,GER | ||||||||
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 14,00 | L/URN,GYN,SEX GER | |||||
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 14,00 | L/URN,GYN,SEX GER | |||||
| 66791 | DITROPAN | tbl 30x5mg | MDD | F | ||||||||
| 04365 | CYSTRIN 5MG | tbl obd 100x5mg | LOY | SF | ||||||||
| 89785 | CYSTRIN 3MG | tbl obd 100x3mg | LOY | SF | ||||||||
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 12,60 | L/URN,GYN,SEX PDD, GER | ||||
| 66820 | MICTONETTEN | drg 100x5mg | APG | D | |||||||
| 92255 | MICTONETTEN | drg 30x5mg | APG | D | |||||||
| 66819 | MICTONETTEN | drg 50x5mg | APG | D | |||||||
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 8,50 | L/URN,GYN,SEX GER | ||||
| 66818 | MICTONORM | drg 100x15mg | APG | D | |||||||
| 92254 | MICTONORM | drg 30x15mg | APG | D | |||||||
| 66817 | MICTONORM | drg 50x15mg | APG | D | |||||||
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 224.1 | G04BX | doxazosin | p.o. | 4 | MG | 20,80 | L/URN | ||||
| 224.2 | G04BX | terazosin | p.o. | 5 | MG | 20,80 | L/URN | ||||
| 76487 | HYTRIN 5MG | tbl 28x5mg | ABB | GB | |||||||
| 224.3 | G04BX | extrakt Pyg. africanum v komb. | p.o. | 2 | DF | 20,60 | L/URN | ||||
| 224.4 | G04BX | mepartricin | p.o. | 150 | KU | 25,00 | L/URN | ||||
| 224.5 | G04BX02 | alfuzosin | p.o. | 7.5 | MG | 25,00 | L/URN | ||||
| 224.6 | G04BX02 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 25,00 | L/URN | ||||
| 224.7 | G04BX04 | finasterid | p.o. | 5 | MG | 25,00 | L/URN | ||||
| 224.8 | G04BX07 | extrakt Pyg. africanum | p.o. | 2 | DF | 20,60 | L/URN | ||||
| 42212 | TADENAN 50MG | cps 30 | DEB | F | |||||||
| 224.9 | G04BX08 | tamsulosin | p.o. | 0.4 | MG | 25,00 | L/URN | ||||
| 224.10 | G04BX09 | extrakt Serenoa repens | p.o. | 320 | MG | 20,60 | L/URN | ||||
| 225 | H01A | hormony předního laloku hypofýzy | parent. | ||||||||
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 61,30 | L/END | ||||
| 01524 | SYNACTHEN | inj10x1ml/0.25mg | CGC | CH | |||||||
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 782,75 | L/J5 | ||||
| 86419 | SAIZEN | inj sic 1x4ut+1ml | SRO | MEX | |||||||
| 56362 | ZOMACTON 12 | inj sic 5x12ut+solv | FEI | D | |||||||
| 96132 | NORDITROPIN PENSET 12UT | inj sic 1x12ut+solv | NOO | DK | |||||||
| 96133 | NORDITROPIN PENSET 24UT | inj sic 1x12ut+solv | NOO | DK | |||||||
| 56033 | NORDITROPIN 12I.U. | inj sic 1x12ut+solv | NOO | DK | |||||||
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H | |||||||
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 84,30 | H | ||||
| 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 308,80 | H |
| 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | LEX | CZ | |||
| 03648 | REMESTYP | inj 5x2ml/0.2mg | FRL | CZ | |||
| 226.3 | H01BA05 | ornipresin | parent. | 5 | U | 28,20 | H |
| 226.4 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 250,90 | H |
| 44357 | REMESTYP 1.0 | inj 5x10ml/1mg | LEX | CZ | |||
| 227 | H01BA | vasopresin a jeho deriváty | lok. | ||||
|---|---|---|---|---|---|---|---|
| 227.1 | H01BA02 | desmopresin (nasálně) | lok. | 25 | RG | 21,10 | |
| 02634 ADIURETIN SD | gtt nas 1x5ml/0.5mg | FRL | CZ | ||||
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H | |||
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 41,10 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ | |||
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 18,50 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ | |||
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | |||
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 192,25 | Z |
| 86238 | KRYPTOCUR | inh sol 1x10gm+pump | HOE | D | |||
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X | |||
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 8237,20 | X |
| 92109 | SOMATOSTATIN | inj sic 1x250rg+1ml | UCB | B | |||
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | |||
| 83084 | SOMATOSTATIN 6MG | inj sic 1x6mg+solv. | UCB | B | |||
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5166,60 | X |
| 93864 | SANDOSTATIN | inj 5x1ml/0.05mg | SAN | CH | |||
| 93865 | SANDOSTATIN | inj 5x1ml/0.1mg | SAN | CH | |||
| 93866 | SANDOSTATIN | inj 5x1ml/0.5mg | SAN | CH | |||
| 93867 | SANDOSTATIN | inj 5x1ml/1mg-lahv. | SAN | CH | |||
| 230.3 | H01CB03 | lantreotid | parent. | 2,14 | MG | 2265,70 | X |
| 231 | H02AA | mineralokortikoidy | p.o. | ||||
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,90 | |
| 23865 | FLUDROCORTISON | tbl 100x0.1mg | SQH | D | |||
| 232 | H02AB | glukokortikoidy | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,50 | |
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 10,45 | |
| 67218 | FORTECORTIN 4 | tbl 30x4mg | MEC | D | |||
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | |||
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,50 | |
| 00105 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-lahv. | LEX | CZ | |||
| 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ | |||
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,50 | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,55 | |
| 86606 | MEDROL | tbl 50x16mg(blistr) | UPJ | B | |||
| 93617 | MEDROL | tbl 50x16mg(lekov.) | UPJ | B | |||
| 232.6 | H02AB07 | prednison | p.o. | 10 | MG | 2,55 | |
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | |||
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | |||
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,80 | |
| 00332 | TRIAMCINOLON LECIVA | tbl 20x4mg | LEX | CZ | |||
| 93268 | TRICORT | tbl 100x4mg | CAD | IND | |||
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 8,35 | |
| 77002 | CORTEF 20MG | tbl 100x20mg | UPJ | USA | |||
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | |||
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,85 | |
| 80588 CORTISON CIBA 25MG | tbl 100x25mg | CGC | CH | ||||
| 233 | H02AB | glukokortikoidy | parent. | O | |||
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,95 | O |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 4,35 | O |
| 89870 | DIPROPHOS | inj 1x1ml | SCH | B | |||
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F | |||
| 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 27,15 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D | |||
| 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,70 | O | |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | ||||
| 96108 | DEXONA | inj 6x2ml 4mg/ml | CAD | IND | ||||
| 96109 | DEXONA | inj 8x6x2ml | CAD | IND | ||||
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 37,00 | O | |
| 67191 | PROMEDROL STERILE SOLUTION | inj 1x0.8ml/40mg | UPJ | B | ||||
| 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B | ||||
| 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,60 | O | |
| 233.7 | H02AB04 | methylprednisolon (od 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,95 | O | |
| 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B | ||||
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,90 | O | |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | ||||
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,55 | O | |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | ||||
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 11,60 | O | |
| 62922 | TRICORT-40 | inj 6x1ml/40mg | CAD | IND | ||||
| 62921 | TRICORT | inj 6x1ml/10mg | CAD | IND | ||||
| 08006 | KENALOG 10 | inj 1x5ml/50mg | LEX | CZ | ||||
| 02126 | KENALOG 40 | inj 1x5ml/200mg | LEX | CZ | ||||
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 10,35 | O | |
| 03950 | SOLU-CORTEF | inj sic 1x100mg | UPJ | B | ||||
| 06199 | SOLU-CORTEF | inj sic 25x100mg | UPJ | B | ||||
| 00484 | HYDROCORTISON SOLUBILE VUAB | inj 1x100mg | VUA | CZ | ||||
| 234 | H03AA | hormony štítné žlázy | p.o. | |||||
|---|---|---|---|---|---|---|---|---|
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,20 | ||
| 61161 | JODTHYROX | tbl 100 | MEC | D | ||||
| 61160 | JODTHYROX | tbl 50 | MEC | D | ||||
| 234.2 | H03AA01 | levothyroxin sodný (nad 50 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,50 | ||
| 85602 | ELTROXIN | tbl 1000x0.1mg | GLA | D | ||||
| 62191 | EUTHYROX 150 | tbl 100x150rg | MEC | D | ||||
| 77587 | L-THYROXIN 100 BERLIN-CHEMIE | tbl 100x100rg | BCE | D | ||||
| 96146 | L-THYROXINE 100 HENNING | tbl 100x100rg | HNB | D | ||||
| 96150 | L-THYROXINE 150 HENNING | tbl 100x150rg | HNB | D | ||||
| 234.3 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 2,05 | ||
| 77584 | L-THYROXIN 50 BERLIN-CHEMIE | tbl 100x50rg | BCE | D | ||||
| 234.4 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,30 | ||||
| 234.5 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 2,50 | ||||
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D | ||||||
| 03876 | THYREOTOM FORTE | tbl 60x150rg | BCE | D | ||||||
| 234.6 | H03CA | jódová terapie | p.o. | 200 | RG | 1,85 | ||||
| 61158 | JODID 100 | tbl 100 | MEC | D | ||||||
| 61159 | JODID 200 | tbl 100 | MEC | D | ||||||
| 235 | H03B | thyreostatika | p.o. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,35 | ||||
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 2,90 | ||||
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | ||||||
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,15 | ||||
| 06073 | FAVISTAN | tbl 20x20mg | ASD | D | ||||||
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,70 | ||||
| 236 | H03B | thyreostatika | parent. | H | ||||||
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,60 H | ||||
| 20617 | FAVISTAN | inj 10x1ml/40mg | ASD | D | ||||||
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA | ||||||
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 413,90 L/DIA | ||||
| 90511 | GLUCAGON | inj sic 1x10mg+sol | LIL | USA | ||||||
| 02392 | GLUCAGON | inj sic 1x1mg+sol | LIL | USA | ||||||
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 830,00 | L/DIA | |||
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK | ||||||
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | ||||||
| 238.1 | H05BA01 | kalcitonin (lososí, do 50 U v jednom balení včetně) | inhal. | 200 | U | 297,00 | L/INT,GYN,ORT, END | |||
| 78279 | MIACALCIC NASAL (+POCITAC DAVEK) | spr 1x14x50ut | SAN | CH | ||||||
| 238.2 | H05BA01 | kalcitonin (lososí, nad 50 U v jednom balení) | inhal. | 200 | U | 263,00 | L/INT,GYN,ORT, END | |||
| 78280 | MIACALCIC NASAL (+POCITAC DAVEK) | spr 1x14x100ut | SAN | CH | ||||||
| 56091 | MIACALCIC NASAL 200 | spr nas 1x2 ml | NPA | CH | ||||||
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 239.1 | H05BA01 | kalcitonin (lososí, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 128,25 | L/INT,GYN,ORT, END | ||||
| 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B | |||||||
| 239.2 | H05BA01 | kalcitonin (lososí, nad 50 U v jedné ampuli) | parent. | 100 | U | 161,00 | L/INT,GYN,ORT, END | ||||
| 89222 | UCECAL 100 I.U. | inj 5x1ml/100ut | UCB | B | |||||||
| 239.3 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 128,25 | L/INT,GYN,ORT, END | ||||
| 239.4 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 161,00 | L/INT,GYN,ORT, END | ||||
| 240 | J01AA | tetracyklinová antibiotika | p.o. | ||||||||
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,10 | |||||
| 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ | |||||||
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | |||||||
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | |||||||
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | |||||||
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | |||||||
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,10 | |||||
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,10 | |||||
| 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,10 | |||||
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,10 | |||||
| 241 | J01AA | tetracyklinová antibiotika | parent. | K | |||||||
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 96,80 K | |||||
| 94790 | VIBRAMYCIN | inj sic 1x200mg | PFI | B | |||||||
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | |||||||
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | |||||||
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 96,80 | K | ||||
| 242 | J01BA | amfenikolová antibiotika | p.o. | ||||||||
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25,30 | |||||
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | |||||||
| 243 | J01BA | amfenikolová antibiotika | parent. | K | |||
|---|---|---|---|---|---|---|---|
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 222,95 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | |||
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 180,35 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | ||||
| 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 17,00 | |
| 96893 | APO-AMPI 250MG | cps 100x250mg | APT | CND | |||
| 96895 | APO-AMPI 500MG | cps 100x500mg | APT | CND | |||
| 60916 | AMPICILIN 250 LECIVA | cps 20x250mg | LEX | CZ | |||
| 60917 | AMPICILIN 250 LECIVA | cps 30x250mg | LEX | CZ | |||
| 60920 | AMPICILIN 500 LECIVA | cps 20x500mg | LEX | CZ | |||
| 60921 | AMPICILIN 500 LECIVA | cps 30x500mg | LEX | CZ | |||
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 20,70 | |
| 84508 | AMPICILIN 250 LECIVA | sir sic 1x5gm/100ml | LEX | CZ | |||
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) | p.o. | 1 | GM | 10,35 | |
| 66370 | OSPAMOX 1000MG | tbl obd 12x100mg | BCA | A | |||
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | |||
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | |||
| 77065 | APO-AMOXI 500MG | cps 100x500mg | APT | CND | |||
| 244.4 | J01CA04 | amoxicilin (tekuté lékové formy) | p.o. | 1 | GM | 13,35 | |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | |||
| 244.5 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 17,00 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K | |||
| 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,70 | K |
| 60248 PENTREXYL | inj sic 50x250mg | BMS | I | ||||
| 246 | J01CA | acylureidová antibiotika | parent. | U/ATB | |||
| 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 1.046,30 | U/ATB |
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1376,90 | U/ATB |
| 93546 | ISIPEN | inj 1x2gm | KRK | SLO | |||
| 12336 | PIPRAKS | inj sic 1x2gm+10ml | ECZ | TR | |||
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 2026,35 | U/ATB |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 247.1 | J01CE02 | fenoxymethylpenicilin (1 MU a více v jedné tabletě) | p.o. | 2 | GM | 21,05 | |||
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | |||||
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | |||||
| 69468 | PENBENE | tbl obd 30x1mu | MCK | D | |||||
| 69467 | PENICILLIN V 1 MEGA VON CT | tbl obd 10x1mu | CTA | D | |||||
| 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 1 MU v jedné tabletě) | p.o. | 2 | GM | 19,55 | |||
| 84626 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-lekov. | SLO | SK | |||||
| 84627 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-lekov. | SLO | SK | |||||
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | |||||
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | |||||
| 247.3 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 15,50 | |||
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | |||||
| 247.4 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 32,20 | |||
| 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO | |||||
| 247.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 kIU v 5 ml včetně) | p.o. | 2 | GM | 77,25 | |||
| 98281 | INFECTOCILLIN 250 SIRUP | gra sus 1x75ml | INF | D | |||||
| 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 kIU v 5 ml) | p.o. | 2 | GM | 26.90 | |||
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | |||||
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 140,25 | K | ||
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | |||||
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 56,75 | K | ||
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | |||||
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.0 | MU | 72,25 | K | ||
| 01089 | PENDEPON | inj 10x600ku | BTA | SK | |||||
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.0 | MU | 33,70 | K | ||
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 81,40 | K | ||
| 01101 | PROKAIN PENICILIN G BIOTIKA | inj 10x600ku | BTA | SK | |||||
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,15 | K | ||
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK | |||||
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,40 | K | ||||
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK | |||||||
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 29,40 | |||||
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 40,90 | |||||
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 29,40 | |||||
| 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ | |||||||
| 60247 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | I | |||||||
| 60437 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | USA | |||||||
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 40,90 | |||||
| 02999 | OXACILIN | plv sus 80ml 4.84gm | GNO | CZ | |||||||
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | |||||||
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 101,00 | K | ||||
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | |||||||
| 92357 | PROSTAPHLIN 250MG | inj sic 50x250mg | BMS | I | |||||||
| 60243 | PROSTAPHLIN 250MG | inj sic 50x250mg | BMS | USA | |||||||
| 92358 | PROSTAPHLIN 500MG | inj sic 50x500mg | BMS | I | |||||||
| 60245 | PROSTAPHLIN 500MG | inj sic 50x500mg | BMS | USA | |||||||
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | ||||||||
| 251.1 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 41,75 | |||||
| 85524 | AMOKSIKLAV | tbl obd 21x375mg | LEK | SLO | |||||||
| 251.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 51,90 | |||||
| 74991 | AMOKSIKLAV | plv sus 1x100ml | LEK | SLO | |||||||
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 40,80 | |||||
| 96416 | AMOKSIKLAV FORTE | plv sus 1x100ml | LEK | SLO | |||||||
| 251.4 | J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 104,80 | |||||
| 251.5 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 137,70 | |||||
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg v 1 tabletě) | p.o. | 1 | GM | 38,00 | |||||
| 94935 | AMOKSIKLAV | tbl obd 16x625mg | LEK | SLO | |||||||
| 85525 | AMOKSIKLAV | tbl obd 21x625mg | LEK | SLO | |||||||
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | ||||
|---|---|---|---|---|---|---|---|---|
| 252.1 | J01CR01 | ampicilin a inhibitor beta-laktamázy | parent. | 1,5 | GM | 180,00 | U/ATB | |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 112,95 | U/ATB | |
| 97659 | AUGMENTIN I.V. | inj 10x600mg | LEX | CZ | ||||
| 97660 | AUGMENTIN I.V. | inj 5x1.2gm | LEX | CZ | ||||
| 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO | ||||
| 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO | ||||
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1862,60 | U/ATB | |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 2026,35 | U/ATB | |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 73,45 | U | |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 406,10 | U/ATB | |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | |||||
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 39,00 | ||
| 67208 | CEPHABENE 500MG | tbl obd 10x500mg | MCK | D | ||||
| 67209 | CEPHABENE 500MG | tbl obd 20x500mg | MCK | D | ||||
| 67211 | CEPHABENE 1000MG | tbl obd 10x1000mg | MCK | D | ||||
| 67212 | CEPHABENE 1000MG | tbl obd 20x1000mg | MCK | D | ||||
| 83719 | CEPHALEXIN DH 250MG DIAG HUMAN | cps 30x250mg | GNS | GB | ||||
| 83720 | CEPHALEXIN DH 500MG DIAG HUMAN | cps 30x500mg | GNS | GB | ||||
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | ||||
| 98017 | CEPHALEXIN DH 500MG DIAG HUMAN | cps 100x500mg | GNS | GB | ||||
| 98018 | CEPHALEXIN DH 500MG DIAG HUMAN | cps 500x500mg | GNS | GB | ||||
| 93666 | CEFACLEN | tbl obd 30x500mg | SLO | SK | ||||
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | ||||
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | ||||
| 93667 | CEFACLEN PRO INFANTIBUS | tbl obd 30x250mg | SLO | SK | ||||
| 06158 | ORACEF | cps16x500mg | KRK | SLO | ||||
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | ||||
| 98015 | CEPHALEXIN DH 250MG DIAG HUMAN | cps 100x250mg | GNS | GB | ||||
| 98016 | CEPHALEXIN DH 250MG DIAG HUMAN | cps 500x250mg | GNS | GB | ||||
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 45,35 | ||
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | ||||
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | ||||
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 117,00 | ||
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 145,00 | ||
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 98,00 | ||
| 56962 | CECLOR | cps 21x250mg | LIL | CH | ||||
| 99231 | CECLOR | cps 15x250mg | LIL | CH | ||||
| 69474 | CECLOR RETARD 375MG | tbl obd 10x375mg | LIL | I | ||||
| 253.6 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 132,00 | ||
| 99217 | CECLOR | sus 75ml 125mg/5ml | LIL | CH | ||||
| 99221 | CECLOR | sus 75ml 125mg/5ml | LIL | I | ||||
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 121,00 | ||
| 99222 | CECLOR | sus 75ml 250mg/5ml | LIL | CH | ||||
| 99226 | CECLOR | sus 75ml 250mg/5ml | LIL | I | ||||
| 253.8 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 53,60 | ||
| 76318 | CEDROX | tbl 12x1gm | HKP | HKJ | ||||
| 68580 | CEDROX | tbl 12x500mg | HKP | HKJ | ||||
| 93905 | DURACEF | cps 12x500mg | BRI | I | ||||
| 253.9 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 75,55 | ||
| 253.10 | J01DA23 | cefixim | p.o. | 0.4 | GM | 115,60 ATB | ||
| 76236 | SUPRAX | plv sus 1x100ml/2gm | GED | H | ||||
| 76235 | SUPRAX | plv sus 1x50ml/1gm | GED | H | ||||
| 76233 | SUPRAX | tbl obd 10x200mg | GED | H | ||||
| 76234 | SUPRAX | tbl obd 20x200mg | GED | H | ||||
| 253.11 | J01DA26 | cefetamet | p.o. | 1 | GM | 110,00 | ATB | |
| 253.12 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 117,00 | ATB | |
| 253.13 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 117,00 | ATB | |
| 253.14 J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 95,00 | |||
| 56963 | CECLOR | cps 21x500mg | LIL | CH | ||||
| 99240 | CECLOR | cps 15x500mg | LIL | CH | ||||
| 69475 | CECLOR RETARD 750MG | tbl obd 10x750mg | LIL | I | ||||
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB | P | |||
|---|---|---|---|---|---|---|---|---|
a) inciální léčba bakteriální meningitidy u dětí mladších 18 let,
b) léčba Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 192,50 | U | |
| 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK | ||||
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 184,20 | U | |
| 83111 | ORIZOLIN | inj sic 1x1000mg | CAD | IND | ||||
| 85510 | VULMIZOLIN | inj sic 50x1gm | BTA | SK | ||||
| 91148 | VULMIZOLIN | inj sic 10x1gm | BTA | SK | ||||
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 959,30 | U/ATB | |
| 91562 | MEFOXIN | inj 1x1gm | VUA | CZ | ||||
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 509,10 | U/ATB | |
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 629,80 | U/ATB | |
| 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 665,30 | U/ATB | |
| 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO | ||||
| 254.7 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1858,35 | U/ATB | |
| 76355 | FORTUM | inj 1x500mg | GLA | I | ||||
| 83038 | FORTUM | inj 1x500mg+5ml sol | GLA | I | ||||
| 254.8 | J01DA12 | cefsulodin | parent. | 6 | GM | 629,80 | U/ATB | |
| 254.9 | J01DA13 | ceftriaxon | parent. | 2 | GM | 839,20 | ambulantně: K/P ústavně: U/ATB | |
| 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO | ||||
| 80663 | LENDACIN 250MG | inj sic 5x250mg | LEK | SLO | ||||
| 254.10 | J01DA22 | ceftizoxim | parent. | 4 | GM | 629,80 | U/ATB | |
| 254.11 | J01DA30 | cefapirin | parent. | 4 | GM | 199,20 U/ATB | ||
| 254.12 | J01DA32 | cefoperazon | parent. | 6 | GM | 1836,75 | U/ATB | |
| 75039 | CEFOBID | inj sic 1x1gm | PFI | TR | ||||
| 254.13 | J01DA37 | cefpirom | parent. | 4 | GM | 1743,20 | U/ATB | |
| 254.14 J01DA24 | cefepim | parent. | 4 | GM | 1729,20 | U/ATB | ||
| 254.15 | J01DA10 | cefotamin nad 1 g v jedné ampuli | parent. | 6 | GM | 595,60 | U/ATB | |
| 94177 | CEFOTAXIME | inj 1x2gm | LEK | SLO | ||||
| 254.16 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1795,35 U/ATB | ||
| 55868 | KEFADIM 2GM | inj sic 1x2gm | LIL | E | ||||
| 55867 | KEFADIM 1GM | inj sic 1x1gm | LIL | E | ||||
| 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB | ||||
|---|---|---|---|---|---|---|---|---|
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1733,60 | U/ATB | |
| 86412 | AZACTAM | inj sic 1x1gm | BMS | I | ||||
| 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2372,20 | U/ATB | |||
| 83488 | MERONEM 500MG I.M. | inj sic 1x5mg+sol | ZNC | GB | ||||||
| 83487 | MERONEM 500MG I.V. | inj sic 10x500mg | ZNC | GB | ||||||
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2372,20 | U/ATB | |||
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | |||||||
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 13,15 | ||||
| 62325 | TRIPRIM 100MG | tbl 10x100mg | MCK | A | ||||||
| 76513 | TRIPRIM 100MG | tbl 20x100mg | MCK | A | ||||||
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 9,90 | ||||
| 62324 | TRIPRIM 200MG | tbl 10x200mg | MCK | A | ||||||
| 76510 | TRIPRIM 200MG | tbl 20x200mg | MCK | A | ||||||
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,95 | ||||
| 00313 | SULFISOXAZOL LECIVA | tbl 20x500mg-blistr | LEX | CZ | ||||||
| 01178 | SULFISOXAZOL LECIVA | tbl 20x500mg-lahv. | LEX | CZ | ||||||
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | |||||||
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,45 | ||||
| 98112 | PRIMOTREN PRO INFANT. | tbl 20x120mg | LEK | SLO | ||||||
| 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 7,15 | ||||
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D | ||||||
| 97868 | ORIPRIM | tbl 2x10x480mg | CAD | IND | ||||||
| 87758 | ORIPRIM | tbl 10x10x480mg | CAD | IND | ||||||
| 98104 | PRIMOTREN | tbl 20x480mg | LEK | SLO | ||||||
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,75 | ||||
| 75459 | PRIMOTREN | sus 1x100ml | LEK | SLO | ||||||
| 87757 | ORIPRIM PRO INFANT. | sus 50ml 240mg/5ml | CAD | IND | ||||||
| 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 7,10 | ||||
| 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,60 | ||||
| 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 7,10 | ||||
| 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,60 | ||||
| 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 7,10 | ||||
| 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 119,70 | K | |||
| 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO | ||||||
| 260 | J01FA | makrolidová antibiotika | p.o. | |||||||
| 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,55 | ||||
| 72544 | ERYC | cps 24x250mg | BOL | H | ||||||
| 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 51,00 | ||||
| 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D | ||||||
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | ||||||
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | ||||||
| 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D | ||||||
| 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 68,80 | ||||
| 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 19,65 | ||||
| 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 49,75 | ||||
| 65367 | RULID 100MG | tbl obd 10x100mg | LEX | CZ | ||||||
| 65366 | RULID 50MG | tbl obd 10x50mg | LEX | CZ | ||||||
| 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 43,00 | ||||
| 96452 | RULID 150MG | tbl obd 20x150mg | LEX | CZ | ||||||
| 55467 | RULID 300MG | tbl obd 10x300mg | LEX | CZ | ||||||
| 96731 | RULID 150MG | tbl obd 10x150mg | LEX | CZ | ||||||
| 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 43,00 | ||||
| 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 51,00 | ||||
| 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 68,80 | ||||
| 83613 | KLACID 250MG | tbl obd 14x250mg | ABB | CH | ||||||
| 83614 | KLACID 250MG | tbl obd 10x250mg | ABB | CH | ||||||
| 83615 | KLACID 250MG | tbl obd 10x250mg | ABB | I | ||||||
| 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 79,60 | ||||
| 75184 | KLACID 125MG/5ML | gra sus 1x60ml | ABB | I | ||||||
| 80481 | KLACID 125MG/5ML | gra sus 1x100ml | ABB | I | ||||||
| 260.11 | J01FA10 | azithromycin (pevné lékové formy do 250 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 94,60 | ||||
| 96819 | SUMAMED | tbl 6x125mg | PLI | CHO | ||||||
| 93590 | SUMAMED | cps 6x250mg | PLI | CHO | ||||||
| 260.12 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 102,70 | |||||
| 96811 | SUMAMED | sir 20ml 100mg/5ml | PLI | CHO | |||||||
| 96812 | SUMAMED FORTE | sir 20ml 200mg/5ml | PLI | CHO | |||||||
| 260.13 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 68,80 | |||||
| 260.14 | J01FA10 | azithromycin (pevné lékové formy nad 250 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 89,90 | |||||
| 96813 | SUMAMED | tbl 3x500mg | PLI | CHO | |||||||
| 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,90 | |||||
| 261 | J01FA | makrolidová antibiotika | parent. | K | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 913,35 | K | ||||
| 88108 | ERYTHROCIN I.V. | inj 1x300mg | ABB | GB | |||||||
| 261.2 | J01FA02 | spiramycin | parent. | 3 | GM | 1278,55 | K | ||||
| 262 | J01FF | linkosamidová antibiotika | p.o. | ATB | |||||||
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 69,70 | ATB | ||||
| 91193 | DALACIN C | cps 100x150mg | UPJ | B | |||||||
| 56867 | KLIMICIN 300MG | cps 16x300mg | LEK | SLO | |||||||
| 03365 | DALACIN C | cps 16x150mg | UPJ | B | |||||||
| 94574 | KLIMICIN | cps 16x150mg | LEK | SLO | |||||||
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 164,30 | ATB | ||||
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,20 | ATB | ||||
| 91997 | NELOREN | cps 16x500mg | LEK | SLO | |||||||
| 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 164,30 | ATB | ||||
| 09284 | LINCOCIN | sir 60ml 250mg/5ml | UPJ | B | |||||||
| 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB | |||||||
| 263.1 | J01FF01 | klindamycin (do 0,3 GM včetně v jedné ampuli) | parent. | 1.8 | GM | 704,10 | U/ATB | ||||
| 97878 | KLIMICIN I.V. A I.M. | inj 10x2ml/300mg | LEK | SLO | |||||||
| 04234 | DALACIN C PHOSPHATE | inj 1x2ml/300mg | UPJ | B | |||||||
| 263.2 | J01FF01 | klindamycin | parent. | 1.8 | GM | 660,60 | U/ATB | ||||
| 98212 | DALACIN C PHOSPHATE | inj 3x6ml 900mg | UPJ | B | |||||||
| 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 50,30 | U/ATB | ||||
| 83593 | MEDOGLYCIN 600MG | inj 100x2ml/600mg | MOE | CY | |||||||
| 67029 | MEDOGLYCIN 600MG | inj 10x2ml/600mg | MOE | CY | |||||||
| 264 | J01GA | streptomycin a jeho deriváty | parent. | ||||
|---|---|---|---|---|---|---|---|
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 87,00 | |
| 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB | |||
| 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 44,85 | U |
| 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,55 | U |
| 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 47,80 | U |
| 96413 | GENTAMICIN 40MG LEK | inj 10x2ml/40mg | LEK | SLO | |||
| 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 24,95 | U |
| 96414 | GENTAMICIN 80MG LEK | inj 10x2ml/80mg | LEK | SLO | |||
| 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2.467,30 | U/ATB |
| 94197 | GARAMYCIN SCHWAMM(10X10X0.5CM) | spn 1x130mg | ESX | CH | |||
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1 | DF | 155,55 | U/ATB |
| 91142 | SEPTOPAL - 20ER-MINIKETTE | imp 5x20 | MEC | D | |||
| 91145 | SEPTOPAL - 20ER-MINIKETTE | imp 1x20 | MEC | D | |||
| 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 125,15 | U/ATB |
| 93684 | BYKOMYCIN | inj sic 20x325ku | BGL | D | |||
| 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 787,00 | U/ATB |
| 12334 | AMIKOZIT 100MG | inj 1x2ml | ECZ | TR | |||
| 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 423,00 | U/ATB |
| 12335 | AMIKOZIT 500MG | inj 1x2ml | ECZ | TR | |||
| 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 531,85 | U/ATB |
| 76494 | NETROMYCINE 50MG/2ML | inj 1x2ml/50mg | SCH | B | |||
| 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 311,55 | U/ATB |
| 90485 | NETROMYCINE (AMPULE) | inj 1x2ml/200mg | SCH | B | |||
| 83736 | NETROMYCINE 400MG/2ML | inj 1x2ml/400mg | SCH | B | |||
| 265.12 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 528,75 | U/ATB |
| 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 634,50 | U/ATB |
| 266 | J01MA | fluorované chinolony | p.o. | ||||
| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 30,00 | |
| 55636 | OFLOXIN 200 | tbl obd 10x200mg | LEX | CZ | |||
| 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 30,00 | |
| 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 30,00 | |
| 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO | |||
| 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 23,00 | |
| 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 23,00 | |
| 44089 0 | GYRABLOCK 40 | tbl obd 100x400mg | MOE | CY | |||
| 44087 | GYRABLOCK 400 | tbl obd 30x400mg | MOE | CY | |||
| 44088 | GYRABLOCK 400 | tbl obd 50x400mg | MOE | CY | |||
| 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 30,00 | |
| 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 30,00 | |
| 266.8 | J01MA09 | sparfloxacin | p.o. | 0.2 | GM | 90,00 | ATB |
| 267 | J01MA | fluorované chinolony | parent. | U/ATB | |||
|---|---|---|---|---|---|---|---|
| 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 224,00 | U/ATB |
| 267.2 | J01MA02 | ciprofloxacin | parent. | 0.5 | GM | 224,00 | U/ATB |
| 96040 | CIPRINOL | inj 5x10ml/100mg | KRK | SLO | |||
| 267.3 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 99,90 | U/ATB |
| 94155 | ABAKTAL | inj 10x5ml/400mg | LEK | SLO | |||
| 267.4 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 224,00 | U/ATB |
| 268 | J01XA | ostatní antibiotika | parent. | U/ATB | |||
| 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1709,20 | U/ATB |
| 76214 | LYPHOCIN | inf sic 10x1gm | LYP | USA | |||
| 92289 | EDICIN 0,5GM | inj.sicc. 1x500mg | LEK | SLO | |||
| 92290 | EDICIN 1GM | inj.sicc. 1x1gm | LEK | SLO | |||
| 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 3000,00 | U/ATB |
| 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 119,60 | U/ATB |
| 61178 | COLIMYCINE | inj sic 50x1mu | RBE | F | |||
| 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 105,45 | U/ATB |
| 269 | J01XB | polymyxinová antibiotika | p.o. | U/ATB | |||
| 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 43,80 | U/ATB |
| 01832 | COLIMYCINE | tbl 50x1.5mu | RBE | F | |||
| 86794 | COLIMYCINE | tbl 50x1.5mu | PRO | F | |||
| 270 | J01XD | imidazolová chemoterapeutika | parent. | U | |||
|---|---|---|---|---|---|---|---|
| 270.1 | J01XD01 | metronidazol | parent. | 1.5 | GM | 180,95 | U |
| 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 47,80 | U |
| 96404 | AVRAZOR | inj 5x3ml/500mg | LEX | CZ | |||
| 271 | J02AA | antimykotická antibiotika | parent. | U | |||
| 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 299,20 | U |
| 71969 | AMPHOTERICIN B | inj sic 1x50mg | SQH | D | |||
| 272 | J02AB | imidazolová antimykotika | p.o. | ||||
| 272.1 | J02AB02 | ketokonazol | p.o. | 0.2 | GM | 28,00 | |
| 04243 | NIZORAL | tbl 10x200mg | JAN | B | |||
| 88192 | NIZORAL | tbl 30x200mg | JAN | B | |||
| 273 | J02AB | imidazolová antimykotika | parent. | U | |||
| 273.1 | J02AB01 | mikonazol | parent. | 1 | GM | 480,40 | U |
| 04159 | DAKTARIN | inj 5x20ml/200mg | JAN | B | |||
| 274 | J02AC | triazolová antimykotika | p.o. | P | |||
a) vaginální mykózy nereagující na lokálně aplikovaná antimykotika,
b) recidivy vaginálních mykóz.
Vícedenní léčbu ordinuje infekcionista, hematolog, onkolog, specialista pracující na transplantačních jednotkách nebo dermatolog:
a) systémové mykózy u imunokomprimovaných pacientů,
b) těžké formy slizničních a nehtových mykóz vyvolaných kandidami nebo dermatofyty na základě kultivačního vyšetření
c) profylakticky u imunokomprimovaných pacientů nebo u pacientů před provedením transplantace,
d) intrakonazol - pouze léčba orální a oesophageální kandidozy.
| 274.1 | J02AC01 | flukonazol (do 100 mg v 1 tabletě nebo 5 ml sirupu včetně) | p.o. | 0.2 | GM | 490,00 | P |
| 93859 | DIFLUCAN | cps 7x50mg | PFI | F | |||
| 274.2 | J02AC01 | flukonazol (od 50 mg do 100 mg v 1 tabletě nebo 5 ml sirupu včetně | p.o. | 0.2 | GM | 446,60 | P |
| 94381 | DIFLUCAN | cps 28x100mg | PFI | F | |||
| 274.3 | J02AC01 | flukonazol (nad 100 mg v 1 tabletě nebo 5 ml sirupu) | p.o. | 0.2 | GM | 446,60 P | |
| 274.4 | J02AC02 | flukonazol (do 150 mg v jednom balení včetně) | p.o. | 0.15 | GM | 380,70 P | |
| 93860 | DIFLUCAN | cps 1x150mg | PFI | F | |||
| 274.5 | J02AC02 | itrakonazol (pevné lékové formy) nad 400mg v jednom balení | p.o. | 0.2 | GM | 117,10 | P |
| 94897 | SPORANOX | cps 15x100mg | JAN | B | |||
| 274.6 | J02AC02 | intrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0,2 | GM | 150,75 | P |
| 33921 | SPORANOX | cps 4x100mg | JAN | B | |||
| 274.7 | J02AX01 | flucytosin | p.o. | 10 | GM | 877,90 | P |
| 274.8 | J02AC02 | intrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 412,70 | P |
| 275 | J02AC | triazolová antimykotika | parent. | U/P | |||
|---|---|---|---|---|---|---|---|
Profylakticky: u imunokomprimovaných pacientů nebo pacientů připravovaných k transplantaci.
| 275.1 | J02AC01 | flukonazol | parent. 0.2 | GM | 1154,90 | U/P |
| 96548 | DIFLUCAN I.V. | inf 1x100ml 2mg/ml | PFI | F | ||
| 275.2 | J02AX01 | flucytosin | parent. 10 | GM | 2.773,00 | U/P |
| 276 | J04AB | Antibiotika k léčbě tuberkulózy | p.o. | |||
|---|---|---|---|---|---|---|
| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 13,40 | |
| 11038 | TUBOCIN | cps 100x150mg | PMM | BG | |||
| 11039 | TUBOCIN | cps 100x300mg | PMM | BG | |||
| 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 128,60 | P |
| 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | ||||
|---|---|---|---|---|---|---|---|
| 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 250,00 | |
| 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 565,80 | |
| 98383 | CAPASTAT | inj sic 5x1gm | LIL | F | |||
| 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | ||||
| 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 0,90 | |
| 03303 | NIDRAZID | tbl 250x100mg | LEX | CZ | |||
| 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | ||||
| 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 9,50 | |
| 75508 | TISAMID | tbl 100x500mg | ORN | SF | |||
| 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 13,10 | |
| 03023 | SURAL | tbl 100x400mg | CHN | H | |||
| 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,45 | |
| 93821 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | SPC | F | |||
| 281 | J05A | antivirotika | p.o. | P | |||
a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,
b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),
c) léčba herpes zoster při lokalizaci v obličeji,
d) profylaxe po alogenní transplantaci kostní dřeně.
Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir a indavir) indikuje infekcionista pracující vAIDS centrech.
Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,
b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,
c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
| 281.1 | J05AB | brivudin | p.o. | 0.5 | GM | 469,40 | P |
| 281.2 | J05AB01 | acyklovir | p.o. | 4 | GM | 445,95 | P |
| 84128 | HERPESIN 400 | tbl 25x400mg | LCM | CZ | |||
| 281.3 | J05AB05 | zidovudin | p.o. | 1.5 | GM | 701,00 | P |
| 96179 | AZITIDIN 100 | tbl 50x100mg | LCM | CZ | |||
| 281.4 | J05AB07 | didanosin | p.o. | 0.4 | GM | 241,85 | P |
| 281.5 | J05AB08 | zalcitabin | p.o. | 2.25 | MG | 247,30 | P |
| 66734 | HIVID 0.75MG | tbl obd 100x0.75mg | HLR | CH | |||
| 281.6 | J05AB09 | famcyklovir | p.o. | 0.75 | GM | 469,40 | P |
| 281.7 | J05AB10 | lamivudin | p.o. | 0.3 | GM | 253,70 | P |
| 56451 | EPIVIR PERORALNI ROZTOK | sol 1x240ml 10mg/ml | GLA | GB | |||
| 281.8 | J05AB11 | valacyklovir | p.o. | 3 | GM | 469,40 | P |
| 87205 | VALTREX | tbl obd 42x500mg | BWE | GB | |||
| 281.9 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 32,90 | P |
| 88174 | ISOPRINOSINE | tbl 5x10(=50)x500mg | EWO | CH | |||
| 281.10 | J05AE01 | saquinavir | p.o. | 1,8 | GM | 568,80 | P |
| 281.11 | J05AE03 | Ritonavir | p.o. | 1,2 | GM | 568,80 | P |
| 281.12 | J05AE | indavir | p.o. | 2,4 | GM | 568,80 | P |
| 44124 | CRIXIVAN 200 | cps 360x200 mg | MSD | NL | |||
| 44126 | CRIXIVAN 400 | cps 180x400 mg | MSD | NL | |||
| 281.13 | J05AB06 | gancyklovir | p.o. | 3 | GM | 2118,90 | P |
| 282 | J05AB | antivirotika ze skupiny nukloeosidů | parent. | U/P | |||
|---|---|---|---|---|---|---|---|
Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,
b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,
c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
Léčbu foskarnetem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů v případě nemožnosti podat gancyklovir nebo při jeho neúčinnosti pro rezistenci,
b) profylaxe a léčba u pacientů s transplantací u gancyklovir CMV rezistentních infekcí nebo v případě nemožnosti podat gancyklovir.
Léčbu zidovudinem indikuje infekcionista pracující v AIDS centrech.
Léčbu cidofovirem ordinuje infekcionosta při terapii a sekundární profylaxi cytomegalovirových retinitid u HIV/AIDS pacientů v případě nemožnosti podat gancyklovir či foskarnet.
| 282.1 | J05AB01 | acyklovir | parent. | 4 | GM | 1587,60 | U/P |
| 93260 | HERPESIN 250 | inj sic 10x250mg | LCM | CZ | |||
| 282.2 | J05AB05 | zidovudin | parent. | 1 | GM | 2811,50 | U/P |
| 282.3 | J05AB06 | gancyklovir | parent. | 0.5 | GM | 2005,80 | U/P |
| 94244 | CYMEVENE | inj sic 1x500mg | SYN | CH | |||
| 282.4 | J05AD01 | foskarnet | parent. | 6.5 | GM | 3075,20 | U/P |
| 282.5 | J05AB12 | cidofovir | parent. | 375 | GM | 35774,10 | U/P |
| 283 | J06AA | imunitní séra | parent. | K/P | |||
|---|---|---|---|---|---|---|---|
Sérum proti záškrtu ordinuje infekcionista nebo pediatr ke komplexní léčbě záškrtu.
Sérum proti hadímu jedu ordinuje lékař k léčbě uštknutí zmijí obecnou. Sérum proti botulismu ordinuje lékař ke komplexní léčbě botulismu.
Sérum proti plynaté sněti ordinuje infekcionista nebo specialista chirurgických oborů k profylaxi a terapii klostiridiových infekcí.
Sérum proti vzteklině ordinuje infekcionista k profylaxi nebo terapii vztekliny.
| 283.1 | J06AA | sérum proti stafylokokovým infekcím | parent. | plně | K/P | |||
| 01194 | STASEA SEVAC | inj. 1x5000ut | SEV | CZ | ||||
| 283.2 | J06AA01 | sérum proti záškrtu | parent. | plně | K/P | |||
| 283.3 | J06AA03 | sérum proti hadímu jedu | parent. | plně | K/P | |||
| 83330 | IPSER EUROPE PASTEUR | inj. 1x5ml | PMX | F | ||||
| 01206 | VENISE SEVAC | inj. 1x10ml/10ku | SEV | CZ | ||||
| 283.4 | J06AA04 | sérum proti botulinu | parent. | plně | K/P | |||||
| 01190 | BOSEA SEVAC | inj. 1x35ml | SEV | CZ | ||||||
| 283.5 | J06AA05 | sérum proti plynaté sněti | parent. | plně | K/P | |||||
| 01195 | GASEA SEVAC | inj. 1x20ml/25ku | SEV | CZ | ||||||
| 283.6 | J06AA06 | sérum proti vzteklině | parent. | plně | K/P | |||||
| 94015 | SERUM ANTIRAB. 1000 U.I.PASTEUR | inj 1x5ml 200ut/ml | PMX | F | ||||||
| 284 | J06BA | imunoglobuliny, normální lidské | parent. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 284.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci | parent. | 1 | DF | 53,50 | O | |||
| 03540 | HISTAGA (HISTAGLOBULIN) | lyo 3x2ml+3x2ml | IMA | SK | ||||||
| 01263 | NORGA I.M.SEVAC | sol inj 10x1.9ml | SEV | CZ | ||||||
| 284.2 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (z tuzemské plazmy zakázkovou frakcionací) | parent. | 1 | GM | 1137,00 | B | |||
| 56054 | NIGA SEVAC | inj sic 1x5gm+solv. | SEV | CZ | ||||||
| 284.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1 | GM | 1137,00 | B | |||
| 62553 | INTRAGLOBIN F PRO INFUS. | inf 1x50ml | BTP | D | ||||||
| 62554 | INTRAGLOBIN F PRO INFUS. | inf 1x100ml | BTP | D | ||||||
| 62555 | INTRAGLOBIN F PRO INFUS. | inf 1x200ml | BTP | D | ||||||
| 03833 | IVEGA (IMUNOGLOBUL.LIDSKY I.V.) | inj sic 500mg bilk. | IMA | SK | ||||||
| 284.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1 | GM | 2000,00 | U | |||
| 285 | J06BB | specifické imunoglobuliny | parent. | K | ||||||
a) neočkované těhotné ženy,
b) novorozenec po kontaktu s varicellou,
c) imunokomprimovaný pacient po kontaktu s varicellou,
d) varicelózní primární pneumonitis.
Léčbu imunoglobulinem proti cytomegalovirové infekci ordinuje infekcionista, onkolog, hematolog nebo pediatr:
a) novorozenec s prokázanou cytomegalovirovou infekcí,
b) generalizovaná cytomegalovirová infekce u imunokomprimovaných pacientů,
c) profylaxe cytomegalovirových infekcí u transplantovaných pacientů při pozitivitě dárce nebo příjemce. Imunoglobulin proti
cytomegalovirové infekci je hrazen dle symbolu U.
Imunoglobulin proti tetanu je hrazen dle symbolu B.
| 285.1 | J06BB | protiencefalický globulin | parent. | 1 | ML | 310,65 | K |
| 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 RG v jedné ampuli včetně) | parent. | 250 | RG | 1440,25 | K |
| 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 RG v jedné ampuli) | parent. | 250 | RG | 1110,00 | K |
| 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | plně | B | |||
| 80530 | HUMAN ANTITETANUS IMMMUNEGLOB. | inj sic 1x250ut+2ml | GFO | E | ||||
| 80531 | HUMAN ANTITETANUS IMMMUNEGLOB. | inj sic 1x500ut+2ml | GFO | E | ||||
| 83607 | TETABULIN | inj 250ut/ml | IMM | A | ||||
| 88069 | TEGA IMUNA | inj 1x2ml/250ut | IMA | SK | ||||
| 285.5 | J06BB03 | imunoglobulin proti neštovicím a pásovému oparu | parent. | 1 | KU | 34566,40 | K/P | |
| 285.6 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | plně | K | |||
| 94265 | AUNATIV | inj. 1x5ml | KBP | S | ||||
| 97897 | HEPATECT (R) | inj. 1x2ml | BTP | D | ||||
| 97898 | HEPATECT (R) | inj. 1x10ml | BTP | D | ||||
| 285.7 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 5070,55 | U/P | |
| 286 | J07AM | očkovací látky proti tetanu | parent. | K | ||||
|---|---|---|---|---|---|---|---|---|
| 286.1 | J07AM01 | tetanový toxoid | parent. | plně | K | |||
| 83622 | ALTEANA SEVAC | inj 10x0.5ml | SEV | CZ | ||||
| 69795 | ALTEANA S IMUNA | inj 10x0.5ml | IMA | SK | ||||
| 69796 | ALTEANA S IMUNA | inj 10x1ml | IMA | SK | ||||
| 69797 | ALTEANA S IMUNA | inj 10x5ml | IMA | SK | ||||
| 69798 | ALTEANA S IMUNA | inj 50x0.5ml | IMA | SK | ||||
| 69799 | ALTEANA S IMUNA | inj 50x1ml | IMA | SK | ||||
| 83443 | TETAVAX | inj 1x0.05ml-strik. | PMX | F | ||||
| 83444 | TETAVAX | inj 20x0.5ml-strik. | PMX | F | ||||
| 83445 | TETAVAX | inj 1x10ml | PMX | F | ||||
| 83447 | TETAVAX | inj 10x20ml | PMX | F | ||||
| 83525 | TETAVAX | inj 20x0.5ml-ampule | PMX | F | ||||
| 83526 | TETAVAX | inj 10x10ml | PMX | F | ||||
| 287 | J07AN | očkovací látky proti tuberkulóze | parent. | O | ||||
| 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 260,70 | O | |
| 66857 | BCG-VACCINE 500 BEHRING | lyo 50x0.1ml+50ml | BEH | A | ||||
| 76189 | BCG-VACCINE 500 BEHRING | lyo 50x0.1ml+50ml | BEH | D | ||||
| 66855 | BCG-VACCINE BEHRING | lyo 1x0.1ml+1ml sol | BEH | D | ||||
| 66856 | BCG-VACCINE BEHRING | lyo 1x0,1ml+1ml sol | BEH | A | ||||
| 288 | J07AX | jiné bakteriální očkovací látky | parent. | K | ||||
| 288.1 | J07AX | jiné bakteriální vakcíny (protistafylokoková vakcína) | parent. | plně | K | |||
| 94269 | POLYSTAFANA SEVAC | inj 10x0.5ml | SEV | CZ | ||||
| 288.2 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,75 | K | |
| 288.3 | J07AX | jiné bakteriální vakcíny (protipseudomonádová vakcína) | parent. | 1 | DF | 210,75 | O | |
| 07388 | PSAEVA SEVAC VACC.PSEUDOMONAE | inj 10x0.3ml | SEV | CZ | ||||
| 289 | J07BG | očkovací látky proti vzteklině | parent. | K | |||
|---|---|---|---|---|---|---|---|
| 289.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | plně | K | ||
| 66854 | MERIEUX INACTIVAT.RABIES VACC. | lyo 1davka+1ml solv | PMX | F | |||
| 75379 | RABIPUR(PCEC RABIES VACCINE) | inj sic 1x2.5ut+1ml | BEH | D | |||
| 90996 | RABIPUR(PCEC RABIES VACCINE) | inj sic 5x2.5ut+1ml | BEH | D | |||
| 93706 | VERORAB | inj sic 1dav.+0.5ml | PMX | F | |||
| 290 | L01AA | alkylační cytostatika | p.o. | ||||
| 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 6,15 | |
| 94174 | CYCLOPHOSPHAMID | tbl 50x50mg | FAO | SF | |||
| 290.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,60 | |
| 01842 | LEUKERAN 2MG | tbl obd 25x2mg | BWE | GB | |||
| 290.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 3,80 | |
| 01843 | LEUKERAN 5MG | tbl obd 25x5mg | BWE | GB | |||
| 290.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,40 | |
| 02050 | ALKERAN | tbl obd 25x2mg | BWE | GB | |||
| 290.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 2,95 | |
| 02051 | ALKERAN | tbl obd 25x5mg | BWE | GB | |||
| 290.6 | L01AA08 | prednimustin | p.o. | 1 | MG | 3,70 | |
| 291 | L01AA | alkylační cytostatika | parent. | B/ONK,HEM | |||
| 291.1 | L01AA01 | cyklofosfamid | parent. | 10 | MG | 3,60 | B |
| 291.2 | L01AA03 | melfalan | parent. | 1 | MG | 12,90 | B/ONK,HEM |
| 75182 | ALKERAN | inj 1x50mg+10mlsolv | BWE | GB | |||
| 291.3 | L01AA05 | chlormethin | parent. | 1 | MG | 35,00 | B/ONK,HEM |
| 291.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,55 | B/ONK,HEM |
| 291.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1 | MG | 1,45 | B/ONK,HEM |
| 70469 | HOLOXAN 2GM | inj sic 1x2gm | ASD | D | |||
| 70468 | HOLOXAN 500MG | inj sic 1x1gm | ASD | D | |||
| 291.6 | L01AC01 | thiotepa | parent. | 1 | MG | 21,80 | B/ONK,HEM |
| 292 | L01AB | alkylsulfaty | p.o. | L/ONK,HEM | |||
|---|---|---|---|---|---|---|---|
| 292.1 | L01AB01 | busulfán (do 0,5 mg v jedné tabletě včetně) | p.o. | 1 | MG | 15,20 | L/ONK,HEM |
| 93587 | MYLERAN | tbl 25x0.5mg | BWE | GB | |||
| 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 | MG | 5,00 | L/ONK,HEM |
| 21157 | MYLERAN | tbl 100x2mg | BWE | GB | |||
| 293 | L01AD | nitrosomočoviny | p.o. | L/ONK,HEM | |||
| 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,85 | L/ONK,HEM |
| 60270 | CEENU LOMUSTINE (CCNU) | cps 20x10mg | BMS | USA | |||
| 293.2 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,55 | L/ONK,HEM |
| 60272 | CEENU LOMUSTINE (CCNU) | cps 20x100mg | BMS | USA | |||
| 293.3 | L01AD02 | lomustin (od 10 do 40 mg v jedné tabletě včetně | p.o. | 1 | MG | 6,15 | L/ONK,HEM |
| 03735 | LOMUSTINE | cps 6 | BMS | USA | |||
| 60271 | CEENU LOMUSTINE (CCNU) | 20x40mg | BMS | USA | |||
| 294 | L01AD | nitrosomočoviny | parent. | B/ONK,HEM | |||
| 294.1 | L01AD01 | karmustin | parent. | 1 | MG | 10,15 | B/ONK,HEM |
| 80470 | BICNU(CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | D | |||
| 83482 | BICNU(CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | USA | |||
| 294.2 | L01AD04 | streptozocin | parent. | 10 | MG | 15,15 | B/ONK,HEM |
| 294.3 | L01AD05 | Ifotemustin | parent. | 1 | MG | 96,65 | B/P |
| 295 | L01BA | antimetabolity ze skupiny analog kyseliny listové | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 295.1 | L01BA01 | metotrexát | p.o. | 1 | MG | 1,50 | |
| 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | LCM | CZ | |||
| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | LCM | CZ | |||
| 296 | L01BA | antimetabolity ze skupiny analog kyseliny listové | parent. | B | |||
| 296.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1 | MG | 8,90 | B |
| 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | LCM | CZ | |||
| 296.2 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,75 | B |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ | |||
| 296.3 | L01BA01 | metotrexát (od 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,15 | B |
| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | LCM | CZ | |||
| 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ | |||
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | |||
| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | LCM | CZ | |||
| 83484 | METHOTREXAT LEDERLE | inf 1x20ml/500mg | LED | D | |||
| 297 | L01BB | antimetabolity ze skupiny analog purinů | p.o. | L/ONK,HEM | |||
|---|---|---|---|---|---|---|---|
| 297.1 | L01BB02 | merkaptopurin | p.o. | 10 | MG | 6,35 | L/ONK,HEM |
| 94241 | PURI-NETHOL | tbl 25x50mg | BWE | GB | |||
| 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9,55 | L/ONK,HEM |
| 298 | L01BB | antimetabolity ze skupiny analog purinů | parent. | B/ONK,HEM | |||
| 298.1 | L01BB04 | cladribin | parent. | 1 | MG | 904,90 | B/ONK,HEM |
| 44013 | LEUSTATIN. | inj 1x10ml/10mg | OBI | USA | |||
| 44014 | LEUSTATIN. | inj 7x10ml/10mg | OBI | USA | |||
| 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 139,20 | B/ONK,HEM |
| 77008 | FLUDARA I.V. | inj sic 5x50mg | SAG D | ||||
| 299 | L01BC | antimetabolity ze skupiny analog pyrimidinu | p.o. | L/ONK,HEM | |||
| 299.1 | L01BC | azaribin | p.o. | 1 | MG | 8,70 | L/ONK,HEM |
| 299.2 | L01BC02 | fluorouracil | p.o. | 10 | MG | 1,70 | L/ONK,HEM |
| 10407 | FTORAFUR | cps 100x400mg | MDX | SU | |||
| 300 | L01BC | antimetabolity ze skupiny analog pyrimidinu | parent. | B/ONK,HEM | |||
| 300.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,30 | B/ONK,HEM |
| 87829 | ALEXAN (AMPULE) | inj 10x5ml/100mg | MAC | D | |||
| 02532 | ALEXAN (AMPULE) | inj 30x2ml/40mg | MAC | D | |||
| 99483 | ALEXAN (LAHVICKY) | inj 10x5ml/100mg | MAC | D | |||
| 99484 | ALEXAN (LAHVICKY) | inj 30x2ml/40mg | MAC | D | |||
| 300.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1 | MG | 1,05 | B/ONK,HEM |
| 96990 | ALEXAN (LAHVICKY) | inj 1x20ml/1000mg | MAC | D | |||
| 300.3 | L01BC02 | fluorouracil | parent. | 10 | MG | 2,90 B/ONK,HEM | |
| 84119 | 5-FU LEDERLE | inj 1x20ml/1gm | LED | D | |||
| 86070 | FLUORO-URACIL | inj 5x5ml/250mg | HLR | CH | |||
| 300.4 | L01BC05 | gemcitabin | parent. | 1 | MG | 6,00 | B/ONK,HEM |
| 301 | L01CA | vinka alkaloidy a jejich deriváty | parent. | B/ONK,HEM | |||
|---|---|---|---|---|---|---|---|
| 301.1 | L01CA01 | vinblastin | parent. | 1 | MG | 27,15 | B/ONK,HEM |
| 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 186,80 | B/ONK,HEM |
| 74990 | CITOMID 1MG | inj sic 1x1mg+10ml | LMR | MEX | |||
| 301.3 | L01CA04 | vinorelbin | parent. | 1 | MG | 110,75 | B/ONK,HEM |
| 302 | L01CB | podofylotoxinové deriváty | p.o. | L/ONK,HEM | |||
| 302.1 | L01CB01 | etoposid | p.o. | 1 | MG | 3,80 | L/ONK,HEM |
| 93697 | LASTET | cps 20x50mg | NKU | J | |||
| 93696 | LASTET | cps 40x25mg | NKU | J | |||
| 303 | L01CB | podofylotoxinové deriváty | parent. | B/ONK,HEM | |||
| 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 4,00 | B/ONK,HEM |
| 93699 | LASTET | inj 10x5ml/100mg | NKU | J | |||
| 303.2 | L01CB02 | teniposid | parent. | 1 | MG | 6,45 | B/ONK,HEM |
| 304 | L01CD | taxany | parent. | X | |||
| 304.1 | L01CD01 | paclitaxel | parent. | 1 | MG | 191,30 | X |
| 44134 | TAXOL | inj. 1x17ml/100mg | BMS | I | |||
| 76204 | TAXOL | inj. 1x5ml/30mg | BMS | I | |||
| 92494 | TAXOL | inj 10x5ml/30mg | BMS | I | |||
| 76688 | TAXOL | inj. 1x5ml/30mg | BMS | USA | |||
| 76689 | TAXOL | inj. 10x5ml/30mg | BMS | USA | |||
| 304.2 | L01CD02 | docetaxel | parent. | 1 | MG | 335,30 | X |
| 305 | L01DA | aktinomyciny | parent. | B/ONK,HEM | |||
| 305.1 | L01DA01 | daktinomycin | parent. | 1 | MG | 680,10 | B/ONK,HEM |
| 21055 | LYOVAC COSMEGEN | inj sic 1x0.5mg | MSD | USA | |||
| 306 | L01DB | antracykliny a jejich deriváty | p.o. | X | |||
| 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 309,15 | X |
| 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I | |||
| 78813 | ZAVEDOS 10MG | cps 1x10mg | FAR | I | |||
| 78814 | ZAVEDOS 25MG | cps 1x25mg | FAR | I | |||
| 307 | L01DB | antracykliny a jejich deriváty | parent. | B/ONK,HEM | |||
|---|---|---|---|---|---|---|---|
| 307.1 | L01DB01 | doxorubicin | parent. | 1 | MG | 35,75 | B/ONK,HEM |
| 12663 | DOXORUBICIN EBEWE 10MG | inj 1x5ml/10mg | EBW | A | |||
| 12664 | DOXORUBICIN EBEWE 50MG | inj 1x25ml/50mg | EBW | A | |||
| 94567 | RASTOCIN | inj 10x10mg | PLI | CHO | |||
| 307.2 | L01DB02 | daunorubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 96122 | DAUNOBLASTINA | inj sic 1/20mg + sol. | FAR | I | |||
| 307.3 | L01DB03 | epirubicin | parent. | 1 | MG | 41,00 | B/ONK,HEM |
| 83704 | FARMORUBICIN PFS | inj 1x25ml/50mg | PHA | I | |||
| 307.4 | L01DB04 | aklarubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 307.5 | L01DB05 | zorubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM |
| 307.6 | L01DB06 | idarubicin | parent. | 1 | MG | 770,85 | B/ONK,HEM |
| 307.7 | L01DB07 | mitoxantron | parent. | 1 | MG | 52,55 | B/ONK,HEM |
| 54033 | REFADOR 2MG/ML | inj 1x15ml/30mg | LCM | CZ | |||
| 308 | L01DC | ostatní cytotoxická antibiotika | parent. | B/ONK,HEM | |||
| 308.1 | L01DC01 bleomycin | parent. | 1 | MG | 65,20 | B/ONK,HEM | |
| 03404 | BLEOCIN | inj 1x15mg | NKU | J | |||
| 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 78,00 | B/ONK,HEM |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 70,90 | B/ONK,HEM |
| 83440 | MITOMYCIN C KYOWA | inj sic 5x20mg | KYA | J | |||
| 309 | L01XA | platinová cytostatika | parent. | B/ONK,HEM | |||
| 309.1 | L01XA01 cisplatina | parent. | 1 | MG | 8,00 | B/ONK,HEM | |
| 96453 | PLATIDIAM | inj 10x10mg/20ml | LCM | CZ | |||
| 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ | |||
| 96455 | PLATIDIAM | inj 1x50mg/100ml | LCM | CZ | |||
| 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1 | MG | 6,85 | B/ONK,HEM |
| 90777 | CYCLOPLATIN 50 | inj sic 10x50mg | LCM | CZ | |||
| 75010 | CYCLOPLATIN | inj sic 1x5ml/50mg | LCM | CZ | |||
| 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | MG | 3,75 | B/ONK,HEM |
| 93665 | CYCLOPLATIN 200 | inj sic 5x200mg | LCM | CZ | |||
| 60924 | CYCLOPLATIN | inj 1x60ml/600mg | LCM | CZ | |||
| 310 | L01XB | methylhydrazinová cytostatika | p.o. | L/ONK,HEM | |||
|---|---|---|---|---|---|---|---|
| 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2,50 | L/ONK,HEM |
| 01814 | NATULAN | cps 50x50mg | HLR | CH | |||
| 311 | L01XX | ostatní cytostatika | p.o. | L/ONK,HEM,URN | |||
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 | GM | 2,35 | L/ONK,HEM,URN |
| 95122 | LITALIR | cps 100x500mg | BMS | D | |||
| 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 4,00 | L/ONK,HEM,URN |
| 08921 | ESTRACYT | cps 100x140mg | KBP | S | |||
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 107,25 | L/ONK,HEM,URN |
| 84009 | VESANOID | cps 100x10mg | HLR | CH | |||
| 312 | L01XX | ostatní cytostatika | parent. | B/ONK,HEM | |||
| 312.1 | L01XX01 | amsakrin | parent. | 1 | MG | 26,75 | B/ONK,HEM | |||||
| 93503 | AMSIDYL | inj 6x85mg/1.7ml+so | GOD | D | ||||||||
| 312.2 | L01XX02 | asparagináza | parent. | 1 | MG | 2848,40 | B/P | |||||
| 92117 | KIDROLASE | inj sic 10x10ku | RBE | F | ||||||||
| 312.3 | L01XX11 | estramustin | parent. | 1 | MG | 1,05 | B/ONK,HEM,URN | |||||
| 312.4 | L01XX13 | dakarbazin | parent. | 10 | MG | 8,10 | B/ONK,HEM | |||||
| 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ | ||||||||
| 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | ||||||||
| 312.5 | L01XX17 | topotekan | parent. | 1 | MG | 3136,70 | X | |||||
| 312.6 | L01XX19 | irinotekan | parent. | 1 | MG | 79,10 | X | |||||
| 312.7 | L01XX09 | miltefosin | lok. | 60 | MG | 10,00 | ||||||
| 313 | L02AA | estrogeny | p.o. | L/ONK,HEM,URN,GYN, SEX | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,40 | L/ONK,HEM,URN GYN,SEX | |||||
| 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,15 | L/ONK,HEM,URN GYN,SEX | ||||
| 87548 | TURISTERON | drg 21x1mg | VJP | D | |||||||
| 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,40 | L/ONK,HEM,URN GYN,SEX | ||||
| 314 | L02AA | estrogeny | parent. | B/ONK,HEM,URN,SEX | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 314.1 | L02AA | polyestradioli phosphas | parent. | 1 | MG | 3,25 | B/ONK,HEM, URN,SEX | ||||
| 88381 | ESTRADURIN | inj sic 10x80mg+2ml | KBP | S | |||||||
| 314.2 | L02AA01 | diethylstilbestrol | parent. | 10 | MG | 6,70 | B/ONK,HEM, URN,SEX | ||||
| 314.3 | L02AA04 | fosfestrol | parent. | 0.1 | GM | 4,90 | B/ONK,HEM, URN,SEX | ||||
| 315 | L02AB | progestiny | p.o. | L/ONK,HEM,URN,GYN, SEX | |||||||
| 315.1 | L02AB01 | megestrol | p.o. | 10 | MG | 3,50 | L/ONK,HEM,URN GYN,SEX | ||||
| 86059 | MEGACE | tbl 100x160mg | BMS | D | |||||||
| 86211 | MEGACE | tbl 100x40mg | BMS | D | |||||||
| 315.2 | L02AB02 | medroxyprogesteron | p.o. | 10 | MG | 2,00 | L/ONK,HEM,URN GYN,SEX | ||||
| 88429 | FARLUTAL | tbl 30x500mg | FAR | I | |||||||
| 91618 | PROVERA | tbl 20x500mg | UPJ | GB | |||||||
| 90793 | PROVERA 100MG | tbl 100x100mg | UPJ | GB | |||||||
| 316 | L02AB | progestiny | parent. | L/ONK,GYN,SEX | |||||||
| 316.1 | L02AB02 | medroxyprogesteron | parent. | 10 | MG | 3,35 | L/ONK,GYN,SEX | ||||
| 90993 | DEPO-PROVERA 500 | inj 1x3.3ml/500mg | UPJ | B | |||||||
| 85678 | FARLUTAL DEPOT | inj 1x2.5ml/500mg | PHA | I | |||||||
| 316.2 | L02AB03 | gestonoron | parent. | 1 | MG | 1,15 | L/ONK,GYN,SEX | ||||
| 317 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | inhal. | Z | |||||||
| 317.1 | L02AE01 | buserelin | inhal. | 1 | MG | 242,30 | Z | ||||
| 90966 | SUPREFACT NASAL | sol nas 4x10gm/10mg | HOE | D | |||||||
| 318 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | parent. | K/P |
|---|
a) léčba karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen, jen po dobu adjuvantní chemo- nebo radioterapie.
b) léčba karcinomu prostaty,
c) léčba myomatózy spojené s poruchou fertility nebo její těžké formy vyžadující předoperační redukci nálezu,
d) léčba těžkých, jinak konzervativně nereagujících forem endometriózy,
e) pubertas precox,
f) indukce ovulace při in vitro fertilizaci pouze na základě předchozího schválení revizním lékařem.
| 318.1 | L02AE01 | buserelin | parent. | 1 | MG | 273,65 | K/P |
| 318.2 | L02AE01 | buserelin (depotní lékové formy) | parent. | 1 | MG | 2009,60 | K/P |
| 318.3 | L02AE02 | leuprorelin | parent. | 1 | MG | 273,65 | K/P |
| 318.4 | L02AE02 | leuprorelin (depotní lékové formy) | parent. | 1 | MG | 1768,45 | K/P |
| 318.5 | L02AE03 | goserelin (depotní lékové formy) | parent. | 1 | MG | 1842,15 | K/P |
| 318.6 | L02AE04 | triptorelin | parent. | 1 | MG | 273,65 | K/P |
| 318.7 | L02AE04 | triptorelin (depotní lékové formy) | parent. | 1 | MG | 1768,45 | K/P |
| 96107 | DECAPEPTYL DEPOT | inj sic 3.75mg+2ml | FEI | D | |||
| 319 | L02BA | antiestrogeny | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 319.1 | L02BA01 | tamoxifen (do 20mg v 1 tabletě včetně) | p.o. | 10 | MG | 3,45 | |
| 67039 | TAMIFEN 10 | tbl 30x10mg | MOE | CY | |||
| 44056 | TAMOXIFEN EBEWE 10 | tbl 30x10mg | EBW | A | |||
| 44057 | TAMOXIFEN EBEWE 20 | tbl 30x20mg | EBW | A | |||
| 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | LCM | CZ | |||
| 71959 | ZITAZONIUM 10MG | tbl 10x10mg | EGI | H | |||
| 71958 | ZITAZONIUM 10MG | tbl 30x10mg | EGI | H | |||
| 44144 | ZITAZONIUM 20MG | tbl 30x20mg | EGI | H | |||
| 31243 | ZITAZONIUM 20MG | tbl 60x20mg | EGI | H | |||
| 31037 | ZITAZONIUM | tbl 60x10mg | EGI | H | |||
| 319.2 | L02BA01 | tamoxifen (nad 20 mg v 1 tabletě) | p.o. | 10 | MG | 2,50 | |
| 44058 | TAMOXIFEN EBEWE 30 | tbl 30x30mg | EBW | A | |||
| 44059 | TAMOXIFEN EBEWE 40 | tbl 30x40mg | EBW | A | |||
| 31384 | ZITAZONIUM 40MG | tbl 30x40mg | EGI | H | |||
| 44146 | ZITAZONIUM 30MG | tbl 30x30mg | EGI | H | |||
| 320 | L02BB | antiandrogeny | p.o. | L/ONK,URN,SEX | |||
| 320.1 | L02BB01 | flutamid | p.o. | 10 | MG | 1,35 | L/ONK,URN,SEX |
| 55953 | FLUTACAN 250MG | tbl 100x250mg | LOY | SF | |||
| 83392 | FLUCINOM | tbl 100x250mg | SCH | B | |||
| 80088 | FLUCINOM (EULEXIN 85) | tbl 100x250mg | SCH | USA | |||
| 320.2 | L02BB02 | nilutamid | p.o. | 1 | MG | 0,70 | L/ONK,URN,SEX |
| 94820 | ANANDRON | tbl 90x50mg | ROU | F | |||
| 320.3 | L02BB03 | bicalutamid | p.o. | 50 | MG | 101,25 | L/ONK,URN,SEX |
| 321 | L02BG | inhibitory tvorby steroidních hormonů | p.o. | L/ONK,END | |||
|---|---|---|---|---|---|---|---|
| 321.1 | L02BG01 | aminogluthetimid | p.o. | 10 | MG | 0,65 | L/ONK,END |
| 07510 | ORIMETEN | tbl 100x250mg | CGC | CH | |||
| 321.2 | L02BG03 | anastrozol | p.o. | 1 | MG | 200,25 | X |
| 321.3 | L02BG04 | letrozol | p.o. 2,5 | MG | 200,25 | X | |
| 322 | L02BG | inhibitory tvorby steroidních hormonů | parent. | X | |||
| 322.1 | L02BG02 | formestan | parent. | 250 | MG | 3690,00 | X |
| 92361 | LENTARON DEPOT 250MG I.M. | inj sic 1x250mg+2ml | CGC | CH | |||
| 323 | L03AA | cytokiny | parent. | X | |||
| 323.1 | L03AA01 | interleukin 2 | parent. | 1 | MG | 8006,85 | X |
| 323.2 | L03AA02 | filgrastim | parent. | 1 | MG | 13931,75 | X |
| 98297 | NEUPOGEN | inj 5x1.6ml | HLR | CH | |||
| 69026 | NEUPOGEN | inj 5x1ml | HLR | CH | |||
| 323.3 | L03AA03 | molgramostim | parent. | 1 | MG | 14357,35 | X |
| 96865 | LEUCOMAX | inj sic 0.15mg+1ml | SAN | CH | |||
| 72549 | LEUCOMAX | inj sic 0.3mg+1ml | SAN | CH | |||
| 96866 | LEUCOMAX | inj sic 0.4mg+1ml | SAN | CH | |||
| 323.4 | L03AA10 | lenograstim | parent. | 1 | MG | 15891,65 | X |
| 323.5 | L03AA04 | interferon alfa | parent. | 1 | MU | 245,00 | X |
| 83942 | HEBERON ALFA R | inj sic 25x3mu | HBC | C | |||
| 89225 | ROFERON A | inj 1x3ml/18mu | HLR | CH | |||
| 25776 | WELFERON | inj 1x1ml/5mu | BWE | GB | |||
| 93101 | WELLFERON | inj 1x1ml/10mu | BWE | GB | |||
| 80514 | HEBERON ALFA R | inj sic 1x3mu | HBC | C | |||
| 91641 | INTRON A | inj 1x10mu | SCH | IRL | |||
| 91639 | INTRON A | inj 1x3mu | SCH | IRL | |||
| 91640 | INTRON A | inj 1x5mu | SCH | IRL | |||
| 323.6 | L03AA08 | interferon gamma | parent. | 1 | MU | 1566,45 | X |
| 323.7 | L03AA11 | interferon beta 1b | parent. | 1 | MU | 330,15 | X |
| 87312 | BETAFERON | inj sic 15+15x2ml | SAG | D | |||
| 323.8 | L03AA11 | interferon beta 1a | parent. | 1 | MU | 440,20 | X |
| 324 | L03AX | ostatní imunostimulační léčiva | lok., p.o. | L/ALG | |||
|---|---|---|---|---|---|---|---|
| 324.1 | L03AX | směs bakteriálních lyzátů | lok. | 1 | BA | 75% | L/ALG,ORL |
| 324.2 | L03AX | směs bakteriálních lyzátů | p.o. | 1 | BA | 75% | |
| 324.3 | L03AX | vaccin. staphyl. phagolys. | lok. | 1 | ML | 37,35 | L/ALG,ORL |
| 94631 | STAVA-NASAL | gtt 10x5ml | BIU | CZ | |||
| 325 | L03AX | ostatní imunostimulační léčiva | parent. | O | |||
| 325.1 | L03A | dialyzát lidských leukocytů | parent. | 1 | DF | 1011,05 | O/ALG,IMU |
| 56930 | IMMODIN SEVAC | inj sic 1x2ml+solv. | SEV | CZ | |||
| 97146 | IMMODIN SEVAC | inj sic 5x2ml+solv. | SEV | CZ | |||
| 325.2 | L03A | thymostimulin (do 10 mg včetně v jedné ampuli) | parent. | 1 | MG | 66,35 | Z |
| 69035 | TP-1 SERONO | inj sic 1x10mg+sol | SRO | CH | |||
| 325.3 | L03AX | bac. propionibacterii acnes | parent. | 1 | MG | 74,50 | O/ONK |
| 325.4 | L03AX | laktobacillus acidophilus | parent. | 3 | DF | 639,80 | O/GYN |
| 325.5 | L03AX | vaccin. staphyl. phagolys. | parent. | 1 | DF | 74,65 | O |
| 325.6 | L03AX03 | BCG vakcína | parent. | 1 | MG | 44,35 | O/ONK,URN |
| 325.7 | L03AX | dialyzát vepřových leukocytů | p.o. | 75% | O/ALG,IMU | ||
| 325.8 | L03A | thymostimulin (nad 10 mg včetně v jedné ampuli) | parent. | 1 | MG | 46,35 | Z |
| 69041 | TP-1 SERONO | inj sic 1x50mg+sol | SRO | CH | |||
| 326 | L04AA | selektivní imunosupresivní léčiva | p.o. | P | |||
a) prevence reakce štěpu proti hostiteli po transplantacích,
b) léčba myelodysplastického syndromu nereagující na standardní léčbu,
c) léčba aplastické anemie nereagující na standardní léčbu,
d) léčba autoimunní hemolytické anemie a autoimunní trombocytopenické purpury nereagující na standardní léčbu,
e) léčba nefrotického syndromu nereagující na standardní léčbu,
f) těžké formy revmatoidní artritidy dospělých a dětí se středně těžkým a těžkým průběhem kloubního postižení nebo se současným postižením jiných orgánů (zvláště plic),
g) těžké generalizované formy psoriázy (psoriasis vulgaris, arthropatica, pustulosa) nereagující na standardní léčbu,
h) systémový lupus erythematodes nereagující na standardní léčbu,
i) těžké formy polymyositidy/dermatomyositidy nereagující na standardní léčbu.
Léčba se zahajuje obvykle v rámci hospitalizace pacienta s odpovídajícím odstupem od jiné terapie (např. PUVA, retinoidy, cytostatika), léčbu provádí pouze pracoviště s dostupností příslušných laboratorních vyšetření (včetně stanovení hladiny cyklosporinu).
j) u myasthenia gravis přepisuje neurolog
Léčbu mophetil mycophenolatem ordinuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů, u kterých byla provedena alogenní transplantace ledvin. Podává se v kombinaci s cyklosporinem a kortikosteroidy.
| 326.1 | L04AA01 | cyklosporin | p.o. | 1 | MG | 1,25 | P | ||
| CONSUPREN 100MG | cps 50x100mg | GNO | CZ | ||||||
| CONSUPREN 25MG | cps 50x25mg | GNO | CZ | ||||||
| CONSUPREN 50MG | cps 50x50mg | GNO | CZ | ||||||
| 326.2 | L04AA01 | cyklosporin (mikroemulgované formy) | p.o. | 1 | MG | 1,30 | P | ||
| 326.3 | L04AA06 | mophetil mycophenolát | p.o. | 10 | MG | 2,60 | P | ||
| 55681 | CELLCEPT | cps 100x250mg | HLR | CH | |||||
| 327 | L04AA | selektivní imunosupresivní léčiva | parent. | U/J10 | |||||
|---|---|---|---|---|---|---|---|---|---|
| 327.1 | L04AA | antilymfocytární IG | parent. | 10 | MG | 106,25 | U/J10 | ||
| 327.2 | L04AA | antithymocytární IG | parent. | 1 | MG | 124,25 | U/J10 | ||
| 327.3 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,70 | U/J10 | ||
| 95041 | SANDIMMUN KONZENTRAT | inf 10x1ml 50mg/1ml | SAN | CH | |||||
| 88514 | SANDIMMUN KONZENTRAT | inf 10x5ml 50mg/1ml | SAN | CH | |||||
| 327.4 | L04AA02 | muromonab-CD3 | parent. | 1 | MG | 2276,90 | U/J10 | ||
| 96997 | CEDETRIN-T(MONOK.PROTIL.A1-CD3) | inj 10x3.2ml | EXB | CZ | |||||
| 93351 | ORTHOCLONE OKT 3 | inj 5x5ml 1ml/ml | CIL | CH | |||||
| 328 | L04AX | ostatní imunosupresiva | p.o. | L/J10,REV,HEM | |||||
| 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,60 | L/J10,REV,HEM NEU,OPH,DER | ||
| 31396 | IMURAN | tbl obd 100x25mg | BWE | GB | |||||
| 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,15 | L/J10,REV,HEM NEU,OPH,DER | ||
| 02418 | IMURAN | tbl obd 100x50mg | BWE | GB | |||||
| 329 | L04AX | ostatní imunosupresiva | parent. | U/J10 | |||||
| 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 10,05 | U/J10 | ||
| 02016 | IMURAN | inj sic 1x50mg+2ml | BWE | GB | |||||
| 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | ||||||
| 330.1 | M01AA | butylpyrazolidiny | p.o. | 3 | DF | 3,40 | |||
| 00179 | KETAZON | drg 20x250mg | LEX | CZ | |||||
| 330.2 | M01AA05 | klofezon | p.o. | 0.6 | GM | 3,40 | |||
| 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | |||||
|---|---|---|---|---|---|---|---|---|
| 331.1 | M01AA | butylpyrazolidiny | parent. | 1 | DF | 7,05 | ||
| 00490 | KETAZON | inj 5x5ml/1gm | LEX | CZ | ||||
| 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | |||||
| 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,80 | ||
| 88917 | REPANIDAL | cps 30x35mg | LEX | CZ | ||||
| 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 3,25 | ||
| 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | ||||
| 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | ||||
| 67403 | INDOBENE 50MG | cps 20x50mg | MCK | D | ||||
| 67404 | INDOBENE 50MG | cps 50x50mg | MCK | D | ||||
| 02630 | INDREN | cps 30x25mg | LEX | CZ | ||||
| 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 4,80 | ||
| 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 4,80 | ||
| 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 4,80 | ||
| 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | ||||
| 75605 | DICLOFENAC AL 25 | tbl obd 100x25mg | APA | D | ||||
| 75604 | DICLOFENAC AL 25 | tbl obd 50x25mg | APA | D | ||||
| 75633 | DICLOFENAC AL RETARD | tbl obd 100x10mg | APA | D | ||||
| 75631 | DICLOFENAC AL RETARD | tbl obd 20x100mg | APA | D | ||||
| 75632 | DICLOFENAC AL RETARD | tbl obd 50x100mg | APA | D | ||||
| 75462 | REWODINA RETARD | tbl obd 100x100mg | VAD | D | ||||
| 332.6 | M01AB05 | diklofenak (lékové formy s rychlým nástupem účinku) | p.o. | 0.1 | GM | 5,75 | ||
| 89136 | DICLOFENAC DUO PHARMAVIT 75MG | cps ret 30x75mg | PVI | H | ||||
| 332.7 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 4,80 | ||
| 332.8 | M01AB09 | lonazolak | p.o. | 0.6 | GM | 4,80 | ||
| 332.9 | M01AB16 | aceklofenak | p.o. | 0.2 | GM | 4,80 | ||
| 332.10 | M01AB55 | diklofenak/misoprostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 30,00 | Z | |
| 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | |||||
| 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,45 | ||
| 02789 | INDOMETACINUM | sup 5x100mg | CHN | H | ||||
| 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 10,80 | ||
| 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 10,80 | ||
| 91969 | DICLOBERL 50 | sup 10x50mg | BCE | D | ||||
| 99894 | DICLOFENAC PHARMAVIT 100MG | sup 6x100mg | PVI | H | ||||
| 66957 | MONOFLAM 100MG | sup 10x100mg | LIC | D | ||||
| 66956 | MONOFLAM 50MG | sup 10x50mg | LIC | D | ||||
| 76913 | REWODINA 100 | sup 10x100mg | VAD | D | ||||
| 76912 | REWODINA 50 | sup 10x50mg | VAD | D | ||||
| 87206 | VERAL 100MG | sup 10x100 | SLO | SK | ||||
| 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 10,80 | ||
| 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | |||||
|---|---|---|---|---|---|---|---|---|
| 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 13,20 | ||
| 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 13,20 | ||
| 94632 | VERAL | inj 5x3ml | LEX | CZ | ||||
| 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | |||||
| 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,55 | ||
| 97711 | APO-PIROXICAM 10 | cps 100x10mg | APT | CND | ||||
| 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | ||||
| 91721 | ARTHREMIN 10 | cps 30x10mg | LEX | CZ | ||||
| 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | ||||
| 68581 | PIROX 10 | tbl 50x10mg | CTA | D | ||||
| 335.2 | M01AC02 | tenoxikam | p.o. | 20 | MG | 2,55 | ||
| 335.3 | M01AC06 | meloxikam | p.o. | 15 | MG | 14,65 | L/ORT,REV | |
| 335.4 | M01AC01 | piroxikam (lékové formy s rychlým nástupem účinku) | p.o. | 20 | MG | 5,75 | ||
| 336 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.rect. | |||||
| 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 11,40 | ||
| 67172 | PIROX 20 | sup 10x20mg | CTA | D | ||||
| 336.2 | M01AC02 | tenoxikam | p.rect. | 20 | MG | 11,50 | ||
| 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 11,50 | ||
| 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | |||||
| 337.1 | M01AC01 | piroxikam | parent. | 20 | MG | 12,30 | ||
| 89853 | PIROX 20 VON CT | inj 5x1ml/20mg | CTA | D | ||||
| 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 12,10 | ||
| 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | |||||
|---|---|---|---|---|---|---|---|---|
| 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,65 | ||
| 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | ||||
| 83721 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 30x400mg | GNS | GB | ||||
| 98321 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 250x400mg | GNS | GB | ||||
| 98324 | IBUPROFEN DH 600MG DIAG HUMAN | tbl obd 250x600mg | GNS | GB | ||||
| 66990 | DOLGIT 800 | tbl obd 20x800mg | DLR | D | ||||
| 98322 | IBUPROFEN DH 600MG DIAG HUMAN | tbl obd 30x600mg | GNS | GB | ||||
| 98323 | IBUPROFEN DH 600MG DIAG HUMAN | tbl obd 100x600mg | GNS | GB | ||||
| 93651 | IBUPROFEN 400 LECIVA | tbl obd 30x400mg | LEX | CZ | ||||
| 56035 | IBUPROFEN 600 LECIVA | tbl obd 30x600mg | LEX | CZ | ||||
| 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 20,00 | ||
| 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 5,20 | ||
| 97983 | APO-NAPROXEN 250MG | tbl 100x250mg | APT | CND | ||||
| 338.4 | M01AE02 | naproxen (tekuté lékové formy) | p.o. | 0.5 | GM | 13,45 | ||
| 338.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 5,20 | ||
| 76655 | KETONAL | cps 25x50mg | LEK | SLO | ||||
| 76653 | KETONAL FORTE | tbl obd 20x100mg | LEK | SLO | ||||
| 76654 | KETONAL RETARD | tbl ret 20x150mg | LEK | SLO | ||||
| 338.6 | M01AE07 | suprofen | p.o. | 0.4 | GM | 5,20 | ||
| 338.7 | M01AE08 | pirprofen | p.o. | 0.8 | GM | 5,20 | ||
| 338.8 | M01AE09 | flurbiprofen | p.o. | 0.2 | GM | 5,20 | ||
| 338.9 | M01AE10 | indoprofen | p.o. | 0.6 | GM | 5,20 | ||
| 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 8,80 | ||
| 96484 | SURGAM | tbl 20x300mg | LEX | CZ | ||||
| 338.11 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 5,20 | ||
| 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | |||||
| 339.1 | M01AE01 | ibuprofen | p.rect. | 1.2 | GM | 9,60 | ||
| 339.2 | M01AE02 | naproxen | p.rect. | 0.5 | GM | 11,40 | ||
| 67107 | NAPROXEN 500 VON CT | sup 10x500mg | CTA | D | ||||
| 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 9,60 | ||
| 76652 | KETONAL | sup 12x100mg | LEK | SLO | ||||
| 06171 | PROFENID 100MG | sup 12 | SPC | F | ||||
| 339.4 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.6 | GM | 11,40 | ||
| 340 | M01A | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové a fenamátů | parent. | |||||
|---|---|---|---|---|---|---|---|---|
| 340.1 | M01AE01 | ibuprofen | parent. | 1.2 | GM | 14,70 | ||
| 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 14,70 | ||
| 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 14,70 | ||
| 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | ||||
| 340.4 | M01AG | etofenamat | parent. | 1 | GM | 14,70 | ||
| 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | L/REV | ||||
| 341.1 | M01AX01 | nabumeton | p.o. | 1 | GM | 20,00 | L/REV,ORT | |
| 341.2 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 12,05 | ||
| 31023 | PROLIXAN 300 | cps 30x300mg | IDA | H | ||||
| 341.3 | M01AX05 | glukosamin sulfat | p.o. | 1.5 | GM | 11,70 | L/REV | |
| 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 12,05 | ||
| 341.5 | M01AX17 | nimesulid (pevné lékové formy) | p.o. | 0.2 | GM | 14,65 | L/REV,ORT | |
| 341.6 | M01AX17 | nimesulid (tekuté lékové formy) | p.o. | 0.2 | GM | 20,00 | L/REV,PDD | |
| 341.7 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,65 | L/REV,ORT | |
| 342 | M01CB | léčiva obsahující zlato | parent. | L/REV | ||||
| 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,75 | L/REV | |
| 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | ||||
| 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | ||||
| 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | P | ||||
součást léčby primární osteoarthrózy kolenních kloubů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných
bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.
| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 33,60 | |
| 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | |||
| 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 23,40 | |
| 92732 | TROLOVOL | tbl obd 50x300mg | ASD | D | |||
| 09738 | TROLOVOL | tbl obd 100x300mg | ASD | D | |||
| 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 200,00 | P |
| 343.4 | M09AX02 | chondroitin sulfat | p.o. | 1.6 | GM | 15,00 | L/REV,ORT |
| 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití, nad 50 g masti | lok. | 1 | GM | 0,80 | ||||||
| 344.2 | M02AA | ketofenylbutazon do 50 g masti včetně v jednom balení | lok. | 1 | GM | 1,00 | ||||||
| 00865 | KETAZON 10% | ung 1x20gm | LEX | CZ | ||||||||
| 344.3 | M02AA05 | benzydamin | lok. | 1 | GM | 1,00 | ||||||
| 344.4 | M02AA06 | etofenamát do 50 g masti včetně v jednom balen | lok. | 1 | GM | 1,00 | ||||||
| 344.5 | M02AA06 | etofenamát nad 50 g masti | lok. | 1 | GM | 0,80 | ||||||
| 344.6 | M02AA07 | piroxikam do 50 g masti včetně v jednom balení | lok. | 1 | GM | 1,00 | ||||||
| 344.7 | M02AA07 | piroxikam nad 50 g masti v jednom balení | lok. | 1 | GM | 0,80 | ||||||
| 344.8 | M02AA10 | ketoprofen do 50 g masti včetně v jednom balení | lok. | 1 | GM | 1,00 | ||||||
| 344.9 | M02AA10 | ketoprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,80 | ||||||
| 344.10 | M02AA13 | ibuprofen do 50 g masti v jednom balení | lok. | 1 | GM | 1,00 | ||||||
| 344.11 | M02AA13 | ibuprofen nad 50 g masti v jednom balení | lok. | 1 | GM | 0,80 | ||||||
| 344.12 | M02AA15 | diklofenak do 50 g masti včetně v jednom balení | lok. | 1 | GM | 1,00 | ||||||
| 67549 | ALMIRAL GEL | gel 1x25gm | MOE | CY | ||||||||
| 55478 | DICLOFENAC LÉČIVA | gel 1x35gm 1% | LEX | CZ | ||||||||
| 344.13 | M02AA15 | diklofenak nad 50 g masti v jednom balení | lok. | 1 | GM | 0,80 | ||||||
| 344.14 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,20 | ||||||
| 344.15 | M02AA17 | kyselina niflumová nad 50 g masti v jednom balení | lok. | 1 | GM | 0,80 | ||||||
| 344.16 | M02AA21 | tolectin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 1,00 | ||||||
| 344.17 | M02AA21 | tolectin nad 50 g masti v jednom balení | lok. | 1 | GM | 0,80 | ||||||
| 344.18 | M02AA23 | indomethacin do 50 g masti včetně v jednom balení | lok. | 1 | GM | 1,00 | ||||||
| 344.19 | M02AA23 | indomethacin nad 50 g masti v jednom balení | lok. | 1 | GM | 0,80 | ||||||
| 88595 | INDOMETHACINOVY GEL 1% GLO | gel 1x50gm | GAO | CZ | ||||||||
| 66959 | VONUM CUTAN | ung 1x75gm | LIC | D | ||||||||
| 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | |||||||||
| 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 1,00 | ||||||
| 03574 | RHEUMOSIN | ung 1x30gm | LEX | CZ | ||||||||
| 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | ||||
|---|---|---|---|---|---|---|---|
| 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 1,00 | |
| 83872 | UNGUENTUM CAMPHORATUM 10% MVM | ung 1x1kg | MVM | CZ | |||
| 83873 | UNGUENTUM CAMPHORATUM 20% MVM | ung 1x1kg | MVM | CZ | |||
| 91114 | VIPROSAL B | ung 1x50gm | TAL | EST | |||
| 91764 | YELLON | gel 1x50gm | SLO | SK | |||
| 346.2 | M02AX10 | různé | lok. | 1 | GM | 0,40 | |
| 00830 | APHLOX | pst 1x200gm | LEX | CZ | |||
| 00803 | PAIN EXPELLER | liq 1x50ml | GNO | CZ | |||
| 347 | M03AA | svalová relaxancia ze skupiny kurarových alkaloidů | parent. | H | |||
| 347.1 | M03AA01 | alkuronium | parent. | 20 | MG | 72,05 | H |
| 02519 | ALLOFERIN | inj 50x2ml 10mg | HLR | CH | |||
| 347.2 | M03AA02 | tubokurarin | parent. | 30 | MG | 57,10 | H |
| 348 | M03AB | svalová relaxancia ze skupiny derivativátů cholinu | parent. | H | |||
| 348.1 | M03AB | decamethonium | parent. | 10 | MG | 24,30 | H |
| 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 59,00 | H |
| 97386 | SUCCINYLCHOLINJODID VUAB | inj 1x100mg | VUA | CZ | |||
| 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 33,75 | H |
| 97387 | SUCCINYLCHOLINJODID VUAB | inj 1x250mg | VUA | CZ | |||
| 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | H | |||
| 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 116,20 | H |
| 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 44,10 | H |
| 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 116,20 | H |
| 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 118,50 | H |
| 97376 | TRACRIUM | inj 2x250ml/250mg | BWE | GB | |||
| 86760 | TRACRIUM | inj 5x2.5ml/25mg | BWE | GB | |||
| 86761 | TRACRIUM | inj 5x5ml/50mg | BWE | GB | |||
| 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 105,85 | H |
| 349.6 | M03AC10 | mivacuronium | parent. | 10 | MG | 132,55 | H |
| 350 | M03AX | ostatní svalová relaxancia | parent. | X | |||
| 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 8950,00 | X |
| 350.2 | M03AX01 | potulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2612,00 | X | |
| 97456 | DYSPORT | inj sic 2x500ut | SPY | GB | ||||
| 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | L/NEU,ORT,REV | ||||
|---|---|---|---|---|---|---|---|---|
| 351.1 | M03BX tetrazepam | p.o. | 0.1 | GM | 18,00 | L/NEU,ORT,REV | ||
| 56233 | MYOLASTAN | tbl obd 10x50mg | SWI | F | ||||
| 351.2 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50 | MG | 10,20 | ||
| 351.3 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,45 | ||
| 351.4 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 27,60 | L/NEU,ORT,REV | |
| 62523 | SIRDALUD | tbl 20x2mg | SAN | CH | ||||
| 351.5 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 20,40 | L/NEU,ORT,REV | |
| 91284 | SIRDALUD | tbl 30x4mg | SAN | CH | ||||
| 351.6 | M03BX04 | tolperison | p.o. | 200 | MG | 2,55 | ||
| 351.7 | M03BX04 | tolperison | parent. | 200 | MG | 8,40 | ||
| 352 | M03CA | přímo působící svalová relaxancia | parent. | T | ||||
| 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7718,60 | T | |
| 91583 | DANTROLEN | inj sic 3x12x20mg+so | RHA | D | ||||
| 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | |||||
| 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,50 | ||
| 97981 | APO-ALLOPURINOL 100MG | tbl 100x100mg | APT | CND | ||||
| 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | |||||
| 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,20 | ||
| 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,90 | ||
| 11854 | DESURIC | tbl 60x100mg | SWI | F | ||||
| 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | |||||
| 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 6,00 | ||
| 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | KCH | D | ||||
| 356 | M05BA | bisfosfonáty | p.o. | P |
|---|
a) osteoporotické patologické zlomeniny,
b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergetickou rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník, vitamin D a jeho deriváty, fluor),
c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,
d) hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo i bez metastáz, mnohočetný myelom.
| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 232,351 | P |
| 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | |||
| 93985 | LODRONAT | cps 60x500mg | BOM | A | |||
| 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 54,70 | P |
| 357 | M05BA | bisfosfonáty | parent. | O/P | |||
|---|---|---|---|---|---|---|---|
a) osteoporotické patologické zlomeniny,
b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergetickou rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník, vitamin D a jeho deriváty, fluor),
c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,
d) hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo i bez metastáz, mnohočetný myelom.
| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2402,60 | O/P |
| 94548 | BONEFOS | inj 5x5ml 60mg/ml | STF | SF | |||
| 93972 | LODRONAT | inj 5x10ml | BOM | A | |||
| 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 3844,20 | O/P |
| 357.3 | M05BA06 | kyselina ibandrovová | parent. | 2 | MG | 9600,00 | O/P |
| 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | H | |||
|---|---|---|---|---|---|---|---|
| 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,80 | H |
| 00736 | AETHER PRO NARCOSI | inh 200gm | SYT | CZ | |||
| 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | H | |||
| 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 311,95 | H |
| 75284 | NARCOTAN | liq 1x250ml | LEX | CZ | |||
| 359.2 | N01AB08 | isofluran | inhal. | 100 | ML | 2343,15 | H |
| 359.3 | N01AB06 | sevofluoran | inhal. | 100 | ML | 2343,15 H | |
| 360 | N01AF | injekční anestetika ze skupiny barbiturátů | parent. | H | |||
| 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 145,90 | H |
| 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 56,20 | H |
| 97388 | THIOPENTAL VUAB | inj sic 1x500mg | VUA | CZ | |||
| 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 32,30 | H |
| 97389 | THIOPENTAL VUAB | inj sic 1x1gm | VUA | CZ | |||
| 361 | N01AH | opioidní anestetika (fentanyl) | parent. | O | |||
|---|---|---|---|---|---|---|---|
| 361.1 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 130,55 | O |
| 01449 | FENTANYL | inj 50x10ml/0.5mg | JAN | B | |||
| 60911 | FENTANYL | inj 5x10ml/0.5mg | JAN | B | |||
| 361.2 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 177,60 | O |
| 76526 | FENTANYL | inj 5x2ml/0.1mg | JAN | B | |||
| 76527 | FENTANYL | inj 50x2ml/0.1mg | JAN | B | |||
| 362 | N01AH | opioidní anestetika (ostatní) | parent. | H | |||
| 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 50,10 | H |
| 87723 | RAPIFEN | inj 5x10ml | JAN | B | |||
| 87721 | RAPIFEN | inj 5x2ml | JAN | B | |||
| 362.2 | N01AH03 | sufentanyl (do 10 RG v ampuli včetně) | parent. | 0.6 | MG | 1435,80 | H |
| 93701 | SUFENTA I.V. | inj 5x2ml/10rg | JAN | B | |||
| 362.3 | N01AH03 | sufentanyl (nad 50 RG v ampuli) | parent. | 0.6 | MG | 767,55 | H |
| 93702 | SUFENTA FORTE I.V. | inj 5x5ml/250rg | JAN | B | |||
| 362.4 | N01AH03 | sufentanyl (od 10 do 50 RG v ampuli včetně) | parent. | 0.6 | MG | 1255,40 | H |
| 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B | |||
| 93703 | SUFENTA I.V. | inj 5x10ml/50rg | JAN | B | |||
| 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 39,10 | H |
| 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 270,35 H | |
| 363 | N01AX | ostatní celková anestetika | parent. | O | |||
| 363.1 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 100 | ML | 231,80 | O |
| 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 10 | ML | 113,00 | O |
| 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,85 | O |
| 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 166,45 | O |
| 23511 | RADENARCON | inj 10x10ml/20mg | VAD | D | |||
| 363.5 | N01AX10 | propofol | parent. | 10 | ML | 126,70 | O | |
| 76089 | DIPRIVAN 1% | inj 5x20ml 10mg/ml | ZNC | GB | ||||
| 76091 | DIPRIVAN 1% PRO INFUS. | inj 1x50ml 10mg/ml | ZNC | GB | ||||
| 75180 | RECOFOL 10MG/ML | inj 5x20ml/200mg | LOY | SF | ||||
| 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 364.1 | N01BA estery aminobenzoové kyseliny | parent. | 100 | ML | 13,50 | O | ||
| 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,30 | O | |
| 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ | ||||
| 00565 | PROCAIN LECIVA 1% | inj 10x10ml 1% | LEX | CZ | ||||
| 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,55 | O | |
| 69669 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x80ml 0.2% | ARD | CZ | ||||
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml 0.2% | ARD | CZ | ||||
| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml 0.2% | ARD | CZ | ||||
| 69672 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | ||||
| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | ||||
| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | ||||
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x250ml 1% | ARD | CZ | ||||
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x500ml 1% | ARD | CZ | ||||
| 86437 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 40x80ml 0.2% | ARD | CZ | ||||
| 86444 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x250ml 0.2% | ARD | CZ | ||||
| 86445 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 12x500ml 0.2% | ARD | CZ | ||||
| 86447 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | ||||
| 86448 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | ||||
| 86450 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 20x250ml 1% | ARD | CZ | ||||
| 86451 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 12x500ml 1% | ARD | CZ | ||||
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml 0.2% | ARD | CZ | ||||
| 89213 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x200ml 0.2% | ARD | CZ | ||||
| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml 0.5% | ARD | CZ | ||||
| 89215 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x200ml 0.5% | ARD | CZ | ||||
| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 1x200ml 1% | ARD | CZ | ||||
| 89217 | INJECTIO PROCAIN.CHLOR.1% ARD | inj 20x200ml 1% | ARD | CZ | ||||
| 01691 | PROCAINII HYDROCHL.0.2% MEDVIR | inj 1x200ml | VYS | CZ | ||||
| 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | O | ||||
| 365.1 | N01BB trimekain | lok. | 1 | GM | 1,25 | O | ||
| 02684 | MESOCAIN | gel 1x20gm | SLO | SK | ||||
| 365.2 | N01BB02 | lidokain | lok. | 1 | ML | 8,95 | O | |
| 62393 | INSTILLAGEL | gel 10x11ml(strik.) | FAP | D | ||||
| 62392 | INSTILLAGEL | gel 10x6ml(strik.) | FAP | D | ||||
| 365.3 | N01BB02 | lidokain (lékové formy spreje, koncentrace 10%) | lok. | 1 | GM | 2,15 | O | |
| 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,70 | O | |
| 69704 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ | ||||
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ | ||||
| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ | ||||
| 86452 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 40x80ml 0.5% | ARD | CZ | ||||
| 86453 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ | ||||
| 86454 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ | ||||
| 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,40 | O | |
| 00502 | MESOCAIN | inj 10x10ml 1% | LEX | CZ | ||||
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,75 O | ||
| 69707 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x80ml 1% | ARD | CZ | ||||
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ | ||||
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ | ||||
| 86455 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 40x80ml 1% | ARD | CZ | ||||
| 86456 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 20x250ml 1% | ARD | CZ | ||||
| 86457 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 12x500ml 1% | ARD | CZ | ||||
| 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,25 | O | |
| 00503 | MESOCAIN | inj 10x5ml 2% | LEX | CZ | ||||
| 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,40 | O | |
| 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,60 | O | |
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 51,40 | O | |
| 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,25 | O | |
| 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,60 | O | |
| 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,25 | O | |
| 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 10,45 | O | |
| 91234 | ULTRACAIN HYPERBAR 5% | inj 10x2ml/100mg | HOE | D | ||||
| 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,90 | O | |
| 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,40 | O | |
| 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,25 | O | |
| 93109 | SUPRACAIN 4% | inj 10x2ml | LEX | CZ | ||||
| 87571 | ULTRACAIN 2% | inj 5x5ml | HOE | D | ||||
| 366.15 | N01BB09 | ropivacain | parent. | 1 | ML | 16,00 | O | |
| 367 | N01BX | ostatní lokální anestetika | lok. | O | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 95,50 | O | |||
| 02088 | CHLORAETHYL | spr 1x100ml | LZK | CZ | ||||||
| 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | |||||||
| 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 100,00 | ||||
| 94309 | MST CONTINUS | tbl 60x10mg | NPP | GB | ||||||
| 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D | ||||||
| 368.2 | N02AA01 | morfin (od 10 mg do 100 mg v jedné tabletě) | p.o. | 0.1 | GM | 67,00 | ||||
| 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB | ||||||
| 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D | ||||||
| 368.3 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 59,85 | ||||
| 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB | ||||||
| 368.4 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 59,30 | ||||
| 80451 | DHC CONTINUS 60MG | tbl 56x60mg | NPP | GB | ||||||
| 80452 | DHC CONTINUS 90MG | tbl 56x90mg | NPP | GB | ||||||
| 368.5 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.24 | GM | 50,50 | ||||
| 80453 | DHC CONTINUS 120MG | tbl 56x120mg | NPP | GB | ||||||
| 368.6 | N02AA01 | morfin (od 30 mg do 100 mg v jedné tabletě) | p.o. | 0.1 | GM | 64,80 | ||||
| 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB | ||||||
| 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | O | ||||||
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 16,35 | O | |||
| 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK | ||||||
| 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,90 | O | |||
| 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK | ||||||
| 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | |||||||
| 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 42,25 | ||||
| 01116 | DOLSIN | gtt 1x10ml/500mg | SLO | SK | ||||||
| 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 2,5 mikrogramu z 1 cm2 za hodinu) | transd. | 1 | CM2 | 21,50 | P | |||
| Lék je aplikován v případech, kdy pacient není schopen perorálního příjmu opioidů. | ||||||||||
| 371 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | parent. | O | |||
|---|---|---|---|---|---|---|---|
| 371.1 | N02AB02 | penthidin ( do 50 mg v jedné ampuli včetně) | p.o. | 0.4 | GM | 58,80 | O |
| 02715 | DOLSIN | inj 10x1ml 5% | HBS | SK | |||
| 371.2 | N02AB02 | pethidin (nad 50 mg v jedné ampuli) | parent. | 0.4 | GM | 37,05 | O |
| 02716 | DOLSIN | inj 10x2ml 5% | HBS | SK | |||
| 371.3 | N02AC03 | piritramid | parent. | 45 | MG | 29,30 | O |
| 02637 | DIPIDOLOR | inj 25x2ml/15mg | GED | H | |||
| 372 | N02AC | analgetika ze skupupiny difenylpropylaminových derivátů | p.o. | ||||
| 372.1 | N02AC05 | benzitramid | p.o. | 10 | MG | 13,00 | |
| 03362 | BURGODIN | tbl 25x5mg | JAN | B | |||
| 373 | N02AD | analgetika ze skupiny benzomorfanových derivátů | p.o. | ||||
| 373.1 | N02AD01 | pentazocin | p.o. | 0.2 | GM | 23,65 | |
| 08968 | FORTRAL | tbl 100x50mg | KRK | SLO | |||
| 374 | N02AD | analgetika ze skupiny benzomorfanových derivátů | parent. | O | |||
| 374.1 | N02AD01 | pentazocin | parent. | 0.2 | GM | 92,40 | O |
| 08966 | FORTRAL | inj 10x1ml/30mg | KRK | SLO | |||
| 375 | N02AX | analgetika ze skupiny ostatních opioidů | p.o., subling. | ||||
| 375.1 | N02AE01 | buprenorfin | sublng. | 1.2 | MG | 98,00 | |
| 375.2 | N02AX01 | tilidin | p.o. | 0.2 | GM | 14,60 | |
| 03558 | VALORON | gtt 10ml 10% | GNO | CZ | |||
| 375.3 | N02AX02 | tramadol (pevné lékové formy) | p.o. | 0.3 | GM | 34,95 | |
| 83094 | TRAMAL | cps 20x50mg | LEX | CZ | |||
| 84375 | PROTRADON | cps 10x50mg | PMP | CZ | |||
| 84376 | PROTRADON | cps 20x50mg | PMP | CZ | |||
| 84748 | TRAMADOL 50 SLOVAKOFARMA | cps 20x50mg | SLO | SK | |||
| 67568 | MABRON 50MG | cps 10x50mg | MOE | CY | |||
| 67569 | MABRON 50MG | cps 20x50mg | MOE | CY | |||
| 43711 | TRAMAL RETARD 100 | tbl obd 10x100mg | LEX | CZ | |||
| 375.4 | N02AX02 | tramadol tekuté lékové formy) | p.o. | 0.3 | GM | 39,00 | |
| 376 | N02AX | analgetika ze skupiny ostatních opioidů | p.rect., parent. | O | |||
|---|---|---|---|---|---|---|---|
| 376.1 | N02AE01 | buprenorfin | parent. | 1.2 | MG | 205,00 | O |
| 376.2 | N02AF01 | butorfanol | parent. | 12 | MG | 70,80 | O |
| 88739 | BEFORAL | inj 5x1ml/2mg | LEX | CZ | |||
| 376.3 | N02AF02 | nalbufin | parent. | 80 | MG | 70,80 | O |
| 376.4 | N02AX01 | tilidin | parent. | 0.2 | GM | 16,75 | O |
| 376.5 | N02AX02 | tramadol | p.rect. | 0.3 | GM | 61,15 | |
| 83096 | TRAMAL | sup 5x100mg | LEX | CZ | |||
| 376.6 | N02AX02 | tramadol (do 50 mg v jedné ampuli včetně) | parent. | 0.3 | GM | 117,85 | O |
| 83097 | TRAMAL 50 | inj 5x1ml/50mg | LEX | CZ | |||
| 06200 | TRAMAL 50 | inj 5x1ml/50mg | GRU | D | |||
| 376.7 | N02AX02 | tramadol (nad 50 mg v jedné ampuli) | parent. | 0.3 | GM | 60,00 | O |
| 90719 | TRAMAL 100 | inj 5x2ml/100mg | GRU | D | |||
| 67560 | MABRON | inj 100x2ml/100mg | MOE | CY | |||
| 67559 | MABRON | inj 10x2ml/100mg | MOE | CY | |||
| 377 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | p.o. | ||||
| 377.1 | N02BA01 | kyselina acetylsalicylová | p.o. | 3 | GM | 6,55 | |
| 00011 | ACYLPYRIN | tbl 10x500mg | SLO | SK | |||
| 377.2 | N02BA02 | aloxiprin | p.o. | 3 | GM | 6,55 | |
| 377.3 | N02BA03 | cholin salicylát | p.o. | 3 | GM | 8,85 | |
| 377.4 | N02BA11 | diflunisal | p.o. | 0.75 | GM | 5,85 | |
| 377.5 | N02BA13 | lysin acetylsalicylát (do 100 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,85 | |
| 377.6 | N02BA13 | lysin acetylsalicylát (nad 100 mg v jedné tabletě) | p.o. | 3 | GM | 6,55 | |
| 378 | N02BA | analgetika ze skupiny kyseliny salicylové a jejich derivátů | parent. | ||||
| 378.1 | N02BA | lysin salicylát | parent. | 3 | GM | 42,75 | |
| 96573 | DOLOROSAN | inj 5x5ml/750mg | LEX | CZ | |||
| 378.2 | N02BA04 | salicylát sodný | parent. | 3 | GM | 41,30 | |
| 00527 | NATRIUM SALICYLICUM BIOTIKA | inj 10x10ml 10% | HBS | SK | |||
| 378.3 | N02BA13 | lysin acetylsalicylát | parent. | 3 | GM | 41,30 | |
| 379 | N02BE | analgetika ze skupiny anilidů | p.o. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 379.1 | N02BE01 | paracetamol (pevné lékové formy do 125 mg v jedné tabletě včetně) | p.o. | 3 | GM | 8,45 | |||||
| 97656 | PARALEN PRO INFANTIBUS | tbl 20x125mg | LEX | CZ | |||||||
| 379.2 | N02BE01 | paracetamol (pevné lékové formy nad 125 mg v jedné tabletě) | p.o. | 3 | GM | 5,05 | |||||
| 83608 | APO-ACETAMINOPHEN 500MG | tbl 100x500mg | APT | CND | |||||||
| 71997 | PARACETAMOL K | tbl 10x500mg | KRK | SLO | |||||||
| 03837 | PARALEN | tbl 10x500mg | LEX | CZ | |||||||
| 84749 | MEDIPYRIN 500 | tbl 10x500mg | SLO | SK | |||||||
| 379.3 | N02BE01 | paracetamol (tekuté lékové formy) | p.o. | 3 | GM | 8,85 | |||||
| 380 | N02BE | analgetika ze skupiny anilidů | p.rect. | ||||||||
| 380.1 | N02BE01 | paracetamol (do 150 mg v jednom čípku včetně) | p.rect. | 3 | GM | 93,05 | |||||
| 91249 | PARALEN PRO INFANTIBUS | sup 5x100mg | LEX | CZ | |||||||
| 67226 | EFFERALGAN JEUNE ENFANT 150MG | sup 10x150mg | UPS | F | |||||||
| 67230 | EFFERALGAN NOURRISSON 80MG | sup 10x80mg | UPS | F | |||||||
| 380.2 | N02BE01 | paracetamol (nad 150 mg v jednom čípku) | p.rect. | 3 | GM | 27,60 | |||||
| 67233 | DAFALGAN ADULTE 600MG | sup 10x600mg | UPS | F | |||||||
| 53169 | EFFERALGAN ADULTE 600MG | sup 10x600mg | UPS | F | |||||||
| 94982 | MEXALEN | sup 6x1000mg | MCK | D | |||||||
| 04343 | PARALEN | sup 5x500mg | LEX | CZ | |||||||
| 67227 | EFFERALGAN GRAND ENFANT 300MG | sup 10x300mg | UPS | F | |||||||
| 381 | N02B | ostatní analgetika | parent. | O | |||||||
| 381.1 | N02BB | metamizol (nad 1 g v 1 ampuli) | parent. | 3 | GM | 18,70 | O | ||||
| 62813 | NOVALGIN | inj 5x5ml/2500mg | HOE | D | |||||||
| 381.2 | N02BB | metamizol (do 1 g v 1 ampuli včetně) | parent. | 3 | GM | 45,10 | O | ||||
| 62437 | NOVALGIN | inj 10x2ml/1000mg | HOE | D | |||||||
| 381.3 | N02BB | aminophenazon v kombinacích | parent. | 1 | DF | 6,75 | O | ||||
| 00457 | EUNALGIT | inj 5x2ml | LEX | CZ | |||||||
| 381.4 | N02BE05 | propacetamol | parent. | 1 | GM | 42,80 | O | ||||
| 85997 | PRO-DAFALGAN 1GM | inj sic 5x1gm+solv. | UPS | F | |||||||
| 85999 | PRO-DAFALGAN 2GM | inj sic 8x2gm+solv. | UPS | F | |||||||
| 53747 | PRO-EFFERALGAN 1GM | inj sic 5x1gm+solv. | UPS | F | |||||||
| 53748 | PRO-EFFERALGAN 2GM | inj sic 8x2gm+solv. | UPS | F | |||||||
| 382 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | p.o. | ||||||||
| 382.1 | N02CA01 | dihydroergotamin | p.o. | 4 | MG | 1,25 | |||||
| 382.2 | N02CA07 | lisurid | p.o. | .075 | MG | 0,75 | |
| 382.3 | N02CA52 | ergotamin, kombinace | p.o. | 4 | DF | 9,60 | |
| 00130 | ERGOFEIN | drg 10 | LEX | CZ | |||
| 383 | N02CA | antimigrenika ze skupiny derivátů námelových alkaloidů | parent. | ||||
|---|---|---|---|---|---|---|---|
| 383.1 | N02CA01 | dihydroergotamin | parent. | 4 | MG | 116,00 | |
| 90795 | DIHYDERGOT | inj 5x1ml 1mg/ml | SAN | CH | |||
| 384 | N02C | jiná antimigrenika | p.o. | ||||
| 384.1 | N02CC01 | sumatriptan | p.o. | 0.1 | GM | 150,00 | |
| 384.2 | N02CX | oxetoron | p.o. | 0.12 | GM | 6,00 | |
| 384.3 | N02CX | pipethiaden | p.o. | 3 | DF | 2,60 | |
| 94583 | MIGRENAL | tbl 50x1mg | LEX | CZ | |||
| 384.4 | N02CX01 | pizotifen | p.o. | 1.5 | MG | 6,00 | |
| 384.5 | N02CC01 | sumatriptan | parent. | 1 | DF | 850,00 | X |
| 385 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | p.o. | ||||
| 385.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.1 | GM | 2,10 | |
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,45 | |
| 68578 | PHENAEMALETTEN | tbl 50x15mg | DET | D | |||
| 385.3 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,45 | |
| 68579 | PHENAEMAL 0.1 | tbl 50x100mg | DET | D | |||
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 5,00 | |
| 86621 | MYSOLINE | tbl 100x250mg | ZNC | GB | |||
| 385.5 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 46,55 | |
| 66562 | LISKANTIN | sus 1x150ml/3.75gm | DET | D | |||
| 83437 | LISKANTIN | sus 1x250ml/6.25gm | DET | D | |||
| 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | parent. | O | |||
| 386.1 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.1 | GM | 134,00 | O |
| 66845 | GARDENAL | inj sic 1x40mg+solv | SPC | F | |||
| 386.2 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.1 | GM | 14,30 | O | |||
| 84449 | LUMINAL | inj 5x1ml/219mg | DET | D | ||||||
| 387 | N03AB | antiepileptika ze skupiny hydantoinů | p.o. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 387.1 | N03AB02 | fenytoin | p.o. | 0.3 | GM | 2,50 | ||||
| 62234 | EPILAN D GEROT | tbl 100x100mg | GER | A | ||||||
| 00297 | SODANTON | tbl 20x100mg | SLO | SK | ||||||
| 387.2 | N03AB04 | mefenytoin | p.o. | 0.4 | GM | 2,50 | ||||
| 387.3 | N03AB52 | fenytoin, kombinace | p.o. | 3 | DF | 2,15 | ||||
| 00291 | SANEPIL | tbl 20 | SLO | SK | ||||||
| 388 | N03AB | antiepileptika ze skupiny hydantoinů | parent. | O | ||||||
| 388.1 | N03AB02 | fenytoin | parent. | 0.3 | GM | 132,60 | O | |||
| 03300 | EPANUTIN | inj 5x5ml/250mg | PDA | GB | ||||||
| 66564 | PHENHYDAN | inj 5x5ml/250mg | DET | D | ||||||
| 389 | N03AD | antiepileptika ze skupiny sukcinimidů | p.o. | |||||||
| 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 17,65 | ||||
| 93710 | SUXILEP | cps 120x250mg | VJP | D | ||||||
| 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 25,00 | ||||
| 68585 | PETNIDAN | sir 1x150ml/7.5gm | DET | D | ||||||
| 02035 | SUXILEP | gtt 50gm 50% | GMD | D | ||||||
| 389.3 | N03AD03 | mesuximid | p.o. | 0.9 | GM | 25,35 | ||||
| 97311 | PETINUTIN 300 | cps 100x300mg | GOD | D | ||||||
| 92066 | PETINUTIN 300 | cps 100x300mg | PDA | D | ||||||
| 390 | N03AE | antiepileptika ze skupiny benzodiazepinů | p.o. | |||||||
| 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 37,90 | ||||
| 03029 | RIVOTRIL | gtt 10ml 25mg | HLR | CH | ||||||
| 390.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8 | MG | 27,40 | ||||
| 03031 | RIVOTRIL | tbl 50x0.5mg | HLR | CH | ||||||
| 390.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8 | MG | 14,45 | ||||
| 03032 | RIVOTRIL | tbl 30x2mg | HLR | CH | ||||||
| 391 | N03AE | antiepileptika ze skupiny benzodiazepinů | parent. | O | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 244,00 | O | |||
| 03636 | RIVOTRIL | inj 25x1mg/1ml+sol | HLR | CH | ||||||
| 392 | N03AF | antiepileptika ze skupiny derivátů karboxamidu | p.o. | |||||||
| 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,65 | ||||
| 62309 | APO-CARBAMAZEPINE 200MG | tbl 100x200mg | APT | CND | ||||||
| 03417 | BISTON | tbl 50x200mg | SLO | SK | ||||||
| 02355 | FINLEPSIN | tbl 50x200mg | VAD | D | ||||||
| 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 18,50 | ||||
| 93619 | TEGRETOL CR | tbl obd 30x400mg | CGC | CH | ||||||
| 75293 | TIMONIL RETARD | tbl 100x150mg | DET | D | ||||||
| 60165 | TIMONIL RETARD | tbl 100x300mg | DET | D | ||||||
| 71954 | TIMONIL RETARD | tbl 50x150mg | DET | D | ||||||
| 60164 | TIMONIL RETARD | tbl 50x300mg | DET | D | ||||||
| 60166 | TIMONIL RETARD | tbl 50x600mg | DET | D | ||||||
| 392.3 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1 | GM | 43,50 | ||||
| 12197 | TEGRETOL 2% | sir 1x100ml 2% | CGC | CH | ||||||
| 72993 | TEGRETOL 2% | sir 1x250ml 2% | CGC | CH | ||||||
| 392.4 | N03AF02 | oxcarbazepin | p.o. | 1 | GM | 11,35 | ||||
| 393 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (kyselina valproová) | p.o. | |||||||
| 393.1 | N03AG01 | valproová kyselina (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 20,90 | ||||
| 61183 | ORFIRIL 150 | drg 50x150mg | DET | D | ||||||
| 61186 | ORFIRIL 150 | drg 100x150mg | DET | D | ||||||
| 393.2 | N03AG01 | valproová kyselina (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 16,00 | ||||
| 61187 | ORFIRIL 300 | drg 100x300mg | DET | D | ||||||
| 61185 | ORFIRIL 600 | drg 50x600mg | DET | D | ||||||
| 61184 | ORFIRIL 300 | drg 50x300mg | DET | D | ||||||
| 393.3 | N03AG01 | valproová kyselina (retardované pevné lékové formy) | p.o. | 1.5 | GM | 31,50 | ||||
| 62705 | ORFIRIL 300 RETARD | drg ret 100x300mg | DET | D | ||||||
| 393.4 | N03AG01 | valproová kyselina (tekuté lékové formy) | p.o. | 1.5 | GM | 26,90 | ||||
| 08770 | CONVULEX | gtt 100ml 300mg/ml | GER | A | ||||||
| 394 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (ostatní) | p.o. | L/NEU,PSY | |||
|---|---|---|---|---|---|---|---|
| 394.1 | N03AG02 | valpromid | p.o. | 1.5 | GM | 26,20 | L/PSY,NEU |
| 93255 | DIPROZIN 300MG | drg 100x300mg | PLI | CHO | |||
| 394.2 | N03AG04 | vigabatrin | p.o. | 2 | GM | 141,65 | L/PSY,NEU |
| 80370 | SABRIL | tbl obd 100x500mg | MDD | GB | |||
| 395 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin | parent. | K | |||
| 395.1 | N03AG01 | valproová kyselina | parent. | 1.5 | GM | 1622,20 | K |
| 84386 | DEPAKINE | inj sic 4x0.4gm+4ml | SWI | F | |||
| 396 | N03AX | ostatní antiepileptika | p.o. | L/PSY,NEU | |||
| 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 16,75 | L/PSY,NEU |
| 55852 | OSPOLOT | tbl obd 50x200mg | DET D | ||||
| 396.2 | N03AX09 | lamotrigin (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 572,00 | L/PSY,NEU |
| 84511 | LAMICTAL 5MG DISPERSIBLE/CHEW. | ctb 30x5mg | BWE | GB | |||
| 396.3 | N03AX09 | lamotrigin (nad 5 mg v jedné tabletě) | p.o. | 0.3 | GM | 194,55 | L/PSY,NEU |
| 68802 | LAMICTAL | tbl 30x100mg | BWE | GB | |||
| 68800 | LAMICTAL | tbl 30x25mg | BWE | GB | |||
| 68801 | LAMICTAL | tbl 30x50mg | BWE | GB | |||
| 84513 | LAMICTAL 100MG DISPERSIBLE/CHEW | ctb 30x100mg | BWE | GB | |||
| 84512 | LAMICTAL 25MG DISPERSIBLE/CHEW. | ctb 30x25mg | BWE | GB | |||
| 396.4 | N03AX10 | felbamat | p.o. | 2.4 | GM | 365,95 | L/PSY,NEU |
| 77003 | TALOXA | sus 230ml 120mg/ml | SCH | B | |||
| 77004 | TALOXA 400MG | tbl 100x400mg | SCH | B | |||
| 77005 | TALOXA 600MG | tbl 100x600mg | SCH | B | |||
| 396.5 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 145,20 | L/PSY,NEU |
| 84398 | NEURONTIN 100MG | cps 100x100mg | PDA | D | |||
| 84396 | NEURONTIN 100MG | cps 20x100mg | PDA | D | |||
| 84400 | NEURONTIN 300MG | cps 100x300mg | PDA | D | |||
| 84399 | NEURONTIN 300MG | cps 50x300mg | PDA | D | |||
| 84402 | NEURONTIN 400MG | cps 100x400mg | PDA | D | |||
| 84401 | NEURONTIN 400MG | cps 50x400mg | PDA | D | |||
| 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | ||||
| 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 5,10 | |
| 00102 | DEPARKIN | drg 50x50mg | LEX | CZ | |||
| 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 14,40 | |
| 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,50 | |||||||
| 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 9,00 | |||||||
| 01337 | KEMADRIN | tbl 100x5mg | BWE | GB | |||||||||
| 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | O | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 60,45 | O | ||||||
| 20056 | AKINETON PRO INFUS. | inj 5x1ml/5mg | KNO | D | |||||||||
| 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,75 | O | ||||||
| 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | ||||||||||
| 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,35 | |||||||
| 96751 | APO-BENZTROPINE 2MG | tbl 100x2mg | APT | CND | |||||||||
| 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | ||||||||||
| 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 25,20 | |||||||
| 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 36,40 | |||||||
| 400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 22,00 | |||||||
| 03591 | NAKOM | tbl 100x275mg | LEK | SLO | |||||||||
| 400.4 | N04BA02 | levodopa/benserazid | p.o. | 0.6 | GM | 25,15 | |||||||
| 12095 | MADOPAR 250 ROCHE | tbl 30x250mg | LEX | CZ | |||||||||
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardované lékové formy) | p.o. | 0.6 | GM | 30,30 | |||||||
| 94843 | SINEMET CR | tbl obd 100x250mg | MSD | NL | |||||||||
| 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | L/NEU,PSY,GER | |||||||||
| 401.1 | N04BB01 | amantadin | p.o. | 0.2 | GM | 5,25 | L/NEU,PSY,GER | ||||||
| 02871 | VIREGYT-K | cps 50x100mg | EGI | H | |||||||||
| 401.2 | N04BB01 | amantadin | parent. | 0.2 | GM | 4,35 | H | ||||||
| 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | L/NEU,PSY,GER | |||||||||
| 402.1 | N04BD01 | selegilin | p.o. | 5.0 | MG | 6,50 | L/NEU,PSY,GER | ||||||
| 92500 | SEPATREM 5 | tbl 50x5mg | LEX | CZ | |||||||||
| 92501 | SEPATREM 10 | tbl 50x10mg | LEX | CZ | |||||||||
| 402.2 | N04BX01 | tolkapon, do 0,1 GM včetně v jedné tabletě | p.o. | 0,3 | GM | 160,20 | X | ||||||
| 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 11,15 | |||
| 02114 | PLEGOMAZIN | drg 50x25mg | EGI | H | |||||
| 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 6,00 | |||
| 62313 | PLEGOMAZIN | drg 30x100mg | EGI | H | |||||
| 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 64,20 | |||
| 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 16,10 | |||
| 02429 | TISERCIN | tbl obd 50x25mg | EGI | H | |||||
| 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,80 | |||
| 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | O | |||||
| 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 26,75 | O | ||
| 00560 | PLEGOMAZIN | inj 10x5ml/25mg | EGI | H | |||||
| 00561 | PLEGOMAZIN | inj 10x2ml/50mg | EGI | H | |||||
| 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 33,70 | O | ||
| 01845 | TISERCIN | inj 10x1ml/25mg | EGI | H | |||||
| 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | ||||||
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,80 | |||
| 00262 | PERFENAZIN LECIVA | tbl obd 50x8mg | LEX | CZ | |||||
| 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 8,45 | |||
| 00274 | PROCHLORPERAZIN LECIVA | tbl 20x10mg | LEX | CZ | |||||
| 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 7,15 | |||
| 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,85 | |||
| 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | O | |||||
| 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 4,50 | O | ||
| 03514 | MODITEN DEPOT | inj 5x1ml/25mg | BTA | SK | |||||
| 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | L/NEU,PSY,GER | |||||
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,85 | L/NEU,PSY,GER | ||
| 01559 | NEULEPTIL | gtt 1x125ml 4% | RRO | F | |||||
| 98066 | NEULEPTIL | gtt 1x30ml 4% | RRO | F | |||||
| 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,85 | L/NEU,PSY,GER |
| 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 9,80 | |
| 00324 | THIORIDAZIN 25 LECIVA | drg 50x25mg | LEX | CZ | |||
| 00325 | THIORIDAZIN 100 LECIVA | drg 20x100mg | LEX | CZ | |||
| 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,20 | |
| 98291 | APO-HALOPERIDOL | tbl 100x1mg | APT | CND | |||
| 67110 | HALOPER 2MG VON CT | tbl 50x2mg | CTA | D | |||
| 67111 | HALOPER 5MG VON CT | tbl 50x5mg | CTA | D | |||
| 67112 | HALOPER 10MG VON CT | tbl 20x10mg | CTA | D | |||
| 67113 | HALOPER 10MG VON CT | tbl 100x10mg | CTA | D | |||
| 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 10,65 | |
| 02539 | HALOPERIDOL | gtt 1x10ml/20mg | GED | H | |||
| 408.3 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2 | MG | 7,90 | |
| 408.4 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2 | MG | 4,00 | |
| 408.5 | N05AD03 | melperon | p.o. | 0.3 | GM | 28,35 | |
| 409 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | parent. | O | |||
| 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 8,45 | O |
| 87645 | HALDOL DECANOAS | inj 1x1ml/100mg | JAN | B | |||
| 87644 | HALDOL DECANOAS | inj 1x3ml/150mg | JAN | B | |||
| 87643 | HALDOL DECANOAS | inj 5x1ml/50mg | JAN | B | |||
| 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 17,65 | O |
| 02538 | HALOPERIDOL | inj 5x1ml/5mg | GED | H | |||
| 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5,65 | O |
| 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 57,30 | O |
| 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 57,30 | O |
| 01443 | DEHYDROBENZPERIDOL | inj 50x10ml/25mg | JAN | B | |||
| 85551 | DEHYDROBENZPERIDOL | inj 5x2ml/5mg | JAN | B | |||
| 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p.o. | ||||
| 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,70 | |
| 87611 | MECLOPIN | tbl 50x5mg | LEX | CZ | |||
| 410.2 | N05AF01 | flupentixol | p.o. | 6 | MG | 17,90 | |
| 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 27,00 | |
| 00082 | MINITHIXEN | drg 50x5mg | LEX | CZ | |||
| 410.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 6,75 | |
| 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30x50mg | LEX | CZ | |||
| 410.5 | N05AF03 | chlorprothixen (od 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 10,35 | |
| 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30x15mg | LEX | CZ | |||
| 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 14,15 | |
| 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | O | |||
|---|---|---|---|---|---|---|---|
| 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,35 | O |
| 88379 | MECLOPIN | inj 5x1ml/25mg | SPX | CZ | |||
| 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 16,55 | O |
| 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,10 | O |
| 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 102,00 | O |
| 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 12,85 | O |
| 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | ||||
| 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 11,80 | |
| 98120 | ORAP | tbl 75x1mg | JAN | B | |||
| 02757 | ORAP FORTE | tbl 20x4mg | JAN | B | |||
| 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,35 | |
| 09684 | SEMAP | tbl 12x20mg | JAN | B | |||
| 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | O | |||
| 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 13,90 O | |
| 09164 | IMAP | inj 1x6ml/12mg | JAN | B | |||
| 98114 | IMAP | inj 3x1ml/2mg | JAN | B | |||
| 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | L/PSY | |||
| 414.1 | N05AH01 | loxapin | p.o. | 0.1 | GM | 53,40 | L/PSY |
| 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 76,75 | L/PSY,NEU |
| 03617 | LEPONEX | tbl 50x25mg | SAN | CH | |||
| 414.3 | N05AH02 | klozapin (od 25 do 50 mg v jedné tabletě včetně | p.o. | 0.3 | GM | 67,70 | L/PSY,NEU |
| 75299 | ALEMOXAN | tbl 100x50mg-blistr | VAD | D | |||
| 93117 | ALEMOXAN | tbl 500x50mg-lekov. | VAD | D | |||
| 75302 | ALEMOXAN | tbl 50x50mg-blistr | VAD | D | |||
| 414.4 | N05AH02 | klozapin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 61,75 | L/PSY |
| 02970 | LEPONEX | tbl 50x100mg | SAN | CH | |||
| 414.5 | N05AH05 | olanzapin | p.o. | 10 | MG | 175,00 | L/PSY |
| 415 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | parent. | H | |||
|---|---|---|---|---|---|---|---|
| 415.1 | N05AH02 | klozapin | parent. | 0.3 | GM | 88,20 | H |
| 416 | N05AL | neuroleptika ze skupiny benzamidů | p.o. | L/PSY,NEU | |||
| 416.1 | N05AL01 | sulpirid (do 50 mg v jedné tabletě včetně) | p.o. | 0.8 | GM | 63,00 | |
| 416.2 | N05AL01 | sulpirid (nad 50 mg v jedné tabletě) | p.o. | 0.8 | GM | 25,15 | L/PSY,NEU |
| 89923 | DOGMATIL 200MG | tbl 12x200mg | EGJ | F | |||
| 07387 | PROSULPIN | tbl 30x200mg | PMP | CZ | |||
| 416.3 | N05AL03 | tiaprid (pevné látkové formy) | p.o. | 0.4 | GM | 34,00 | |
| 91116 | TIAPRIDAL | tbl 20x100mg | LSY | F | |||
| 416.4 | N05AL03 | tiaprid (tekuté lékové formy) | p.o. | 0.4 | GM | 47,60 | |
| 417 | N05AL | neuroleptika ze skupiny benzamidů | parent. | O/PSY,NEU | |||
| 417.1 | N05AL01 | sulpirid | parent. | 0.8 | GM | 79,50 | O/PSY,NEU |
| 89922 | DOGMATIL 100 | inj 6x2ml/100mg | EGJ | F | |||
| 417.2 | N05AL03 | tiaprid | parent. | 0.4 | GM | 56,70 | O |
| 91117 | TIAPRIDAL | inj 12x2ml/100mg | LSY | F | |||
| 418 | N05AN | lithium | p.o. | ||||
| 418.1 | N05AN01 | lithium do 0,3 GM včetně v jedné tabletě | p.o. | 1 | GM | 5,45 | |
| 02481 | LITHIUM CARBONICUM SLOVAKOFARMA | tbl 100x300mg | SLO | SK | |||
| 418.1 | N05AN01 | lithium nad 0,3 GM v jedné tabletě | p.o. | 1 | GM | 3,25 | |
| 04385 | CONTEMNOL | tbl 100x50mg | SLO | SK | |||
| 419 | N05AX | ostatní antipsychotika | p.o. | L/PSY | |||
| 419.1 | N05AX08 | risperidon | p.o. | 6 | MG | 156,40 | L/PSY |
| 75900 | RISPERDAL 1MG | tbl obd 20x1mg | JAN | B | |||
| 75902 | RISPERDAL 2MG | tbl obd 20x2mg | JAN | B | |||||
| 75903 | RISPERDAL 2MG | tbl obd 60x2mg | JAN | B | |||||
| 75906 | RISPERDAL 4MG | tbl obd 20x4mg | JAN | B | |||||
| 75907 | RISPERDAL 4MG | tbl obd 60x4mg | JAN | B | |||||
| 419.2 | N05AE03 | sertindol | p.o. | 1 | DF | 156,40 | L/PSY | ||
| 420 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Léčbu alprazolamem ordinuje psychiatr, neurolog nebo internista: léčba panické úzkosti. | |||||||||
| 420.1 | N05BA23 | tofisopam | p.o. | 0.15 | GM | 0,70 | |||
| 420.2 | N05BA01 | diazepam | p.o. | 10 | MG | 0,70 | |||
| 02476 | DIAZEPAM SLOVAKOFARMA | tbl 20x2mg | SLO | SK | |||||
| 02477 | DIAZEPAM SLOVAKOFARMA | tbl 20x5mg | SLO | SK | |||||
| 02478 | DIAZEPAM SLOVAKOFARMA | tbl 20x10mg | SLO | SK | |||||
| 420.3 | N05BA02 | chlordiazepoxid | p.o. | 30 | MG | 0,70 | |||
| 420.4 | N05BA03 | medazepam | p.o. | 20 | MG | 0,70 | |||
| 420.5 | N05BA04 | oxazepam | p.o. | 50 | MG | 0,70 | |||
| 420.6 | N05BA05 | klorazepát draselný | p.o. | 20 | MG | 0,70 | |||
| 420.7 | N05BA06 | lorazepam | p.o. | 2.5 | MG | 0,70 | |||
| 420.8 | N05BA08 | bromazepam | p.o. | 10 | MG | 0,70 | |||
| 420.9 | N05BA09 | klobazam | p.o. | 20 | MG | 0,70 | |||
| 420.10 | N05BA11 | prazepam | p.o. | 30 | MG | 0,70 | |||
| 420.11 | N05BA12 | alprazolam (do 1 mg v jedné tabletě) | p.o. | 1 | MG | 0,70 | |||
| 420.12 | N05BA12 | alprazolam (1 mg a více v jedné tabletě) | p.o. | 1 | MG | 2,55 | P | ||
| 86656 | NEUROL 1.0 | tbl 30x1mg | LEX | CZ | |||||
| 421 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | p.rect. | L/NEU,PSY,PDD | |||||
| 421.1 | N05BA01 | diazepam (do 5 mg v jednom čípku včetně) | p.rect. | 10 | MG | 118,85 | L/NEU,PSY,PDD | ||
| 69417 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/5mg | DET | D | |||||
| 421.2 | N05BA01 | diazepam (nad 5 mg v jednom čípku) | p.rect. | 10 | MG | 72,65 | L/NEU,PSY,PDD | ||
| 69418 | DIAZEPAM DESITIN RECTAL TUBE | enm 5x2.5ml/10mg | DET | D | |||||
| 422 | N05BA | anxiolytika ze skupiny derivátů benzodiazepinu | parent. | ||||
|---|---|---|---|---|---|---|---|
| 422.1 | N05BA01 | diazepam | parent. | 10 | MG | 7,95 | |
| 96610 | APAURIN | inj 10x2ml/10mg | KRK | SLO | |||
| 422.2 | N05BA05 | klorazepát draselný | parent. | 20 | MG | 15,00 | |
| 423 | N05BX | ostatní anxiolytika | p.o. | ||||
| 423.1 | N05BB01 | hydroxyzin | p.o. | 75 | MG | 0,70 | |
| 423.2 | N05BC01 | meprobamat | p.o. | 1.2 | GM | 0,70 | |
| 423.3 | N05BX01 | mefenoxalon | p.o. | 1.2 | GM | 15,50 | |
| 03645 | DIMEXOL | tbl 30x200mg | LEX | CZ | |||
| 85656 | DORSIFLEX | tbl 30x200mg | LEK | SLO | |||
| 424 | N05CA | hypnotika ze skupiny barbiturátů | parent. | H | |||
| 424.1 | N05CA01 | pentobarbital | parent. | 0.1 | GM | 23,85 | H |
| 425 | N05CD | hypnotika ze skupiny benzodiazepinů | parent. | O | |||
| 425.1 | N05CD03 | flunitrazepam | parent. | 1 | MG | 6,50 | O |
| 90559 | ROHYPNOL | inj 5x1ml+5x1ml sol | LEX | CZ | |||
| 425.2 | N05CD08 | midazolam (do 5 mg v jedné ampuli včetně) | parent. | 15 | MG | 126,20 | O |
| 425.3 | N05CD08 | midazolam (nad 5 mg v jedné ampuli) | parent. | 15 | MG | 83,85 | O |
| 62486 | DORMICUM | inj 25x3ml/15mg | HLR | CH | |||
| 86633 | DORMICUM | inj 5x10ml/50mg | HLR | CH | |||
| 426 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | p.o. | ||||
| 426.1 | N06AA01 | desipramin | p.o. | 0.1 | GM | 17,50 | |
| 60438 | PETYLYL | drg 50x25mg(blistr) | VAD | D | |||
| 426.2 | N06AA02 | imipramin | p.o. | 0.1 | GM | 11,40 | |
| 00200 | MELIPRAMIN | drg 50x25mg | EGI | H | |||
| 426.3 | N06AA04 | klomipramin | p.o. | 0.1 | GM | 18,05 | |
| 08557 | ANAFRANIL | drg 30x25mg | CGC | CH | |||
| 93828 | ANAFRANIL SR GEIGY 75 | tbl obd 20x75mg | CGC | ||||
| 20857 | HYDIPHEN | drg 50x25mg | VAD | ||||
| 426.4 | N06AA05 | opipramol | p.o. | 0.15 | GM | 12,30 | |
| 426.5 | N06AA07 | lofepramin | p.o. | 105 | MG | 18,50 | |
| 426.6 | N06AA08 | dibenzepin | p.o. | 0.3 | GM | 18,50 | ||
| 02641 | NOVERIL 240 | tbl 20x240mg | WAN | CH | ||||
| 426.7 | N06AA09 | amitriptylin | p.o. | 75 | MG | 2,05 | ||
| 00030 | AMITRIPTYLIN SLOVAKOFARMA | drg 50x25mg | SLO | SK | ||||
| 426.8 | N06AA10 | nortriptylin | p.o. | 75 | MG | 10,00 | ||
| 12343 | NORTRILEN 25MG | tbl 50x25mg | LUN | DK | ||||
| 426.9 | N06AA16 | dosulepin | p.o. | 150 | MG | 8,85 | ||
| 03851 | PROTHIADEN 10 | tbl obd 50x10mg | LEX | CZ | ||||
| 04207 | PROTHIADEN 25 | drg 30x25mg | LEX | CZ | ||||
| 77047 | PROTHIADEN 75 | tbl obd 30x75mg | LEX | CZ | ||||
| 426.10 | N06AA21 | maprotilin | p.o. | 100 | MG | 13,95 | ||
| 04257 | LUDIOMIL 75 | drg 20x75mg | CGC | CH | ||||
| 67090 | MAPROTILIN 50 VON CT | tbl obd 20x50mg | CTA | D | ||||
| 67088 | MAPROTILIN 25 VON CT | tbl obd 20x25mg | CTA | D | ||||
| 426.11 | N06AA22 | venlafaxin | p.o. | 75 | MG | 29,00 | L/NEU,PSY,SEX | |
| 427 | N06AA | antidepresiva ze skupiny neselektivních inhibitorů reuptake monoaminů | parent. | O | ||||
|---|---|---|---|---|---|---|---|---|
| 427.1 | N06AA01 | desipramin | parent. | 0.1 | GM | 98,65 | O | |
| 427.2 | N06AA02 | imipramin | parent. | 0.1 | GM | 52,90 | O | |
| 01477 | MELIPRAMIN | inj 10x2ml/25mg | EGI | H | ||||
| 427.3 | N06AA04 | klomipramin | parent. | 0.1 | GM | 98,65 | O | |
| 02884 | ANAFRANIL | inj 10x2ml 25mg | CGC | CH | ||||
| 427.4 | N06AA08 | dibenzepin | parent. | 0.3 | GM | 98,65 | O | |
| 427.5 | N06AA09 | amitriptylin | parent. | 75 | MG | 28,55 | O | |
| 04079 | AMITRIPTYLIN LECIVA | inj 10x2ml/20mg | LEX | CZ | ||||
| 427.6 | N06AA21 | maprotilin | parent. | 100 | MG | 111,80 | O | |
| 94560 | LUDIOMIL | inj 10x5ml/25mg | CGC | CH | ||||
| 428 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | p.o. | L/PSY,SEX | ||||
| 428.1 | N06AB03 | fluoxetin | p.o. | 20 | MG | 19,50 | ||
| 92346 | DEPREX | cps 30x20mg | LEX | CZ | ||||
| 13022 | PORTAL | cps 14x20mg | LEK | SLO | ||||
| 13023 | PORTAL | cps 28x20mg | LEK | SLO | ||||
| 428.2 | N06AB04 | citalopram | p.o. | 20 | MG | 26,50 | L/PSY,SEX,NEU, INT | ||||
| 428.3 | N06AB05 | paroxetin | p.o. | 20 | MG | 26,50 | L/PSY,SEX,NEU, INT | ||||
| 428.4 | N06AB06 | sertralin | p.o. | 50 | MG | 26,50 | L/PSY,SEX,NEU, INT | ||||
| 428.5 | N06AB08 | fluvoxamin | p.o. | 100 | MG | 26,50 | L/PSY,SEX,NEU, INT | ||||
| 429 | N06AB | antidepresiva ze skupiny selektivních inhibitorů reuptake serotoninu | parent. | O/PSY,SEX | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 429.1 | N06AB04 | citalopram | parent. | 20 | MG | 236,45 | O/PSY,SEX | ||||
| 60113 | SEROPRAM | inf 10x1ml/40mg | LUN | DK | |||||||
| 430 | N06A | ostatní antidepresiva | p.o. | L/PSY,SEX,NEU | |||||||
| 430.1 | N06AF01 | isocarbaxazid | p.o. | 15 | MG | 4,40 | L/PSY,SEX,NEU | ||||
| 430.2 | N06AF04 | tranylcypromin | p.o. | 10 | MG | 5,15 | L/PSY,SEX,NEU | ||||
| 430.3 | N06AG02 | moklobemid | p.o. | 0.3 | GM | 25,70 | L/PSY,SEX,NEU | ||||
| 85901 | AURORIX 300MG | tbl obd 30x300mg | HLR | CH | |||||||
| 96222 | AURORIX | tbl obd 30x150mg | HLR | CH | |||||||
| 430.4 | N06AX03 | mianserin (do 10 mg v jedné tabletě včetně) | p.o. | 60 | MG | 19,20 | L/PSY,SEX,NEU | ||||
| 67353 | MIANSERIN 10 VON CT | tbl obd 20x10mg | CTA | D | |||||||
| 430.5 | N06AX03 | mianserin (nad 10 mg v jedné tabletě) | p.o. | 60 | MG | 18,00 | L/PSY,SEX,NEU | ||||
| 430.6 | N06AX05 | trazodon | p.o. | 0.3 | GM | 14,55 | L/PSY,SEX,NEU | ||||
| 430.7 | N06AX09 | viloxazin | p.o. | 0.2 | GM | 14,55 | L/PSY,SEX,NEU | ||||
| 430.8 | N06AX14 | tianeptin | p.o. | 37.5 | MG | 26,50 | L/PSY,SEX,NEU, INT | ||||
| 431 | N06BA | centrálně působící stimulancia | p.o. | L/NEU,PSY,PDD,SEX | |||||||
| 431.1 | N06BA04 | methylphenidat | p.o. | 30 | MG | 9,30 | L/NEU,PSY,PDD, SEX | ||||
| 83328 | RITALIN | tbl 30x10mg | CGC | CH | |||||||
| 432 | N06BX | ostatní psychostimulancia a nootropika | p.o. | ||||||||
| 432.1 | N06BX02 | pyritinol (pevné lékové formy) | p.o. | 0.3 | GM | 8,00 | |||||
| 432.2 | N06BX02 | pyritinol (tekuté lékové formy) | p.o. | 0.3 | GM | 21,50 | |||||
| 432.3 | N06BX03 | piracetam (pevné lékové formy) | p.o. | 2.4 | GM | 8,00 | |||||
| 96718 | OIKAMID | cps 60x400mg | PLI | CHO | |||||||
| 66646 | PIRACETAM AL 800 | tbl obd 30x800mg | APA | D | |||||||
| 66647 | PIRACETAM AL 800 | tbl obd 50x800mg | APA | D | |||
| 66648 | PIRACETAM AL 800 | tbl obd 100x800mg | APA | D | |||
| 432.4 | N06BX03 | piracetam (tekuté lékové formy) | p.o. | 2.4 | GM | 21,50 | |
| 88156 | NOOTROPIL 20% ORAL | sol 1x125ml 20% | UCB | B | |||
| 04289 | NOOTROPIL 33% ORAL | sol 1x125ml 33% | UCB | B | |||
| 432.5 | N06BX17 | vinpocetin | p.o. | 15 | MG | 8,00 | |
| 432.6 | N06BX19 | extrakty z Ginkgo biloba | p.o. | 120 | MG | 8,00 | |
| 433 | N06BX | ostatní psychostimulancia a nootropika | parent. | H | |||
|---|---|---|---|---|---|---|---|
| 433.1 | N06BX01 | meklofenoxat | parent. | 0.5 | GM | 85,45 | H |
| 03643 | CETREXIN | inj sic 5x250mg+sol | LEX | CZ | |||
| 433.2 | N06BX02 | pyritinol | parent. | 0.3 | GM | 85,45 | H |
| 433.3 | N06BX03 | piracetam | parent. | 6 | GM | 64,35 | H |
| 96719 | OIKAMID | inj 10x5ml/1gm | PLI | CHO | |||
| 433.4 | N06BX17 | vinpocetin | parent. | 15 | MG | 27,15 | H |
| 04062 | CAVINTON | inj 10x2ml/10mg | GED | H | |||
| 434 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | p.o. | ||||
| 434.1 | N07AA01 | neostigmin | p.o. | 60 | MG | 19,80 | |
| 00318 | SYNTOSTIGMIN | tbl 20x15mg | SLO | SK | |||
| 53940 | SYNTOSTIGMIN | tbl 20x15mg (blistr) | SLO | SK | |||
| 434.2 | N07AA02 | pyridostigmin (do 10 mg v jedné tabletě včetně) | p.o. | 180 | MG | 26,45 | |
| 01335 | KALYMIN | tbl obd 50x10mg | VAD | D | |||
| 434.3 | N07AA02 | pyridostigmin (nad 10 mg v jedné tabletě) | p.o. | 180 | MG | 17,20 | |
| 01356 | MESTINON | drg 20x60mg | HLR | CH | |||
| 434.4 | N07AA03 | distigmin | p.o. | 5 | MG | 5,95 | |
| 02360 | UBRETID | tbl 20x5mg | HNP | A | |||
| 02130 | UBRETID | tbl 50x5mg | HNP | A | |||
| 434.5 | N07AA30 | ambenonium | p.o. | 60 | MG | 18,45 | |
| 435 | N07AA | parasympatomimetika ze skupiny inhibitorů cholinesterázy | parent. | ||||
| 435.1 | N07AA01 | neostigmin | parent. | 2 | MG | 18,45 | |
| 00612 | SYNTOSTIGMIN | inj 10x1ml/0.5mg | HBS | SK | |||
| 435.2 | N07AA02 | pyridostigmin | parent. | 10 | MG | 115,80 | ||
| 01468 | KALYMIN MITE | inj 10x1ml/1mg | VAD | D | ||||
| 435.3 | N07AA03 | distigmin | parent. | 0.25 | MG | 5,75 | ||
| 02135 | UBRETID | inj 25x1ml/0.5mg | HNP | A | ||||
| 436 | N07CA | léčiva s antivertiginózním účinkem | p.o. | |||||
|---|---|---|---|---|---|---|---|---|
| 436.1 | N07CA | jiné piperazinové deriváty | p.o. | 3 | DF | 4,90 | ||
| 436.2 | N07CA01 | betahistin | p.o. | 24 | MG | 11,65 | ||
| 436.3 | N07CA02 | cinarizin | p.o. | 90 | MG | 1,90 | ||
| 99884 | CINARIZIN FORTE | tbl 50x75mg | LEK | SLO | ||||
| 07390 | CINEDIL | tbl 50x75mg | ALK | MAC | ||||
| 97899 | CINNABENE | cps 50x75mg | MCK | A | ||||
| 436.4 | N07CA03 | flunarizin | p.o. | 10 | MG | 4,90 | ||
| 437 | N07XX | ostatní léčiva nervové soustavy | parent. | X | ||||
| 437.1 | N07XX01 | tirilazad | parent. | 150 | MG | 5346,30 | X | |
| 83502 | FREEDOX TM | inf 1x100ml/150mg | UPJ | B | ||||
| 438 | P01AB | chemoterapeutika ze skupiny nitroimidazolových derivátů | p.o. | |||||
| 438.1 | P01AB01 | metronidazol | p.o. | 2 | GM | 13,60 | ||
| 438.2 | P01AB01 | metronidazol | p.rect. | 2 | GM | 8,55 | ||
| 42279 | METRONIDAZOL POLFA | sup 10x1gm | POL | PL | ||||
| 438.3 | P01AB02 | tinidazol | p.o. | 2 | GM | 13,60 | ||
| 438.4 | P01AB03 | ornidazol | p.o. | 1.5 | GM | 22,50 | ||
| 91132 | AVRAZOR | tbl 6x500mg | LEX | CZ | ||||
| 439 | P01BA | antimalarika ze skupiny aminochinolonových derivátů | p.o. | |||||
a) systémový lupus erythematodes,
b) revmatoidní arthritis,
c) juvenilní chronická arthritis,
d) diskoidní forma lupus erythematodes.
Léčbu meflochinem ordinuje infekcionista: léčba tropické malárie (z oblastí s vysokou rezistencí vůči chlorochinu na Plasmodium falciparum).
| 439.1 | P01BA01 | chlorochin | p.o. | 0.5 | GM | 2,40 | |
| 00098 | DELAGIL | tbl 30x250mg | IDA | H | |||
| 439.2 | P01BA02 | hydroxychlorochin | p.o. | 0.4 | GM | 20,60 | P |
| 01385 | PLAQUENIL | drg 100x200mg | WIN | GB | |||
| 439.3 | P01BA05 | meflochin | p.o. | 1 | GM | 385,40 | P |
| 440 | P01BD | antimalarika ze skupiny diaminopyrimidinů | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 440.1 | P01BD01 | pyrimethamin | p.o. | 75 | MG | 9,60 | |
| 02443 | DARAPRIM | tbl 30x25mg | BWE | GB | |||
| 440.2 | P01BD51 | pyrimethamin, kombinace | p.o. | 75 | MG | 52,00 | |
| 441 | P01CX | ostatní léčiva k léčbě protozoóz | parent. | X | |||
| 441.1 | P01CX01 | pentamidin isethionát | parent. | 0.28 | GM | 1071,15 | X |
| 97578 | PENTACARINAT 300 | inj sic 1x300mg | RBE | F | |||
| 442 | P02CA | anthelmintika ze skupiny benzimidazolových derivátů | p.o. | ||||
| 442.1 | P02CA01 | mebendazol | p.o. | 0.2 | GM | 15,30 | |
| 83748 | WORMIN | tbl 144x100mg-blist | CAD | IND | |||
| 91781 | WORMIN | tbl 144x100mg-strip | CAD | IND | |||
| 83747 | WORMIN | tbl 6x100mg(blistr) | CAD | IND | |||
| 83746 | WORMIN | tbl 6x100mg(strip) | CAD | IND | |||
| 02639 | VERMOX | tbl 6x100mg | JAN | B | |||
| 442.2 | P02CA02 | tiabendazol | p.o. | 3 | GM | 128,30 | |
| 442.3 | P02CA03 | albendazol | p.o. | 0.4 | GM | 66,00 | |
| 443 | P02CB | anthelmintika ze skupiny piperazinu a jeho derivátů | p.o. | ||||
| 443.1 | P02CB01 | piperazin | p.o. | 2 | GM | 4,05 | |
| 00165 | HELMIRAZIN | tbl 50x300mg | SLO | SK | |||
| 444 | P02CE | anthelmintika ze skupiny imidazothiazolových derivátů | p.o. | ||||
| 444.1 | P02CE01 | levamizol | p.o. | 0.15 | GM | 27,00 | |
| 04030 | DECARIS | tbl 2x50mg | GED | H | |||
| 445 | P02CX | ostatní anthelmintika | p.o. | ||||
| 445.1 | P02CX01 | pyrvinium | p.o. | 0.3 | GM | 18,10 | |
| 02139 | PYRVINIUM | sus 1x100ml | GNO | CZ | |||
| 446 | P02DA | anticestodika ze skupiny derivátů kyseliny salicylové | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 446.1 | P02DA01 | niklosamid | p.o. | 2 | GM | 134,20 | |
| 02969 | YOMESAN | tbl 4x500mg | BAY | D | |||
| 447 | P03AB | ektoparazitika ze skupiny halogenovaných léčiv | lok. | ||||
| 447.1 | P03AB02 | lindan (lékové formy gelu) | lok. | 1 | GM | 2,60 | |
| 447.2 | P03AB02 | lindan (lékové formy lotia) | lok. | 1 | ML | 1,15 | |
| 62364 | JACUTIN | lot 1x100ml | HEM | D | |||
| 97547 | JACUTIN | lot 1x200ml | HEM | D | |||
| 62365 | JACUTIN | lot 1x1000ml | HEM | D | |||
| 92765 | SKABICID | lot 1x100gm | AVE | CZ | |||
| 447.3 | P03AB02 | lindan (lékové formy spreje) | lok. | 1 | ML | 1,20 | |
| 448 | P03AC | ektoparazitika ze skupiny pyrethrinů | lok. | ||||
| 448.1 | P03AC | esdepallethrin | lok. | 1 | ML | 1,20 | |
| 76126 | SPREGAL | spr 1x160gm | SCT | F | |||
| 448.2 | P03AC04 | permerthrin | lok. | 1 | ML | 1,20 | |
| 449 | R01AC | protialergická léčiva k lokálnímu podání | lok. | L/ALG,TRN,ORL | |||
| 449.1 | R01AC01 | kyselina kromogliková | lok. | 40 | MG | 14,95 | L/ALG,TRN,ORL |
| 83761 | CROMOBENE | spr nas 1x15ml | MCK | D | |||
| 83652 | CROMOHEXAL | spr nas 1x15ml | HEX | D | |||
| 86429 | CROMOHEXAL | spr nas 1x30ml | HEX | D | |||
| 449.2 | R01AC02 | levokabastin | lok. | 0.6 | MG | 11,05 | L/ALG,TRN,ORL |
| 449.3 | R01AC03 | azelastin | lok. | 0.56 | MG | 11,05 | L/ALG,TRN,ORL |
| 450 | R01AD | kortikosteroidy k lokálnímu podání | lok. | L/ALG,TRN,ORL | |||
| 450.1 | R01AD01 | beclomethason | lok. | 0.4 | MG | 4,25 | |
| 12830 | BECONASE | spr nas 200x50rg | GLA | GB | |||
| 10165 | BECONASE NASAL | aer 200x50rg | GLA | GB | |||
| 450.2 | R01AD04 | flunisolid | lok. | 0.15 | MG | 8,75 | L/ALG,TRN,ORL |
| 62532 | SYNTARIS NASAL | aer 20ml 0.25mg/ml | SYN | CH | |||
| 450.3 | R01AD05 | budesonid | lok. | 0.3 | MG | 8,90 | L/ALG,TRN,ORL |
| 450.4 | R01AD08 | flutikason | lok. | 0.3 | MG | 18,00 | L/ALG,TRN,ORL |
| 450.5 | R01AX03 | ipratropium bromid | lok. | 240 | RG | 9,30 | L/ALG,TRN,ORL | |
| 451 | R03AC | inhalační selektivní beta-2 sympatomimetika | inhal. | |||||
|---|---|---|---|---|---|---|---|---|
| 451.1 | R03AC | fenoterol/cromoglykat | inhal. | 0.6 | MG | 28,05 | L/ALG,TRN | |
| 94415 | DITEC | aer dos 10ml | BNE | A | ||||
| 94416 | DITEC | aer dos 10ml | BOE | D | ||||
| 451.2 | R03AC02 | salbutamol (lékové formy aerosolu) | inhal. | 0.8 | MG | 3,45 | ||
| 89016 | SALAMOL INHALER | aer dos 200x100rg | GNO | CZ | ||||
| 76364 | VENTOLIN INHALER | aer 200x100rg | GLA | E | ||||
| 451.3 | R03AC02 | salbutamol (lékové formy prášku k inhalaci) | inhal. | 0.8 | MG | 7,40 | ||
| 83047 | VENTODISKS | inh plv 15x8x400rg | GLA | F | ||||
| 83046 | VENTODISKS | inh plv 15x8x200rg | GLA | F | ||||
| 451.4 | R03AC02 | salbutamol (lékové formy roztoku) | inhal. | 10 | MG | 13,65 | ||
| 94814 | VENTOLIN SOL.AD RESPIR. | inh 1x20ml/120mg | GLA | GB | ||||
| 451.5 | R03AC03 | terbutalin (lékové formy aerosolu) | inhal. | 2 | MG | 3,60 | ||
| 451.6 | R03AC03 | terbutalin (lékové formy prášku k inhalaci) | inhal. | 2 | MG | 7,40 | ||
| 451.7 | R03AC04 | fenoterol (lékové formy aerosolu) | inhal. | 0.6 | MG | 2,80 | ||
| 92588 | BEROTEC 200 DOSIER AEROSOL | aer 1x10ml(=14gm) | BOE | D | ||||
| 02863 | BEROTEC 200 DOSIER AEROSOL | aer 1x15ml(=21gm) | BOE | D | ||||
| 451.8 | R03AC04 | fenoterol (lékové formy roztoku) | inhal. | 4 | MG | 25,20 | ||
| 12070 | BEROTEC 0.1% | inh sol 1x20ml 0.1% | BOE | D | ||||
| 451.9 | R03AC04 | fenoterol (lékové formy prášku k inhalaci) | inhal. | 0.6 | MG | 7,40 | ||
| 75874 | BEROTEC INHAETTEN | cps inh 100x0.2mg | BOE | D | ||||
| 451.10 | R03AC06 | hexoprenalin (lékové formy aerosolu) | inhal. | 1.5 | MG | 2,80 | ||
| 451.11 | R03AC12 | salmeterol (lékové formy aerosolu) | inhal. | 0.1 | MG | 21,10 | L/ALG,TRN | |
| 451.12 | R03AC12 | salmeterol (lékové formy prášku k inhalaci) do 0,025 miligramů včetně v jedné dávce | inhal. | 0.1 | MG | 35,00 | L/ALG,TRN | |
| 451.13 | R03AC13 | salmeterol (lékové formy prášku k inhalaci) nad 0,025 miligramů v jedné dávce | inhal. | 0.1 | MG | 32,00 | L/ALG,TRN | |
| 451.14 | R03AC13 | formoterol (lékové formy prášku k inhalaci) do 4,5 RG včetně v jedné dávce | inhal. | 24 | RG | 35,00 | L/ALG,TRN | |
| 451.13 | R03AC13 | formoterol (lékové formy prášku k inhalaci) nad 4,5 RG v jedné dávce | inhal. | 24 | RG | 32,00 | L/ALG,TRN | |
| 452 | R03AK | inhalační sympatomimetika a jiná antiastmatika | inhal. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 452.1 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy aerosolu) | inhal. | 6 | DF | 5,15 | ||||
| 87899 | BERODUAL | aer dos 15ml/300df | BOE | D | ||||||
| 452.2 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy roztoku) | inhal. | 4 | ML | 21,10 | ||||
| 452.3 | R03AK03 | fenoterol a jiná antiastmatika (lékové formy prášku k inhalaci) | inhal. | 3 | DF | 13,30 | ||||
| 452.4 | R03AK04 | salbutamol v kombinaci s ipratropium bromid | inhal. | 6 | DF | 7,50 | L/ALG,TRN | |||
| 453 | R03BA | inhalační kortikosteroidy | inhal. | |||||||
| 453.1 | R03BA01 | beklomethason (lékové formy aerosolu) do 100 RG včetně v jedné dávce | inhal. | 0.8 | MG | 6,50 | ||||
| 12828 | BECLAZONE 100RG | aer dos 200x100rg | GNO | CZ | ||||||
| 453.2 | R03BA01 | beklomethason (lékové formy aerosolu) nad 100 RG v jedné dávce | inhal. | 0.8 | MG | 5,35 | ||||
| 12829 | BECLAZONE 250RG | aer dos 200x250rg | GNO | CZ | ||||||
| 453.3 | R03BA01 | beklomethason (lékové formy prášku k inhalaci do 100 RG včetně v 1 dávce) | inhal. | 0.8 | MG | 21,25 | ||||
| 453.4 | R03BA02 | beklomethason (lékové formy prášku k inhalaci nad 100 RG v 1 dávce) | inhal. | 0.8 | MG | 19,10 | ||||
| 453.5 | R03BA02 | budesonid (lékové formy aerosolu) | inhal. | 0.8 | MG | 15,60 | ||||
| 453.6 | R03BA02 | budesonid (lékové formy prášku k inhalaci,do 200 RG v 1 dávce včetně) | inhal. | 0.8 | MG | 21,25 | ||||
| 453.7 | R03BA02 | budesonid (lékové formy prášku k inhalaci, nad 200 RG v 1 dávce) | inhal. | 0.8 | MG | 19,10 | ||||
| 453.8 | R03BA02 | budesonid (lékové formy suspense k inhalaci) do 0,25 mg včetně v 1 ml | inhal. | 0,8 | MG | 21,25 | ||||
| 453.9 | R03BA02 | budesonid (lékové formy suspense k inhalaci) nad 0,25 mg v 1 ml | inhal. | 0.8 | MG | 19,10 | ||||
| 453.10 | R03BA03 | flunisolid (lékové formy aerosolu) | inhal. | 1 | MG | 15,60 | ||||
| 453.11 | R03BA03 | flunisolid (lékové formy prášku k inhalaci) | inhal. | 1 | MG | 21,25 | ||||
| 453.12 | R03BA05 | flutikason (lékové formy aerosolu) | inhal. | 0.6 | MG | 15,60 | ||||
| 453.13 | R03BA05 | flutikason (lékové formy prášku k inhalaci do 100 RG včetně v jedné dávce) | inhal. | 0,6 | MG | 21,25 | ||||
| 453.14 | R03BA05 | flutikason (lékové formy prášku k inhalaci nad 100 RG v jedné dávce) | inhal. | 0,6 | MG | 19,10 | ||||
| 454 | R03BB | inhalační anticholinergika | inhal. | ||||
|---|---|---|---|---|---|---|---|
| 454.1 | R03BB01 | bromid ipratropia (lékové formy aerosolu) | inhal. | 0.12 | MG | 5,50 | |
| 80103 | ATROVENT | aer dos 15ml(21gm) | BOE | D | |||
| 454.2 | R03BB01 | bromid ipratropia (lékové formy prášku k inhalaci) | inhal. | 0.12 | MG | 2,30 | |
| 75847 | ATROVENT INHALETTEN | cps inh 100x0.2mg | BOE | D | |||
| 454.3 | R03BB01 | bromid ipratropia (lékové formy roztoku) | inhal. | 4 | ML | 35,10 | L/ALG,TRN,ORL |
| 92351 | ATROVENT 0.025% | inh sol 1x20ml | BOE | D | |||
| 455 | R03BC | inhalační protialergická léčiva | inhal. | ||||
| 455.1 | R03BC01 | kyselina kromoglyková (lékové formy aerosolu) | inhal. | 40 | MG | 17,90 | |
| 92439 | CROMOGEN 5MG | inh aer dos 112x5mg | GNO | CZ | |||
| 455.2 | R03BC01 | kyselina kromoglyková (lékové formy prášku k inhalaci) | inhal. | 80 | MG | 22,15 | |
| 90538 | INTAL | cps 30(3x10)x20mg | LEX | CZ | |||
| 455.3 | R03BC01 | kyselina kromoglyková (lékové formy roztoku) | inhal. | 80 | MG | 13,80 | |
| 455.4 | R03BC01 | kyselina kromoglyková (lékové formy prášku k insuflaci) | lok. | 40 | MG | 19,55 | |
| 455.5 | R03BC03 | nedokromil | inhal. | 8 | MG | 30,00 | L/ALG,TRN |
| 455.6 | R03BC01 | kyselina kromoglyková | p.o. | 80 | MG | 7,75 | P |
| Diagnózu prokazuje a léčbu indikuje alergolog a klinický imunolog na základě alergologického vyšetření kožním eventuálně expozičním testem nebo průkazem specifických IgE protilátek: při prokázané potravinové alergii se závažnými místními či celkovými příznaky, které nelze eliminací alergenů z potravy plně upravit. | |||||||
| 93797 | NALCROM | cps 100x100mg | FIS | GB | |||
| 456 | R03CB | celkově podávaná neselektivní sympatomimetika | p.o. | ||||
| 456.1 | R03CA02 | efedrin | p.o. | 50 | MG | 1,45 | |
| 00126 | EPHEDRIN SLOVAKOFARMA | tbl 20x25mg | SLO | SK | |||
| 456.2 | R03CB03 | orciprenalin | p.o. | 60 | MG | 6,70 | |
| 457 | R03CB | celkově podávaná neselektivní sympatomimetika | parent. | O | |||
| 457.1 | R03CA01 | epinefrin | parent. | 0.5 | MG | 3,40 | O |
| 00362 | ADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ | |||
| 457.2 | R03CA02 | efedrin | parent. | 50 | MG | 5,40 | O |
| 00447 | EPHEDRIN BIOTIKA | inj 10x1ml/50mg | HBS | SK | |||
| 457.3 | R03CB03 | orciprenalin | parent. | 0.5 | MG | 7,45 | O | ||||
| 03104 | ASTMOPENT | inj 10x1ml/0.5mg | POL | PL | |||||||
| 458 | R03CC | celkově podávaná selektivní sympatomimetika | p.o. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 458.1 | R03CC02 | salbutamol (pevné lékové formy) | p.o. | 12 | MG | 5,90 | |||||
| 91085 | SALBUTAMOL POLFA | tbl 30x4mg | POL | PL | |||||||
| 458.2 | R03CC02 | salbutamol (tekuté lékové formy) | p.o. | 12 | MG | 13,40 | |||||
| 458.3 | R03CC03 | terbutalin | p.o. | 15 | MG | 5,90 | |||||
| 458.4 | R03CC05 | hexoprenalin | p.o. | 1.5 | MG | 5,90 | |||||
| 458.5 | R03CC08 | prokaterol (pevné lékové formy) | p.o. | 0.1 | MG | 5,90 | |||||
| 94493 | LONTERMIN | tbl 20x0.05mg | LEK | SLO | |||||||
| 458.6 | R03CC08 | prokaterol (tekuté lékové formy) | p.o. | 0.1 | MG | 18,30 | |||||
| 458.7 | R03CC13 | klenbuterol (pevné lékové formy) | p.o. | 0.04 | MG | 6,85 | |||||
| 23366 | CONTRASPASMIN | tbl 50x0.02mg | VAD | D | |||||||
| 91845 | SPIROPENT | tbl 20x0.02mg | BOE | D | |||||||
| 458.8 | R03CC13 | klenbuterol (tekuté lékové formy) | p.o. | 0.04 | MG | 34,55 | |||||
| 86889 | SPIROPENT | sir 1x100ml | BOE | D | |||||||
| 459 | R03CC | celkově podávaná selektivní sympatomimetika | parent. | O | |||||||
| 459.1 | R03CC03 | terbutalin | parent. | 0.5 | MG | 20,30 | O | ||||
| 459.2 | R03CC05 | hexoprenalin | parent. | 5 | RG | 20,30 | O | ||||
| 75599 | IPRADOL | inj 5x2ml/5rg | HNP | A | |||||||
| 460 | R03D | ostatní antiastmatika k celkovému podání | p.o. | ||||||||
| 460.1 | R03DA04 | teofylin (retardované lékové formy první skupiny) | p.o. | 0.4 | GM | 3,10 | |||||
| 99137 | SPOPHYLLIN RETARD 100MG | tbl ret 50x100mg | SLO | SK | |||||||
| 98064 | SPOPHYLLIN RETARD 250MG | tbl ret 50x250mg | SLO | SK | |||||||
| 460.2 | R03DA04 | teofylin (retardované lékové formy druhé skupiny do 250 mg včetně v jedné tabletě) | p.o. | 0.4 | GM | 4,90 | |||||
| 94192 | TEOTARD | cps ret 40x200mg | KRK | SLO | |||||||
| 86721 | AFONILUM SR 375MG | cps 100x375mg | KNO | D | |||||||
| 86720 | AFONILUM SR 375MG | cps 50x375mg | KNO | D | |||||||
| 460.3 | R03DA04 | teofylin (retardované lékové formy druhé skupiny nad 250 mg v jedné tabletě) | p.o. | 0.4 | GM | 4,60 | |||||
| 94191 | TEOTARD | cps ret 40x350mg | KRK | SLO | |||||||
| 61238 | THEOPLUS | tbl ret 30x300mg | PFB | F | |||||||
| 460.4 | R03DA05 | aminofylin | p.o. | 0.6 | GM | 5,00 | |||||
| 00316 | SYNTOPHYLLIN | drg 50x100mg | SLO | SK | |||||||
| 460.5 | R03DA05 | aminofylin (retardované lékové formy do 150 mg včetně) | p.o. | 0.6 | GM | 10,15 | |||||
| 97502 | EUPHYLLIN CR 150 | cps 50x150mg | CCS | CZ | |||||||
| 460.6 | R03DA05 | aminofylin (retardované lékové formy od 150 do 250 mg včetně) | p.o. | 0,6 | GM | 7,50 | |||||
| 97503 | EUPHYLLIN CR 250 | cps 50x250mg | CCS | CZ | |||||||
| 76430 | EUPHYLLIN CR 350 | cps 50x350mg | CCS | CZ | |||||||
| 460.7 | R03DA05 | aminofylin (retardované lékové formy nad 250 mg) | p.o. | 0,6 | GM | 6,00 | |||||
| 91741 | AMINOPHYLLINUM RETARD | tbl ret 20x350mg | LEK | SLO | |||||||
| 460.8 | R03DC01 | zafirlukast | p.o. | 40 | MG | 49,70 | Z | ||||
| 12329 | ACCOLATE 20 | tbl obd 28x20mg | ZNC | GB | |||||||
| 12330 | ACCOLATE 20 | tbl obd 56x20mg | ZNC | GB | |||||||
| 12331 | ACCOLATE 40 | tbl obd 28x40mg | ZNC | GB | |||||||
| 12332 | ACCOLATE 40 | tbl obd 56x40mg | ZNC | GB | |||||||
| 461 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | p.rect. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 461.1 | R03DA05 | aminofylin | p.rect. | 0.6 | GM | 6,50 | |||||
| 03353 | SYNTOPHYLLIN | sup 10 (neo) | LEC | CZ | |||||||
| 462 | R03DA | ostatní antiastmatika k celkovému podání ze skupiny xantinů | parent. | O | |||||||
| 462.1 | R03DA05 | aminofylin | parent. | 0.6 | GM | 31,95 | O | ||||
| 00610 | SYNTOPHYLLIN | inj 5x10ml/240mg | HBS | SK | |||||||
| 96371 | AMINOPHYLLINUM I.V. | inj 50x10ml/250mg | LEK | SLO | |||||||
| 463 | R05CB | mukolytika | p.o. | ||||||||
| 463.1 | R05CB | prednoxdiazin | p.o. | 300 | MG | 2,00 | |||||
| 463.2 | R05CB01 | acetylcystein - pevné formy | p.o. | 0.5 | GM | 6,90 | |||||
| 72949 | ACETYLCYSTEIN AL 200 | tbl eff 50x200mg | APA | D | |||||||
| 72950 | ACETYLCYSTEIN AL 600 | tbl eff 10x600mg | APA | D | |||||||
| 72951 | ACETYLCYSTEIN AL 600 | tbl eff 20x600mg | APA | D | |||||||
| 72952 | ACETYLCYSTEIN AL 600 | tbl eff 50x600mg | APA | D | |||||||
| 463.3 | R05CB01 | acetylcystein - tekuté formy | p.o. | 0.5 | GM | 9,00 | |||||
| 463.4 | R05CB02 | bromhexin (pevné lékové formy) | p.o. | 24 | MG | 2,00 | |||||
| 463.5 | R05CB02 | bromhexin (tekuté lékové formy) | p.o. | 24 | MG | 3,30 | |||||
| 463.6 | R05CB03 | karbocystein (pevné lékové formy) | p.o. | 11.5 | GM | 15,25 | |
| 463.7 | R05CB06 | karbocystein (tekuté lékové formy) | p.o. | 1.5 | GM | 25,60 | |
| 96449 | FENORIN | sir 125ml 50mg/ml | LEK | SLO | |||
| 62230 | FENORIN P | sir 125ml 25mg/ml | LEK | SLO | |||
| 463.8 | R05CB06 | ambroxol (pevné lékové formy) | p.o. | 0.15 | GM | 8,50 | |
| 43952 | AMBROXOL AL 30 TABLETTEN | tbl 100x30mg | APA | D | |||
| 43951 | AMBROXOL AL 30 TABLETTEN | tbl 50x30mg | APA | D | |||
| 463.9 | R05CB06 | ambroxol (tekuté lékové formy) | p.o. | 0.15 | GM | 12,35 | |
| 464 | R05CB | mukolytika | inhal. | ||||
|---|---|---|---|---|---|---|---|
a) při nedostatečné účinnosti inhalačních mukolytik nebo amiloridu,
b) při častých respiračních infekcích vyžadujících antibiotickou léčbu.
| 464.1 | R05CB01 | acetylcystein | inhal. | 1.6 | GM | 50,60 | |
| 464.2 | R05CB02 | bromhexin | inhal. | 24 | MG | 3,55 | |
| 464.3 | R05CB05 | mesna | inhal. | 600 | MG | 46,35 | |
| 03614 | MISTABRON | sol 6x3ml/600mg | UCB | B | |||
| 464.4 | R05CB13 | alfadornáza | inhal. | 2.5 | MG | 1225,05 | P |
| 77521 | PULMOZYME 2500UT(2.5MG) | inh sol 6x2.5ml | HLR | CH | |||
| 465 | R05CB | mukolytika | parent. | ||||
|---|---|---|---|---|---|---|---|
| 465.1 | R05CB01 | acetylcystein | parent. | 0.5 | GM | 6,35 | |
| 02206 | BRONCHOLYSIN | inj 5x5ml/1gm | LEX | CZ | |||
| 465.2 | R05CB02 | bromhexin | parent. | 24 | MG | 41,30 | |
| 465.3 | R05CB06 | ambroxol | parent. | 0.15 | GM | 231,20 | |
| 465.4 | R05CA03 | guaifenesin | parent. | 0.9 | GM | 16,95 | |
| 03565 | GUAJACURAN | inj 5x20ml/1gm | LEX | CZ | |||
| 92347 | GUAJACURAN 5% | inj 6x20ml/1gm | LEX | CZ | |||
| 465.5 | R05CB06 | ambroxol (koncentrát k infuzi) | parent. | 1 | DF | 351,70 | H |
| 12839 | MUCOSOLVAN | inf 1x50ml/1000mg | BOE | D | |||
| 466 | R05DA | antitusika ze skupiny derivátů opioidů | p.o. | ||||
| 466.1 | R05DA01 | ethylmorfin do 15 MG včetně | p.o. | 50 | MG | 5,70 | |
| 00118 | DIOLAN | tbl 10x15mg | SLO | SK | |||
| 44590 | DIOLAN 15MG | tbl 10x15mg(blistr) | SLO | SK | |||
| 466.2 | R05DA01 | ethylmorfin nad 15 MG | p.o. | 50 | MG | 5,05 | ||
| 00119 | DIOLAN | tbl 10x30mg | SLO | SK | ||||
| 44589 | DIOLAN 30MG | tbl 10x30mg(blistr) | SLO | SK | ||||
| 466.3 | R05DA04 | kodein | p.o. | 0.1 | GM | 11,50 | ||
| 00088 | CODEIN SLOVAKOFARMA | tbl 10x15mg | SLO | SK | ||||
| 00090 | CODEIN SLOVAKOFARMA | tbl 10x30mg | SLO | SK | ||||
| 56992 | CODEIN SLOVAKOFARMA 15MG | tbl 10x15mg-blistr | SLO | SK | ||||
| 56993 | CODEIN SLOVAKOFARMA 30MG | tbl 10x30mg-blistr | SLO | SK | ||||
| 466.4 | R05DA08 | folkodin | p.o. | 50 | MG | 3,75 | ||
| 466.5 | R05DA09 | dextromethorphan | p.o. | 90 | MG | 3,75 | ||
| 466.6 | R05DA20 | kombinace antitusik | p.o. | 3 | DF | 3,75 | ||
| 467 | R05DB | antitusika chemicky blízká lokálním anestetikům | p.o., p.rect., parent. | |||||
|---|---|---|---|---|---|---|---|---|
| 467.1 | R05DB | dropropizin | p.o. | 25 | MG | 2,50 | ||
| 04212 | DITUSTAT | gtt 1x10ml | GNO | CZ | ||||
| 467.2 | R05DB13 | butamirát (pevné lékové formy) | p.o. | 25 | MG | 5,95 | ||
| 467.3 | R05DB13 | butamirát (tekuté lékové formy) | p.o. | 25 | MG | 9,75 | ||
| 94859 | TUSSIN | gtt 1x10ml | GNO | CZ | ||||
| 467.4 | R05DB03 | klobutinol | parent. | 120 | MG | 114,60 | H | |
| 467.5 | R05DB05 | pentoxyverin (do 8 mg v jednom čípku včetně) | p.rect. | 100 | MG | 142,30 | L/PDD | |
| 92252 | SEDOTUSSIN 8MG BABIES | sup 6x8mg | UCB | B | ||||
| 467.6 | R05DB05 | pentoxyverin (nad 8 mg v jednom čípku) | p.rect. | 100 | MG | 64,85 | L/PDD | |
| 92253 | SEDOTUSSIN 20MG CHILDREN | sup 6x20mg | UCB | B | ||||
| 468 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | p.o. | |||||
| 468.1 | R06AA | embramin | p.o. | 50 | MG | 1,35 | ||
| 468.2 | R06AA02 | difenhydramin | p.o. | 0.2 | GM | 9,50 | ||
| 468.3 | R06AA04 | klemastin | p.o. | 2 | MG | 7,90 | ||
| 02005 | TAVEGYL | tbl 20x1mg | SAN | CH | ||||
| 468.4 | R06AA07 | difenylpyralin | p.o. | 10 | MG | 7,90 | ||
| 468.5 | R06AA52 | difenhydramin, kombinace | p.o. | 0.2 | GM | 9,50 | ||
| 469 | R06AA | antihistaminika ze skupiny derivátů aminoalkyletherů | parent. | O | |||
|---|---|---|---|---|---|---|---|
| 469.1 | R06AA04 | klemastin | parent. | 2 | MG | 33,55 | O |
| 02559 | TAVEGYL | inj 5x2ml/2mg | SAN | CH | |||
| 470 | R06AB | antihistaminika ze skupiny derivátů alkylaminů | p.o. | ||||
| 470.1 | R06AB03 | dimetinden (pevné lékové formy) | p.o. | 4 | MG | 8,70 | |
| 60135 | FENISTIL RETARD | tbl ret 20x2.5mg | ZYM | CH | |||
| 470.2 | R06AB03 | dimetinden (tekuté lékové formy) | p.o. | 4 | MG | 9,50 | |
| 470.3 | R06AB56 | dexbromfeniramin, kombinace | p.o. | 2 | DF | 8,70 | |
| 471 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | p.o. | ||||
| 471.1 | R06AD02 | prometazin (pevné lékové formy) | p.o. | 25 | MG | 5,10 | |
| 00276 | PROTHAZIN | drg 20x25mg | RPG | D | |||
| 471.2 | R06AD02 | prometazin (tekuté lékové formy) | p.o. | 25 | MG | 9,50 | |
| 471.3 | R06AD03 | thiethylperazin | p.o. | 13 | MG | 4,65 | |
| 09844 | TORECAN | drg 50x6.5mg | KRK | SLO | |||
| 471.4 | R06AD03 | thiethylperazin | p.rect. | 13 | MG | 23,70 | |
| 09847 | TORECAN | sup 6x6.5mg | KRK | SLO | |||
| 472 | R06AD | antihistaminika ze skupiny derivátů fenothiazinu | parent. | O | |||
| 472.1 | R06AD02 | prometazin | parent. | 25 | MG | 7,65 | O |
| 87916 | PHENERGAN | inj 5x2ml/50mg | SPC | F | |||
| 472.2 | R06AD03 | thiethylperazin | parent. | 13 | MG | 28,40 | O |
| 91836 | TORECAN | inj 5x1ml/6.5mg | KRK | SLO | |||
| 473 | R06AX | jiná antihistaminika k systémovému použití | p.o. | ||||
| 473.1 | R06AE06 | oxatomid | p.o. | 60 | MG | 7,20 | |
| 473.2 | R06AE07 | cetirizin (pevné lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.3 | R06AE07 | cetirizin (tekuté lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.4 | R06AK | kombinace antihistaminik | p.o. | 2 | DF | 1,10 | |
| 473.5 | R06AX | bisulepin | p.o. | 4 | MG | 3,35 | |
| 02479 | DITHIADEN | tbl 20x2mg | LEX | CZ | |||
| 473.6 | R06AX01 | bamipin | p.o. | 0.1 | GM | 6,20 | |
| 473.7 | R06AX02 | cyproheptadin (pevné lékové formy) | p.o. | 12 | MG | 6,20 | |
| 473.8 | R06AX02 | cyproheptadin (tekuté lékové formy) | p.o. | 12 | MG | 9,50 | |
| 473.9 | R06AX09 | azatadin | p.o. | 2 | MG | 6,20 | |
| 473.10 | R06AX11 | astemizol (pevné lékové formy) | p.o. | 10 | MG | 8,00 | |
| 91839 | HISMANAL | tbl 30x10mg | JAN | B | |||
| 473.11 | R06AX11 | astemizol (tekuté lékové formy) | p.o. | 10 | MG | 9,50 | |
| 473.12 | R06AX12 | terfenadin | p.o. | 0.12 | GM | 8,00 | |
| 87117 | TERFENADIN 60 STADA | tbl 20x60mg | STD | D | |||
| 87118 | TERFENADIN 60 STADA | tbl 50x60mg | STD | D | |||
| 473.13 | R06AX13 | loratadin (pevné lékové formy) | p.o. | 10 | MG | 9,50 | |
| 88734 | FLONIDAN | tbl 10x10mg | LEK | SLO | |||
| 53639 | FLONIDAN | tbl 30x10mg | LEK | SLO | |||
| 473.14 | R06AX13 | loratadin (tekuté lékové formy) | p.o. | 10 | MG | 9,50 | |
| 01700 | FLONIDAN | sus 1x120ml | LEK | SLO | |||
| 473.15 | R06AX17 | ketotifen (pevné lékové formy) | p.o. | 2 | MG | 8,00 | |
| 87171 | KETOTIFEN TROM | cps 30x1mg | TRM | D | |||
| 85890 | ZADITEN | tbl 30x1mg | SLO | SK | |||
| 473.16 | R06AX17 | ketotifen (tekuté lékové formy) | p.o. | 2 | MG | 9,50 | |
| 473.17 | R06AX18 | akrivastin | p.o. | 24 | MG | 8,00 | |
| 473.18 | R06AX25 | mizolastin | p.o. | 10 | MG | 9,50 | |
| 474 | R06AX | jiná antihistaminika k systémovému použití | parent. | O | |||
|---|---|---|---|---|---|---|---|
| 474.1 | R06AX | bisulepin | parent. | 4 | MG | 25,70 | O |
| 04071 | DITHIADEN | inj 10x2ml/1mg | LEX | CZ | |||
| 474.2 | R06AX | medosulepin/vápník | parent. | 2 | DF | 31,50 | O |
| 00508 | METHIADEN CALCIUM | inj 5x10ml | LEC | CZ | |||
| 475 | R07AA | plicní surfaktanty | parent. | T | |||
| 475.1 | R07AA01 | kolfosceril palmitát | parent. | 108 | MG | 13638,10 | T |
| 475.2 | R07AA02 | přirozené fosfolipidy (telecího původu) | parent. | 1 | DF | 13638,10 | T |
| 475.3 | R07AA02 | přirozené fosfolipidy (vepřového původu) | parent. | 160 | MG | 20548,15 | T |
| 87226 | CUROSURF | sus 2x1.5ml/120mg | CHS | I | |||
| 476 | S01AA | antibiotika k lokálnímu podání | lok. | ||||
|---|---|---|---|---|---|---|---|
| 476.1 | S01AA | azidamfenikol | lok. | 1 | ML | 3,10 | |
| 90770 | OPHTHALMO-AZAPHENICOL | gtt oph 1x10ml | GNO | CZ | |||
| 476.2 | S01AA | neomycin/bacitracin/hydrokortison | lok. | 1 | GM | 5,50 | |
| 01077 | OPHTHALMO-FRAMYKOIN COMPOSITUM | ung oph 1x5gm | LEX | CZ | |||
| 476.3 | S01AA | neomycin/polymyxin/fenylefrin | lok. | 1 | ML | 20,00 | L/OPH |
| 476.4 | S01AA | polymyxin/neomycin/gramicidin | lok. | 1 | ML | 20,00 | L/OPH |
| 476.5 | S01AA01 | chloramfenikol (lékové formy očních kapek) | lok. | 1 | ML | 2,85 | |
| 476.6 | S01AA01 | chloramfenikol (lékové formy očních mastí) | lok. | 1 | GM | 4,55 | |
| 03016 | OPHTHALMO-CHLORAMPHENICOL LECIV | ung oph 1x5gm 1% | LEX | CZ | |||
| 476.7 | S01AA11 | gentamicin | lok. | 1 | ML | 3,10 | |
| 476.8 | S01AA12 | tobramycin (lékové formy očních kapek) | lok. | 1 | ML | 3,10 | |
| 476.9 | S01AA12 | tobramycin (lékové formy očních mastí) | lok. | 1 | GM | 3,10 | |
| 476.10 | S01AA20 | antibiotika v kombinaci s jinými léčivy | lok. | 1 | ML | 3,10 | |
| 476.11 | S01AA30 | neomycin/bacitracin | lok. | 1 | GM | 5,00 | |
| 01076 | OPHTHALMO-FRAMYKOIN | ung oph 1x5gm | LEX | CZ | |||
| 477 | S01AB | chemoteraputika k lokálnímu podání | lok. | ||||
| 477.1 | S01AB | sulfathiazol | lok. | 1 | GM | 3,50 | |
| 477.2 | S01AB04 | sulfacetamid | lok. | 1 | ML | 7,60 | |
| 93577 | SULPHACETAMID | gtt oph 12x0.5ml | POL | PL | |||
| 478 | S01AD | antivirotika k lokálnímu podání | lok. | L/OPH | |||
| 478.1 | S01AD02 | trifluorothimidin | lok. | 1 | GM | 87,40 | L/OPH |
| 478.2 | S01AD03 | acyklovir | lok. | 1 | GM | 87,40 | L/OPH |
| 93990 | VIROLEX | ung oph 1x4.5gm 3% | KRK | SLO | |||
| 478.3 | S01AD04 | trifluorothimidin (lékové formy očních kapek) | lok. | 1 | ML | 54,45 | L/OPH |
| 65513 | TRIHERPINE | gtt oph 1x5ml | CBV | CH | |||
| 479 | S01AX | ostatní antiinfektiva | lok. | L/OPH | |||
|---|---|---|---|---|---|---|---|
| 479.1 | S01AX | jiná antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 2,20 | |
| 00802 | OPHTHALMO-SEPTONEX | gtt oph 1x10ml | GNO | CZ | |||
| 479.2 | S01AX | jiná antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 3,95 | |
| 00876 | OPHTHALMO-SEPTONEX | ung oph 1x5gm | LEX | CZ | |||
| 479.3 | S01AX13 | ciprofloxacin | lok. | 1 | ML | 35,00 | L/OPH |
| 479.4 | S01AX | lomefloxacin | lok. | 1 | ML | 35,00 | L/OPH |
| 480 | S01BA | kortikosteroidy k lokálnímu podání | lok. | ||||
| 480.1 | S01BA01 | dexamethason (lékové formy očních kapek) | lok. | 1 | ML | 3,65 | |
| 93718 | DEXAMETHASONE POLFA | sus oph 10ml 0.1% | POL | PL | |||
| 480.2 | S01BA01 | dexamethason (lékové formy očních mastí) | lok. | 1 | GM | 3,70 | |
| 480.3 | S01BA02 | hydrokortison | lok. | 1 | GM | 4,95 | |
| 02668 | OPHTHALMO-HYDROCORTISON LECIVA | ung oph 1x5gm 0.5% | LEX | CZ | |||
| 480.4 | S01BA03 | kortison | lok. | 1 | ML | 20,00 | L/OPH |
| 00757 | CORTISON SPOFA | gtt oph 1x3ml | SPX | CZ | |||
| 480.5 | S01BA04 | prednizolon (lékové formy očních kapek) | lok. | 1 | ML | 20,00 | L/OPH |
| 480.6 | S01BA04 | prednizolon (lékové formy očních mastí) | lok. | 1 | GM | 20,00 | L/OPH |
| 480.7 | S01BA07 | fluorometholon | lok. | 1 | ML | 20,00 | L/OPH |
| 481 | S01BC | nesteroidní protizánětlivá léčiva k lokálnímu podání | lok. | ||||
| 481.1 | S01BC | alkylazuleny | lok. | 1 | GM | 3,55 | |
| 00874 | OPHTHALMO-AZULEN | ung oph 1x5gm | LEX | CZ | |||
| 481.2 | S01BC02 | oxyfenbutazon | lok. | 1 | GM | 15,00 | |
| 481.3 | S01BC03 | diklofenak | lok. | 1 | ML | 42,00 | L/OPH |
| 481.4 | S01BC04 | flurbiprofen | lok. | 1 | ML | 42,00 | L/OPH |
| 482 | S01CA | kortikosteroidy a antiinfektiva k lokálnímu podání | lok. | L/OPH | |||
| 482.1 | S01CA | chloramfenikol/dexamethason | lok. | 1 | ML | 20,00 | L/OPH |
| 482.2 | S01CA | gentamicin/betamethason (lékové formy očních kapek) | lok. | 1 | ML | 14,15 | L/OPH,ORL |
| 91712 | GARASONE | gtt oph 1x5ml | SCH | B | |||
| 482.3 | S01CA | gentamicin/betamethason (lékové formy očních mastí) | lok. | 1 | GM | 18,00 | L/OPH,ORL | ||||
| 91711 | GARASONE | ung oph 1x5gm | SCH | B | |||||||
| 482.4 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních kapek) | lok. | 1 | ML | 20,00 | L/OPH | ||||
| 482.5 | S01CA01 | dexamet./neomycin/polymyxin (lékové formy očních mastí) | lok. | 1 | GM | 20,00 | L/OPH | ||||
| 482.6 | S01CA01 | oxytetracyklin/dexamethason | lok. | 1 | GM | 20,00 | L/OPH | ||||
| 482.7 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 20,00 | L/OPH | ||||
| 482.8 | S01CA02 | prednizolon a antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 20,00 | L/OPH | ||||
| 482.9 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních kapek) | lok. | 1 | ML | 20,00 | L/OPH | ||||
| 482.10 | S01CA07 | fluorometolon a antiinfektiva (lékové formy očních mastí) | lok. | 1 | GM | 30,00 | L/OPH | ||||
| 483 | S01EA | lokální sympatomimetika k léčbě glaukómu | lok. | L/OPH | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 483.1 | S01EA01 | epinefrin | lok. | 0.2 | ML | 6,15 | L/OPH | ||||
| 09108 | GLAUCON 2% | gtt oph 1x10ml 2% | ALC | USA | |||||||
| 483.2 | S01EA02 | dipivefrin | lok. | 0.2 | ML | 6,15 | L/OPH | ||||
| 483.3 | S01EA04 | klonidin | lok. | 1 | ML | 11,85 | L/OPH | ||||
| 49501 | AROCLONIN 1/16% | gtt oph 10 ml | ANW | D | |||||||
| 20766 | AROCLONIN 1/8% | gtt oph 10 ml | ANW | D | |||||||
| 484 | S01EB | lokální parasympatomimetika k léčbě glaukómu | lok. | L/OPH | |||||||
| 484.1 | S01EB01 | pilokarpin (lékové formy gelu) | lok. | 1 | GM | 44,15 | |||||
| 91606 | PILOGEL HS | gel oph 1x5gm | ALC | USA | |||||||
| 484.2 | S01EB01 | pilokarpin (lékové formy olejových očních kapek) | lok. | 1 | ML | 16,65 | |||||
| 03865 | PILOCARPIN ANKERPHARM 2% | gtt ole oph 1x10ml | ANW | D | |||||||
| 484.3 | S01EB01 | pilokarpin (lékové formy očních kapek) | lok. | 1 | ML | 10,95 | |||||
| 04146 | PILOCARPIN ANKERPHARM 2% | gtt oph 1x10ml | ANW | D | |||||||
| 484.4 | S01EB02 | karbachol (koncentrace do 1% včetně) | lok. | 1 | ML | 8,70 | L/OPH | ||||
| 20932 | JESTRYL VISKOS | gtt oph 1x10ml 1% | ANW | D | |||||||
| 484.5 | S01EB02 | karbachol (koncentrace od 1 do 1,5% včetně) | lok. | 1 | ML | 6,20 | L/OPH | ||||
| 484.6 | S01EB02 | karbachol (koncentrace nad 1,5%) | lok. | 1 | ML | 6,75 | L/OPH | ||||
| 484.7 | S01EB06 | neostigmin | lok. | 1 | ML | 14,20 | L/OPH | ||||
| 485 | S01EC | inhibitory karboanhydrázy k celkovému podání | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 485.1 | S01EC01 | acetazolamid | p.o. | 0.75 | GM | 5,50 | |
| 00113 | DILURAN | tbl 20x250mg | LEX | ||||
| 485.2 | S01EC01 | acetazolamid (lékové formy s řízeným uvolňováním) | p.o. | 0.75 | GM | 30,00 | |
| 485.3 | S01EC02 | diklofenamid | p.o. | 0.1 | GM | 6,40 | |
| 485.4 | S01EC03 | dorzolamid | lok. | 1 | ML | 68,00 | L/OPH |
| 486 | S01ED | lokální beta-blokátory k léčbě glaukómu | lok. | ||||
| 486.1 | S01ED01 | timolol (koncentrace do 0,25% včetně) | lok. | 1 | ML | 16,50 | |
| 76186 | ARUTIMOL 0.25% | gtt oph 1x5ml | ANW | D | |||
| 70474 | ARUTIMOL 0.25% | gtt oph 3x5ml | ANW | D | |||
| 87113 | TIMOLOL-POS 0.25% | gtt oph 1x5ml | URS | D | |||
| 98210 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.25% | LEX | CZ | |||
| 93294 | OCUPRES-E | gtt oph 5ml 0.25% | CAD | IND | |||
| 96022 | OFTENSIN 0.25% | gtt oph 1x10ml | POL | PL | |||
| 486.2 | S01ED01 | timolol (koncentrace nad 0,25%) | lok. | 1 | ML | 19,00 | |
| 93293 | OCUPRES-E | gtt oph 5ml 0.50% | CAD | ||||
| 96020 | OFTENSIN 0.5% | gtt oph 1x10ml | POL | ||||
| 87114 | TIMOLOL-POS 0.5% | gtt oph 1x5ml | URS | ||||
| 76187 | ARUTIMOL 0.5% | gtt oph 1x5ml | ANW | D | |||
| 70475 | ARUTIMOL 0.5% | gtt oph 3x5ml | ANW | D | |||
| 98211 | TIMOPTOL(LAHV.PE) | gtt oph 5ml 0.50% | LEX | CZ | |||
| 486.3 | S01ED02 | betaxolol | lok. | 1 | ML | 32,00 | L/OPH |
| 486.4 | S01ED03 | levobunolol | lok. | 1 | ML | 32,00 | L/OPH |
| 486.5 | S01ED04 | metipranolol | lok. | 1 | ML | 13,50 | |
| 486.6 | S01ED05 | carteolol | lok. | 1 | ML | 32,00 | L/OPH |
| 487 | S01F | mydriatika a cykloplegika | lok. | O/OPH | |||
| 487.1 | S01FA04 | cyklopentolát | lok. | 1 | ML | 35,90 | O/OPH |
| 487.2 | S01FA06 | tropikamid | lok. | 1 | ML | 9,70 | O/OPH |
| 21155 | MYDRUM | gtt oph 10ml 0.5% | ANW | D | |||
| 487.3 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1 | ML | 41,25 | O/OPH |
| 488 | S01G | dekongestanty a antialergika | lok. | L/OPH,ALG | |||
| 488.1 | S01GA52 | tetryzolin/antihistaminikum | lok. | 1 | ML | 4,55 | L/OPH,ALG |
| 21521 | PROTHANON | gtt oph 10ml | GMD | D | |||
| 488.2 | S01GX | antazolin/tetryzolin | lok. | 1 | ML | 4,55 | L/OPH,ALG | |||
| 488.3 | S01GX01 | kyselina kromoglyková (lékové formy očních kapek) | lok. | 1 | ML | 6,55 | L/OPH,ALG | |||
| 68575 | CROMOHEXAL | gtt oph 1x10ml 2% | HEX | D | ||||||
| 83769 | ALLERGOCROM | gtt oph 1x10ml 2% | URS | D | ||||||
| 488.4 | S01GX01 | kyselina kromoglyková (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,55 | L/OPH,ALG,ORL | |||
| 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D | ||||||
| 488.5 | S01GX02 | levokabastin | lok. | 1 | ML | 20,00 | L/OPH,ALG | |||
| 488.6 | S01GX05 | lodoxamid | lok. | 1 | ML | 20,00 | L/OPH,ALG | |||
| 488.7 | S01GX03 | kyselina spaglumová | lok. | 1 | ML | 9,00 | L/OPH,ALG | |||
| 489 | S01HA | lokální místní anestetika | lok. | L/OPH | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 489.1 | S01HA | místní anestetika | lok. | 1 | ML | 1,15 | L/OPH | |||
| 489.2 | S01HA02 | oxybuprokain | lok. | 1 | ML | 12,10 | L/OPH | |||
| 66524 | NOVESIN 0.4% | gtt oph 1x10ml | CBV | CH | ||||||
| 490 | S01 | jiná oftalmologika | lok. | |||||||
| 490.1 | S01XA | tolazolin (koncentrace 10%) | lok. | 1 | GM | 15,25 | L/OPH | |||
| 490.2 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 3,00 | ||||
| 04179 | LACRISYN | gtt oph 1x10ml | GNO | CZ | ||||||
| 490.3 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1408,15 | Z | |||
| 31339 | IAL | inj 1x2ml/20mg | FID | I | ||||||
| 490.4 | S01XA02 | retinol | lok. | 1 | GM | 3,00 | ||||
| 491 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | L/ORL | ||||||
| 491.1 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | ML | 28,00 | L/ORL | |||
| 491.2 | S03AA03 | polymyxin B | lok. | 1 | ML | 2,70 | L/ORL | |||
| 02830 | POLYMYXIN B | gtt oto 10ml 100ku | GNO | CZ | ||||||
| 491.3 | S02BA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | GM | 23,45 | L/ORL,PDD | |||
| 84575 | OTOBACID N | gtt oto 1x6gm | ASH | D | ||||||
| 492 | V01AA | extrakty alergenů | p.o. | L/ALG | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 492.1 | V01AA | extrakty alergenů (bakteriální, z plísní, nejvyšší koncentrace) | p.o. | 1 | BA | 442,60 | L/ALG | |||
| 97141 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 97144 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98390 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98393 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98396 | H-AL BACT.SEVAC P.O.SMES HCD | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98402 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98405 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98408 | H-AL BACT.SEVAC P.O.STA.+NEIS.P | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98411 | H-AL BACT.SEVAC P.O.SMES DCD | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 492.2 | V01AA | extrakty alergenů (bakteriální, z plísní, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 919,00 | L/ALG | |||
| 97139 | H-AL BACT.SEVAC P.O.PROTEUS V+M | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 97142 | H-AL BACT.SEVAC P.O.STREP.PNEU | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 97145 | H-AL BACT.SEVAC P.O.STAPH.AUR. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98391 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98394 | H-AL BACT.SEVAC P.O.SMES HCD | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98397 | H-AL BACT.SEVAC P.O.SM.PROTIAKN | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98400 | H-AL BACT.SEVAC P.O.STA.+STR.PN | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98403 | H-AL BACT.SEVAC P.O.STA.+HAEM.I | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98406 | H-AL BACT.SEVAC P.O.STA.+NEIS.P | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98409 | H-AL BACT.SEVAC P.O.SMES DCD | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98454 | H-AL MYCO SEVAC P.O.SMES KANDID | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98460 | H-AL MYCO SEVAC P.O.SM.PL.DOMOV | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98457 | H-AL MYCO SEVAC P.O.SM.PL.VENK. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 492.3 | V01AA | extrakty alergenů (z hmyzu, z roztočů, nejvyšší koncentrace) | p.o. | 1 | BA | 843,00 | L/ALG | |||
| 98444 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol 5000pnu 1x9ml | SEV | CZ | ||||||
| 98453 | H-AL MIT.SEVAC P.O.SMES ROZTOCU | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 492.4 | V01AA | extrakty alergenů (z hmyzu, z roztočů, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 1757,70 | L/ALG | |||
| 98442 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol od 0.5pnu 6x9ml | SEV | CZ | ||||||
| 98443 | H-AL INS.SEVAC P.O.VCELI EXTR. | sol od 0.05pnu 6x9 | SEV | CZ | ||||||
| 98446 | H-AL INS.SEVAC P.O.VOSI EXTR. | sol od 0.05pnu 6x9 | SEV | CZ | ||||||
| 98448 | H-AL INS.SEVAC P.O.VCEL+VOS.EXT | sol od 0.5pnu 6x9ml | SEV | CZ | ||||||
| 98449 | H-AL INS.SEVAC P.O.VCEL+VOS.EXT | sol od 0.05pnu 6x9 | SEV | CZ | ||||||
| 98451 | H-AL MIT.SEVAC P.O.SMES ROZTOCU | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 492.5 | V01AA | extrakty alergenů (z plísní, individuální alergeny) | p.o. | 1 | BA | 876,00 | L/ALG | |||
| 492.6 | V01AA | extrakty alergenů (z prachu obohacené, individuální alergeny) | p.o. | 1 | BA | 827,10 | L/ALG | |||
| 492.7 | V01AA | extrakty alergenů (z prachu, včetně obohacených nejvyšší koncentrace) | p.o. | 1 | BA | 281,00 | L/ALG | |||
| 98432 | H-AL DUSTS SEVAC P.O.BYT.PR. | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 492.8 | V01AA | extrakty alergenů (z prachu, včetně obohacených, plná terapeutická dávka pro pacienta) | p.o. | 1 | BA | 997,60 | L/ALG | |||
| 98412 | H-AL DMX SEVAC P.O.BYT.PR.OBOH. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98413 | H-AL DMX SEVAC P.O.BYT.PR.OBOH. | sol od 1pnu 6x9ml | SEV | CZ | ||||||
| 98415 | H-AL DMX SEVAC P.O.BYT.PR.+ROZ | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98430 | H-AL DUSTS SEVAC P.O.BYT.PR. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98431 | H-AL DUSTS SEVAC P.O.BYT.PR. | sol od 1pnu 6x9ml | SEV | CZ | ||||||
| 492.9 | V01AA | extrakty alergenů (z pylů, nejvyšší koncentrace) | p.o. | 1 | BA | 491,80 | L/ALG | |||
| 98081 | H-AL POL.SEVAC P.O.POLL.MIXT. | sol od 10pnu 3x9ml | SEV | CZ | ||||||
| 98483 | H-AL POL.SEVAC P.O.SM.T.I+SAM.N | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 98492 | H-AL POL.SEVAC P.O.SM.T.I+BR+AG | sol 10000pnu 1x9ml | SEV | CZ | ||||||
| 492.10 | V01AA | extrakty alergenů (z pylů, plná terapeutická dávka pro pacienta a individuální alergeny) | p.o. | 1 | BA | 897,50 | L/ALG | |||
| 98463 | H-AL POL.SEVAC P.O.JAR.SM.CASNA | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98466 | H-AL POL.SEVAC P.O.JAR.SM.POZD. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98469 | H-AL POL.SEVAC P.O.PODZ.SM.PYL. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98472 | H-AL POL.SEVAC P.O.POLL.MIXT. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98475 | H-AL POL.SEVAC P.O.SMES TRAV I. | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98478 | H-AL POL.SEVAC P.O.SM.TR.I+BE.P | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98484 | H-AL POL.SEVAC P.O.SM.T.I+ART.M | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98490 | H-AL POL.SEVAC P.O.SM.T.I+BR+AG | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98493 | H-AL POL.SEVAC P.O.SMES TRAV II | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98481 | H-AL POL:SEVAC P.O.SM.T.I+SAM.N | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 98487 | H-AL POL.SEVAC P.O.ARTEMIS.MIX | sol od 0.1pnu 6x9ml | SEV | CZ | ||||||
| 492.11 | V01AA | extrakty alergenů (standardizované, úvodní dávka) | p.o. | 1 | DF | 75 % | L/ALG | |||
| 492.12 | V01AA | extrakty alergenů (standardizované, udržovací dávka dávka) | p.o. | 1 | DF | 75 % | L/ALG | |||
| 493 | V01AA | extrakty alergenů | intrader. | O/ALG | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 493.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | intrader. | 1 | BA | 137,70 | O/ALG | |||
| 98502 | D-AL BACTO SEVAC | inj 5ml/100pnu | USO | CZ | ||||||
| 98504 | D-AL BACTO SEVAC | inj 5ml/1000pnu | USO | CZ | ||||||
| 98506 | D-AL DUSTS SEVAC | inj 5ml/100pnu | USO | CZ | ||||||
| 98508 | D-AL DUSTS SEVAC | inj 5ml/1000pnu | USO | CZ | ||||||
| 98510 | D-AL MYCO SEVAC | inj 5ml/100pnu | USO | CZ | ||||||
| 98512 | D-AL MYCO SEVAC | inj 5ml/1000pnu | USO | CZ | ||||||
| 98514 | D-AL MITES SEVAC | inj 5ml/100pnu | USO | CZ | ||||||
| 98516 | D-AL MITES SEVAC | inj 5ml/1000pnu | USO | CZ | ||||||
| 98518 | D-AL POLLENS SEVAC | inj 5ml/100pnu | USO | CZ | ||||||
| 98520 | D-AL POLLENS SEVAC | inj 5ml/1000pnu | USO | CZ | ||||||
| 98523 | D-AL INSECTS SEVAC | inj 5ml od 0.5pnu | USO | CZ | ||||||
| 98524 | D-AL FOODS SEVAC-KONC.DLE DRUHU | inj po 5ml | USO | CZ | ||||||
| 494 | V01AA | extrakty alergenů | PRICK test | O/ALG | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 494.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | PRICK test | 1 | BA | 534,50 | O/ALG | ||||
| 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | |||||||
| 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | |||||||
| 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | |||||||
| 494.2 | V01AA | extrakty alergenů (diagnostické, kontrola) | PRICK test | 1 | BA | 372,20 | O/ALG | ||||
| 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | |||||||
| 494.3 | V01AA | extrakty alergenů (diagnostické, souprava) | PRICK test | 1 | BA | 539,50 | O/ALG | ||||
| 494.4 | V01AA | extrakty alergenů (diagnostické, souprava), jinde nezařazené | PRICK test | 1 | BA | 50 % | O/ALG | ||||
| 495 | V01AA | extrakty alergenů | parent. | L/ALG | |||||||
| 495.1 | V01AA | extrakty alergenů (bakteriální indiviuální dle rozpisu lékaře) | parent. | 1 | BA | 982,60 | L/ALG | ||||
| 495.2 | V01AA | extrakty alergenů (bakteriální, z plísní, nejvyšší koncentrace) | parent. | 1 | BA | 580,90 | L/ALG | ||||
| 495.3 | V01AA | extrakty alergenů (bakteriální, z plísní, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 1194,30 | L/ALG | ||||
| 99670 | H-AL BACT.SEVAC INJ.SMES HCD | inj 5x10ml | USO | CZ | |||||||
| 99671 | H-AL BACT.SEVAC INJ.SMES HCD | inj 6x10ml | USO | CZ | |||||||
| 99673 | H-AL BACT.SEVAC INJ.SM.PROTIAKN | inj 5x10ml | USO | CZ | |||||||
| 99674 | H-AL BACT.SEVAC INJ.SM.PROTIAKN | inj 6x10ml | USO | CZ | |||||||
| 99727 | H-AL MYCO SEVAC INJ.SM.KANDIDA | inj 5x10ml | USO | CZ | |||||||
| 99730 | H-AL MYCO SEVAC INJ.SM.PL.VENK. | inj 5x10ml | USO | CZ | |||||||
| 99733 | H-AL MYCO SEVAC INJ.SM.PL.DOMOV | inj 5x10ml | USO | CZ | |||||||
| 495.4 | V01AA | extrakty alergenů (obecné individuální alergeny dle rozpisu lékaře) | parent. | 1 | BA | 927,70 | L/ALG | ||||
| 495.5 | V01AA | extrakty alergenů (z hmyzu, z roztočů, nejvyšší koncentrace) | parent. | 1 | BA | 764,30 | L/ALG | ||||
| 99711 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 1x5000pnu | USO | CZ | |||||||
| 99726 | H-AL MIT.SEVAC INJ.SM.ROZTOCU | inj 1x10000pnu | USO | CZ | |||||||
| 495.6 | V01AA | extrakty alergenů (z hmyzu, z roztočů, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 1711,30 | L/ALG | ||||
| 99709 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 6x10ml | USO | CZ | |||||||
| 99710 | H-AL INS.SEVAC INJ.VCELI EXTR. | inj 7x10ml | USO | CZ | |||||||
| 99712 | H-AL INS.SEVAC INJ.VOSI EXTR. | inj 6x10ml | USO | CZ | |||||||
| 99715 | H-AL INS.SEVAC KOMARI | inj 6x10ml | USO | CZ | |||||||
| 99716 | H-AL INS.SEVAC KOMARI | inj 7x10ml | USO | CZ | |||||||
| 99721 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 6x10ml 1:1 | USO | CZ | |||||||
| 99722 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 7x10ml 1:1 | USO | CZ | |||||||
| 99724 | H-AL MIT.SEVAC INJ.SM.ROZTOCU | inj 5x10ml | USO | CZ | |||||||
| 99725 | H-AL MIT.SEVAC INJ.SM.ROZTOCU | inj 6x10ml | USO | CZ | ||||
| 99723 | H-AL INS.SEVAC INJ.VCEL+VOS.EXT | inj 1x5000pnu 1:1 | USO | CZ | ||||
| 495.7 | V01AA | extrakty alergenů (z hmyzu, z roztočů depotní, nejvyšší koncentrace) | parent. | 1 | BA | 1327,70 | L/ALG | |
| 495.8 | V01AA | extrakty alergenů (z hmyzu, z roztočů depotní, ostatní koncentrace) | parent. | 1 | BA | 491,80 | L/ALG | |
| 83556 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 100pnu/1ml | SEV | CZ | ||||
| 83557 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 1000pnu/3ml | SEV | CZ | ||||
| 99804 | H-AL MIT.SEVAC DEP.SMES ROZTOCU | inj 100pnu/3ml | SEV | CZ | ||||
| 495.9 | V01AA | extrakty alergenů (z plísní dle rozpisu lékaře, individuální alergeny) | parent. | 1 | BA | 708,10 | L/ALG | |
| 495.10 | V01AA | extrakty alergenů (z prachu, včetně obohacených nejvyšší koncetrace) | parent. | 1 | BA | 379,40 | L/ALG | |
| 495.11 | V01AA | extrakty alergenů (z prachu, včetně obohacených, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 997,60 | L/ALG | |
| 99679 | H-AL DMX SEVAC INJ.BYT.PR.OBOH. | inj 6x10ml | USO | CZ | ||||
| 99680 | H-AL DMX SEVAC INJ.BYT.PR.OBOH. | inj 7x10ml | USO | CZ | ||||
| 99681 | H-AL DMX SEVAC INJ.BYT.PR.OBOH. | inj 1x10000pnu | USO | CZ | ||||
| 99682 | H-AL DMX SEVAC INJ.BPO+ROZT. | inj 6x10ml 1:1 | USO | CZ | ||||
| 99694 | H-AL DUSTS SEVAC INJ.BYT.PRACH | inj 6x10ml | USO | CZ | ||||
| 99695 | H-AL DUSTS SEVAC INJ.BYT.PRACH | inj 7x10ml | USO | CZ | ||||
| 495.12 | V01AA | extrakty alergenů (z prachu, včetně obohacených depotní, nejvyšší koncentrace) | parent. | 1 | BA | 295,10 | L/ALG | |
| 495.13 | V01AA | extrakty alergenů (z prachu, včetně obohacených depotní, ostatní koncentrace) | parent. | 1 | BA | 42,20 | L/ALG | |
| 83552 | H-AL DMX SEVAC DEP.BYT.PR.OBOH. | inj 100pnu/1ml | SEV | CZ | ||||
| 495.14 | V01AA | extrakty alergenů (z pylů, nejvyšší koncentrace) | parent. | 1 | BA | 445,10 | L/ALG | |
| 99755 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 1x10000pnu | USO | CZ | ||||
| 99780 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 1x10000pnu | USO | CZ | ||||
| 99784 | H-AL POL.SEVAC INJ.SM.T.I+SAM.N | inj 1x10000pnu | USO | CZ | ||||
| 99792 | H-AL POL.SEVAC INJ.SM.T.I+ART.M | inj 1x10000pnu | USO | CZ | ||||
| 99796 | H-AL POL.SEVAC INJ.SM.TRAV II | inj 1x10000pnu | USO | CZ | ||||
| 99800 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 1x10000pnu | USO | CZ | ||||
| 495.15 | V01AA | extrakty alergenů (z pylů, udržovací dávka) | parent. | 1 | BA | 43,60 | L/ALG | |
| 99756 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 10-100pnu/10ml | USO | CZ | ||||
| 495.16 | V01AA | extrakty alergenů (z pylů, plná terapeutická dávka pro pacienta) | parent. | 1 | BA | 850,00 | L/ALG | |
| 99740 | H-AL POL.SEVAC INJ.JAR.SM.CASNA | inj 5x10ml | USO | CZ | ||||
| 99742 | H-AL POL.SEVAC INJ.JAR.SM.CASNA | inj 4x10ml | USO | CZ | ||||
| 99744 | H-AL POL.SEVAC INJ.JAR.SM.POZDN | inj 5x10ml | USO | CZ | ||||
| 99746 | H-AL POL.SEVAC INJ.JAR.SM.POZDN | inj 4x10ml | USO | CZ | ||||
| 99748 | H-AL POL.SEVAC INJ.PODZ.SM.PYL. | inj 5x10ml | USO | CZ | ||||
| 99750 | H-AL POL.SEVAC INJ.PODZ.SM.PYL. | inj 4x10ml | USO | CZ | ||||
| 99752 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 3x5ml+2x10ml | USO | CZ | |||||||||
| 99753 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 3x5ml+3x10ml | USO | CZ | |||||||||
| 99754 | H-AL POL.SEVAC INJ.POLLIN.MIXT. | inj 1x5+3x10ml | USO | CZ | |||||||||
| 99773 | H-AL POL.SEVAC INJ.SM.TRAV I | inj 5x10ml | USO | CZ | |||||||||
| 99777 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 5x10ml | USO | CZ | |||||||||
| 99778 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 6x10ml | USO | CZ | |||||||||
| 99779 | H-AL POL.SEVAC INJ.SM.T.I+BE.P | inj 4x10ml | USO | CZ | |||||||||
| 99781 | H-AL POL.SEVAC INJ.SM.T.I+SAM.N | inj 5x10ml | USO | CZ | |||||||||
| 99783 | H-AL POL.SEVAC INJ.SM.T.I+SAM.N | inj 4x10ml | USO | CZ | |||||||||
| 99785 | H-AL POL.SEVAC INJ.SM.T.I+BR+AG | inj 5x10ml | USO | CZ | |||||||||
| 99786 | H-AL POL.SEVAC INJ.SM.T.I+BR+AG | inj 6x10ml | USO | CZ | |||||||||
| 99787 | H-AL POL.SEVAC INJ.SM.T.I+BR+AG | inj 4x10ml | USO | CZ | |||||||||
| 99789 | H-AL POL.SEVAC INJ.SM.T.I+ART.M | inj 5x10ml | USO | CZ | |||||||||
| 99791 | H-AL POL.SEVAC INJ.SM.T.I+ART.M | inj 4x10ml | USO | CZ | |||||||||
| 99793 | H-AL POL.SEVAC INJ.SM.TRAV II | inj 5x10ml | USO | CZ | |||||||||
| 99795 | H-AL POL.SEVAC INJ.SM.TRAV II | inj 4x10ml | USO | CZ | |||||||||
| 99797 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 5x10ml | USO | CZ | |||||||||
| 99798 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 6x10ml | USO | CZ | |||||||||
| 99799 | H-AL POL.SEVAC INJ.ARTEMIS.MIX. | inj 4x10ml | USO | CZ | |||||||||
| 495.17 | V01AA | extrakty alergenů (z pylů individuální alergeny dle rozpisu lékaře) | parent. | 1 | BA | 513,00 | L/ALG | ||||||
| 495.18 | V01AA | extrakty alergenů (z pylů depotní, nejvyšší koncentrace) | parent. | 1 | BA | 434,90 | L/ALG | ||||||
| 99812 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 25000pnu/5ml | SEV | CZ | |||||||||
| 495.19 | V01AA | extrakty alergenů (z pylů depotní, ostatní koncentrace) | parent. | 1 | BA | 88,10 L/ALG | |||||||
| 83554 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 250pnu/1ml | SEV | CZ | |||||||||
| 83555 | H-AL POL.SEVAC DEP.POLLIN.MIXT. | inj 2500pnu/3ml | SEV | CZ | |||||||||
| 83558 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 250pnu/1ml | SEV | CZ | |||||||||
| 83559 | H-AL POL.SEVAC DEP.JAR.SM.CAS. | inj 2500pnu/3ml | SEV | CZ | |||||||||
| 83560 | H-AL POL.SEVAC DEP.SM.PODZIMNI | inj 250pnu/1ml | SEV | CZ | |||||||||
| 83561 | H-AL POL.SEVAC DEP.SM.PODZIMNI | inj 2500pnu/3ml | SEV | CZ | |||||||||
| 83562 | H-AL POL.SEVAC DEP.SMES TRAV I | inj 250pnu/1ml | SEV | CZ | |||||||||
| 83563 | H-AL POL.SEVAC DEP.SMES TRAV I | inj 2500pnu/3ml | SEV | CZ | |||||||||
| 495.20 | V01AA | extrakty alergenů (standardizované,úvodní dávka) | parent. | 1 | DF | 75 % | L/ALG | ||||||
| 495.21 | V01AA | extrakty alergenů (standardizované,udržovací dávka) | parent. | 1 | DF | 75 % | L/ALG | ||||||
| 496 | V03A | všechny jiné terapeutické přípravky | lok. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 496.1 | V03A | antistafylokokový fág. lyzát | lok. | 20 | ML | 274,40 | |||||||
| 86170 | STAFAL SEVAC | sus 1x10ml | SEV | CZ | |||||||||
| 497 | V03AB | antidota | parent. | K | |||||||||
| 497.1 | V03AB | deferaxamin | parent. | 1 | GM | 402,60 | K | ||||||
| 01445 | DESFERAL | inj sic 10x500mg | CGC | CH | |||||||||
| 497.2 | V03AB | trimedoxim + atropin | parent. | plně | K | ||||||||
| 497.3 | V03AB | obedoxim | parent. | plně | K | ||
| 497.4 | V03AB03 | edetáty | parent. | plně | K | ||
| 497.5 | V03AB06 | thiosulfát | parent. | plně | K | ||
| 497.6 | V03AB08 | dusitan sodný | parent. | plně | K | ||
| 497.7 | V03AB14 | protamin | parent. | 1 | ML | 6,35 | K |
| 85787 | PROTAMIN SULFAT 1% GALENIKA | inj 5x5ml/50mg 1% | GLN | YU | |||
| 497.8 | V03AB15 | naloxon | parent. | 0.4 | MG | 12,10 | K |
| 88866 | INTRENON | inj 10x1ml/400rg | LEX | CZ | |||
| 94763 | NALOXONE POLFA | inj 10x1ml/0.4mg | POL | PL | |||
| 497.9 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100 | ML | 19,90 | K |
| 497.10 | V03AB19 | fysostigmin | parent. | 1 | MG | 10,55 | K |
| 00557 | PHYSOSTIGMIN SPOFA | inj 10x1ml/1mg | SPX | CZ | |||
| 497.11 | V03AB24 | digitalisový antitoxin | parent. | 80 | MG | 33477,20 | K |
| 497.12 | V03AB25 | flumazenil | parent. | 0.5 | MG | 795,70 | K |
| 93214 | ANEXATE | inj 5x5ml/0.5mg | HLR | CH | |||
| 498 | V03AF | antidota užívaná při léčbě cytostatiky | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 498.1 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 123,30 | |
| 96963 | CALCIUMFOLINAT-EBEWE | cps 20x15mg | EBW | A | |||
| 498.2 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 127,15 | |
| 96964 | CALCIUMFOLINAT-EBEWE | cps 20x100mg | EBW | A | |||
| 498.3 | V03AF01 | mesna | p.o. | 1,2 | MG | 300,45 | B/ONK,HEM |
| 499 | V03AF | antidota užívaná při léčbě cytostatiky | parent. | B/ONK,HEM | |||
| 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 30,40 | B/ONK,HEM |
| 72562 | UROMITEXAN 200MG | inj 15x2ml/200mg | ASD | D | |||
| 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 50,55 | B/ONK,HEM |
| 75274 | UROMITEXAN 400MG | inj 15x4ml/400mg | ASD | D | |||
| 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4491,80 | B/ONK,HEM |
| 96542 | CARDIOXANE | inj sic 1x500mg | CNC | NL | |||
| 499.4 | V03AF03 | kalcium folinát | parent. | 60 | MG | 239,60 | B/ONK,HEM | ||||
| 88636 | LEUCOVORIN CA LACHEMA 10 | inj sic 10x10mg | LCM | CZ | |||||||
| 12441 | LEUCOVORIN CA LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | |||||||
| 75004 | LEUCOVORIN CA LACHEMA 25 | inj sic 1x25mg | LCM | CZ | |||||||
| 91561 | LEUCOVORIN CA LACHEMA 25 | inj sic 10x25mg | LCM | CZ | |||||||
| 12442 | LEUCOVORIN CA LACHEMA 50 | inj 5x5ml/50mg | LCM | CZ | |||||||
| 500 | V03AK | tkáňová lepidla | lok. | X | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3568,70 | X | ||||
| 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 181,60 | X | ||||
| 89822 | TACHOCOMB (2.5X3X0.5CM) | spn 1x1ks | HNP | A | |||||||
| 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | |||||||
| 501 | V04CD | testy sekrece hormonů hypofýzy | p.o. | K/END | |||||||
| 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 431,55 | K/END | ||||
| 01359 | METOPIRONE | cps 50x250mg | CGC | CH | |||||||
| 502 | V04CF | tuberkulinový test | parent. | O | |||||||
| 502.1 | V04CF01 | tuberkulin | parent. | 0.6 | RG | 283,80 | H | ||||
| 68918 | TUBERCULIN PPD RT 23,SSI | inj 10x1.5ml/0.6rg | SST | DK | |||||||
| 68920 | TUBERCULIN PPD RT 23,SSI | inj 10x5ml/2rg | SST | DK | |||||||
| 42088 | TUBERCULIN PPD RT 23,SSI | inj 1x1.5ml/0.6rg | SST | DK | |||||||
| 68919 | TUBERCULIN PPD RT 23,SSI | inj 1x5ml/2rg | SST | DK | |||||||
| 503 | V04CL | testy pro alergické choroby | intrader. | O/ALG | |||||||
| 503.1 | V04CL | testy pro alergické choroby (diagnostické alergeny) | intrader. | 1 | BA | 207,90 | O/ALG | ||||
| 84296 | D-AL SEVAC PRICK TEST | sol 1x3ml/3000pnu | SEV | CZ | |||||||
| 84298 | D-AL INSECTS SEVAC PRICK TEST | sol 500pnu vc.+kom. | SEV | CZ | |||||||
| 84299 | D-AL INSECTS SEVAC PRICK TEST | sol 500pnu vosa | SEV | CZ | |||||||
| 84302 | D-AL DUSTS SEVAC PRICK TEST | sol 1000pnu | SEV | CZ | |||||||
| 84303 | D-AL DUSTS SEVAC PRICK TEST | sol red. 1:1 | SEV | CZ | |||||||
| 84307 | D-AL MYCO SEVAC PRICK TEST | sol 1000pnu | SEV | CZ | |||||||
| 84310 | D-AL FOODS SEVAC PRICK TEST | sol red. 1:1 | SEV | CZ | |||||||
| 503.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1 | BA | 506,40 | O/ALG | ||||
| 69219 | ALK WASSERIG SQ (DIAG.) 100KU/ML | lyo 5x4.5ml+solv. | EAS | A | |||||||
| 84294 | D-AL POLLENS SEVAC PRICK TEST I | kit 17x3ml/3000pnu | SEV | CZ | |||||||
| 504 | V04CX | jiná diagnostika | p.o. | ||||||||
| 504.1 | V04CX | jiná diagnostika (přípravky uvolňující CO2) | p.o. | 1 | DF | 1,25 | |||||
| 91134 | CONTRATIN | gra 60x2gm | IHO | CZ | |||||||
| 504.2 | V04D | diagnostická radiofarmaceutika (přípravky uvolňující CO2) | p.o. | 1 | DF | 23,40 | ||||
| 06300 | CO2 GRANULAT GUERBET | gra 10x2.938gm | GUE | D | ||||||
| 505 | V04CX | jiná diagnostika | intrader. | O | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 505.1 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 130,00 | O | |||
| 94513 | IMUNOSKINTEST SEVAC I.D. | inj 8x1ml | SEV | CZ | ||||||
| 505.2 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50 | MG | 244,10 | O | |||
| 90636 | PATENTBLAU V | inj 1x2ml/50mg | BGL | D | ||||||
| 506 | V04CX | jiná diagnostika | parent. | O | ||||||
| 506.1 | V04CG03 | histamin | parent. | 10 | MG | 10,30 | O | |||
| 00479 | HISTAMIN SPOFA 1% AD DIAGNOSIM | inj 10x1ml/10mg | SPX | CZ | ||||||
| 506.2 | V04CG30 | kofein a benzoát sodný | parent. | 0.1 | GM | 5,10 | O | |||
| 00416 | COFFEINUM NATRIUM BENZ. LECIVA | inj 10x1ml 10% | LEX | CZ | ||||||
| 506.3 | V04CH01 | inulin | parent. | 5 | GM | 500,55 O | ||||
| 506.4 | V04CJ02 | protirelin | parent. | 0.2 | MG | 220,70 | O | |||
| 91950 | TRH BERLIN-CHEMIE | inj sic 1x0.2mg | BCE | D | ||||||
| 506.5 | V04CK01 | sekretin | parent. | 29 | RG | 941,00 | O | |||
| 88438 | SEKRETOLIN DIAGNOSTIKUM | inj sic 1x29rg+10ml | HOE | D | ||||||
| 506.6 | V04CM01 | gonadorelin (do 25 RG v jedné ampuli včetně) | parent. | 0.1 | MG | 230,80 | O | |||
| 506.7 | V04CM01 | gonadorelin (nad 25 RG v jedné ampuli) | parent. | 0.1 | MG | 695,90 | O | |||
| 09612 | RELEFACT LH-RH | inj 10x1ml/100rg | HOE | D | ||||||
| 506.8 | V04CX | jiná diagnostika (fluorescein, 10% koncentrace) | parent. | 1 | ML | 35,35 | O | |||
| 506.9 | V04CX | jiná diagnostika (fluorescein, 25% koncentrace) | parent. | 1 | ML | 131,35 | O | |||
| 506.10 | V04CE01 | galaktóza | parent. | 1 | DF | 924,65 | O | |||
| 68662 | ECHOVIST-300 | gra 2x3gm+sol+mandr | SAG | D | ||||||
| 507 | V06CA | výživa bez fenylalaninu | p.o. | L/J4 | ||||||
| 507.1 | V06CA | výživa bez fenylalaninu (suplementovaný bílkovinný hydrolyzát) | p.o. | 1 | GM | 9,05 | L/J4 | |||
| 91926 | LOFENALAC | plv 1x454gm | MJO | USA | ||||||
| 94078 | SINFEMIX | plv 1x250gm | IMA | SK | ||||||
| 507.2 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,25 | L/J4 | ||||
| 88063 | SINFENAL | plv 1x250gm | IMA | SK | |||||||
| 507.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1 | GM | 11,70 | L/J4 | ||||
| 83123 | PKU 1 | plv po 2x500gm | MLP | D | |||||||
| 83124 | PKU 2 | plv po 2x500gm | MLP | D | |||||||
| 83125 | PKU 3 | plv po 2x500gm | MLP | D | |||||||
| 53291 | P-AM 1 | plv 3x500mg | SHS | D | |||||||
| 507.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 18 měsíců) | p.o. | 1 | GM | 23,65 | L/J4 | ||||
| 68847 | ANALOG PKU | plv 6x400gm | SGR | GB | |||||||
| 94414 | ANALOG PKU | plv 1x400gm | SGR | GB | |||||||
| 507.5 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1 | GM | 14,50 | L/J4 | ||||
| 53290 | P-AM MATERNAL | plv 6x500mg | SHS | D | |||||||
| 508 | V06DA | kombinace sacharidy/proteiny/minerály/vitamíny | p.o. | H | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 508.1 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 80 | GM | 89,40 | H | ||||
| 508.2 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 73,15 | H | ||||
| 91569 | FRESUBIN NUSSGESCHMACK | sol 12x500ml | FRE | D | |||||||
| 91568 | FRESUBIN NUSSGESCHMACK | sol 1x500ml | FRE | D | |||||||
| 91565 | FRESUBIN SCHOKOLADENGESCHMACK | sol 12x500ml | FRE | D | |||||||
| 91564 | FRESUBIN SCHOKOLADENGESCHMACK | sol 1x500ml | FRE | D | |||||||
| 91566 | FRESUBIN VANILLEGESCHMACK | sol 12x500ml | FRE | D | |||||||
| 91567 | FRESUBIN VANILLEGESCHMACK | sol 1x500ml | FRE | D | |||||||
| 509 | V06DB | kombinace tuk/sacharidy/proteiny/minerály/vitamíny | p.o. | H | |||||||
| 509.1 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100 | GM | 45,90 | H | ||||
| 98325 | ISOCAL | plv 1x425gm | MJO | NL | |||||||
| 61454 | NUTRISON | plv 1x430gm | NUT | NL | |||||||
| 75153 | FANTOMALT | plv 1x400gm | NUT | NL | |||||||
| 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 81,20 | H | ||||
| 510 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | L/J7 | |||||||
| 510.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5 | DF | 106,90 | L/J7 | ||||
| 88115 | KETOSTERIL | tbl obd 100 | FRE | D | |||||||
| 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny | p.o. | L/J11 | |||||||
| 511.1 | V06DE | náhrady mléka obsahující bílkovinu kravského mléka | p.o. | 100 | GM | 27,50 | L/J11 | ||||
| 72883 | ENFALAC PRAEMATURE FORMULA | plv 1x400gm | BMS | USA | |||||||
| 511.2 | V06DE | náhrady mléka obsahující bílkovinu kravského mléka, s nízkým obsahem laktózy | p.o. | 100 | GM | 33,80 | L/J11 | ||||
| 61450 | NUTRILON LOW-LACTOSE | plv 1x400gm | NUT | NL | |||||||
| 511.3 | V06DE | náhrady mléka obsahující proteinové hydrolyzáty | p.o. | 100 | GM | 30,00 | L/J11 | ||||
| 511.4 | V06DE | náhrady mléka obsahující proteinové hydrolyzáty, s nízkým obsahem laktózy | p.o. | 100 | GM | 65,00 | L/J11 | ||||
| 512 | V06DF | náhrady mléka obsahující sojovou bílkovinu | p.o. | L/J11 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 512.1 | V06D | náhrady mléka obsahující sojovou bílkovinu | p.o. | 100 | GM | 28,60 | L/J11 | ||||
| 75946 | ISOMIL | plv 1x400gm | ABB | USA | |||||||
| 513 | V06DX | jiné kombinace přípravků pro výživu | p.o. | L/J11 | |||||||
| 513.1 | V06DX | MCT olej | p.o. | 100 | ML | 105,50 | L/J11 | ||||
| 95198 | MCT OIL | sol 1x946ml | BMS | USA | |||||||
| 514 | V07AB | rozpouštědla a ředidla, včetně irigačních roztoků | parent. | ||||||||
| 514.1 | V07AB | voda na injekci (do 2 ml v jedné ampuli včetně) | parent. | 1 | ML | 2,95 | |||||
| 00383 | AQUA PRO INJECTIONE BIOTIKA | inj 10x2ml | BTA | SK | |||||||
| 514.2 | V07AB | voda na injekci (nad 2 do 10 ml v jedné ampuli včetně) | parent. | 10 | ML | 3,80 | |||||
| 00387 | AQUA PRO INJECTIONE BIOTIKA | inj 10x10ml | BTA | SK | |||||||
| 00388 | AQUA PRO INJECTIONE BIOTIKA | inj 50x10ml | BTA | SK | |||||||
| 55807 | AQUA PRO INJECTIONE BIOTIKA | inj 100x10ml | BTA | SK | |||||||
| 83699 | WATER FOR INJECTION B.P.CORE | inj 50x5ml | CPL | IND | |||||||
| 83700 | WATER FOR INJECTION B.P.CORE | inj 50x10ml | CPL | IND | |||||||
| 514.3 | V07AB | voda na injekci nad 10 ml v jedné ampuli nebo lahvi | parent. | 100 | ML | 12,45 | |||||
| 00657 | AQUA PRO INJECTIONE IMUNA | inf 1x400ml | IMA | SK | |||||||
| 66642 | AQUA PRO INJECTIONE CIV | sol 1x500ml | CIV | CZ | |||||||
| 67802 | AQUA PRO INJECTIONE IMUNA | inf 1x500ml | IMA | SK | |||||||
| 69789 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x500ml | ARD | CZ | |||||||
| 70528 | AQUA PRO INJECTIONE MEDICAMENTA | inf 1x500ml | MVM | CZ | |||||||
| 89245 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x400ml | ARD | CZ | |||||||
| 91876 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | |||||||
| 92782 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x1000ml (vak) | MKS | CZ | |||||||
| 92783 | AQUA PRO INJECTIONE MEDIEKOS | sol 1x2000ml (vak) | MKS | CZ | |||||||
| 53364 | AQUA PRO INJECTIONE INFUSIA | sol 1x500ml | IHO | CZ | |||||||
| 53363 | AQUA PRO INJECTIONE INFUSIA | sol 1x250ml | IHO | CZ | |||||||
| 97727 | WATER FOR INJECTION BIEFFE | inf 1x500ml(sklo) | BFF | I | |||||||
| 97726 | WATER FOR INJECTION BIEFFE | inf 1x250ml(sklo) | BFF | I | |||||||
| 69788 | AQUA PRO INJECTIONE ARDEAPHARMA | inf 1x300ml | ARD | CZ | |||||||
| 515 | V08A | rozpustné nefrotropní RTG kontrastní látky | p.o. | K | |||||
|---|---|---|---|---|---|---|---|---|---|
| 515.1 | V08AA05 | kyselina ioxitalamová | p.o. | 10 | ML | 60,55 | K | ||
| 93497 | TELEBRIX GASTRO | sol 1x100ml | BGL | D | |||||
| 515.2 | V08AB04 | iopamidol | p.o. | 10 | ML | 60,55 | K | ||
| 516 | V08AA | rozpustné nefrotropní hyperosmolární RTG kontrastní látky | parent. | K | |||||
| 516.1 | V08A | meglumin amidotrizoát | parent. | 10 | ML | 75,20 | K | ||
| 516.2 | V08AA03 | iodamid (koncentrace 300 mg I/ml) | parent. | 10 | ML | 42,00 | K | ||
| 516.3 | V08AA03 | iodamid (koncentrace 380 mg I/ml) | parent. | 10 | ML | 46,00 | K | ||
| 516.4 | V08AA03 | iodamid (koncentrace 410 mg I/ml) | parent. | 10 | ML | 89,40 | K | ||
| 516.5 | V08AA05 | kyselina ioxitalamová (koncentrace 300 mg I/ml) | parent. | 10 | ML | 51,85 | K | ||
| 92348 | TELEBRIX N 300 | inj 6x20ml | LEX | CZ | |||||
| 516.6 | V08AA05 | kyselina ioxitalamová (koncentrace 350 mg I/ml a více) | parent. | 10 | ML | 60,00 | K | ||
| 92349 | TELEBRIX N 350 | inj 6x20ml | LEX | CZ | |||||
| 92350 | TELEBRIX N 380 | inj 6x20ml | LEX | CZ | |||||
| 517 | V08AB | rozpustné nefrotropní nízkoosmolání RTG kontrastní látky | parent. | K | |||||
| Vyšetření iotrolanem ordinuje rentgenolog: a) pro intrathekální podání, b) v ostatních případech po předchozím schválení revizním lékařem. | |||||||||
| 517.1 | V08AB02 | iohexol (koncentrace 180 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 248,85 | K | ||
| 87801 | OMNIPAQUE 180 | inj 10x10ml | NYI | N | |||||
| 87802 | OMNIPAQUE 180 | inj 10x15ml | NYI | N | |||||
| 517.2 | V08AB02 | iohexol (koncentrace 240 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 214,70 | K | ||
| 04337 | OMNIPAQUE 240 | inj 25x20ml | NYI | N | |||||
| 87602 | OMNIPAQUE 240 | inj 6x20ml | NYI | N | |||||
| 517.3 | V08AB02 | iohexol (koncentrace 240 mg I/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 297,30 | K | ||
| 94219 | OMNIPAQUE 240 | inj 10x10ml | NYI | N | |||||
| 517.4 | V08AB02 | iohexol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,15 | K | ||
| 04338 | OMNIPAQUE 240 | inj 10x50ml | NYI | N | |||||
| 04339 | OMNIPAQUE 240 | inj 6x200ml | NYI | N | |||||
| 517.5 | V08AB02 | iohexol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K |
| 04328 | OMNIPAQUE 300 | inj 6x20ml | NYI | N | |||
| 04329 | OMNIPAQUE 300 | inj 25x20ml | NYI | N | |||
| 517.6 | V08AB02 | iohexol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 345,60 | K |
| 94220 | OMNIPAQUE 300 | inj 10x10ml | NYI | N | |||
| 517.7 | V08AB02 | iohexol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 04330 | OMNIPAQUE 300 | inj 10x50ml (sklo) | NYI | N | |||
| 62466 | OMNIPAQUE 300 | inj 10x50ml (pp) | NYI | N | |||
| 87600 | OMNIPAQUE 300 | inj 10x100ml | NYI | N | |||
| 517.8 | V08AB02 | iohexol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 278,85 | K |
| 04332 | OMNIPAQUE 350 | inj 6x20ml | NYI | N | |||
| 04333 | OMNIPAQUE 350 | inj 25x20ml | NYI | N | |||
| 517.9 | V08AB02 | iohexol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K |
| 87603 | OMNIPAQUE 350 | inj 10x50ml (sklo) | NYI | N | |||
| 62467 | OMNIPAQUE 350 | inj 10x50ml (pp) | NYI | N | |||
| 04335 | OMNIPAQUE 350 | inj 10x100ml | NYI | N | |||
| 75261 | OMNIPAQUE 350 | inj 6x200ml | NYI | N | |||
| 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 255,10 | K |
| 88645 | HEXABRIX 320(HEXABRIX 85) | inj 20ml | BGL | D | |||
| 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 201,25 | K |
| 517.12 | V08AB04 | iopamidol (koncentrace 200 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 261,15 | K |
| 517.13 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 322,80 | K |
| 517.14 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 200,20 | K |
| 97773 | IOPAMIRO 300 | inj 10x30ml | BCC | I | |||
| 517.15 | V08AB04 | iopamidol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 182,70 | K |
| 517.16 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 394,10 | K |
| 517.17 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, od 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 242,20 | K |
| 517.18 | V08AB04 | iopamidol (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 195,00 | K |
| 517.19 | V08AB05 | iopromid (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 110 | ML | 165,15 | K |
| 77015 | ULTRAVIST-240 | inj 10x50ml | SAG | D | |||
| 93623 | ULTRAVIST-240 | inj 1x50ml | SAG | D | |||
| 517.20 | V08AB05 | iopromid (koncentrace 300 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K |
| 77024 | ULTRAVIST-300 | inj 10x20ml | SAG | D | |||
| 517.21 | V08AB05 | iopromid (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 77017 | ULTRAVIST-300 | inj 10x100ml | SAG | D | |||
| 77016 | ULTRAVIST-300 | inj 10x50ml | SAG | D | |||
| 93627 | ULTRAVIST-300 | inj 1x50ml | SAG | D | |||
| 93628 | ULTRAVIST-300 | inj 1x100ml | SAG | D | |||
| 517.22 | V08AB05 | iopromid (koncentrace 370 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 223,30 | K |
| 77019 | ULTRAVIST-370 | inj 10x100ml | SAG | D | |||
| 77020 | ULTRAVIST-370 | inj 10x200ml | SAG | D | |||
| 77018 | ULTRAVIST-370 | inj 10x50ml | SAG | D | |||
| 93625 | ULTRAVIST-370 | inj 1x100ml | SAG | D | |||
| 93626 | ULTRAVIST-370 | inj 1x200ml | SAG | D | |||
| 93624 | ULTRAVIST-370 | inj 1x50ml | SAG | D | |||
| 517.23 | V08AB06 | iotrolan (koncentrace 240 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 462,70 | K/P |
| 96349 | ISOVIST 240 | inj 1x10ml 240mg/ml | SAG | D | |||
| 517.24 | V08AB06 | iotrolan (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 575,30 | K/P |
| 96351 | ISOVIST 300 | inj 1x10ml 300mg/ml | SAG | D | |||
| 517.25 | V08AB07 | ioversol (koncentrace 160 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 128,65 | K |
| 68772 | OPTIRAY 160 | inj 10x50ml | MME | D | |||
| 517.26 | V08AB07 | ioversol (koncentrace 240 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 165,15 | K |
| 68922 | OPTIRAY 240 | inj 10x100ml | MME | D | |||
| 98298 | OPTIRAX 240 | inj 10x50ml | MME | D | |||
| 517.27 | V08AB07 | ioversol (koncentrace 300 mg I/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 345,60 | K |
| 92365 | OPTIRAY 300 | inj 10x10ml | MME | D | |||
| 517.28 | V08AB07 | ioversol (koncentrace 300 mg I/ml, od 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 249,60 | K |
| 68923 | OPTIRAY 300 | inj 10x20ml | MME | D | |||
| 517.29 | V08AB07 | ioversol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 68850 | OPTIRAY 300 | inj 10x50ml | MME | D | |||
| 92366 | OPTIRAY 300 | inj 10x75ml | MME | D | |||
| 92368 | OPTIRAY 300 | inj 10x150ml | MME | D | |||
| 92369 | OPTIRAY 300 | inj 10x200ml | MME | D | |||
| 92367 | OPTIRAY 300 | inj 10x100ml | MME | D | |||
| 517.30 | V08AB07 | ioversol (koncentrace 320 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 201,25 | K |
| 68773 | OPTIRAY 320 | inj 10x50ml | MME | D | |||
| 517.31 | V08AB07 | ioversol (koncentrace 350 mg I/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 278,85 | K |
| 92370 | OPTIRAY 350 | inj 10x30ml | MME | D | |||
| 517.32 | V08AB07 | ioversol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K |
| 68925 | OPTIRAY 350 | inj 10x100ml | MME | D | |||
| 92371 | OPTIRAY 350 | inj 10x200ml | MME | D | |||
| 68851 | OPTIRAY 350 | inj 10x50ml | MME | D | |||
| 517.33 | V08AB10 | iomeprol (koncentrace 150 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 124,80 | K |
| 517.34 | V08AB10 | |iomeprol (koncentrace 200 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 147,65 | K |
| 517.35 | V08AB10 | |iomeprol (koncentrace 250 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 169,55 | K |
| 517.36 | V08AB10 | |iomeprol (koncentrace 300 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 249,601 | K |
| 517.37 | V08AB10 | |iomeprol (koncentrace 300 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 192,00 | K |
| 517.38 | V08AB10 | |iomeprol (koncentrace 350 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 278,851 | K |
| 517.39 | V08AB10 | |iomeprol (koncentrace 350 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 214,50 | K |
| 517.40 | V08AB10 | |iomeprol (koncentrace 400 mg I/ml, do 30 ml v ampuli) | parent. | 10 | ML | 307,801 | K |
| 517.41 | V08AB10 | iomeprol (koncentrace 400 mg I/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 236,75 | K |
| 517.42 | V08AB9 | iodixanol (koncentrace 150 mg I/ml, nad 50 ml v jedné ampuli) | parent. | 10 | ML | 128,65 | K |
| 517.43 | V08AB9 | iodixanol (koncentrace 270mg I/ml, do 30 ml v jedné ampuli) | parent | 10 | ML | 249,60 | K |
| 517.44 | V08AB9 | iodixanol (koncentrace 270mg I/ml, nad 50 ml v jedné ampuli) | parent | 10 | ML | 192,00 | K |
| 517.45 | V08AB9 | iodixanol (koncentrace 320mg I/ml, do 30 ml v jedné ampuli) | parent | 10 | ML | 278,85 | K |
| 517.46 | V08AB9 | iodixanol (koncentrace 320mg I/ml, nad 50 ml v jedné ampuli) | parent | 10 | ML | 214,50 | K |
| 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K | |||
|---|---|---|---|---|---|---|---|
| 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg I/ml) | parent | 10 | ML | 75,95 | K |
| 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg I/ml) | parent | 10 | ML | 38,25 | K |
| 518.3 | V08AC04 | adipiodon | parent | 10 | ML | 40,25 | K |
| 03394 | ENDOBIL PRO INF. I. V. | inf 100ml | BCC | I | |||
| 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | ||||
|---|---|---|---|---|---|---|---|---|
| 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 307,60 | K | |
| 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 473,15 | K | |
| 03552 | LIPIODOL ULTRA-FLUID | inj 5x5ml | BGL | D | ||||
| 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | ||||
| 520.1 | V08BA | síran barnatý | p.o. | 100 | GM | 34,05 | K | |
| 06303 | MICROPAQUE | sus 1x2000ml | GUE | D | ||||
| 94370 | PRONTOBARIO 60% | sus 1x5lt | BCC | I | ||||
| 520.2 | V08BA | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 165,55 | K | |
| 44367 | MICROPAQUE CT | sus 1x2000ml/100gm | GUE | D | ||||
| 520.3 | V08BA | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 46,80 | K | |
| 91066 | MICROPAQUE COLON | plv 1x800gm | GUE | D | ||||
| 520.4 | V08BA | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 96,75 | K | |
| 62535 | PRONTOBARIO ESOFAGO | sus 6x250ml (tuba) | BCC | I | ||||
| 520.5 | V08BA | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,95 | K | |
| 06304 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUE | D | ||||
| 521 | V08CA | paramagnetické kontrastní látky | parent. | K | ||||
| 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | |
| 75660 | MAGNEVIST | inj 1x10ml | SAG | D | ||||
| 75659 | MAGNEVIST | inj 1x5ml | SAG | D | ||||
| 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | |
| 96352 | MAGNEVIST | inj 1x20ml | SAG | D | ||||
| 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 2024,00 | K | |
| 55822 | OMNISCAN 0.5MMOL/ML | inj 10x5ml | NYI | N | ||||
| 78815 | OMNISCAN 0.5MMOL/ML | inj 10x10ml | NYI | N | ||||
| 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1882,35 | K | |
| 78816 | OMNISCAN 0.5MMOL/ML | inj 10x15ml | NYI | N | ||||
| 78817 | OMNISCAN 0.5MMOL/ML | inj 10x20ml | NYI | N | ||||
Čl. II
Tato vyhláška nabývá účinnosti dnem 1. července 1998.
Ministryně:
MUDr. Roithová, MBA v. r.